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A B S T R A C T
Background
The mean age of women undergoing local treatment for pre-invasive cervical disease (cervical intra-epithelial neoplasia; CIN) or early
cervical cancer (stage IA1) is around their 30s and similar to the age of women having their first child. Local cervical treatment has been
correlated to adverse reproductive morbidity in a subsequent pregnancy, however, published studies and meta-analyses have reached
contradictory conclusions.
Objectives
To assess the effect of local cervical treatment for CIN and early cervical cancer on obstetric outcomes (after 24 weeks of gestation) and
to correlate these to the cone depth and comparison group used.
Search methods
We searched the following databases: Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library, 2017, Issue
5), MEDLINE (up to June week 4, 2017) and Embase (up to week 26, 2017). In an attempt to identify articles missed by the search
or unpublished data, we contacted experts in the field and we handsearched the references of the retrieved articles and conference
proceedings.
Selection criteria
We included all studies reporting on obstetric outcomes (more than 24 weeks of gestation) in women with or without a previous local
cervical treatment for any grade of CIN or early cervical cancer (stage IA1). Treatment included both excisional and ablative methods.
We excluded studies that had no untreated reference population, reported outcomes in women who had undergone treatment during
pregnancy or had a high-risk treated or comparison group, or both
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Data collection and analysis
We classified studies according to the type of treatment and the obstetric endpoint. Studies were classified according to method and
obstetric endpoint. Pooled risk ratios (RR) and 95% confidence intervals (CIs) were calculated using a random-effects model and inverse
variance. Inter-study heterogeneity was assessed with I2 statistics. We assessed maternal outcomes that included preterm birth (PTB)
(spontaneous and threatened), preterm premature rupture of the membranes (pPROM), chorioamnionitis, mode of delivery, length
of labour, induction of delivery, oxytocin use, haemorrhage, analgesia, cervical cerclage and cervical stenosis. The neonatal outcomes
included low birth weight (LBW), neonatal intensive care unit (NICU) admission, stillbirth, perinatal mortality and Apgar scores.
Main results
We included 69 studies (6,357,823 pregnancies: 65,098 pregnancies of treated and 6,292,725 pregnancies of untreated women). Many
of the studies included only small numbers of women, were of heterogenous design and in their majority retrospective and therefore at
high risk of bias. Many outcomes were assessed to be of low or very low quality (GRADE assessment) and therefore results should be
interpreted with caution. Women who had treatment were at increased overall risk of preterm birth (PTB) (less than 37 weeks) (10.7%
versus 5.4%, RR 1.75, 95% CI 1.57 to 1.96, 59 studies, 5,242,917 participants, very low quality), severe (less than 32 to 34 weeks)
(3.5% versus 1.4%, RR 2.25, 95% CI 1.79 to 2.82), 24 studies, 3,793,874 participants, very low quality), and extreme prematurity
(less than 28 to 30 weeks) (1.0% versus 0.3%, (RR 2.23, 95% CI 1.55 to 3.22, 8 studies, 3,910,629 participants, very low quality), as
compared to women who had no treatment.
The risk of overall prematurity was higher for excisional (excision versus no treatment: 11.2% versus 5.5%, RR 1.87, 95% CI 1.64 to
2.12, 53 studies, 4,599,416 participants) than ablative (ablation versus no treatment: 7.7% versus 4.6%, RR 1.35, 95% CI 1.20 to
1.52, 14 studies, 602,370 participants) treatments and the effect was higher for more radical excisional techniques (less than 37 weeks:
cold knife conisation (CKC) (RR 2.70, 95% CI 2.14 to 3.40, 12 studies, 39,102 participants), laser conisation (LC) (RR 2.11, 95% CI
1.26 to 3.54, 9 studies, 1509 participants), large loop excision of the transformation zone (LLETZ) (RR 1.58, 95% CI 1.37 to 1.81, 25
studies, 1,445,104 participants). Repeat treatment multiplied the risk of overall prematurity (repeat versus no treatment: 13.2% versus
4.1%, RR 3.78, 95% CI 2.65 to 5.39, 11 studies, 1,317,284 participants, very low quality). The risk of overall prematurity increased
with increasing cone depth (less than 10 mm to 12 mm versus no treatment: 7.1% versus 3.4%, RR 1.54, 95% CI 1.09 to 2.18, 8
studies, 550,929 participants, very low quality; more than 10 mm to 12 mm versus no treatment: 9.8% versus 3.4%, RR 1.93, 95% CI
1.62 to 2.31, 8 studies, 552,711 participants, low quality; more than 15 mm to 17 mm versus no treatment: 10.1 versus 3.4%, RR 2.77,
95% CI 1.95 to 3.93, 4 studies, 544,986 participants, very low quality; 20 mm or more versus no treatment: 10.2% versus 3.4%, RR
4.91, 95% CI 2.06 to 11.68, 3 studies, 543,750 participants, very low quality). The comparison group affected the magnitude of effect
that was higher for external, followed by internal comparators and ultimately women with disease, but no treatment. Untreated women
with disease and the pre-treatment pregnancies of the women who were treated subsequently had higher risk of overall prematurity
than the general population (5.9% versus 5.6%, RR 1.24, 95% CI 1.14 to 1.34, 15 studies, 4,357,998 participants, very low quality).
pPROM (6.1% versus 3.4%, RR 2.36, 95% CI 1.76 to 3.17, 21 studies, 477,011 participants, very low quality), low birth weight
(7.9% versus 3.7%, RR 1.81, 95% CI 1.58 to 2.07, 30 studies, 1,348,206 participants, very low quality), NICU admission rate (12.6%
versus 8.9%, RR 1.45, 95% CI 1.16 to 1.81, 8 studies, 2557 participants, low quality) and perinatal mortality (0.9% versus 0.7%, RR
1.51, 95% CI 1.13 to 2.03, 23 studies, 1,659,433 participants, low quality) were also increased after treatment.
Authors’ conclusions
Women with CIN have a higher baseline risk for prematurity. Excisional and ablative treatment appears to further increases that risk.
The frequency and severity of adverse sequelae increases with increasing cone depth and is higher for excision than it is for ablation.
However, the results should be interpretedwith caution as theywere based on low or very low quality (GRADE assessment) observational
studies, most of which were retrospective.
P L A I N L A N G U A G E S U M M A R Y
Obstetric outcomes after conservative treatment for cervical intraepithelial lesions
The issue
Cervical intra-epithelial neoplasia (CIN) is a pre-cancerous lesion of the cervix uteri (neck of the womb) caused by human papillomavirus
(HPV), which may develop into cervical cancer, if not treated. Local treatment involves destroying or removing the abnormal area of
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the cervix, leaving most of the cervix, and the uterus in place maintaining the ability to become pregnant in the future, if desired.
Certain types of local treatment may also be suitable for very early cervical cancer (stage IA1) if the tumour is very small and very
unlikely to have spread beyond the cervix. There are many studies investigating whether the local treatment for CIN and early cervical
cancer increases the risk of preterm birth (PTB) in subsequent pregnancies. However, there is no definite conclusion and this creates
confusion for both the medical staff and women who may be recommended treatment, but also want to have children in the future.
The aim of the review
We aimed to assess whether the local conservative treatment techniques for cervical precancer (CIN) and early cervical cancer increased
the risk of complications for mother and baby during pregnancy occurring after treatment, and especially whether treatment is associated
with an increase in the risk of PTB.We also studied whether the risk of PTB increases with increasing amount of cervical tissue removed.
Selection criteria
We included all studies that investigated the effect of treatment of CIN and early cervical cancer on late pregnancy outcomes (beyond
24 weeks of gestation) in women who had been treated previously for CIN and early cervical cancer, as compared to women who had
not been treated. We excluded studies that had no untreated comparison group, reported pregnancy outcomes in women who had
undergone treatment during pregnancy, or had a high-risk treated, comparison group or both.
What are the main findings?
We included 69 studies (6,357,823 pregnancies: 65,098 pregnancies of treated and 6,292,725 pregnancies of untreated women).
Treatment was associated with an increased risk of PTB before 37 pregnancy weeks, as well as an increased risk of severe PTB (less
than 32 to 34 pregnancy weeks), extreme PTB (less than 28 to 30 pregnancy weeks) and pPROM (premature preterm rupture of the
membranes) as compared to untreated women. The risk of overall PTB was higher for women treated by excisional methods (where
tissue is cut away) than by ablative treatments (where tissue is destroyed instead of being cut away). Multiple treatments, as well as
increasing amounts of tissue removed at the time of treatment, were associated with an increased risk of overall PTB. However, women
with CIN who were not treated also had a higher risk of overall PTB than the general population. Low birth weight (LBW) < 2500g),
neonatal intensive care unit (NICU) admission and perinatal mortality rates were also found to be increased after treatment.
What is the quality of the evidence?
Due to the nature of the intervention and outcomes studied, we were only able to include observational studies, of which the majority
were retrospective. These types of studies are of low quality with a high level of variability between the studies, therefore the level of
evidence for most outcomes can only be considered to be of low or very low quality.
What are the conclusions?
Women with CIN have a higher baseline risk for PTB than the general population and the treatment for CIN probably increase this
risk further. The risk for PTB is probably higher when excisional techniques are used than for ablative treatments. Also, the risk of PTB
appears to increase with multiple treatments and increasing amounts of tissue removed. However, these results should be interpreted
with caution due to the low and very low quality of the included studies.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
The ef fect of treatment for CIN on maternal outcomes
Patient or population: women with known obstetric outcomes
Setting: hospitals/ clinics
Intervention: t reatment for CIN before pregnancy
Comparison: women with no treatment
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with [comparison] Risk with [intervention]
PTB (< 37 w) Study populat ion RR 1.75
(1.57 to 1.96)
5,242,917
(59 observat ional stud-
ies)
⊕©©©
VERY LOW 1
54 per 1000 95 per 1000
(85 to 106)
PTB (< 32 to 34 w) Study populat ion RR 2.25
(1.79 to 2.82)
3,793,874
(24 observat ional stud-
ies)
⊕©©©
VERY LOW 2
14 per 1000 32 per 1000
(26 to 40)
PTB (< 28 to 30 w) Study populat ion RR 2.23
(1.55 to 3.22)
3,910,629
(8 observat ional stud-
ies)
⊕©©©
VERY LOW 3
3 per 1000 7 per 1000
(5 to 11)
PTB (< 37 w) - Repeat
cones versus No Treat-
ment
Study populat ion RR 3.78
(2.65 to 5.39)
1,317,284
(11 observat ional stud-
ies)
⊕©©©
VERY LOW 4
41 per 1000 156 per 1000
(109 to 222)
pPROM (<3 7 w) Study populat ion RR 2.36
(1.76 to 3.17)
477,011
(21 observat ional stud-
ies)
⊕©©©
VERY LOW 5
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34 per 1000 80 per 1000
(60 to 108)
PTB (< 37 w) - Depth ≤
10 mm to 12 mm versus
No Treatment
Study populat ion RR 1.54
(1.09 to 2.18)
550,929
(8 observat ional stud-
ies)
⊕©©©
VERY LOW 6
34 per 1000 53 per 1000
(37 to 75)
PTB (< 37 w) - PTB (< 37
w) - Depth ≥10 mm to
12 mm versus No Treat-
ment
Study populat ion RR 1.93
(1.62 to 2.31)
552,711
(8 observat ional stud-
ies)
⊕⊕⊕©
LOW 7
34 per 1000 66 per 1000
(55 to 79)
PTB (< 37w) - PTB
(<37w) - Depth ≥15 to
17mm versus No Treat-
ment
Study populat ion RR 2.77
(1.95 to 3.93)
544,986
(4 observat ional stud-
ies)
⊕⊕⊕⊕
VERY LOW 8
34 per 1000 94 per 1000
(66 to 134)
PTB (< 37 w) - PTB (<
37 w) - Depth ≥ 20 mm
versus No Treatment
Study populat ion RR 4.91
(2.06 to 11.68)
543,750
(3 observat ional stud-
ies)
⊕⊕⊕⊕
VERY LOW 9
34 per 1000 167 per 1000
(70 to 397)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Low-quality evidence (based on observat ional studies only) is downgraded one level because of considerable heterogeneity
(I2 90%)
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2 Low-quality evidence (based on observat ional studies only) is downgraded one level because of considerable heterogeneity
(I2 83%) and suspected publicat ion bias
3 Low-quality evidence (based on observat ional studies only) is downgraded one level because of considerable heterogeneity
(I2 84%)
4 Low-quality evidence (based on observat ional studies only) is downgraded one level because of considerable heterogeneity
(I2 75%)
5 Low-quality evidence (based on observat ional studies only) is downgraded one level because of considerable heterogeneity
(I2 79%)
6 Low-quality evidence (based on observat ional studies only) is downgraded one level because of substant ial heterogeneity (I
2 67%)
7 Low-quality evidence (based on observat ional studies only); heterogeneity was low (I2 37%)
8 Low-quality evidence (based on observat ional studies only) is downgraded one level because of moderate heterogeneity (I2
53%)
9 Low-quality evidence (based on observat ional studies only) is downgraded one level because of considerable heterogeneity
(I2 77%)
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B A C K G R O U N D
Description of the condition
Cervical cancer remains the commonest gynaecological malig-
nancy worldwide, and accounts for 7.5% of female cancer deaths.
Over half a million new cases are diagnosed each year around the
world, with the vast majority occurring in the developing world,
where a woman’s risk of cervical cancer by age 74 is almost double
that in the developedworld (1.6%versus 0.9%) (Ferlay 2015).The
introduction of cervical screening programmes over the last 20
years has produced a profound decrease in the incidence and mor-
tality from cervical cancer (Arbyn 2009; Quinn 1999). This is due
to the treatment of pre-invasive lesions, cervical intra-epithelial
neoplasia (CIN), detected by screening (IARC 2005).
CIN is an abnormality in the squamous cells of the cervix and,
if left untreated, cervical cancer may develop. The condition is
asymptomatic and interventions are usually performed only on
women with higher grade CIN of grade (CIN 2 or 3). This is
because cervical treatment has been correlated with adverse ob-
stetric sequelae (Kyrgiou 2006), while many of the low-grade le-
sions (also known as LSIL, low-grade squamous intra-epithelial le-
sions or CIN 1) resolve spontaneously in young individuals (NHS
Cervical Screening Programme 2016).
The average age of a woman diagnosed and treated for CIN is be-
tween 25 and 30 years of age, although itmay occur inwomen con-
siderably younger (NHS Cervical Screening Programme 2016).
As the pre-cancerous lesions typically occur in young women of
reproductive age, the impact of their treatment on the outcomes
of subsequent pregnancies has been an area of active research for
the past decade. Whilst it is paramount that effective treatment is
undertaken, it is also important that this treatment has minimal
adverse effects on future fertility and pregnancy outcomes for this
young female population.
Description of the intervention
The conservative methods for treatment of CIN are classified into
excisional and ablative. These techniques remove or destroy the
transformation zone (TZ) containing the abnormal cells whilst
preserving cervical function. Excisional methods include cold
knife conisation (CKC), laser conisation (LC), needle excision of
the transformation zone (NETZ), also known as straight wire ex-
cision of the transformation zone (SWETZ), large loop excision
of the transformation zone (LLETZ) (Kitchener 1995; Prendiville
1989), also known as loop electrosurgical excisional procedure
(LEEP) and Fischer cone biopsy excisor (FCBE). Ablative meth-
ods include laser ablation (LA), radical diathermy (RD), cold co-
agulation (CC) and cryotherapy (CT).
The mean age of women undergoing treatment for pre-invasive
cervical disease is around their 30s and similar to the age of women
having their first child (Herbert 2000; Paraskevaidis 1992). Lo-
cal cervical treatment has been correlated with an increased risk
of preterm birth, perinatal morbidity and mortality in a subse-
quent pregnancy (Albrechtsen 2008; Arbyn2008; Bruinsma 2011;
Kyrgiou 2006; Kyrgiou 2014; Noehr 2009a). The underlying
mechanism is unclear; hypotheses include immunomodulation re-
lating to human papillomavirus (HPV) infection affecting partu-
rition pathways, unexplained confounders in women with CIN
and acquired ‘mechanical weakness’ secondary to loss of cervical
tissue (Kyrgiou 2012).
In England alone in 2013 to 2014, 3.6 million women
aged between 25 and 64 years attended for cervical screen-
ing and over 23,800 cervical procedures were carried out (
CervicalCancerScreening 2015), the vastmajority in an outpatient
setting. In contrast in the USA, there are approximately 400,000
cases of pre-invasive disease per year (Henk 2010). The regulations
in colposcopy are more liberal than in the UK leading to wide
variation in clinical practice. In Germany, treatment for CIN is
still commonly performed with the cold knife under general anal-
gesia (Petry 2008). The long-term sequelae of treatment remains
therefore an important international issue to both healthcare pro-
fessionals and women, whatever the clinical setting.
How the intervention might work
The characteristics of the conservative methods of treatment are
well-described and established in the medical literature (Martin-
Hirsch 2013). LLETZ, LC and LA are usually performed under
local anaesthesia in an outpatient setting, while CKC requires gen-
eral anaesthesia and hospitalisation. Theoretically, the excisional
techniques (CKC, LC, NETZ, LLETZ, FCBE) are superior over
ablative techniques (LA, RD, CC, CT) as they allow a comprehen-
sive histological evaluation of the excised tissue and the whole TZ
with precise evaluation of excision margins. Ablative techniques
destroy the TZ epithelium and preclude histological evaluation
and, therefore, demand accurate pre-treatment biopsy at a separate
visit. LLETZ is the most favoured technique (Kitchener 1995),
by combining all the advantages of the excisional techniques men-
tioned above together with a relatively shorter duration, low cost,
good compliance, simplicity and easier learning curve for practi-
tioners.
The best available evidence suggests that thesemethods (CKC,LC,
LLETZ, LA) present similar low morbidity and are equally suc-
cessful, in terms of eradicating CIN (Martin-Hirsch 2013; Nuovo
2000) and in preventing invasive cervical cancer (Chew 1999;
Paraskevaidis 1991; Soutter 1997). However, the existing data re-
garding future fertility and pregnancy outcomes are conflicting.
Why it is important to do this review
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Observational studies have indicated that the treatment of CIN
could have detrimental effects on fertility and pregnancy outcome;
although the conclusions are usually equivocal, perhaps due to the
weakness associated with small sample sizes used in the studies.
We have not found any published randomised controlled trials
(RCTs) comparing pregnancy outcome between treated and un-
treated women in the literature and because of the pre-malignant
nature of the condition treated, it is perhaps unlikely that one will
be ever conducted. Thus, the only available level of evidence on
this subject may have to be provided by systematic reviews and
meta-analyses of observational studies.
Media publicity has heightened public awareness that treatment
for cervical precancer is associated with an increased reproductive
morbidity. There has been a substantial increase in enquiries from
patients and clinicians on the risks associated with different treat-
ment techniques and cone depths (Founta 2010; Kyrgiou 2015a),
and as to how this risk may be managed and prevented. With a
rapidly evolving evidence base and lack of a robust synthesis of
the published literature, these questions are becoming increasingly
difficult to answer.
Since the first systematic review of the reproductive risk associ-
ated with treatment almost a decade ago (Kyrgiou 2006), more
than 50 observational studies have been published confirming
(Jakobsson 2007; Ortoft 2010) or disputing these associations
(Castanon 2012; Reilly 2012); some of these reporting data from
large population-based datasets. Individual attempts to synthe-
sise parts of this rapidly evolving evidence base in small system-
atic reviews and meta-analyses reached contradictory conclusions
(Arbyn2008; Bruinsma 2011;Conner 2014;Crane 2003;Danhof
2015; Jin 2014; Kyrgiou 2006; Kyrgiou 2014;) and initiated de-
bates and confusionwithin the scientific community (Arbyn 2008;
Conner 2014; Crane 2003; Danhof 2015; Jin 2014). Whether
these discrepancies were due to questionable quality of some of
these primary and secondary studies or differences in the explored
comparisons (Bruinsma 2011; Conner 2014; Danhof 2015; Jin
2014), the subject is open to a definitive comprehensive high-qual-
ity synthesis of the existing evidence that will be highly informative
to women, clinicians and policy makers (Arbyn 2008; Bruinsma
2011; Conner 2014; Danhof 2015; Jin 2014; Kyrgiou 2014).
Because many large studies (Albrechtsen 2008; Bruinsma 2007;
Castanon 2012; Heinonen 2013; Jakobsson 2007; Jakobsson
2009; Noehr 2009a; Ortoft 2010; Reilly 2012; Shanbhag 2009)
have been published since Kyrgiou’s first meta-analysis (Kyrgiou
2006), we decided to update it in order to incorporate the latest
studies and pay attention especially to the effect of the comparison
group and the depth of the excised cone; two areas on which other
meta-analyses do not emphasise.
O B J E C T I V E S
To assess the effect of local cervical treatment for CIN and early
cervical cancer on obstetric outcomes (after 24 weeks of gestation)
and to correlate these to the cone depth and comparison group
used.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all studies reporting on late obstetric outcomes (be-
yond 24 weeks of gestation) in women with one or more previous
local cervical treatments for CIN or early invasive disease (stage
IA1), as compared to women without treatment. The interven-
tions included any type of conservative treatment, either excisional
or ablative (See:Types of interventions).
Studies were included irrespective of the type of untreated control
group, which could have been drawn from one of the following
sources: a) external group from general population that was mostly
matched or adjusted for confounders; b) internal group with self-
matching of the pregnancies for the same women before and af-
ter treatment; c) internal group with the pre-treatment and post-
treatment pregnancies of a given population; d) women attend-
ing colposcopy with or without CIN/biopsy but no treatment;
e) women with high-grade disease but no treatment (high-grade
squamous intra-epithelial lesion (HSIL)). As the studies are non-
randomised, the choice of comparison group can impact on the
magnitude of effect of the proposed comparisons. We know that
women with CINmay have demographic and behavioural charac-
teristics or even background immunological imbalances that place
them at higher baseline risk of adverse reproductive outcomes. The
different comparison groups have advantages and disadvantages
and subgroup analyses for the different groups will allow better
assessment of the true effects of treatment. More details are de-
scribed in Assessment of risk of bias in included studies.
We excluded studies that did not include an untreated control
group, compared different treatment techniques without an un-
treated control, reported on only fertility or early obstetric out-
comes (before 24 weeks of gestation), reported only on obstetric
outcomes beyond 24 weeks of gestation that are not listed below
(see: Types of outcome measures), compared outcomes for treat-
ments performed during pregnancy, or those that described out-
comes in high-risk women (i.e. women with history of miscarriage
or women conceiving through assisted reproductive technology
(ART))
Types of participants
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We included women who had a pregnancy with or without a pre-
vious conservative treatment for CIN/early cervical cancer (stage
IA1). We included women irrespective of the grade of the lesion
for both squamous and glandular intra-epithelial neoplasia. There
was also no age restriction.
Types of interventions
Any comparison of interventions for treatment of CIN or stage
IA1 cervical cancer by conservative methods of either:
• excision (cold knife conisation (CKC); laser conisation
(LC); needle excision of the transformation zone (NETZ), also
known as straight wire excision of the transformation zone
(SWETZ); large loop excision of the transformation zone
(LLETZ), also known as loop electrosurgical excisional
procedure (LEEP); Fischer cone biopsy excisor (FCBE));
• ablation (laser ablation (LA); radical diathermy (RD); cold
coagulation (CC); cryotherapy (CT)).
In studies that reported on the impact of several treatment tech-
niques, we extracted data for each specific method, where possible.
If the outcomes were not reported separately for each technique,
we analysed the intervention under broader terms, i.e. excisional
treatment not otherwise specified (NOS), ablative treatmentNOS
and treatment NOS.
Types of outcome measures
Primary outcomes
• Maternal outcomes
◦ overall (less than 37 weeks) prematurity (both
iatrogenic and spontaneous)
◦ severe (less than 32 to 34 weeks) prematurity
◦ extreme (less than 28 to 30 weeks) prematurity
◦ overall prematurity in singleton and multiple
pregnancies
◦ overall prematurity in nulliparous and parous women
◦ overall prematurity for single and multiple cones
◦ overall prematurity for different cone depths and
volumes
◦ overall prematurity for different comparison groups
Secondary outcomes
• Maternal outcomes
◦ overall spontaneous (i.e. non-iatrogenic) prematurity
◦ severe spontaneous prematurity
◦ extreme spontaneous prematurity
◦ threatened preterm birth
◦ premature rupture of the membranes
◦ chorioamnionitis
◦ mode of delivery (caesarean section, instrumental
deliveries)
◦ length of labour (precipitous, prolonged)
◦ induction of labour or use of oxytocin
◦ haemorrhage (antepartum, postpartum)
◦ analgesia (epidural, pethidine, not otherwise specified)
◦ cervical stenosis
◦ cervical cerclage
• Neonatal outcomes
◦ low birth weight (less than 2500 g, less than 2000 g,
less than 1500 g, less than 1000 g)
◦ admission to neonatal intensive unit (NICU)
◦ perinatal mortality
◦ stillbirth
◦ Apgar score
In cases of heterogeneity in the cut-offs used for cone depth and
prematurity classification, these were grouped together when pos-
sible (i.e. 32 to 34 weeks to include both cut-offs, 10 to 12 mm
cone depth to include studies grouping at both these cut-offs in-
cluding or not the values equal to these numbers).
Search methods for identification of studies
The literature searches started from 1948 when the conservative
methods of treatment for CIN were introduced into clinical prac-
tice and included references published up to June 2017.
Electronic searches
We searched the following electronic databases.
• Cochrane Central Register of Controlled Trials
(CENTRAL) (CENTRAL, 2017, Issue 5) (Appendix 1).
• MEDLINE (1948 to June week 4, 2017) (Appendix 2).
• Embase (1980 to 2017, week 26) (Appendix 3).
The searches started from inception to date in order to capture all
studies published since the late 1970s. The treatment techniques
used predominantly to manage the disease have changed over the
years, although there are still clinical indications for the oldest
techniques.
We used the ’related articles’ feature in MEDLINE to retrieve
additional references.
Searching other resources
We searched Metaregister, Physicians Data
Query, www.controlled-trials.com/rct, www.clinicaltrials.gov and
www.cancer.gov/clinicaltrials for ongoing studies. We contacted
the main investigators of any relevant ongoing trials for further
information.
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We searched conference proceedings and abstracts through ZE-
TOC (http://zetoc.mimas.ac.uk)) and WorldCat Dissertations.
We searched reports of conferences in the following sources.
• Annual Meeting of the British Society of Colposcopy and
Cervical Pathology.
• Annual Meeting of the International Federation of Cervical
Pathology and Colposcopy.
• Annual Meeting of European Federation of Colposcopy.
• Annual Meeding of the American Society of Colposcopy
and Cervical Pathology.
In an attempt to identify any articles missed by the initial search
or any unpublished data, we handsearched the references of the
retrieved articles andmeta-analyses and the proceedings of relevant
conferences. We contacted experts in the field, including directors
of UK cancer and colposcopy registries, to identify further reports
of studies.
We included both published and unpublished studies, if they met
the inclusion criteria for the review.
Data collection and analysis
Selection of studies
We downloaded all titles and abstracts retrieved by electronic
searches to the reference management database Endnote. We also
added titles and abstracts retrieved from other sources to End-
note. We removed duplicates and two review authors (MK, AA)
independently examined the remaining references. Titles and ab-
stracts retrieved from other sources were also added to the End-
Note database. We excluded those studies which clearly did not
meet the inclusion criteria and we obtained copies of the full text
of potentially relevant references. We assessed the eligibility of re-
trieved papers independently, compared the results and resolved
disagreements by discussion. If necessary, we reached consensus
with the involvement of a third review author (MA). We docu-
mented reasons for exclusion.
Data extraction and management
We classified the studies according to treatment modality (i.e.
CKC, LC, LLETZ, LA etc) and in groups of excisional or ablative
techniques.
From each study, we extracted data on the study design and setting,
the study population, the interventions examined, the comparison
group, the quality of the data and risk of bias and the outcomes
assessed. We retrieved from each study and outcome, the number
of events in treated and untreated women. If required, we con-
tacted authors to obtain additional data if the numbers provided
in the published report did not allow sufficient precision in the
data extraction.
More specifically, we extracted the following data.
• Author, year of publication, journal and language.
• Country.
• Setting where the study was conducted (hospital-based
versus population-based).
• Inclusion and exclusion criteria.
• Study design, methodology, source of information.
• Study population:
◦ total number enrolled and number included in each
group;
◦ grade of CIN;
◦ cone size;
◦ single/multiple pregnancy;
◦ single/multiple treatment;
◦ nulliparous/parous women;
◦ control for confounding factors:
⋄ age;
⋄ smoking;
⋄ parity;
⋄ socio-economic status;
⋄ race;
⋄ history of previous preterm birth (PTB);
⋄ others.
• Intervention details:
◦ type of procedure used (excisional or ablative);
◦ specific type of procedure used (excisional: CKC, LC,
NETZ, LLETZ, FCBE; ablative: LA, RD, CC, CT).
• Comparison group:
◦ external untreated comparison group (general
population);
◦ internal comparison group:
⋄ self-matching: the treated group consisted of only
parous women and the pregnancy after treatment was compared
to the pregnancy before treatment;
⋄ pre-treatment pregnancies: in some studies, the
treated group consisted of both nulliparous and parous women
and the comparison group consisted of the pregnancies of the
parous women before treatment.
◦ untreated women with colposcopy with or without a
biopsy who did not undergo treatment;
◦ untreated women with untreated high-grade disease.
• Risk of bias (Assessment of risk of bias in included studies).
• Outcomes reported in each study.
◦ Primary outcomes:
⋄ overall (less than 37 weeks) prematurity (both
iatrogenic and spontaneous);
⋄ severe (less than 32 to 34 weeks) prematurity;
⋄ extreme (less than 28 to 30 weeks) prematurity;
⋄ overall prematurity in singleton and multiple
pregnancies;
⋄ overall prematurity in nulliparous and parous
women;
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⋄ overall prematurity for single and multiple cones;
⋄ overall prematurity for different cone depths and
volumes;
⋄ overall prematurity for different comparison
groups.
◦ Secondary outcomes:
⋄ maternal outcomes: overall (less than 37 weeks)
spontaneous (i.e. non-iatrogenic) prematurity, severe (less than
32 to 34 weeks) spontaneous prematurity, extreme (less than 28
weeks) spontaneous prematurity, threatened preterm birth,
premature rupture of the membranes, chorioamnionitis, mode of
delivery (caesarean section, instrumental deliveries), length of
labour (precipitous, prolonged), induction of labour or use of
oxytocin, haemorrhage (antepartum, postpartum), analgesia
(epidural, pethidine, not otherwise specified), cervical stenosis,
cervical cerclage;
⋄ neonatal outcomes: low birth weight (LBW) (less
than 2500 g, less than 2000 g, less than 1500 g, less than 1000
g), perinatal mortality, stillbirth, Apgar score.
◦ For each reported outcome, we extracted information
on:
⋄ the outcome definition;
⋄ number of participants allocated to each group;
⋄ for the dichotomous outcomes of interest:
number of adverse pregnancy events in each group (treated and
untreated), in order to estimate the risk ratio (RR), and missing
participants.
Two review authors (MK, AA) abstracted data independently in
a data abstraction form specially designed for the review. They
resolved differences by discussion or by appeal to a third review
author (EP) if necessary.
Assessment of risk of bias in included studies
To assess the risk of bias in included RCTs, we planned to use
Cochrane’s’Risk of bias’ tool, comprising assessments of the fol-
lowing study characteristics: sequence generation; allocation con-
cealment; blinding (of participants, healthcare providers and out-
come assessors); incomplete outcome data; selective reporting of
outcomes; other possible sources of bias (Higgins 2011).
As RCTs comparing women with CIN with non-treated are not
feasible or ethical due to the pre-malignant nature of the condi-
tion, we anticipated that published evidence might rely only on
observational cohort studies. As the comparison groups (treated
for CIN with a particular procedure versus non-treated) are non-
randomised, effects and effect sizes cannot be attributed with cer-
tainty to the treatment alone. The differences in the size of the
treatment effect across studies may be partly explained by the
choice of control population, because women with CINmay have
demographic and behavioural characteristics or even background
immunological imbalances that place them at higher baseline risk
of adverse reproductive outcomes.
It should also be noted that all eligible comparison groups have ad-
vantages and limitations. A recent meta-analysis showed that the
use of historical external controls might produce inherent biases
that could inflate the contribution of cervical treatment to adverse
outcomes, even if the authors control for possible confounders
(such as age, parity, smoking etc; Bruinsma 2011). The use of
internal controls (pregnancies in the index woman before treat-
ment) is an attractive alternative approach, but even this might be
inadequate for confounders that are liable to change with time.
Women with mild precancerous lesions that do not warrant exci-
sion treatment probably provide the best, although still imperfect,
comparator. In contrast, those with high-grade disease who ne-
glect treatment advice aimed at preventing cancer may have high
risk for confounders related to low socioeconomic class that may
influence fertility or pregnancy outcomes.
For non-randomised studies (NRS), we assessed the risk of bias in
the following domains: Incomplete outcome Data (Attrition bias)
was considered to be present if for more than 20% of the cohort
the outcome data were missing or the method to collect outcome
data was not systematic; Selective reporting (Reporting bias) was
considered to be present if outcome data were not reported strat-
ified according to all included study types; Performance and se-
lection bias was assessed in whether the treatment assignment was
reported appropriately, based on the representativeness of both the
treatment and comparison groups, i.e. whether the treated cohort
indeed represented the population at risk and was not subjected
to possible selection bias, whether the comparison groups were
drawn from the same source as the treated group and on their com-
parability, i.e. whether the authors used internal or self-matched
comparison group, or otherwise matched or adjusted for the pos-
sible confounders or effect modifiers; no other possible sources of
bias were assessed.
Weused theGRADE (Grading ofRecommendations, Assessment,
Development and Evaluation) (GRADE Working Group 2004)
approach to assess the quality of evidence provided by the included
studies. We used GRADEpro (GRADE profiler) software to gen-
erate ’Summary of findings’ tables to include an assessment of the
more clinically relevant outcomes .
Measures of treatment effect
We calculated risk ratio (RR) and 95% confidence intervals (95%
CIs) for each adverse pregnancy outcome in the treated versus un-
treated women for dichotomous outcomes. We separated studies
by general type of treatment (excisional or ablative) and we fur-
ther grouped them by specific treatment procedure and by specific
comparison group. We used a random-effects model to pool RR
(Dersimonian 1986). We used unadjusted data for the analyses.
Unit of analysis issues
In studies with multiple treatment groups, we proportionally di-
vided the ‘shared’ comparison group into the number of treatment
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groups (i.e. based on the number of treated women for each tech-
nique), in order to avoid duplicate inclusion of some untreated
women in the same forest plot. We treated comparisons between
each treatment group and the split comparison group as indepen-
dent comparisons.
When more than one comparison group was described in the
included studies, the comparison groups were summed together if
appropriate (i.e. external, any CIN or HSIL without treatment).
If an external and internal self-matching group was available, only
data on the external group were included. In one study (Castanon
2012), with both internal controls, pre-conisation population was
used in preference to self-matching.
Dealing with missing data
We contacted study authors about inclusion/exclusion criteria and
eligibility of their study. We further contacted authors for addi-
tional data not presented in the original manuscript i.e. data ac-
cording to different cone depths.
Assessment of heterogeneity
We assessed inter-study heterogeneity with Cochran Q test
(Cochran 1954), by visual inspection of forest plots, by estimation
of the percentage heterogeneity between studies which cannot be
ascribed to sampling variation (I2 statistic) (Higgins 2003), and
by a formal statistical test of the significance of the heterogeneity
(Deeks 2001). If there was evidence of substantial heterogeneity,
we investigated and reported the possible reasons for this.
Assessment of reporting biases
For the outcomes presented in the ’Summary of findings’ tables
that included more than 10 studies, we explored potential publi-
cation bias graphically by the funnel plot in the Cochrane Review
Manager software (Review Manager 2104).
Data synthesis
We pooled the results of the studies in meta-analyses. For dichoto-
mous outcomes, we calculated RR and 95% CIs and these were
then pooled. We analysed the data separately for each treatment
modality, in groups of ablative and excisional techniques, and as a
whole, irrespective of the type of method used. We further anal-
ysed the data according to the cone depth.
Several studies provided separate data for overall and spontaneous
PTB (sPTB) (less than37 weeks of gestation). If only data on
sPTB were provided, these were also included in the overall PTB
analysis (Crane 2006; Noehr 2009a; Ortoft 2010; Poon 2012;
Stout 2015). If studies provided data on nulliparous and parous
women separately, these were presented together and were also
included in the respective forest plots for overall PTB (i.e. Analysis
1.15; Analysis 1.16). This was also the case for single and multiple
treatment and singleton and multiple pregnancies .
We used random-effects models with inverse variance weighting
for all meta-analyses (Dersimonian 1986).
If data were not of suitable quality for meta-analysis, we reported
the results as a narrative in the text of the review.
Subgroup analysis and investigation of heterogeneity
Given the non-randomised nature of the included studies, we as-
sessed whether the choice of comparison group impacts on the risk
estimate for each outcome and over-inflates the effect of treatment
that could be partly attributed to other confounders. We there-
fore distinguished the different untreated comparison groups used
across studies and performed analyses for the risk of PTB for each
individual comparator (external; internal (self-matching); internal
(pre-treatment pregnancies); colposcopy but no treatment; HSIL
but no treatment). We performed separate analyses according to
the comparison group for PTB (less than 37 weeks of gestation).
Furthemore, for the outcome of PTB (less than 37 weeks of gesta-
tion), we also performed analyses according to parity (nulliparous
and parous women separately), number of treatments (women
with single and multiple treatments separately), and number of fe-
tuses (women with singleton andmultiple pregnancies separately).
Sensitivity analysis
Finally, we performedmeta-regression analysis to assess the impact
of some factors on the risk of PTB (less than37 weeks). These
included the year of study (1979 to 1989, 1990 to 1999, 2000 to
2009, 2010 to 2015); type of treatment (excision or ablation); type
of comparator (external, internal - pregnancies before treatment,
internal - self-matching, CIN but no treatment, HSIL but no
treatment).
R E S U L T S
Description of studies
The characteristics of the included and excluded studies and
the outcomes examined are described in the Characteristics of
included studies and in the Characteristics of excluded studies,
respectively.
Results of the search
We retrieved 3219 citations from the literature search. Of those,
2849 were excluded based on the title or abstract; 370 were re-
trieved in full text for evaluation. We identified 69 studies that
fulfilled the inclusion criteria and 289 were excluded (of these 289
studies, 242 were reviews/meta-analyses, conference proceedings,
letters or duplicates; the remaining 47 studies are listed in detail in
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Excluded studies andCharacteristics of excluded studies); 12 stud-
ies are awaiting classification. No unpublished studies could be
identified. The details, including reasons for exclusion, are present
in the PRISMA flowchart (Moher 2009; Figure 1).
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Figure 1. Flow diagram.
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Included studies
Sixty-nine studies fulfilled the inclusion criteria of this systematic
review and were also included in the meta-analysis. We identi-
fied no unpublished studies. The detailed characteristics of the in-
cluded studies are shown in Characteristics of included studies. All
studies were cohorts and retrospective, except for five prospective
studies (Fischer 2010; Frega 2013;Guo 2013; Poon 2012; Simoens
2012). Fifteen studies were population-based (the datawere drawn
from registers, or they included a large number of hospitals cov-
ering a large area) (Albrechtsen 2008; Andia 2011; El-Bastawissi
1999; Frega 2013; Heinonen 2013; Jakobsson 2007; Jones 1979;
Kristensen 1985; Kristensen 1993; Larsson 1982; Noehr 2009a;
Noehr 2009b; Reilly 2012; Shanbhag 2009; Sjoborg 2007) and
the remaining studies were hospital-based (the data were drawn
from hospital records). There were no RCTs.
Seven studies were identified in non-English language and were
not included (He 2007; Kalitsaris 1991; Kasum 1991; Lund 1986;
Praest 1979; Spuhler 1995; Zornoza-Garcia 2009) given the large
number of included studies and the lowquality of these small stud-
ies we considered that their inclusion would not alter the conclu-
sions of the review. In future updates we will consider the inclusion
of these reports (Characteristics of studies awaiting classification).
Five studies published after April 2016, week 2 are awaiting clas-
sification in future updates of this review (Aleman 2016; Bjorge
2016; Brie 2016; Jancar 2016; Zebitay 2017).
Many of the included studies included cohorts treated with a vari-
ety of treatment modalities. Specifically, 14 studies examined the
impact of cold knife conisation; (CKC) (Bruinsma 2007; Buller
1982; Crane 2006; Ehsanipoor 2014; Guo 2013; Jones 1979;
Klaritsch 2006; Kuoppala 1986; Larsson 1982; Ludviksson 1982;
Moinian 1982;Ortoft 2010; Sozen 2014;Weber 1979), 10 of laser
conisation (LC) (Andersen 1999; Bekassy 1996; Forsmo 1996;
Hagen 1993; Lima 2011; Raio 1997; Sadler 2004; Sagot 1995;
Simoens 2012; Spitzer 1995), one of needle excision of the trans-
formation zone (NETZ) (Ortoft 2010), 32 of large loop exci-
sion of the transformation zone (LLETZ) (Acharya 2005; Andia
2011; Blomfield 1993; Braet 1994; Bruinsma 2007; Crane 2006;
Cruickshank 1995; Ehsanipoor 2014; Frega 2013; Frey 2013;
Gunasekera 1992; Guo 2013; Haffenden 1993; Heinonen 2013;
Himes 2007; Jakobsson 2009; Kitson 2014; Lima 2011; Martyn
2015; Noehr 2009a; Noehr 2009b; Ortoft 2010; Paraskevaidis
2002; Parikh 2008; Poon 2012; Sadler 2004; Samson 2005;
Simoens 2012; Stout 2015; Tan 2004; Turlington 1996; Werner
2010), one of Fischer cone biopsy Excisor (FCBE) (Anwar
2016), eight of laser ablation (LA) (Anderson 1984; Bruinsma
2007; Forsmo 1996; Gunasekera 1992; Sadler 2004; Saunders
1986; Spitzer 1995; van Rooijen 1999), one of radical diathermy
(RD) (Bruinsma 2007), two of cryotherapy (CT) (Crane 2006;
Hemmingsson 1982), 15 of excision not otherwise specified
(NOS) (Albrechtsen 2008; Armarnik 2011; Castanon 2012;
El-Bastawissi 1999; Fischer 2010; Jakobsson 2007; Martyn 2015;
Miller 2015; Reilly 2012; Shanbhag 2009; Simoens 2012; Sjoborg
2007; van de Vijner 2010; Van Hentenryck 2012; Wuntakal
2013), five of ablation NOS (Ehsanipoor 2014; El-Bastawissi
1999; Jakobsson 2007; Reilly 2012; Shanbhag 2009) and three of
treatment NOS (Kirn 2015; Kristensen 1985; Kristensen 1993).
There were five types of comparison groups: external (gen-
eral population) (Acharya 2005; Albrechtsen 2008; Andersen
1999; Anderson 1984; Andia 2011; Armarnik 2011; Bekassy
1996; Blomfield 1993; Braet 1994; Castanon 2012; Crane
2006; Cruickshank 1995; Ehsanipoor 2014; El-Bastawissi 1999;
Fischer 2010; Forsmo 1996; Frega 2013; Frey 2013; Gunasekera
1992; Haffenden 1993; Hagen 1993; Heinonen 2013; Jakobsson
2007; Jakobsson 2009; Jones 1979; Kirn 2015; Klaritsch 2006;
Kristensen 1985; Kristensen 1993; Kuoppala 1986; Lima 2011;
Ludviksson 1982; Miller 2015; Noehr 2009a; Noehr 2009b;
Ortoft 2010; Paraskevaidis 2002; Parikh 2008; Poon 2012; Raio
1997; Reilly 2012; Samson 2005; Saunders 1986; Shanbhag
2009; Simoens 2012; Sjoborg 2007; Sozen 2014; Tan 2004;
van de Vijner 2010; Van Hentenryck 2012; van Rooijen 1999;
Weber 1979; Werner 2010); internal (pre-treatment pregnan-
cies) (Acharya 2005; Albrechtsen 2008; Andia 2011; Buller 1982;
Castanon 2012; Cruickshank 1995;Hemmingsson 1982; Larsson
1982; Moinian 1982; Sagot 1995; Spitzer 1995; Stout 2015;
Werner 2010; Wuntakal 2013); internal (self-matching) (Anwar
2016; Bekassy 1996; Castanon 2012; Jakobsson 2009; Kristensen
1993; Ortoft 2010; Raio 1997; Sjoborg 2007); women who at-
tended colposcopy with or without biopsy who did not undergo
treatment (Bruinsma 2007;Castanon 2012; Frey 2013;Guo 2013;
Himes 2007; Kitson 2014; Martyn 2015; Miller 2015; Noehr
2009a; Poon 2012; Sadler 2004; Stout 2015; Wuntakal 2013),
and women with untreated high-grade squamous intra-epithelial
lesion (HSIL) (El-Bastawissi 1999; Ortoft 2010; Shanbhag 2009).
As many studies were old, dating back to the 1980s, we ensured
that we avoided overlapping the same patients in different reports,
particularly those from the Scandinavian countries. More specif-
ically, seven studies were identified from Denmark. Weber 1979
was an old hospital-based study (delivery during 1974 to 1975),
with no overlappingwith the othermore recent studies. Kristensen
1985 identified treated women from the registry of a Danish
county (1973 to1980), but only women delivering in a specific
university hospital (up to 1982) were included. Kristensen 1993
was a population-based study from the whole of Denmark includ-
ing only parous women, with their first infant delivered in 1982,
and their second during 1982 to 1987 (treatment during 1977 to
1987). There was no overlapping with Kristensen 1985. Andersen
1999 was a hospital-based study including women treated during
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1985 to 1989. There was a negligible degree of overlapping with
Kristensen 1993 (for women with delivery in 1982, treatment
during 1985 to 1987 and subsequent delivery until 1987). Noehr
2009a was a population-based study from the whole of Denmark
that was comprised of women treated during 1997 to 2005 with
subsequent singleton pregnancy at the same time period. There
was no overlapping with the previous studies. Noehr 2009b had
the same designwithNoehr 2009a and the only difference was that
only women with twin pregnancies were included. Ortoft 2010
identified treated women from the Danish nationwide pathology
database (1989 to 2007), but only women delivering at Aarhus
University Hospital until 2007 were included. Approximately 8%
of all Danish births take place in this hospital. Women delivering
during 1997 to 2005 (nine years) were also included in Noehr
2009a, but women delivering during 1989 to 1996 and 2006 to
2007 (10 years) were not included in Noehr 2009a. Because there
was no way to eliminate the overlapping, we decided to include
both studies.
Four studies were identified from Finland. Some of the authors in
Jakobsson 2007 (population-based study from the whole of Fin-
land), Jakobsson 2009 (hospital-based study) and Heinonen 2013
(population-based study from the whole of Finland) were com-
mon, and we carefully avoided duplication. More details about the
outcomes extracted from each study are listed in Characteristics
of included studies. Kuoppala 1986 was another hospital-based
study from Finland, but there was no overlapping with the afore-
mentioned population-based studies.
Five studies were identified from Norway. Albrechtsen 2008 was
a population-based study from the whole of Norway (excisional
treatment during 1953 to 1979 or 1986 to 2003 and subsequent
pregnancy during 1967 to 2003). All participants in Acharya 2005
and Sjoborg 2007 were also included in Albrechtsen 2008, thus
we excluded Acharya 2005 and Sjoborg 2007 from the analyses,
which also included Albrechtsen 2008. There was no overlapping
between Acharya 2005 and Sjoborg 2007. Forsmo 1996 was a hos-
pital-based study which included women treated with LLETZ or
LA during 1983 to 1988. There was overlapping with Albrechtsen
2008 for women treated with LLETZ during 1986 to 1988, but
there was no way to eliminate this overlapping. In Hagen 1993,
all women had received LLETZ during 1983to 1985 and there
was no overlapping with Albrechtsen 2008.
Six studies were identified from Sweden. Five of these studies were
hospital-based (Bekassy 1996; Hemmingsson 1982; Ludviksson
1982;Moinian 1982; van Rooijen 1999). Larsson 1982 identified
women from the South Swedish Regional Tumour Registry, but
only women delivering in two hospitals were included. One of
these hospitals was also included in Bekassy 1996, but the studies
took place in different periods with no overlapping.
Although case-control studies and studies assessing the impact
of treatment performed during pregnancy were excluded, we in-
cluded the study by Ortoft 2010, as only 18 women (2.5%) were
treated during pregnancy, and the case-control study by Castanon
2012, as additional data were provided by the authors.
There was no risk of overlapping for studies from other countries.
Excluded studies
The characteristics of the 47 excluded studies (not including re-
views/meta-analyses, conference proceedings, letters or duplicates)
are shown in Characteristics of excluded studies. The PRISMA
flowchart is shown in Figure 1 . We excluded studies without an
untreated comparison group (Althuisius 2001; Berghella 2004;
Berretta 2013; Bull-Phelps 2007; Chevreau 2017; Conner 2013;
Ferenczy 1995; Gordon 1991; Gronroos 1979; Khalid 2012; Kim
2016; Kindinger 2016; Kullander 1971; Leiman 1980; Liu 2014;
Liverani 2016; Macvicar 1968; Mariya 2016; Masamoto 2008;
Michelin 2009; Monaghan 1982; Nam 2010; Novikova 1994;
Patrelli 2008; Radha Bai Prabhu 2010; Rafaeli-Yehudai 2014;
Sangkarat 2014; Shin 2010; Wakita 1990; Wongtiraporn 2014),
studies with women treated during pregnancy (Mitsuhashi 2000;
Rosen 1991; Seki 2010; Sljivancanin 2013), or late obstetric out-
comes (beyond 24 weeks) that we did not study in this meta-anal-
ysis (Ciavattini 2015; Gentry 2000; Kalliala 2012; Naleway 2015;
Ricciotti 1995; Spracklen 2013), case-control studies (Watson
2012), studies with a high-risk treated and/or comparison group
(i.e. previous history of mid trimester loss (Pils 2014), conceived
through assisted reproductive technology (ART) (Ciavattini 2014;
Pinborg 2015)), and studies assessing the impact of CIN on out-
comes without information as to whether treatment was per-
formed (Al-Halal 2013; Smaldone 2010; Zuo 2011).
Risk of bias in included studies
The included studies were non-randomised studies (NRS); they
were prospective or retrospective cohorts andwere therefore at high
risk of underlying bias. The included studies varied with regard
to design, the data source, the study and comparison populations,
the reported outcomes, the length of follow-up and the matching
for possible confounders, as described above.
The summary of the authors’ judgements about each ’Risk of bias’
item is presented in Figure 2 and the detailed evaluation of ’Risk
of bias’ domains separately for each included study in Figure 3.
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Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Adescriptionof the quality of the evidence is provided based on the
GRADE assessment on maternal outcomes (Summary of findings
for the main comparison) and on fetal outcomes (Summary of
findings 2).
Allocation
Representativeness of intervention group
Risk of bias due to unrepresentative intervention group was gen-
erally considered low. In six studies (Anderson 1984; Cruickshank
1995; Martyn 2015; Sjoborg 2007; Spitzer 1995; Turlington
1996), the representativeness of the intervention group was con-
sidered inadequate due to considerable, over 20%, non-responder
rate to follow-up questionnaires, which might result in selection
bias due to women in higher social classes being more prone to
answer. In one study (Sozen 2014), the intervention group was
considered unrepresentative due to the very small number of par-
ticipants (15 patients) and in one study (van de Vijner 2010), the
representativeness was unclear due to lack of information regard-
ing the number of women providing questionnaire-based follow-
up data.
Representativeness of comparison group
The representativeness of the comparison group was considered
good in all but three studies. In two studies (Bekassy 1996;
Jakobsson 2009), the untreated external comparison group was
not drawn from the same source as the treated population and in
one study (Ludviksson 1982), the source of reference population
was unclear.
Comparability of the groups
The comparison group used and the adjustment for possible risk
factors are important measures of study quality and risk of bias.
Of the studies that used an external comparison group (n = 53,
Included studies), 49 matched for known risk factors or per-
formed a regression analysis to control for known confounders.
Only four studies did not include any measures to control for con-
founders (Klaritsch 2006; Kristensen 1993; Lima 2011; Parikh
2008) and were hence considered to be of high risk of bias. Of the
remaining 49 studies, 29 studies used matching (Acharya 2005;
Andersen 1999; Anderson 1984; Bekassy 1996; Blomfield 1993;
Braet 1994; Cruickshank 1995; Fischer 2010; Forsmo 1996; Frega
2013; Gunasekera 1992; Haffenden 1993; Hagen 1993; Jones
1979; Kirn 2015; Kristensen 1985; Kuoppala 1986; Ludviksson
1982; Paraskevaidis 2002; Raio 1997; Samson 2005; Saunders
1986; Simoens 2012; Sozen 2014; Tan 2004; van de Vijner
2010; VanHentenryck 2012; van Rooijen 1999;Weber 1979), 17
studies used regression analysis (Albrechtsen 2008; Andia 2011;
Armarnik 2011; Castanon 2012; Crane 2006; Ehsanipoor 2014;
Heinonen 2013; Jakobsson 2007; Jakobsson 2009; Miller 2015;
Noehr 2009a; Noehr 2009b; Ortoft 2010; Poon 2012; Reilly
2012; Shanbhag 2009; Werner 2010) and three studies used both
matching and regression analysis (El-Bastawissi 1999; Frey 2013;
Sjoborg 2007). In five studies (Andersen 1999; Haffenden 1993;
Saunders 1986; Tan 2004; van de Vijner 2010), the risk was
considered unclear due to incomplete matching between the two
groups.
Of the 13 studies that had an internal comparison group
(pre-treatment pregnancies), two used matching (Larsson 1982;
Spitzer 1995) and four studies also performed regression analy-
sis (Albrechtsen 2008; Castanon 2012; Werner 2010; Wuntakal
2013). Of the eight studies that had an internal comparison group
(self-matching), three studies also performed regression analysis
(Castanon 2012; Jakobsson 2009; Sjoborg 2007).
Of the 15 studies that used as a comparison group women who
attended colposcopy with or without biopsy who did not undergo
treatment or untreated HSIL, 10 studies performed regression
analysis (Bruinsma 2007; Castanon 2012; El-Bastawissi 1999;
Miller 2015; Noehr 2009a; Ortoft 2010; Poon 2012; Sadler 2004;
Shanbhag 2009; Wuntakal 2013), four studies used matching for
confounders (Guo 2013; Kitson 2014;Martyn 2015; Stout 2015),
and one study (Frey 2013) used both matching and regression
analysis. The most common confounding factors that were used
in matching or regression analysis were age, parity, smoking, race/
ethnicity and social class.
Blinding
Relevant assignment described (Performance bias)
Bias due to unclear or inappropriate treatment assignment was
considered low in most studies. In two studies the risk was deemed
high, due to the conisation type not being described (Kristensen
1985) and the CKC treatment being described to be more radical
than as usual (Moinian 1982). In one study (Kristensen 1993),
the risk was unclear as the method of treatment was not specified
but could have included three different types of treatment.
Incomplete outcome data
Overall 12/69 studies (17%) were considered to be at high risk of
attrition bias due to incomplete outcome data. In 10 studies in-
formation about the subsequent pregnancies was missing for more
than 20% of the study population (Anderson 1984; Buller 1982;
Castanon 2012; Cruickshank 1995; Martyn 2015; Sagot 1995;
Sjoborg 2007; Spitzer 1995; Tan 2004; Turlington 1996), in one
study (Saunders 1986), the method to retrieve subsequent preg-
nancy data was deemed non-systematic, i.e. contacting local gen-
eral practitioners, and in one study (Shanbhag 2009), the method
of CIN treatment was unclear for more than 50% and these
women were excluded from all analyses. In four studies (Anwar
2016; Frey 2013; Guo 2013; van de Vijner 2010), the number
of women lost to follow-up and therefore the risk of attrition bias
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was unclear and for all other studies the risk was deemed to be
low.
Selective reporting
Reporting bias due to selective reporting was considered low in
almost all included studies. For two studies (Bruinsma 2007;
Noehr 2009b), the risk was deemed high due to the results being
reported only for the whole treated-group, not stratified according
to the treatment type. For one study (Simoens 2012), the risk was
considered to be unclear due to reporting the outcomes only after
some, not all included treatments.
Other potential sources of bias
The outcome ascertainment was made with a questionnaire in
seven studies (Martyn 2015; Ortoft 2010; Poon 2012; Spitzer
1995; Turlington 1996; van de Vijner 2010; Weber 1979), which
might predispose to recall bias and misclassification and the risk of
other bias was hence considered high in these studies. A further five
studies were as well considered to be of high risk of other bias, due
to contradictions between the tables and the text (Himes 2007;Tan
2004; Van Hentenryck 2012), due to including treated women
in comparison groups (Forsmo 1996), and marked temporal dif-
ferences in outcomes between the exposed and unexposed groups
(Hemmingsson 1982). The risk of other bias was considered un-
clear in six studies. In two studies (Albrechtsen 2008; Castanon
2012), some women in the comparison group might have been
being treated but the effect of this possible misclassification was
deemed unclear, in one study some of the data were discrepant but
the possible effect of this again deemed unclear (Armarnik 2011),
and in two studies (Noehr 2009a; Noehr 2009b), the LLETZ
groupmight have includedwomen treatedwith LC aswell, but the
number was considered negligible and unclear whether it would
introduce bias.
We assessed the presence of publication bias for the outcomes
presented in the ’Summary of findings’ tables if more than 10
studies were included. There was evidence of publication bias only
for PTB at < 32 to 34 weeks of gestation. None of the other
outcomes showed any evidence of publication bias.
Effects of interventions
See:Summary of findings for themain comparisonThe effect of
treatment for CIN on maternal outcomes; Summary of findings
2 The effect of treatment for CIN on neonatal outcomes
MATERNAL OUTCOMES
Preterm birth
The risk of preterm birth was increased after cervical treatment.
This was the case for prematurity rate overall at less than 37 weeks
of gestation (Analysis 1.1: 59 studies, 5,242,917 women, 10.7%
versus 5.4%, risk ratio (RR) 1.75, 95% confidence interval (CI)
1.57 to 1.96; Analysis 1.2: 59 studies, 5,242,917 women, 10.7%
versus 5.4%, RR1.78, 95%CI 1.60 to 1.98, very lowquality of ev-
idence because of considerable (I2 90%and88%, respectively) het-
erogeneity (Summary of findings for the main comparison)); for
severe prematurity less than 32 to 34 weeks of gestation (Analysis
1.3: 24 studies, 3,793,874 women, 3.5% versus 1.4%, RR 2.25,
95% CI 1.79 to 2.82; Analysis 1.4: 24 studies, 3,793,874 women,
3.5% versus 1.4%, RR 2.35, 95% CI 1.88 to 2.95, very low qual-
ity of evidence because of considerable (I2 83% and 82%, respec-
tively) heterogeneity and suspected publication bias (Summary
of findings for the main comparison)); and extreme prematurity
less than 28 to 30 weeks of gestation (Analysis 1.5: 8 studies,
3,910,629 women, 1.0% versus 0.3%, RR 2.23, 95% CI 1.55
to 3.22; Analysis 1.6: 8 studies, 3,910,629 women, 1.0% versus
0.3%, RR 2.43, 95% CI 1.69 to 3.49, very low quality of ev-
idence because of considerable (I2 84% and 82%, respectively)
heterogeneity (Summary of findings for the main comparison)).
We further conducted analyses for more specific gestational ages
cut-offs (i.e. 34 weeks or less (Analysis 1.7 (RR 2.59, 95% CI 1.78
to 3.77); Analysis 1.8 (RR 2.56, 95% CI 1.78 to 3.69)), less than
32 to 33 weeks (Analysis 1.9 (RR 2.08, 95% CI 1.55 to 2.79);
Analysis 1.10 (RR 2.26, 95%CI 1.70 to 3.01)), less than 30 weeks
(Analysis 1.11 (RR 2.86, 95% CI 0.12 to 69.11); Analysis 1.12
(RR 2.86, 95% CI 0.12 to 69.11)), less than 28 weeks (Analysis
1.13 (RR 2.22, 95% CI 1.54 to 3.22); Analysis 1.14 (RR 2.52,
95% CI 1.71 to 3.72)) for broader treatment groups as well as
individual techniques. The impact of treatment was not different
for nulliparous (Analysis 1.15) and multiparous (Analysis 1.16)
women. The effect of multiple treatment on the risk of prematu-
rity was substantially higher than the effect of single treatments
(single treatment versus no treatment (Analysis 1.17): 17 studies,
1,367,023 women, 7.5% versus 4.2%, RR 1.75, 95% CI 1.49
to 2.06; repeat treatment versus no treatment (Analysis 1.18): 11
studies, 1,317,284 women, 13.2% versus 4.1%, RR 3.78, 95%
CI 2.65 to 5.39, very low quality of evidence because of consid-
erable (I2 75%) heterogeneity (Summary of findings for the main
comparison)). The relative risk of preterm birth for two excisional
treatments not otherwise specified (NOS) was as high as 5.48
(95% CI 2.68 to 11.24) and that of two loop excisions as high as
2.81 (95% CI 2.33 to 3.39), as compared to no treatment.
The magnitude of the effect of treatment was higher for excision (
Analysis 1.1.1: RR1.87, 95%CI1.64 to 2.12) rather than ablation
(Analysis 1.1.2: RR 1.35, 95% CI 1.20 to 1.52) and for more
radical treatment techniques. The risk of preterm birth at less than
37 weeks of gestation for individual treatment techniques varied:
cold knife conisation (CKC) (Analysis 1.2.1: RR 2.70, 95% CI
2.14 to 3.40); laser conisation (LC) (Analysis 1.2.2: RR 2.11, 95%
CI 1.26 to 3.54); large loop excision of the transformation zone
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(LLETZ) (Analysis 1.2.4: RR 1.58, 95% CI 1.37 to 1.81); laser
ablation (LA) (Analysis 1.2.6: RR 1.04, 95%CI 0.86 to 1.26); CT
(Analysis 1.2.7: RR 1.02, 95% CI 0.22 to 4.77); excision NOS
(Analysis 1.2.9: RR 1.90, 95% CI 1.50 to 2.41); ablation NOS
(Analysis 1.2.10: RR 1.46, 95% CI 1.27 to 1.66) and treatment
NOS (Analysis 1.2.11: (RR 2.57, 95% CI 1.39 to 4.77). Similar
trends were noted for severe (Analysis 1.4) and extreme (Analysis
1.6) prematurity. Some, but not all, types of treatments were also
associated with an increased risk of preterm birth for women with
singleton (Analysis 1.19) or multiple pregnancies (Analysis 1.20;
Analysis 1.21; Analysis 1.22), but the results were inconsistent due
to the small number of studies.
Preterm birth - dimensions of excised cone
We further analysed the data on the risk of pretermbirth at less than
37weeks of gestation for different cone depths. The risk for treated
versus untreated women was greater for womenwith cone depth≤
10 mm to 12 mm (Analysis 1.23: 8 studies, 550,929 women, 7.1
% versus 3.4%, RR 1.54, 95%CI 1.09 to 2.18, very low quality of
evidence because of substantial (I2 67%) heterogeneity (Summary
of findings for themain comparison)), and themagnitude of effect
increased with increasing cone depth (≥ 10 mm to 12 mm (
Analysis 1.24): 8 studies, 552,711 women, 9.8% versus 3.4%, RR
1.93, 95% CI 1.62 to 2.31, low quality of evidence (Summary of
findings for the main comparison);≥ 15 mm to 17 mm (Analysis
1.25): 4 studies, 544,986 women, 10.1 % versus 3.4%, RR 2.77,
95% CI 1.95 to 3.93, very low quality of evidence because of
moderate (I2 53%) heterogeneity (Summary of findings for the
main comparison); ≥ 20 mm (Analysis 1.26): 3 studies, 543,750
women, 10.2 % versus 3.4%, RR 4.91, 95% CI 2.06 to 11.68,
very low quality of evidence because of considerable (I2 67%)
heterogeneity (Summary of findings for the main comparison)). A
similar increasing effect was observed, although based on only one
study, with increasing cone volume (less than 6 cc (Analysis 1.27):
1 study, 550 women, 8.1% versus 3.6%, RR 2.25, 95%CI 1.09 to
4.66; > 6 cc (Analysis 1.28): 1 study, 284 women, 50.0% versus
3.6%, RR 13.90, 95% CI 5.09 to 37.98). We have performed
additional analyses assessing several more specific cone depths/
volumes without merging these in broader groups (Analysis 1.29;
Analysis 1.30; Analysis 1.31; Analysis 1.32; Analysis 1.33; Analysis
1.34; Analysis 1.35; Analysis 1.36; Analysis 1.37; Analysis 1.38;
Analysis 1.39; Analysis 1.40; Analysis 1.41; Analysis 1.42).
The comparison of treated women for different cone depths re-
vealed that deep excisions increased the risk of preterm birth (less
than 37 weeks) as opposed to less deep excisions and the mag-
nitude of the effect increased in longer cones (≥ 10 mm to 12
mm versus ≤ 10 mm to 12 mm (Analysis 1.43): 7 studies, 6359
women, 12.3 % versus 7.8%, RR 1.54, 95% CI 1.31 to 1.80; ≥
15 mm to 17 mm versus ≤ 15 mm to 17 mm (Analysis 1.44):
4 studies, 4275 women, 10.1 % versus 5.7%, RR 1.82, 95% CI
1.47 to 2.26; ≥ 20 mm versus ≤ 20 mm (Analysis 1.45): 3 stud-
ies, 3944 women, 10.2 % versus 5.6%, RR 2.79, 95% CI 1.24
to 6.27). The findings were similar for the comparison of cone
volumes (> 3 cc versus less than 3 cc (Analysis 1.46): 1 study, 278
women, 15.0 % versus 7.3%, RR 2.04, 95% CI 0.95 to 4.39; >
6 cc versus less than 6 cc (Analysis 1.47): 1 study, 278 women,
50.0% versus 8.1%, RR 6.18, 95% CI 2.53 to 15.13). Further
subgroup analyses of comparisons of more specific cone depths are
also shown (Analysis 1.48; Analysis 1.49; Analysis 1.50).
Preterm birth - effect of the comparison group
The impact that the choice of comparison group may have on the
magnitude of effect was assessed by additional analysis that classi-
fied different studies according to the comparator used. The mag-
nitude of effect was higher when an external comparison group
was used (Analysis 1.51: 44 studies, 5,192,047 women, 10.5%
versus 5.4%, RR 1.92, 95% CI 1.70 to 2.16), followed by inter-
nal comparators (self-matching (Analysis 1.52): 8 studies, 2987
women, 10.9% versus 7.0%, RR 1.59, 95% CI 1.19 to 2.13; pre-
treatment pregnancies (Analysis 1.53): 13 studies, 83,404 women,
14.1% versus 6.4%, RR 1.39, 95% CI 0.98 to 1.96) and ulti-
mately women with disease but no treatment (Analysis 1.54: 13
studies, 74,958 women, 8.8% versus 6.0%, RR 1.27, 95% CI
1.14 to 1.41). A further analysis of treated women versus those
with untreatedHSILwas also explored although this included only
three studies (Analysis 1.55: 3 studies, 3764 women, 12% versus
7.8%, RR 1.37, 95% CI 0.85 to 2.19). The forest plot where we
compared treatment in general to the different comparison groups
can be seen in Analysis 1.56. When women with disease but no
treatment and the pregnancies of the parous women before treat-
ment were compared to the general population, the risk of preterm
birth was higher (Analysis 1.57: 15 studies, 4,357,998 women,
5.9% versus 5.6%, RR 1.24, 95% CI 1.14 to 1.34) based on very
low-quality evidence. These groups were also analysed separately
(Analysis 1.57.1; Analysis 1.57.2; Analysis 1.57.3).
Furthermore, we performed a series of analyses for different cone
depths and comparison groups with particularly emphasis on the
comparisons of different depths of treatment versus untreated
women with CIN (Analysis 1.58; Analysis 1.59; Analysis 1.60;
Analysis 1.61; Analysis 1.62; Analysis 1.63; Analysis 1.64; Analysis
1.65; Analysis 1.66; Analysis 1.67; Analysis 1.68; Analysis 1.69;
Analysis 1.70; Analysis 1.71; Analysis 1.72; Analysis 1.73; Analysis
1.74; Analysis 1.75). The subgroup analysis of the risk of preterm
birth (less than 37 weeks of gestation) according to cone depth
when compared to women with CIN but not treated revealed
similar direction of effect although for cone depth ≤ 10 mm to
12 mm, the difference was less marked. The number of the stud-
ies was however small for many comparisons (treatment versus
women with untreated CIN = cone depth ≤ 10 mm to 12 mm
(Analysis 1.60): 4 studies, 43,145 women, 7.0% versus 5.0%, RR
1.11, 95%CI 0.85 to 1.43;≥ 10 mm to 12 mm (Analysis 1.67): 4
studies, 45,275women, 9.6%versus 5.0%, RR 1.52, 95%CI 1.37
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to 1.68; ≥ 15 mm to 17 mm (Analysis 1.69): 3 studies, 33,934
women, 9.6% versus 4.3%, RR 2.30, 95% CI 1.57 to 3.35; ≥ 20
mm (Analysis 1.71): 2 studies, 32,717 women, 9.3% versus 4.2%,
RR 4.32, 95% CI 0.93, 20.03) based on low- or very low-quality
evidence.
Preterm birth - sensitivity and meta-regression analysis
Themono-variate meta-regression analysis suggested that the type
of treatment and comparator affected the risk of preterm birth,
although the year of study did not. Type of treatment and compar-
ison group remained important factors for risk of preterm birth
(PTB) in a multivariate regression analysis. When we performed
further meta-regression restricting only to excisional treatments
and using as a comparator women with colposcopy/biopsy, we
found that all treatments were associated with an increased risk of
PTB (RR 1.34, 95% CI 1.10 to 1.64, for LLETZ; RR 2.3, 95%
CI 1.39 to 3.85, for CKC; RR 1.6, 95% CI 0.91 to 2.87, for LC;
and RR 4.26, 95% CI 1.96 to 9.33, for needle excision of the
transformation zone) (data not shown).
Other Maternal outcomes
Maternal outcomes other than preterm birth were assessed in sev-
eral studies and many of these were found to be increased after
cervical treatment. This increase was more frequent for excisional
as opposed to ablative techniques and with increasing treatment
radicality, although the number of studies assessing each individ-
ual treatment method was frequently small.
Cervical treatment increased the risk of spontaneous overall, se-
vere and extreme preterm birth (less than 37 weeks (Analysis 2.1):
14 studies, 1,024,731 women, 7.0% versus 3.7%, RR 1.76, 95%
CI 1.47 to 2.11; less than 32 to 34 weeks (Analysis 2.2): 7 studies,
655,675 women, 1.8% versus 0.6%, RR 2.63, 95% CI 1.91 to
3.62; less than 28 weeks (Analysis 2.3): 2 studies, 626,670 women,
0.6% versus 0.2%, RR 3.18, 95% CI 1.64 to 6.16). The risk of
spontaneous preterm birth (less than 37 weeks) was higher for
CKC (Analysis 2.1.1: RR 3.53, 95% CI 2.05 to 6.05) followed by
excision NOS (Analysis 2.1.7: RR 1.70, 95% CI 1.17 to 2.46),
LLETZ (Analysis 2.1.4: RR 1.60, 95% CI 1.22 to 2.08) and abla-
tionNOS (Analysis 2.1.8: RR 1.42, 95%CI 1.20 to 1.70). Needle
excision of the transformation zone (NETZ) (Analysis 2.1.3) and
LA (Analysis 2.1.5) were only assessed in one study, respectively.
There was substantial heterogeneity for the comparisons assessing
spontaneous preterm birth at all cut-offs (P value less than 0.05)
based on low- or very low-quality evidence.
The risk of pPROM less than 37 weeks (Analysis 2.4: 21 studies,
477,011 women, 6.1% versus 3.4%, RR 2.36, 95% CI 1.76 to
3.17, very lowquality of evidence because of considerable (I2 79%)
heterogeneity (Summary of findings for the main comparison))
was also increased after treatment. The risk of pPROMwas higher
for CKC (Analysis 2.4.1: RR 4.11, 95%CI 2.05 to 8.25) followed
byLLETZ (Analysis 2.4.4: RR2.15, 95%CI1.48 to 3.12).NETZ
(Analysis 2.4.3) was only assessed in one study and LA (Analysis
2.4.5) did not significantly affect the risk but was only assessed in
two studies based on low- or very low-quality evidence. We also
included analyses at different gestational cut-offs (Analysis 2.5;
Analysis 2.6)
Treatment increased the risk of admission for threatened preterm
birth (Analysis 2.7; 5 studies, 903 women, 9.1% versus 3.2%, RR
2.44, 95% CI 1.37 to 4.33) and chorioamnionitis (Analysis 2.8; 4
studies, 29,198women, 3.5%versus 1.1%, RR 3.43, 95%CI 1.36
to 8.64).The mode of delivery (caesarean section (Analysis 2.9;
very low quality of evidence because of imprecision and strongly
suspected publication bias (Summary of findings 2)) or instru-
mental delivery (Analysis 2.10)), the length of labour (precipi-
tous (Analysis 2.11) or prolonged (Analysis 2.12)), the rate of in-
duction of labour with or without oxytocin to (Analysis 2.13),
the use of oxytocin (Analysis 2.14), the use of analgesia (epidu-
ral (Analysis 2.15), pethidine (Analysis 2.16) or NOS (Analysis
2.17)), cervical stenosis (Analysis 2.18) or antepartum haemor-
rhage (Analysis 2.19). was not affected by treatment. The risk of
postpartum haemorrhage was increased after treatment, but this
outcome included just one study (Analysis 2.20; 1 study, 149
women, 18.7% versus 4.1%, RR 4.60, 95% CI 1.38 to 15.36).
The risk of massive obstetric haemorrhage was not increased but
there was only one small study (Analysis 2.21). As expected, the
rate of cervical cerclage insertion was higher for treated as opposed
to non-treated women (Analysis 2.22; 8 studies, 141,300 women,
4.0% versus 0.7%, RR 14.29, 95% CI 2.85 to 71.65) and more
so for CKC (Analysis 2.22.1: RR 31.42, 95% CI 2.32 to 426.22)
and excisional treatment NOS (Analysis 2.22.4: RR 42.45, 95%
CI 28.99 to 62.16) based on low- or very low-quality evidence.
Neonatal outcomes
More than 30 studies assessed one or more neonatal outcomes.
Cervical treatment (excisional or ablative) was associated with
a higher frequency of adverse neonatal outcomes as opposed to
women who had not been treated (comparison group not speci-
fied). The association with adverse neonatal events was stronger
and more frequent for excisional as opposed to ablative techniques
and with increasing treatment radicality, although the number of
studies for each individual treatment technique was often limited.
More specifically, cervical treatment overall increased the risk of
low birth weight (LBW) for some, but not all, cut-offs, although
the number of studies was small for most cut-offs (less than 2500 g
(Analysis 3.1): 30 studies, 1,348,206 women, 7.9% versus 3.7%,
RR 1.81, 95% CI 1.58 to 2.07, very low quality of evidence be-
cause of substantial (I2 63%) heterogeneity (Summary of findings
2); less than 2000 g (Analysis 3.2): 3 studies, 74,981 women,
4.7% versus 1.1%, RR 2.49, 95% CI 0.97 to 6.36; less than 1500
g (Analysis 3.3)): 5 studies, 76,836 women, 2.0% versus 0.5%,
RR 3.00, 95% CI 1.54 to 5.85; less than 1000 g (Analysis 3.4):
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2 studies, 2185 women, 1.1% versus 0.3%, RR 2.09, 95% CI
0.06 to 74.71). Treatment also increased the risk of neonatal in-
tensive care unit (NICU) admission (Analysis 3.5: 8 studies, 2557
women, 12.6% versus 8.9%, RR 1.45, 95% CI 1.16 to 1.81, low
quality of evidence (Summary of findings 2)) and perinatal mor-
tality (Analysis 3.6: 23 studies, 1,659,433 women, 0.9% versus
0.7%, RR 1.51, 95% CI 1.13 to 2.03, low quality of evidence
(Summary of findings 2)). Subgroup analyses of the perinatal mor-
tality for different gestational ages at delivery was also included
(Analysis 3.7; Analysis 3.8; Analysis 3.9). The rate of stillbirth was
not affected by treatment (Analysis 3.10), while the analysis on
the impact of treatment on the Apgar scores only included a small
number of studies (Analysis 3.11; Analysis 3.12; Analysis 3.13).
The rate of neonates born with A birth weight of less than 2500
g was more frequently observed in women treated with CKC (
Analysis 3.1.1: 5 studies, 30,304 women, RR 2.51, 95% CI 1.78
to 3.53), LLETZ (Analysis 3.1.3: 12 studies, 3357 women, RR
2.11, 95% CI 1.51 to 2.94), excisional (Analysis 3.1.6: 10 studies,
823,648 women, RR 2.01, 95% CI 1.62 to 2.49) or ablative (
Analysis 3.1.7: 4 studies, 483,402 women, RR 1.36, 95% CI 1.19
to 1.55) treatment NOS, but not so for laser ablation (Analysis
3.1.4: RR 1.07, 95% CI 0.59 to 1.92), although only four studies
with a total of 1104 participants assessed that comparison. The
rate of NICU admission was increased overall (Analysis 3.5), and
for LLETZ (Analysis 3.5.2: 5 studies, 1994 women, RR 1.42,
95% CI 1.01 to 1.99) and excisional technique NOS (Analysis
3.5.4: 2 studies, 434 women, RR 1.76, 95% CI 1.13 to 2.75).
Perinatal mortality was greater for treated women overall (Analysis
3.6), and for excisional technique NOS (Analysis 3.6.7: 5 studies,
820,028 women, RR 1.85, 95% CI 1.02 to 3.36), but not for
the individual techniques, possibly due to the limited number of
studies and the low prevalence of the outcome. Subgroup analysis
according to the different comparison groups or cone depths was
not possible due to the limited number of studies assessing each
outcome based on low- or very low-quality evidence.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
The ef fect of treatment for CIN on neonatal outcomes
Patient or population: women with known obstetric outcomes
Setting: hospitals/ clinics
Intervention: t reatment for CIN before pregnancy
Comparison: women with no treatment
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with No Treatment Risk with Treatment
LBW (< 2500 g) - Treat-
ment versus No Treat-
ment
Study populat ion RR 1.81
(1.58 to 2.07)
1,348,206
(30 observat ional stud-
ies)
⊕©©©
VERY LOW 1
37 per 1000 66 per 1000
(58 to 76)
NICUAdmission - Treat-
ment versus No Treat-
ment
Study populat ion RR 1.45
(1.16 to 1.81)
2557
(8 observat ional stud-
ies)
⊕⊕©©
LOW 2
89 per 1000 130 per 1000
(104 to 162)
Perinatal Mortality -
Treatment versus No
Treatment
Study populat ion RR 1.51
(1.13 to 2.03)
1,659,433
(23 observat ional stud-
ies)
⊕⊕©©
LOW 3
7 per 1000 11 per 1000
(8 to 14)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent2
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Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Low-quality evidence (based on observat ional studies only) is downgraded one level because of substant ial heterogeneity (I
2 63%)
2 Low-quality evidence (based on observat ional studies only); there was no heterogeneity (I2 0%)
3 Low-quality evidence (based on observat ional studies only); heterogeneity was low (I2 36%)
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D I S C U S S I O N
Summary of main results
The results of this systematic review suggest that all types of local
cervical treatment technique (excisional or destructive) are asso-
ciated with an increased risk of preterm birth (PTB) and adverse
obstetric sequelae. This is the first systematic review that includes
subgroup analyses according to the depth (and volume) of treat-
ment, the number of treatments and the comparison group used.
The knowledge that local treatment for cervical pre-cancer, partic-
ularly excisional treatment, increases the risk of PTB has led toma-
jor changes in clinical practice. With a rapidly evolving evidence
base and inconsistencies in the published literature (Castanon
2012; Conner 2013; Danhof 2015; Jakobsson 2009; Jin 2014;
Reilly 2012), a high-quality synthesis of the evidence should be
available for effective patient counselling at colposcopy and ante-
natal clinics.
This meta-analysis documents that any local cervical treatment for
cervical pre-invasive or early invasive disease increases the risk of
PTB and adverse sequelae in a subsequent pregnancy, although the
impact of small excisions, as opposed to just having the disease,
remains uncertain and is likely to be small. Cervical treatment
was found to be associated with an increased risk of overall, severe
and extreme prematurity, spontaneous PTB, threatened preterm
labour, pPROM, chorioamnionitis, low birth weight, neonatal ad-
mission and perinatal death. The rate of cervical cerclage was un-
surprisingly substantially increased in treatedwomen as opposed to
untreated controls. Treatment equally affected outcomes for nulli-
parous as well as parous, singleton and multiple pregnancies. The
analysis suggested that local treatment had no impact on mode of
delivery, length of labour, the induction rate, the use of analgesia,
the rate of stenosis and haemorrhage .
The magnitude of the effect of treatment was higher for more rad-
ical techniques (i.e. cold knife conisation (CKC) > large loop ex-
cision of the transformation zone (LLETZ) > laser ablation (LA))
and for excision rather than ablation. Multiple conisations in-
creased four-fold the risk of PTB compared to untreated controls.
Subgroup analyses clearly demonstrated that the risk of PTB di-
rectly correlates to the cone dimensions (depth and volume) and
progressively increases with increasing cone depth (‘dose-effect’).
Although the risk was increased even for excisions measuring less
than 10mm in depth, this was almost two-fold higher for excisions
of more than 10 mm, three-fold higher for more than 15 MM to
17 mm and almost five-fold higher for excisions exceeding 20 mm
in depth.
It has been previously suggested that the impact of treatment on
the risk of PTBmay not be a consequence of treatment but rather a
product of other confounders present in women with cervical dis-
ease (Castanon 2012; Kyrgiou 2012; Reilly 2012). Our subgroup
analyses that stratified the risk to the comparator used, clearly doc-
uments that although the risk of PTB is increased after treatment,
irrespective of the comparison group used, the choice of compara-
tor may over-inflate or under-estimate the effect of treatment. The
magnitude of effect was higher when external controls were used,
followed by internal control, followed by women who had cer-
vical intra-epithelial neoplasia (CIN), but who were not treated.
The analyses in women with high-grade squamous intra-epithelial
lesion (HSIL) but no treatment only included three studies and
3764 participants; we were unable to draw any firm conclusions
from this comparison. When we assessed the risk of PTB accord-
ing to the cone depth when compared to women with CIN but
no treatment, we noted the same direction of effect. Although the
difference in the risk for PTB for small excisions (10 mm to 12
mm or less) as opposed to just having CIN but no treatment did
not differ greatly, the number of studies assessing that comparison
was however small and firm conclusions cannot be drawn. We
also found that women with CIN have a higher baseline risk of
prematurity when compared to the general population.
Overall completeness and applicability of
evidence
For some of the outcomes of interest, we identified only a small
number of studies and a limited number of participants. The cut-
off used for the definitions of severe and extreme prematurity and
for different cone depths varied slightly across studies; these were
merged in broader groups for the analysis. Individual patientmeta-
analysis data is required to more accurately describe the stratified
risk of PTB for individual cone depths. The data on the cone
dimensions relied on retrospective documentation data recorded
in histopathology reports of formalin-fixed samples with obvious
limitations. The formulas used for the volume calculation also
varied across studies. Future research should aim to correlate out-
comes with prospective precise done depth and cervical measure-
ments.
Both the included and excluded studies demonstrated awide range
of inclusion/exclusion criteria and outcome measures limiting sta-
tistical pooling of all the primary studies. There should be agree-
ment amongst academic colposcopists and obstetricians on core
research clinical outcome measures in line with the CROWN
initiative of the premier reproductive health journals (http://
www.crown-initiative.org/aims-and-scope/). This would improve
the applicability of findings of primary and secondary research
internationally.
Quality of the evidence
This meta-analysis included a large number of studies (69 cohorts)
with sufficient sample size and power to explore several compar-
isons of treatment techniques and cone depths. We performed
analyses for the different comparison groups used across studies
and made observations on how this impacts on the results.
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However, the results should be interpreted with caution. Due to
the pre-malignant nature of the disease, no randomised controlled
trials (RCTs) could be identified. All the included studies were
cohorts, in the vast majority retrospective. Such reports are at
known risk of recall bias and inadequate adjustment for known
and unknown confounders, while some of the outcomes of inter-
est were difficult to measure objectively. Many of the studies relied
on data collected from structured interviews and mailed question-
naires and in some of these, the response rate was small, increasing
also the risk of incomplete outcome data (attrition). Altogether
13 studies were considered to be of very low quality because of
attrition bias or recall bias or small number of participants, but
we were able to upgrade 31 studies to moderate quality because
they were population-based, had a large number of participants
or were prospective. Still, the quality of the evidence based on the
GRADE assessment was low or very low for the assessed maternal
or fetal outcomes (Summary of findings for the main comparison)
and low or high for analyses regarding the effect of the cone depth
(Summary of findings 2). Although the overall number of studies
was large, for some outcomes and comparisons the numbers of
studies was small and the analyses did not have sufficient sample
sizes to support definite conclusions.
Meta-regression was possible for some, but not all, possible con-
founders. For many moderators, the data were reported only in a
proportion of the included studies. When these studies were not
deemed representative of the whole population of studies, we did
not perform meta-regression as this would introduce bias. Sensi-
tivity and subgroups analyses based on the studies’ quality did not
change the effect of the meta-analysis.
Potential biases in the review process
This review relies on non-randomised studies and therefore at high
risk of bias. Many of the included studies were of low or very low
quality.
We opted for the use of unadjusted data for the analysis that was
recommended during the protocol and early stages of this review.
More recent guidance recommends the use of adjusted as opposed
to unadjusted data. This is because unadjusted data may over-in-
flate or underestimate the effect of treatment due to other con-
founding factors. Despite existing controversies, it is possible that
the use of adjusted datamay better control for existing confounders
that may affect the magnitude of the effect in observational stud-
ies. In future updates of this review adjusted data will be incorpo-
rated to meet he more recent recommendations.
There was no evidence of publication bias apart from one outcome
(PTB <32 to 34 weeks of gestation).
One of the major strengths of this systematic review is that this
provides a full assessment of the up-to-date literature for all clini-
cally relevant outcomes. However, the reporting of a large number
of outcomes increases the chance of type 1 statistical error (out-
comes will be found to be statistically significant just by chance;
incorrect rejection of a true null hypothesis).
Agreements and disagreements with other
studies or reviews
The knowledge that local treatment for cervical precancer, par-
ticularly excisional, increases the risk of PTB has led to major
changes in clinical practice. With an increasing evidence base sug-
gesting that this risk is higher for more radical techniques, there
has been a tendency to use less aggressive treatments. Although
it was previously thought that the various techniques had com-
parable efficacy (Martin-Hirsch 2013), evidence from a popula-
tion-based study raised concerns that less radical treatment may
increase the risk of post-treatment invasion (Arbyn 2014; Strander
2014). Although the decreased number of hysterectomies may ex-
plain this increase, the move to less conservative methods in an-
other plausible explanation. Additionally, since the first documen-
tation of the reproductive risk associated with treatment almost
a decade ago (Kyrgiou 2006), subsequent observational studies
and evenmeta-analyses reached contradictory conclusions (Arbyn
2008; Bruinsma 2011; Conner 2014; Danhof 2015; Jin 2014;
Kyrgiou 2014) and initiated debates within the scientific com-
munity. With some authors raising concerns that the progressive
reduction in the radicality of treatment has led to increased risk
of future of invasion (Arbyn 2014; Strander 2014), and others
advocating the move to less radical techniques like laser ablation
(LA) for the prevention of treatment-associated future perinatal
morbidity and mortality (Paraskevaidis 2007), high-quality syn-
thesis of the evidence had become an urgent unmet need. Some
of the previous small meta-analyses suffered methodological flaws
and attempted analysis of individual treatment techniques or sub-
groupsminimising the validity of their findings in context with the
rest of the literature (Conner 2014; Danhof 2015; Jin 2014). All
of the published meta-analyses failed to analyse the data according
to major confounders and stratifiers of risk, the comparison group
and the depth of the excision. Although Bruinsma and colleagues
first approached the comparison group as a possible confounder,
data on the depth and dimensions of the treatment were not avail-
able (Bruinsma 2011).
Preterm birth is a major cause of neonatal death and disability and
represents an enormous cost to health services and society. While
pregnant, these women make up a large proportion of preterm
clinics referrals. These referrals have increased from almost none in
1999, to more than 40% in 2012 (Kindinger 2016). Ultrasound-
directed surveillance is labour-intensive, costly, and may be associ-
ated with maternal anxiety, more so because 85% of women post-
excision are effectively low risk and will deliver at term (Bruinsma
2011; Kyrgiou 2006).
With rapidly accumulating evidence correlating cervical treatment
to adverse reproductive morbidity, quantification of the compar-
ative obstetric morbidity for different treatment techniques and
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cone depths was required to assist clinicians’ decision-making and
counselling. The results of this meta-analysis will allow clinicians,
patients and policy makers to balance the absolute increase in re-
productivemorbiditywith increasing treatment radicality. Patients
should be informed that treatment increases the risk of PTB, as
opposed to having CIN only, but the absolute increase in risk in
small type 1 excisions is likely to be low, if any.
Furthermore, the quantified individual risk stratified by treatment
and cone depth could allow obstetricians the selection of those
considered to be at high risk of PTB that would benefit from in-
tensive surveillance antenatally and minimise the unnecessary in-
terventions for those at low risk. The antenatal management of
women after treatment has been inconsistent and largely unit- or
clinician-dependent (Buller 1982). The risks and benefits associ-
ated with various interventions in pregnant women with a his-
tory of cervical treatment have not been fully assessed in properly
designed studies (Kindinger 2016). Future research should assess
their value in this distinct clinical group and devise a logical pre-
vention strategy.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Women with cervical intra-epithelial neoplasia (CIN) have a
higher baseline risk of preterm birth (PTB) compared to women
from the general population. Local cervical treatment for pre-in-
vasive or early invasive disease further increases the risk, more so
for excisional treatment, but also for ablative techniques. The risk
of PTB increases with increasing cone depth (and volume) and
techniques that remove or destroy larger parts of the cervix. The
increase in risk for small excisions, as opposed to having CIN, is
likely to be small, if any. However, for many outcomes the quality
of evidence was judged to be low or very low, creating uncertainty
about the confidence in the effect estimate.
When deciding to treat women of reproductive age, every effort
should be made to perform a local treatment that will optimise the
chances of a healthy pregnancy without compromising the com-
pleteness of the local treatment. Quality assurance in treatment of
disease should include audit of dimensions of excisional specimens
and persistent disease rates to ensure that treatment depth is kept
to acceptable parameters (i.e. at least 8 mm to involved crypts)
and that oncological outcomes are not compromised. Clinical ex-
perience is important in achieving the optimal balance between
complete removal of the lesion and minimum damage of healthy
cervical tissue. Unecessary large excisions may lead to severe ad-
verse obstetric outcomes, whilst overly conservative excisions that
compromise clearance of the disease may result in high recurrence
rates and the need for repeat excision multiplying the frequency
and severity of the reproductive sequelae. Clinicians should inform
women about the increased risk of adverse reproductive outcomes
in a future pregnancy after treatment, particularly for large and
repeat treatments. These women may be offered more intensive
surveillance when pregnant (Kindinger 2016).
Implications for research
Future research should use individual patient data and network
meta-analyses methodologies to quantify the oncological and re-
productive impact of different treatment techniques. It is also im-
portant to investigate why women who have CIN appear to be sus-
ceptible to both CIN and PTB, or whether HPV-induced disease
alone is the principal factor in increasing premature delivery. It is
likely that a combination of immunological and other factors play
a role. The uptake of prophylactic vaccination has been mixed in
the developed world and minimal in low-income countries. The
impact of cervical treatment is still going to be relevant for many
decades and therefore robust clinical research in this field should
remain a priority.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Acharya 2005
Methods Retrospective cohort study
Comparison group: A) External - matching for age (+/- 3 years), parity, date of delivery,
smoking (+/- 5 cigarettes per day) and previous obstetric history
B) Internal (pre-treatment pregnancies)
Information source - Hospital records of the University Hospital of Northern Norway
Participants A) Treated group: 79women < 45 years who had a LLETZ (December 1995 toDecember
2000) and subsequently delivered (> 20 weeks) at the University Hospital of Northern
Norway. Inclusion criteria: only first pregnancies (> 20 weeks) following LLETZ
Exclusion criteria: Women with ectopic pregnancies, miscarriages, TOPs
Untreated group: 158 matched women who were identified using routinely entered data
from the birth register
B) Of the 79 women of the treated group, 45 were parous. The last pregnancy before
LLETZ of these 45 women can serve as an internal comparison group
Interventions LLETZ
Outcomes PTB (< 37 weeks); threatened PTL; chorioamnionitis; induction of labour; LBW (<
2500 g); perinatal mortality
Notes Because all women included in this study have been also included in Albrechtsen 2008,
we excluded it from the analyses in which Albrechtsen 2008 has been also included.
A total of 428 women < 45 years had LLETZ performed during the study period and 89
of them had a pregnancy after the procedure. Ten women were excluded (three ectopic
pregnancies, two TOPs and five miscarriages) from the study. Data from 79 women
whose pregnancies progressed > 20 weeks and 158 matched controls were analysed. The
histological diagnosis was normal in 3 (3.8%), CIN1 in 5 (6.3%), CIN2 in 18 (22.8%)
, and CIN3 in 53 (67.1%) of cases
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
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Acharya 2005 (Continued)
Representative intervention group? Low risk All eligible for the study women having
LLETZ and subsequently delivering in a
single university hospital between Decem-
ber 1995 to December 2000
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for date of delivery, age, par-
ity, previous obstetric history and smoking
habit
Albrechtsen 2008
Methods Retrospective cohort study
Comparison groups:
A) External
B) Internal (pre-treatment pregnancies)
Both had regression analysis for age and birth order
Information source - Cancer Registry of Norway, Medical Birth Registry of Norway,
Central Population Registry, Cause of Death Registry
Participants Treated group: all pregnancies proceeding beyond 24 weeks of gestation (n = 14,882)
of all women in Norway who delivered during 1967 to 2003 after cervical conisation
(CKC, LLETZ, LC)
Untreated group: A) all pregnancies proceeding beyond 24 weeks of gestation (n = 2,
155,505) of all women in Norway who delivered during 1967 to 2003 without previous
cervical conisation
B) all pregnancies proceeding beyond 24 weeks of gestation (n = 56,927) of all women in
Norway who delivered during 1967 to 2003 before cervical conisation (CKC, LLETZ,
LC)
Exclusion criteria: women≥ 45years at the time of cervical conization; women who had
their CIN diagnosis during 1980 to 1985 because it is not known if they had a treatment
(these women were included in the untreated group)
Interventions Excisional NOS (CKC, LC, LLETZ)
Outcomes PTB (< 37 weeks); PTB (< 33 weeks); PTB (< 28 weeks)
Notes Since 1953, the cancer registry has collected information on all cancer diagnoses as well
as premalignant lesions, including intraepithelial neoplasia with staging.
The compulsory reporting system is based on clinical, pathology, and cytology reports.
During 1953 to 1979 and from 1986 onwards, treatment of intraepithelial neoplasia
with cervical conisation has also been notified, though without specification of surgical
method. During 1980 to 1985, only data on histological diagnoses-that is, the grade of
intraepithelial neoplasia- were notified and the researchers excluded these women from
the exposed group and included them in the not treated group
226 pregnancies after treatment were late miscarriages (< 24 weeks). 209 pregnancies
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Albrechtsen 2008 (Continued)
before treatment were late miscarriages. 8501 pregnancies of the untreated group were
late miscarriages. In this meta-analysis, these pregnancies were subtracted from the total
number
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from na-
tional registries; Cancer registry: includes
all cancer diagnoses as well as premalignant
lesions plus their treatment (during 1980 to
1985 did not include treatment); Birth reg-
istry: the proportion of women with miss-
ing data on gestational age amounted to 5.
3%, while data on birth weight were almost
complete
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Unclear risk During 1980 to 1985 the Cancer registry
included only the grade of CIN and did
not include the treatment. The researchers
excluded those women from the treated
group and included them in the untreated
group, even though they might have had
treatment before or after pregnancy. Be-
cause the population of this study is big
enough, it is not estimated that this proba-
ble misclassification has affected the results
of the study to a significant extent
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women inNorway
who delivered during 1967 to 2003, before
or after cervical conisation (a population-
based study)
Representative comparison group? Low risk A) The untreated external comparison
group was drawn from the same source as
the treated group
B) Internal matching (self-matching)
Comparability of treatment groups? Low risk A) Regression analysis for age (at delivery
or treatment) and birth order
B) Internal matching (self-matching)
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Andersen 1999
Methods Retrospective cohort study
Comparison group: External - matching for age and parity
Information source - Hospital records of the Aalborg Hospital
Participants Treated group - 75 pregnancies (< 27 weeks) of 62 women who had undergone LA before
the pregnancy at the Aalborg Hospital (LA during 1985 to 1989)
Exclusion: 6 patients with TOP, 3 with miscarriage and 1 with ectopic pregnancy
Untreated group - 150 pregnancies of women without previous treatment (the next two
women entering the delivery ward who were matched by age and parity)
Interventions LC
Outcomes PTB (≤ 37 weeks); PTB (≤ 37 weeks) (D < 15 mm); PTB (≤ 37 weeks) (D = 15 mm to
20 mm); PTB (≤ 37 weeks) (D > 20 mm); pPROM; CS; perinatal mortality; stillbirth;
Apgar score (≤ 5) (1 min);
Notes From 1985 to 1989, combination LC was performed in 536 patients. After LC, 72
patients became pregnant. After the exclusion of the 10 ineligible women, the remaining
62 patients had 75 pregnancies (> 27 weeks)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All women who had had LC in a single
hospital (1985 to 1989) and subsequently
had a pregnancy (> 27 weeks)
Representative comparison group? Low risk The control group was drawn from the
same source as the treated group
Comparability of treatment groups? Unclear risk Matching for age and parity. No match-
ing for smoking, although the interven-
tion group had substantially higher rate of
smoking (62.7% vs 27.3%)
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Anderson 1984
Methods Retrospective cohort study
Comparison group: External - matching for age, race, births and miscarriages/TOP
Information source - hospital records (for the ascertainment of the exposure) and postal
questionnaires (for the ascertainment of the outcome); additional information from
obstetricians who delivered other women
Participants Treated group - 68 deliveries of women who had been treated by LA as their initial
treatment for CIN at the Samaritan Hospital for women, London, between December
1978 and February 1984, and subsequently had a pregnancy. Women who were treated
in the previous 3 months were excluded
Untreated group - 70 deliveries of women without previous treatment who delivered at
the St Mary’s Hospital, London
Interventions LA
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); CS; instrumental deliveries (forceps)
; prolonged labour (> 12 hours); LBW (< 2500 g)
Notes 1013patientswere treated byLA as their initial therapy forCINat the SamaritanHospital
for Women, London, between December 1978 and February 1984, and were followed
up for at least 10months thereafter. A questionnaire was sent to all the women, apart from
those treated in the previous 3 months, asking for information about pregnancies before
and after LA. About 25% of the questionnaires were returned by the Post Office as the
women had moved away and could not be traced. This proportion is not surprising in a
mobile, urban population. Additional information was obtained from obstetricians who
delivered other women. In total, the researched found 118 pregnancies in 110 patients.
Of these pregnancies, 68 ended to delivery and were included in the analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk 25% of the women did not reply to
the postal questionnaire because they had
moved away and could not be traced. There
is a high risk of attrition bias, although this
proportion is not surprising in a mobile,
urban area
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Recall bias because postal questionnaires
were used for the ascertainment of the out-
come
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
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Anderson 1984 (Continued)
Representative intervention group? High risk 25% of the women did not reply to the
questionnaire, because they had moved
away. The women who replied are more
likely to belong to a higher socioeconomic
class
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age, race, births and miscar-
riages/TOP
Andia 2011
Methods Retrospective cohort study
Comparison group: A) External
B) Internal (pre-treatment pregnancies)
Both had regression analysis for age, parity and smoking
Information source - Databases of the Cervical Pathology Units of the 5 main hospitals
of the Basque Country participating in this study (Basurto, Cruces, Donostia, Galdakao,
and Txagorritxu); Basque Country Health Service databases
Participants Treated group - 189 women who had undergone LLETZ during 1988 to 2007 at the
5 main hospitals of the Basque Country (Basurto, Cruces, Donostia, Galdakao, and
Txagorritxu) and subsequently delivered
Untreated group - A) 189 women who delivered during 1988 to 2007 without previous
treatment and were identified from the Basque Country Health Service databases
B) Internal population of women that had pregnancies before LLETZ (n = 189)
Inclusion criteria (for both groups): only singletons were included
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (nulliparous); PTB (< 37 weeks) (parous); PTB (<
37 weeks) (singleton pregnancies); PTB (< 35 weeks); PTB (< 32 weeks); CS; LBW (<
2500 g); LBW (1500 g)
Notes Adjusting for maternal age, parity, and maternal smoking did not affect the results
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
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Andia 2011 (Continued)
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk A stratified random sampling of the women
having LLETZ during 1988 to 2007 at the
five main hospitals of the Basque Country
and subsequently delivering
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for age, parity, smoking
Anwar 2016
Methods Retrospective cohort study
Comparison group: Internal (self-matching)
Information source - Colposcopy Electronic Data Base (CYRIS) for identification of
the treated women & Trust Electronic Pathology Data (WebV) for details of the cone
biopsy treatment; Hospital Episode Statistics and electronic maternity data (CMIS) for
identification of the women who subsequently achieved pregnancy & obstetric case notes
by the local audit department for pregnancy details
Participants Treated group - 15 women (23 pregnancies) who underwent electrosurgical cone biopsy
using FCBE electrode at Diana Princess of Wales Hospital Grimsby between January
2000 and December 2011 and subsequently delivered at the same hospital before March
2013
Untreated group - The 48 pregnancies of these 15 women before treatment
Interventions FCBE (Fischer Cone Biopsy Excisor)
Outcomes PTB (< 37 weeks)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Small number of included treated women;
there is possible bias due to unknown loss
to follow-up of women who delivered at
units other than the host institution
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
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Anwar 2016 (Continued)
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women undergo-
ing treatment anddelivering in a single hos-
pital
Representative comparison group? Low risk Internal comparison group (self-matching)
Comparability of treatment groups? Low risk Internal comparison group (self-matching)
Armarnik 2011
Methods Retrospective cohort study
Comparison group: External - unmatched; regression analysis for age, birth order, year
of delivery, smoking and cervical incompetence with cerclage
Information source - medical records in combination with a computerised perinatal
database (Soroka University Medical Center, Israel)
Participants Treated group - 53 deliveries of womenwhohad undergone conisation and then delivered
at the Soroka University Medical Centre
Untreated group - 104,617 deliveries of women who delivered at the Soroka University
Medical Centre without previous conisation
Exclusion criteria: multiple gestations; patients lacking prenatal care
Interventions Excision NOS (CKC, LC, LLETZ, other)
Outcomes PTB (< 34 weeks); CS; epidural use; cervical cerclage; perinatal mortality
Notes Using the delivery record database, 53 deliveries after conisation were found. Using the
medical records, 57 deliveries after conisation were found. The discrepancy between
these two databases is because the delivery record database had a recording gap
LLETZ was the most common treatment (LLETZ: 18; CKC: 7; LC: 2; other: 14; >1
conisation: 1)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk 4/57women (7%) were not included in the
analysis, because of a recording gap in the
delivery record database
Selective reporting (reporting bias) Low risk No reporting bias is obvious
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Armarnik 2011 (Continued)
Other bias Unclear risk Table 1 in page 767: When we add the
women according to the conisation type,
the sum is 42.Whenwe add the women ac-
cording to the histology of cervical biopsy
or the smoking status during pregnancy,
the sum is 40. There is a difference of two
women
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single hospital
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for age, birth order, year
of delivery, smoking and cervical incompe-
tence with cerclage
Bekassy 1996
Methods Retrospective cohort study
Comparison group: A) External - matching for age, parity and time of delivery
B) Internal (self-matching)
Information source - Anaesthetic records of University Hospital of Lund, Sweden, and
NationalMedical Birth Registry at theNational Board ofHealth andWelfare, Stockholm
Participants A) Treated group - 250 women who had undergone LC at University Hospital of Lund,
Sweden, and had a subsequent delivery, between January 1980 and June 1988
Untreated group - 250 women selected from the National Medical Birth Registry
B) Of the 250 women of the treated group, 148 were parous. For these women, self-
matching was also possible
Interventions LC (’laser miniconisation’)
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (nulliparous); PTB (< 37 weeks) (parous); PTB (<
37 weeks) (single cone); PTB (< 37 weeks) (repeat cones); CS; instrumental deliveries
(ventouse/forceps); prolonged labour (> 12 hours); cervical stenosis; LBW (< 2500 g);
perinatal mortality; stillbirth
Notes From January 1980 to June 1988, 1485 women between age 16 to 58 were treated by
carbon dioxide laser miniconisation because of CIN at University Hospital of Lund.
These women were identified retrospectively via certain operation code numbers in the
Anaesthetic hospital records. Each woman had also a specific 10-tailed patient identifica-
tion number (PIN), which is also used by the National Medical Birth Registry to register
births in Sweden. The information of these 1485 women was transferred to a magnetic
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Bekassy 1996 (Continued)
tape which was then run against data held at the National Medical Birth registry and
250 women having a delivery after treatment (3 had twin pregnancies) were identified.
Of these women, 245 delivered at the Department of Obstetrics and Gynaecology, Uni-
versity Hospital of Lund, and the other 45 at 21 different hospitals around Sweden. 20
women had LC twice before pregnancy
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records and national registries
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible women having LC at the Uni-
versity Hospital of Lund between January
1980 to June 1988
Representative comparison group? Unclear risk A) The untreated group was not drawn
from the same source as the treated group
B) Internal comparison group (self-match-
ing)
Comparability of treatment groups? Low risk A) Matching for age, parity and time of
delivery
B) Internal comparison group (self-match-
ing)
Blomfield 1993
Methods Retrospective cohort study
Comparison group: External - matching for age, parity and ethnic group
Information source - Computer database of Dudley Road hospital
Participants Treated group - 40 women who had undergone LLETZ and were subsequently delivered
at Dudley Road Hospital, between January 1989 and January 1992
Untreated group - 80 women without previous treatment delivering immediately before
and after the cases at Dudley Road Hospital
Interventions LLETZ
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Blomfield 1993 (Continued)
Outcomes PTB (< 37 weeks); sPTB (< 37 weeks); CS; instrumental deliveries (ventouse/forceps)
; induction of labour; oxytocin use; epidural use; LBW (< 2500 g); NICU admission;
perinatal mortality
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from com-
puterised hospital records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible women that had LLETZ at
Dudley Road Hospital between January
1982 to January 1992; low risk. However,
more than 60% of the women delivering at
Dudley Road Hospital are nonwhite
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age, parity and ethnic group
Braet 1994
Methods Retrospective cohort study
Comparison group: External - matching for age (+/- 5 years), parity and smoking
Information source - Hospital records of Rotherham District General Hospital
Participants Treated group - 78 women who had undergone LLETZ in Rotherham District General
Hospital between 1 December 1998 and 15 October 1992 and had a viable pregnancy
afterwards. Only the first pregnancy after treatment was included. Only singleton preg-
nancies were included
Untreated group - 78 women who were the next following patients delivered in the same
hospital
Interventions LLETZ
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Braet 1994 (Continued)
Outcomes PTB (< 37weeks); PTB (< 37weeks) (singleton pregnancies); pPROM;CS; instrumental
deliveries (ventouse/forceps); APH; LBW (< 2 500 g); perinatal mortality
Notes Between 1 December 1988 and 15 October 1992, a total of 1000 women had LLETZ in
Rotherham District General Hospital. It was possible to identify 84 viable pregnancies
in patients who had undergone the procedure before conception. Of the 84 pregnancies,
5 were second pregnancies after LLETZ and one was a twin pregnancy. The other 78
women were finally included in the treated group
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women that had
LLETZ in a hospital between 1988 to 1992
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Patients from the same unit matched for
age (+/- 5 years), parity and smoking
Bruinsma 2007
Methods Retrospective cohort study
Comparison groups:
A) Women with colposcopy before pregnancy, but no treatment
B) Women with colposcopy during pregnancy, but no treatment
Both had regression analysis for age, illicit drug use during pregnancy, delivery at the
RWH, marital status, maternal medical condition, previous TOP, previous miscarriage,
previous PTB, previous treatment
Information source - Records of the Cervical Dysplasia Clinic of the Royal Women’s
Hospital (RWH) (for the ascertainment of the exposure); Victorian Perinatal Data Col-
lection Unit (PDCU) (for the ascertainment of the outcomes)
Participants Treated group - 1951 women who were referred to the Royal Women’s Hospital (RWH)
during 1982 to 2000, received treatment for CIN and thereafter had a pregnancy in the
state of Victoria during 1983 to 2002. Women with hysterectomy or treatment during
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Bruinsma 2007 (Continued)
pregnancy were excluded
Untreated group - 3597 women who were referred to the RWHduring 1982 to 2000 and
then delivered in the state of Victoria during 1983 to 2002 without receiving treatment
(referral during the index pregnancy:1303; referral before the index pregnancy:2294)
Inclusion criteria (for both groups): referral to the RWH either for assessment of an
abnormality detected on a routine Pap smear or for evaluation of a cervix that appeared
abnormal; only the first pregnancy after the referral/treatment
Exclusion criteria (for both groups): missing date of birth; multiple pregnancies; referral
to the RWH for assessment of a non-cervical lesion; women recorded in their clinic
record as having no previous children and were 45 years or older at time of initial visit
or who indicated that they had children but were older than 40 years at initial visit in
1982 or 41 years in 1983, etc
Interventions CKC, LLETZ, LA, RD
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); PTB (< 32 weeks); PTB
(< 28 weeks); sPTB; pPROM; CS; instrumental deliveries (ventouse/forceps); LBW (<
2500 g); perinatal mortality; stillbirth
Notes Since 1982, the Victorian Perinatal Data Collection Unit (PDCU) has collected data on
all births in the state of Victoria greater than or equal to 20 weeks of gestation or 400 g
All women were followed up for at least 2 years (range 2 to 20 years), the median follow-
up time being 9 years for treated women and 10 years for untreated women
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) High risk All outcomes, except for PTB (< 37 weeks)
, are presented only for the whole treated
group and not separately according to the
type of treatment
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women undergo-
ing treatment forCINduring1982 to2000
in the largest treatment centre in Victoria
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
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Bruinsma 2007 (Continued)
Comparability of treatment groups? Low risk Regression analysis (for the outcome of
PTB) for age, illicit drug use during preg-
nancy, delivery at the RWH, marital sta-
tus, maternal medical condition, previous
TOP, previous miscarriage, previous PTB,
previous treatment
Buller 1982
Methods Retrospective cohort study
Comparison group - Internal (pre-treatment pregnancies)
Information source -Hospital records ofUniversity of CaliforniaHospital, San Fransisco,
and Kaiser Hospital, Honolulu
Participants Treated group - 47deliveries ofwomenwhohadundergone diagnostic and/or therapeutic
conization of the cervix at either the University of California Hospital, California, or
Kaiser Hospital, Honolulu, between 1968 and 1978, and had a subsequent delivery.
Inclusion criteria: Women of reproductive age (arbitrarily defined as age 39 or less) at
the time of surgery. Exclusion criteria: Women with a hysterectomy or a sterilisation
procedure and women who were lost to follow-up
Untreated group - 79 deliveries of the women of the treated group who had also a delivery
before the treatment
Interventions CKC
Outcomes PTB (< 37 weeks); Threatened PTL; CS
Notes 503 underwent diagnostic and/or therapeutic conization of the cervix at either the Uni-
versity of California Hospital, San Fransisco, or Kaiser Hospital, Honolulu, between
1968 and 1978. Of these, 314 were of reproductive age, arbitrarily defined as age 39 or
less, at the time of surgery. A hysterectomy or a sterilisation procedure was subsequently
performed on 87 of these 314 patients. An additional 61 patients were lost to follow-up
within 12 months of the conisation. Of the remaining 166 patients, 61 patients achieved
88 pregnancies and the other 105 patients did not become pregnancies after conisation.
Of the 88 pregnancies, 47 led to a labour. The same women before the treatment had
106 pregnancies (79 led to a labour)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk 227 women were eligible for the study. Of
these, 61 (26.9%) were lost to follow-up
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
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Buller 1982 (Continued)
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible women that had CKC in two
hospitals between 1968 to1978
Representative comparison group? Low risk Internal comparison group (pre-treatment
pregnancies)
Comparability of treatment groups? Low risk Internal comparison group (pre-treatment
pregnancies)
Castanon 2012
Methods Castanon 2012 (this is the main study):
Retrospective cohort study
Comparison groups - A) External (general population)
B) Women with punch biopsy but no treatment
C) Internal (pre-treatment pregnancies)
D) Internal (self-matching: same women before and after treatment)
Regression analysis for age, parity and study site for some comparison groups, but not
for the ones that we used in our meta-analysis (see ”Notes“)
Information source - Records of the 12 participating NHS hospitals (for the ascertain-
ment of the exposure); hospital episode statistics of inpatient obstetric records for the
whole of England (for the ascertainment of the outcomes)
Castanon 2014:
Case-control study nested in a retrospective cohort study
Matching for age, parity, study site and whether the birth occurred before or after the first
colposcopy; regression analysis for age, parity, study site and index ofmultiple deprivation
Participants Castanon 2012:
Study period for the treatment/biopsy: January 1987 to December 2009
Study period for the delivery: April 1998 to April 2010
Location for the treatment/biopsy: one of the 12 participating NHS hospitals
Location for the delivery: any NHS hospital
Treated group - 4776 deliveries of women who had undergone excisional treatment and
subsequently had a pregnancy
Untreated group - A) 510,660 deliveries (general population of England)
B) 7263 deliveries of women who had undergone punch biopsy but no treatment and
subsequently had a pregnancy
C) The deliveries (1173) of the treated group before their treatment
D) For 372 women who had at least one delivery both before and after the delivery,
internal matching (self-matching) was also possible: the first delivery after treatment was
compared with the last delivery before treatment
Exclusion criteria (for all groups): Pregnancies with no gestational age recorded, with
gestational age > 43 weeks, with gestational age < 20 weeks or with no year of birth
recorded as well as multiple pregnancies
Additional exclusion criteria (for the women with treatment or punch biopsy): Women
52Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Castanon 2012 (Continued)
for whom the date of histology was unknown
Castanon 2014:
Study period for the treatment/biopsy: April 1988 to December 2011
Study period for the delivery: April 1998 to March 2011
Location for the treatment/biopsy: one of the 12 participating NHS hospitals
Location for the delivery: any NHS hospital
Cases - 768 women with a preterm birth after excisional treatment or punch biopsy.
Only the earliest occurring singleton preterm birth (with any parity) in each woman was
included
Controls - 830 matched women with a term birth after excisional treatment or punch
biopsy
Inclusion criteria: births at 37weeks’ gestational age, womenwith incomplete colposcopy
records, women for whom the only pathology sample reported was non-cervical, women
who were recorded as being sterilised while pregnant, women with a diagnosis of cervical
cancer at any time, women whose pregnancy was at high risk (diabetes mellitus, hyper-
tension, placenta praevia with haemorrhage, supervision of high risk pregnancy, mental
disorders, and diseases of the nervous system complicating pregnancy, childbirth, and
the puerperium)
Interventions Excision NOS (CKC, LC, LLETZ, other)
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (D < 10 mm); PTB (< 37 weeks) (D ≥ 10 mm);
PTB (< 37 weeks) (singleton pregnancies); PTB (< 33 weeks)
Notes Castanon 2012: In addition to the treated/comparison groups that we used in our meta-
analysis, the authors had a variant of those as well: only the first birth recorded in the
dataset for each woman during the study period, after exclusion of antepartum stillbirths
and stillbirths of indeterminate timing. For these groups there was regression analysis
for age, parity and study site, but no regression analysis for the groups that we selected.
However, we selected the latter, because the population is bigger and we had no reason
to restrict to the first pregnancy of each woman during the study period
Castanon 2014: this was a case-control study nested in this retrospective cohort study.
The cases were 768 preterm births and the controls were 830 term births, all occurring
after excisional treatment or punch biopsy. The main outcome of this study was the
depth of the cone in the cases and controls stratified in the following categories: 1 mm
to -9 mm, 10 mm to 14 mm, 15 mm to 19 mm, ≥ 20mm. The cases and the controls,
as a case-control study, were different from the cases and the controls of all the other
studies. We have contacted the investigators of the study and also used the published
data to extract the PTB (< 37 weeks) rate for women with excision of < 10 mm in depth
and≥10 mm in a treated group versus women who had punch biopsy but no treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Of the total number of pregnancies (n =
26897) of the women with a pregnancy be-
fore or after treatment/punch biopsy, 8050
pregnancies (29.9%) had an unknown ges-
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tational age
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Unclear risk The authors do not have information as
to whether the punch biopsy group may
have had a history of ablative treatment or
whether the treatment group had antenatal
interventions when pregnant. There is no
evidence of the efficacy of these interven-
tions so it is unclear whether this is a source
of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk Women having treatment at one of the
12 participating NHS hospitals (represen-
tation from the whole England) and then
delivering at any NHS hospital
Representative comparison group? Low risk A/B) The untreated group was drawn from
the same source as the treated group
C/D) Internal controls
Comparability of treatment groups? Low risk A) General population of the whole Eng-
land
B)Women with punch biopsy (it is consid-
ered that possible confounding factors are
not different between this group and the
treated group and thus, this is one of the
best comparison groups, in general)
C/D) Internal controls
No regression analysis for the comparison
groups that we used (see ”Notes“ above)
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Methods Retrospective cohort study
Comparison groups: A) Untreated women without a history of sPTB (low risk); this is
the control group we used for out meta-analysis
B) Untreated women with a history of sPTB (high risk)
Both had regressional analysis for maternal age, gestational age at the time of transvaginal
ultrasonography, parity, smoking, antepartum bleeding after 20 weeks of gestation and
previous sPTB
Information source - Hospital records of theWomen’s Health Centre of the Health Care
Corporation of St. John’s
Participants Treated group - 132 (LLETZ = 75, CKC = 21, CT = 36) pregnant women with singleton
gestations from June 2001 to June 2004 at the Women’s Health Centre of the Health
Care Corporation of St. John’s who previously had LLETZ , CKC or cryotherapy
Untreated group - A) 81 women without history of sPTB or treatment for cervical
dysplasia (low-risk control group)
B) 63 women with a history of sPTB not having had treatment for cervical dysplasia
Interventions CKC; LLETZ; CT
Outcomes sPTB (< 37 weeks); sPTB (< 37 weeks) (singleton pregnancies); sPTB (< 34 weeks);
CS; induction of labour; APH; LBW (< 2500 g); NICU admission; perinatal mortality;
Apgar score (< 7) (5min)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single hospital during June 2001 to
June 2004
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regressional analysis for maternal age, ges-
tational age at the time of transvaginal ul-
trasonography, parity, smoking, antepar-
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tum bleeding after 20 weeks of gestation,
and sPTB
Cruickshank 1995
Methods Retrespective cohort study
Comparison group: A) External - matching for age, parity, husband’s or partner’s social
class, height and daily cigarette consumption
B) Internal (pre-treatment pregnancies)
Information source - AberdeenMaternity andNeonatal Databank, postal questionnaires
Participants A) Treated group - 149 women who had undergone LLETZ between 1989 and 1991.
Only the first singleton pregnancies following treatment that progressed to 20 weeks
of gestation were included. Multiple pregnancies were excluded. We also excluded 2
miscarriages, giving a total of 147 women
Untreated group - 298 women without previous treatment (two controls for each case).
We excluded 3 miscarriages, giving a total of 295 women
B) The 147 deliveries of the treated group after LLETZ were compared with the 133
deliveries of the treated group before LLETZ
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); PTB (< 28 weeks); CS;
precipitous labour (< 2 hours); stillbirth
Notes 1000 women who had undergone LLETZ between 1989 and 1991 were identified via
Aberdeen Maternity and Neonatal Databank. A postal questionnaire was sent to these
women in 1993 and 653 replied. Of these, 149 had a singleton pregnancy after treatment
andwere included in the treated group.The control groupwas also pooled fromAberdeen
Maternity and Neonatal Databank
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Postal questionnaires were used for the se-
lection of the treated group and many
women did not reply (347/1000 = 34.7%)
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk For the treated group, questionnaires were
used for the ascertainment of the outcome;
there is a risk of recall bias and misclassifi-
cation of the outcome
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
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Representative intervention group? High risk Postal questionnaires were used for the se-
lection of the treated group and many
women did not reply (34.7%). The women
who replied are more likely to have a higher
educational level
Representative comparison group? Low risk A) The untreated group was drawn from
the same source as the treated group
B) Internal comparison group (pre-treat-
ment pregnancies)
Comparability of treatment groups? Low risk A) Matching for age, parity, husband’s
or partner’s social class, height and daily
cigarette consumption
B) Internal comparison group (pre-treat-
ment pregnancies)
Ehsanipoor 2014
Methods Retrospective cohort study
Comparison group: External - unmatched; regression analysis for age, parity, race, history
of PTB, history of tobacco use, history of drug use and chorionicity
Information source - maternal prenatal records and impatient hospital charts from two
community hospitals in California
Participants Treated group - 110 women who had a twin pregnancy (≥ 24 weeks of gestation) at two
community hospitals in California during 1998 to 2005 and had previously undergone
treatment for CIN (CKC = 10, LLETZ = 36, LA/CT = 64)
Exclusion:womenwith colposcopy or biopsy only, pregnancieswithmajor fetal anomalies
or intrauterine death, multi-fetal pregnancy reduction, indicated delivery prior to 34
weeks, twin-twin transfusion syndrome, or cerclage placement
Untreated group - 766 women who had a twin pregnancy (≥ 24 weeks of gestation) at
two community hospitals in California during 1998 to 2005 with no history of cervical
procedures
Interventions CKC; LLETZ; Ablation NOS (LA, CT)
Outcomes PTB (< 37 weeks) (multiple pregnancies); PTB (< 34 weeks) (multiple pregnancies);
PTB (< 28 weeks) (multiple pregnancies)
Notes No woman had more than one twin delivery during the time period specified
If a participant had undergone both an ablative and excisional procedure, she was in-
cluded in the excisional group
A total of 110 (12.6%) women had undergone a prior procedure for cervical dysplasia.
This included 10 with a CKC, 36with a LEEP, 59 with cryotherapy and 5 had undergone
CO2 laser ablation. One of the participants with a CKC also had cryotherapy. One
participant had undergone cryotherapy twice and none of the women had more than
one excisional procedure
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Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women having a
twin pregnancy in two hospitals in Califor-
nia during 1998 to 2005
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for age, parity, race, his-
tory of PTB, history of tobacco use, history
of drug use and chorionicity
El-Bastawissi 1999
Methods Retrospective cohort study
Comparison groups:
A) External from general population - matching for age and country of origin (foreign
vs USA)
B) Women with Carcinoma in situ (CIS) but no treatment - unmatched
Both had regressional analysis for parity, race, maternal smoking, marital status and
history of TOPs
Information source - Cancer Surveillance System (a population-based cancer registry
covering 13 counties of western Washington) at the Fred Hutchinson Cancer Research
Center in Seattle, Washington, and Birth Certificates from the Department of Health
in Washington state
Participants Treated group - 1096 women who were less than 50 years old with CIS, were diagnosed
between1984 and1992,were treatedwith excisional or ablative therapy and subsequently
delivered live singletons between 1984 and 1995 (the women were identified by the
Cancer Surveillance System)
Untreated group - A) 9201 women (random sample selected from birth certificates, but
frequency-matched for age and the country of origin) without cervical cancer who gave
birth during the same years without previous treatment
B) 330 women with untreated CIS
Only women (for both the treated and untreated group) residing in the 13 counties
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of western Washington covered by the Cancer Survellance system were included. Only
women who indicated the same father of the index infant and previous children were
included
Interventions Excision NOS (CKC, LC, LLETZ); Ablation NOS (LA, CT)
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); CS; LBW (< 2500 g)
Notes From the 1851 women with CIS, 1539 women had a pregnancy after the CIS diagnosis.
Of these women, 212 had no surgical procedure before pregnancy, 227 had D&C or
ECC before pregnancy, 85 had cryosurgery or LA before pregnancy, and 1011 had
conisation before pregnancy. For 4 women, the procedure (if any) before pregnancy was
unknown
From the 1851 women with CIS, 312 were pregnant at the time of the diagnosis. Of
these women, 118 had no surgical procedure during pregnancy, 33 had D&C or ECC
during pregnancy, 6 had cryosurgery or LA during pregnancy, and 142 had conisation
during pregnancy. For 13 women, the procedure (if any) during pregnancy was unknown
It is possible to make the following comparisons in our meta-analysis:
a) Women with CIS and treatment before pregnancy versus women with CIS but no
treatment (diagnosis of CIS before pregnancy)
b) Women with CIS and treatment before pregnancy versus women with CIS but no
treatment (diagnosis of CIS during pregnancy)
c) Women with CIS and treatment before pregnancy versus women with CIS but no
treatment (diagnosis of CIS before or during pregnancy)
d) Women with CIS and treatment before pregnancy versus general population
Women that had treatment during pregnancy were excluded according to the exclusion
criteria of the systematic review
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information on birth weight, gestation
length, and delivery method was complete
for 98.8%, 83.2%, and 93.8% of women
with CIS versus 99.7%, 86.7%, and 94.7%
for comparison women, respectively
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women from 13
counties of westernWashington (a popula-
tion-based study)
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Representative comparison group? Low risk Both untreated groups were drawn from
the same source as the treated group
Comparability of treatment groups? Low risk Matching for age and country of origin
(foreign vs USA). Regressional analysis for
parity, race, maternal smoking, marital sta-
tus and history of TOPs
Fischer 2010
Methods Prospective cohort study
Comparison group: External - matching for age (+/- 5 years), race, the number of prior
vaginal deliveries at ≥ 20 weeks and gestational age at the time of cervical sonography
(+/- 2 weeks)
Information source - medical records of one of the southern New Jersey maternal-fetal
medicine offices
Participants Treated group - 85 pregnant women presenting to one of the southern New Jersey
maternal-fetal medicine offices (during 2001 to 2007) with a history of LLETZ (n = 68)
, CKC (n = 15), or both (n = 2)
Unterated group - 85 pregnant women referred from the referred obstetrical ultrasound
population (during 2007 to 2008) without previous cervical surgery
Exclusion criteria (for both groups): multiple gestations, a clinical history of cervical
insufficiency (defined as a history of repeat midtrimester pregnancy loss associated with
painless cervical dilatation), presence of a cerclage or planned cerclage, ruptured mem-
branes, or a fetal aneuploidy or major anomaly recognized at the time of cervical sonog-
raphy
Interventions Excision NOS (CKC; LLETZ)
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); PTB (< 34 weeks); CS;
cervical cerclage
Notes No enrolled patients were excluded from analysis after cervical sonography had been
performed
The researchers had difficulty finding amatched control for one of the study participants,
a 40-year-old Caucasian with four previous vaginal deliveries. They finally identified a
Filipino gravida who otherwise matched the study patient
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk No enrolled patient was excluded from
analysis after cervical sonography had been
performed
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Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other source of bias is obvious
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women having a
cervical sonography during 2001 to 2007
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age (+/- 5 years), race, the
number of prior vaginal deliveries at ≥ 20
weeks, gestational age at the time of cervical
sonography (+/- 2 weeks)
Forsmo 1996
Methods Retrospective cohort study
Comparison group: External - matching for age (+/- 3 years), parity and place of delivery
(hospital with perinatal care unit, smaller hospital or local district maternity wards)
Information source - Medical records, postal questionnaires
Participants Treated group - 71 women who were treated by LC or LA (LC = 51; LA = 20) in the
Department of Obstetrics and Gynaecology, University Hospital of Tromso, Norway,
during 1983-88 and had subsequently a delivery (deliveries till June 1992 were included)
. Only first deliveries after treatment (delivery after 24th week) were included. Only
singletons were reported by the women
Control group - 174 women who delivered without previous treatment
Interventions LC; LA
Outcomes LBW (< 2500 g); LBW (< 2000 g); LBW (< 1500 g); perinatal mortality; stillbirth
Notes During 1983 to 1988, 356 women were treated for CIN I-III with laser conisation or ab-
lation in theDepartment of Obstetrics and Gynecology, University Hospital of Thomso,
Norway. Twelve women (3.4%) were lost afterwards. In June 1992, a postal question-
naire was sent to the other 344 women. 319 women (93%) replied. The short ques-
tionnaire comprised questions about pregnancy outcome after treatment, birth weights,
complications in pregnancy or delivery, and place of delivery. A total of 87 women, all
women, reported that they fell pregnant at least once after treatment. Of these women,
71 had a delivery after 24 weeks of gestation. Information about gestational length and
verification of birth weight in women with≤ 2500 g was collected frommedical records.
Data concerning treatment, diagnosis and parity before pregnancy were previously reg-
istered
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Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 12 women (3.4%) did not receive a
postal questionnaire, because theywere lost
after treatment. Of the other 344 eligible
for the study women, 319 (93%) replied
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk There are some contradictions: in the table
III where the LBW rates are presented, the
authors have also included the women of
the treated group with miscarriage (n = 11)
, TOP (n = 3) and ectopic pregnancy (n =
2). In these cases, there is no birth weight
to be calculated. It is not clear if there are
also miscarriages, ectopic pregnancies and
TOPs in the total number of the controls
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women that had
LC or LA at the University Hospital of
Tromso between 1983 to 1988
Representative comparison group? Low risk The untreated group was drawn from the
same area and period although not neces-
sarily from the same hospital
Comparability of treatment groups? Low risk Matching for age (+/- 3 years), parity, place
of delivery (hospital with perinatal care
unit, smaller hospital or local district ma-
ternity wards)
Frega 2013
Methods Prospective cohort study
Comparison group: External - matching for parity (all women were nulliparous) and
race (all women were white)
Information source - records of university teaching hospitals and country hospitals across
Italy
Participants Study period - January 2003 to January 2007
Treated group - 475 pregnant women who had previously undergone LLETZ for CIN
2/3; Inclusion criteria: women with only one previous LLETZ, no repeated cervical
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excisional or ablative treatments and no relapse of CIN for at least 12 months after
LLETZ
Untreated group - 441 pregnant women with no previous treatment for CIN
Inclusion criteria (for both groups): women of age 42 years or younger, women who had
spontaneous pregnancy, white women and nulliparous women
Exclusion criteria (for both groups): twin pregnancies, any major disease (e.g. cardiovas-
cular disease, diabetes, HIV infection, or hypertension) and alcohol, smoke or substance
abuse
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (nulliparous); PTB (< 37 weeks) (single cone);
PTB (< 37 weeks) (singleton pregnancies)
Notes In the treated group, 69/475 women had a miscarriage (≤ 24 weeks of gestation). In
the untreated group, 62/441 women had a miscarriage (≤ 24 weeks of gestation). These
women were not in the denominator for the calculation of the PTB rate
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk 18/493 (3.7%) pregnant women in the
treated group were lost to follow-up; 21/
462 (4.5%) pregnant women in the un-
treated group were lost to follow-up
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women deliver-
ing at the participatinghospitals across Italy
during 2003 to January 2007
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for parity (all women were nul-
liparous) and race (all women were white).
The mean age in the treated group was 30.
8 vs 31.9 in the untreated group
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Methods Retrospective cohort study
Comparison groups:
A) External from women that had cervical smear
B) Women with punch biopsy but no treatment
Both had matching for age and year of treatment/Pap test/punch biopsy, and regression
analysis for age, parity, race, meternal diabetes, maternal BMI, neonate birth weight and
prior CS
Information source - clinical databases of surgical pathology at the nine participating
hospitals (for the ascertainment of the exposure); structured phone interviews and con-
firmation from medical files after informed consent (for the ascertainment of the out-
comes)
Participants Treated group - 598 women who had undergone LLETZ at one of the nine participating
hospitals during 1996 to 2006 and then had a singleton pregnancy beyond 20 weeks of
gestation
Untreated group - A) 588 women who had had Pap test only at one of the nine partic-
ipating hospitals during 1996 to 2006 and then had a singleton pregnancy beyond 20
weeks of gestation
B) 552 women who had had punch biopsy but no treatment at one of the nine partic-
ipating hospitals during 1996 to 2006 and then had a singleton pregnancy beyond 20
weeks of gestation
Inclusion criteria: only the first pregnancy after procedure (LLETZ, Pap test, punch
biopsy)
Exclusion criteria: women in the untreated groupswho reported any history of LLETZ or
other cervical excisional treatment; women with missing data (pregnancy history, mode
of delivery, dates of the cervical procedure/delivery), women for whom medical records
were unavailable
Interventions LLETZ
Outcomes PTB (< 37 weeks); CS; induction of labour
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not specified how many women had miss-
ing data on the outcomes of the index preg-
nancy
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
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Representative intervention group? Low risk All eligible for the study women having
LLETZ at nine hospitals during 1996 to
2006 and then delivering
Representative comparison group? Low risk The untreated groups were drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age and year of treatment/
Pap test/punch biopsy; regression analysis
for age, parity, race, meternal diabetes, ma-
ternal BMI, neonate birth weight and prior
CS
Gunasekera 1992
Methods Retrospective cohort study
Comparison group: External - matching for age, parity, race, duration of pregnancy and
smoking habit
Information source - Hospital records of the Department of Obstetrics and Gynaecology
of Watford General Hospital, Hertfordshire
Participants Treated group - 140 women who had undergone LA or LLETZ for CIN (LLETZ = 23;
LA = 117) at Watford General Hospital and had a subsequent intra-uterine pregnancy,
whose outcome was known. The observation period was February 1987 to January 1991
Untreated group - 140 matched women
Interventions LLETZ; LA
Outcomes PTB (< 37 weeks); CS; instrumental deliveries (forceps); prolonged labour (> 12 hours)
Notes The majority of patients had been treated with the laser because this method had been
in use longer than LLETZ
3 patients who had been treated with LC were too small a group to analyse
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
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Representative intervention group? Low risk All eligible for the study women who were
treated with LA or LLETZ in a single gen-
eral hospital and had a subsequent preg-
nancy, between February 1987 to January
1991
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age, parity, race, duration of
pregnancy and smoking habit
Guo 2013
Methods Prospective cohort study
Comparison group: Women with colposcopic biopsy (CIN1 or less) but no treatment -
matching for smoking (all women were non-smokers)
Information source - Records of the First Affiliated Hospital of Zhengzhou University,
China
Participants Treated group - 84 women who underwent LLETZ or CKC (CCK = 36, LLETZ = 48)
at the University Hospital of Zhengzhou during January 2005 to January 2009, wanted
thereafter to become pregnant and succeeded in becoming pregnant; Exclusion criteria:
women with postoperative infertility, multiple-time conisation or positive incisal edge
Untreated group - 68 women who became pregnant after exclusion of CIN II or above
with colposcopic biopsy and did not receive any other surgical procedures
Exclusion criteria (for both groups): history of infertility or recurrent miscarriages, evi-
dence of premature delivery, smoking habits
Interventions CKC; LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 34 weeks); pPROM; CS;
precipitous labour; prolonged labour; LBW (< 2500 g); Aprgar score (< 7) (1min)
Notes The follow-up lasted two years.
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not specified how many women were lost
to follow-up
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
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Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women undergo-
ing CKC or LLETZ in a single hospital
during January 2005 to January 2009
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Women with colposcopic biopsy (CIN1
or less); matching for smoking (all women
were non-smokers)
Haffenden 1993
Methods Retrospective cohort study
Comparison group: External - matching for age and parity
Information source - Hospital records of Gloucestershire Royal Hospital
Participants Treated group - 152 women who had undergone LLETZ at Gloucestershire Royal Hos-
pital between April 1988 and December 1989 and had a subsequent delivery (delivery
after 24 weeks) at the same hospital
Untreated group - 152 women without previous treatment delivering at Gloucestershire
Royal Hospital (the next following suitable woman after case)
Interventions LLETZ
Outcomes PTB (< 37 weeks); CS; instrumental deliveries (ventouse/forceps); precipitous labour (<
2 hours); prolonged labour (> 12 hours); induction of labour; oxytocin use; epidural use;
LBW (2500 g)
Notes Between April 1988 and December 1989, 1000 women with cervical smears showing
repeatedly borderline changes of dyskaryosis and who had satisfactory colposcopy under-
went LLETZ at the Gloustershire Royal Hospital. Pregnancies in this study group which
occurred since LLETZ and which resulted in referral to Gloucestershire Royal Hospital
were identified. Deliveries after 24 weeks’ gestation were matched against a control: the
delivery of the next women of the same age and parity at Gloucestershire Royal Hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
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Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk The treated group included all women
that underwent LLETZ between 1988 and
1989 in a single hospital
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Unclear risk Matching for age and parity. The interven-
tion group had substantially higher rate of
smoking (36% vs 14.4%)
Hagen 1993
Methods Retrospective cohort study
Comparison group: External - matching for age (+/- 3 years) and parity (equal); regres-
sion analysis for maternal height, marital status, level of education, smoking, previous
TOP, and, in the index pregnancy, occurrence of gestational hypertension or antepartum
haemorrhage and the mode of delivery
Information source - Hospital records of University Hospital of Trondheim, Norway
Participants Treated group - 56 women who had undergone LLETZ at the Department of Obstetrics
and Gynaecology, University Hospital, Trondheim, Norway between 1983 and 1985,
were 38 years of age or younger at the time of operation and had been delivered of live
infants beyond 22 weeks gestation after the conisation and before 1991 (all infants were
singletons). Only the first birth after treatment was included
Untreated group - 112 women without previous treatment delivered at the same hospital
(the first two women after each case)
Interventions LC
Outcomes PTB (≤ 37 weeks); PTB (≤ 37 weeks) (nulliparous); PTB (≤ 37 weeks) (parous); PTB
(≤ 37 weeks) (singleton pregnancies); CS; instrumental deliveries (ventouse/forceps);
APH
Notes During the three year period from a January 1983 to 31 December 1985, 351 women
underwent LC of the cervix. 6 women were lost afterwards. 247 women who were 38
years of age or younger at the time of operation were studied for reproductive events. By
1 January 1991, 79 of these women had become pregnant
Risk of bias
Bias Authors’ judgement Support for judgement
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Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records. Of the 351 who had undergone
LLETZ between 1983 to 1985, only 6 (1.
71%) were lost after the treatment
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Unclear risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All women that had LLETZ at the Univer-
sity Hospital of Trondheim between 1983
to 1985
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age and parity; regression
analysis for maternal height, marital status,
level of education, smoking, previous TOP,
and, in the index pregnancy, occurrence
of gestational hypertension or antepartum
haemorrhage and the mode of delivery
Heinonen 2013
Methods Retrospective cohort study
Comparison group: External - unmatched; regression analysis for maternal age, socioe-
conomic status, marital status, urbanism, time since LLETZ, previous PTBs
Information source - Hospital Discharge Register (for the ascertainment of the exposure)
; Medical Birth Register (for the ascertainment of the outcome)
Participants Treated group - 7636 singleton deliveries of women of reproductive age (15 to 49 years)
who had undergone LLETZ during 1997 to 2009 and delivered during 1998 to 2009
Untreated group - 658,179 singleton deliveries (1998 to 2009) of women without pre-
vious LLETZ
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones);
PTB (< 37 weeks) (singleton pregnancy)
Notes The 3 studies (Heinonen 2013, Jakobsson 2009, Jakobsson 2007) refer to overlapping
populations from the Finnish Register
We considered as primary study themost recent (Heinonen 2013) that was a population-
based study assessing the impact of LLETZ from 1997 to 2009. From this study we
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extracted PTB (< 37 weeks) rates, overall as well as for single cones, repeat cones and
singleton pregnancies
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from national
registers
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women in Finland
undergoing LLETZ during 1997 to 2009
and subsequently delivering during 1998
to 2009 (a population-based study)
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for maternal age, so-
cioeconomic status, marital status, urban-
ism, time since LLETZ, previous PTBs
Hemmingsson 1982
Methods Retrospective cohort study
Comparison group: Internal (pre-treatment pregnancies)
Information source - Hospital records of the University Hospital of Uppsala,Sweden
Participants Treated group - 115 pregnancies of women who had undergone CT for CIN at the
Department of Gynaecological Oncology of the University Hospital of Uppsala between
1973 to 1979 and had a subsequent pregnancy (≥ 28 weeks of gestation). Exclusion
criteria: women > 40 years of age at the time of cryotherapy
Untreated group - 65 pregnancies before the cryotherapy of the same women
Interventions CT
Outcomes PTB (< 36 weeks); pPROM; CS; cervical stenosis; perinatal mortality
Notes Almost all womenwere delivered at theUniversityHospital ofUppsala.Most pre-therapy
pregnancies were completed during 1973 to 1975 (86%) in contrast with post-therapy
pregnancies, of which 76% occurred in 1976 to 1980
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The only difference found in this study about the effect of cryosurgery was an increase in
the number of CS in the post-therapy group.However, the higher CS rate only reflects a
general trend towards a higher CS rate in Sweden (in 1973 the CS rate at the department
was 6% but rose to 13% in 1980)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk The CS rate was six times higher in the
treated group than in the untreated group.
The higher CS rate probably reflects the
general trend towards a higher CS rate in
Sweden in the last 10 years before the pub-
lication. This is discussed by the authors
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds.
Representative intervention group? Low risk All eligible for the study women who had
undergone cryotherapy for CIN in a single
University Hospital between 1973 to 1979
and had a subsequent pregnancy
Representative comparison group? Low risk Internal comparison group (pre-treatment
pregnancies)
Comparability of treatment groups? Low risk Internal comparison group (pre-treatment
pregnancies)
Himes 2007
Methods Retrospective cohort study
Comparison group: Women with colposcopic biopsy but no treatment - unmatched;
regression analysis for age, race, marital status, payor status, years of education, tobacco
use, history of preterm delivery and height of the cone specimen
Information source - Hospital records (pathological and obstetric database)
Participants Treated group - 114 women who had undergone LLETZ between November 2001 and
December 2004 and subsequently delivered a singleton, non-anomalous pregnancy of
at least 20 weeks of gestation at Magee-Womens Hospital. Exclusion criteria: Women
with CKC, women with treatment during pregnancy, women with cervical cerclage
Untreated group - 962 women who had undergone colposcopic biopsy between Novem-
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ber 2001 and December 2004 and subsequently delivered a singleton, non-anomalous
pregnancy of at least 20 weeks of gestation at Magee-Womens Hospital. Exclusion cri-
teria: Women with cervical cerclage
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); sPTB (< 37 weeks);
pPROM
Notes The numbers of patients with CKC was small and their exclusion did not change the
results
3 women had conisation during pregnancy and they were excluded
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospi-
tal records (pathological and obstetric
database)
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Table 2 in page 316 is wrong, but the cor-
rect data can be pooled from the text
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single hospital
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for age, race, marital
status, payor status, years of education, to-
bacco use, history of preterm delivery and
height of the cone specimen
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Methods Retrospective cohort study
Comparison group: External - unmatched; regression analysis for age, parity, smoking
Information source - Hospital Discharge Register (information on all inpatient episodes
in health care facilities since 1967); Finnish Medical Birth Register
Participants Treated group - 8422 singleton pregnancies of reproductive-aged women (15 to 49
years) in Finland who had undergone treatment for CIN during 1986 to 2003 and had
a subsequent delivery during 1987 to 2004 (excision:4846; ablation:3576). Exclusion
criteria: Women with irrelevant cervical treatments (such as TOPs and excisions of
polyps)
Untreated group - all singleton pregnancies (1,056,855) of women in Finland who did
not have a history of treatment for CIN and delivered during 1987 to 2004
Interventions Excision NOS (CKC, LC, LLETZ); Ablation NOS (LA, CT, electrocoagulation)
Outcomes PTB (< 37 weeks); PTB (< 28 weeks); LBW (< 2500 g); perinatal mortality
Notes The 3 studies (Heinonen 2013, Jakobsson 2009, Jakobsson 2007) refer to overlapping
populations from the Finnish Register
We considered as primary study themost recent (Heinonen 2013) that was a population-
based study assessing the impact of LLETZ from 1997 to 2009. From Jakobsson 2007,
we extracted data on the PTB (< 37 weeks) but after exclusion of all patients that were
treated after 1997 because we wanted to avoid duplication with Heinonen 2013. We
also proportionally adjusted the control population to avoid duplication. We further
analysed PTB (< 28 weeks), LBW (< 2500 g) and perinatal mortality as this data are not
provided in any other study
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from na-
tional registers; It is estimated that 95%
of all hospitalizations are registered in the
Hospital Discharge Register; Less than 0.
1% of all newborns are missing from the
Medical Birth Register
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study Finnish women
having a singleton delivery between 1987
to 2004 (a population-based study)
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Representative comparison group? Low risk The control group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk The women in the treated group were
slightly older, were more often nulliparous
(42.8% vs 30.9%), were twice as often
smokers (26.6% vs 15.2%), and had lower
socioeconomic status. However, adjusting
for age, parity and smoking did not change
the results of the study. The researchers
were not able to adjust also for the socioe-
conomic status (they were unable to define
the socioeconomic status for all women),
but in Finland socioeconomic status and
smoking are strongly correlated
Jakobsson 2009
Methods Retrospective cohort study
Comparison groups:
A) External: no matching
B) Internal (self-matching)
Both had regression analysis for age, parity, or both
Information source - Hospital Discharge Register, Medical Birth Register and hospital
records of the Helsinki University Hospital and the Maternity Hospital, Finland
Participants A) Treated group - 624 women who had undergone LLETZ for CIN during 1997 to
2003 and subsequently delivered at the Helsinki University Hospital or the Maternity
Hospital, Finland, until 2006. Inclusion criteria: only singleton pregnancies. Exclusion
criteria: women who were treated during pregnancy; women with a delivery during the
study year but before LLETZ; women with a previous CKC; multiple pregnancies
Untreated group - 554,507 women having a singleton delivery during 1997 to 2006
(general population of Finland)
B) 258 women of the treated group had also a delivery before LLETZ. For these women
internal matching (self-matching) was possible, in addition to the external comparison
group
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (nulliparous); PTB (< 37 weeks) (parous)
Notes The 3 studies (Heinonen 2013, Jakobsson 2009, Jakobsson 2007) refer to overlapping
populations from the Finnish Register
We considered as primary study themost recent (Heinonen 2013) that was a population-
based study assessing the impact of LLETZ from 1997 to 2009. From Jakobsson 2009
that refers to two hospitals in Southern Finland, we have included as outcomes the PTB
(< 37 weeks) for nulliparous as opposed to multiparous women that is not described
in the other two cohorts. We also included data in the analysis from this paper on self-
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matching (internal controls). These data are not presented in the other two references
of the same population. In order to minimise overlap, we have only included data for
the internal comparison in the separate forest plot for internal matching but not in the
merged one, as it was impossible to discriminate the possible overlap with Heinonen
2013.
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from national
registries andhospital records. For somepa-
rameters, there was incomplete data (e.g.
for 45.5% of the women, the cone size was
unknown and for 7.7% of the women, the
CIN diagnosis was unknown). Complete
data for the duration of pregnancy
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in two hospitals during 1997 to 2006
Representative comparison group? Unclear risk A) The external comparison group was not
drawn from the same source as the treated
group (itwas drawn from the national Birth
Register covering the whole of Finland,
whereas the treated group was drawn from
two specific hospitals)
B) Internal (self-matching)
Comparability of treatment groups? Low risk A) External: Regressional analysis for age,
parity, or both. No conspicuous differ-
ence between the treated and the exter-
nal comparison group, regarding socioeco-
nomic class, smoking during pregnancy, al-
cohol consumption during pregnancy, or
substance abuse during pregnancy
B) Internal (self-matching)
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Methods Retrospective cohort study
Comparison group: External - matching for age (+/- 5 years), parity, social class, date
of delivery (same month or immediately preceding or following month) and singleton
birth
Information source - Clinical records available from the Cardiff Cervical Cytology Study
(for cases), Cardiff Birth Survey (for controls)
Participants Treated group - 66 pregnancies of all women from Cardiff who had undergone CKC
between February 1965 and April 1974 and subsequently had a singleton pregnancy (up
to April 1975) proceeding beyond 28 weeks’ gestation
Untreated group - 264 pregnancies of women fromCardiff having a singleton pregnancy
without previous treatment
Interventions CKC
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); sPTB (< 37 weeks); CS;
instrumental deliveries (ventouse/forceps); precipitous labour (< 2 hours); prolonged
labour (> 12 hours); LBW (< 2500 g); perinatal mortality; stillbirth
Notes Between February 1965 and April 1974, 600 women from Cardiff had CKC. 372 of
these women were potentially fertile and up to April 1975, 76 had 91 pregnancies after
the CKC. 13 pregnancies aborted spontaneously, 11 were terminated and there was
one twin pregnancy. The other 66 singleton pregnancies were included. 10 pregnancies
were the second one after the treatment and one pregnancy was the third one after the
treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records and registries
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible women from Cardiff that had
CKCbetweenFebruary 1965 toApril 1974
(a population-based study)
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
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Comparability of treatment groups? Low risk Matching for age (+/- 5 years), parity, social
class, date of delivery (same month or im-
mediately preceding or following month)
and singleton birth
Kirn 2015
Methods Retrospective cohort study
Comparison group: External - matching for age, parity and smoking
Information source - University Hospital of the Ludwig-Maximilians
University, Munich
Participants Treated group - 135 patients who delivered at the University Hospital of the Ludwig-
Maximilians University between 2006 and 2012 and had undergone cervical conisation
before giving birth; exclusion criteria: twin pregnancies
Untreated group - 135 women who had not undergone cervical conisation before giving
birth
Interventions Excision NOS
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton); CS
Notes At first, 144 patients with treatment before pregnancy were identified. However, 3 pa-
tients were excluded for having twin pregnancies and six women could not be matched
and therefore were also excluded
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single university hospital between 2006
to 2012
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
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Comparability of treatment groups? Low risk Matching for age, parity and smoking
Kitson 2014
Methods Retrospective cohort study
Comparison group: Women with punch biopsy but no treatment - matching for age,
parity and smoking
Information source - maternity and colposcopy databases of a large tertiary unit in the
North East of England
Participants Treated group - 278 women who had undergone LLETZ during 2000 to 2010 and
subsequently delivered in a large tertiary unit in the North East of England during 2008
to 2011. Only the first pregnancy after treatment was included
Untreated group - 278 women who delivered in the same unit during the same time
period and had had punch biopsy but no treatment before birth
Inclusion criteria (for both groups): singleton pregnancies of at least 20weeks of gestation
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); PTB (< 34 weeks); sPTB;
pPROM; CS; instrumental deliveries; LBW (< 2500 g); NICU admission
Notes 30 women underwent two or more LLETZ procedures. The mean gestational age of
these women did not differ from the mean gestational age of the women who underwent
only one LLETZ procedure
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Unclear risk Excised cones were formalin fixed at the
time of receipt in the pathology lab which
is known to result in tissue retraction and
hence a reduction in the measured dimen-
sions
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a large tertiary unit during 2008 to 2011
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Representative comparison group? Low risk The untreated group was drawn from the
same source
Comparability of treatment groups? Low risk Matching for age, parity and smoking
Klaritsch 2006
Methods Retrospective cohort study
Comparison group: External - no matching, no regression analysis
Information source - Hospital records
Participants Treated group - 76 singleton deliveries of 65 women who delivered at the Department of
Obstetrics & Gynaecology, Medical University of Graz, Austria, between 1992 to 2002
and had previously undergone CKC at the same hospital or other hospital. Exclusion
criteria: Women with LLETZ, repeated conisation, previous PTB or multiple gestations.
No woman had undergone CKC during pregnancy
Untreated group - all singleton deliveries (29711) of the women who delivered at the
Department of Obstetrics &Gynaecology, Medical University of Graz, Austria, between
1992 to 2002 and did not have a history of cervical conisation
Interventions CKC
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (singleton preg-
nancies); PTB (< 34 weeks); pPROM; CS; chorioamnionitis; LBW (< 2500 g); perinatal
mortality
Notes There were 29,809 singleton deliveries at the University Hospital of Graz between 1992
and 2002. 98 deliveries of 86 women with history of conisation were identified. The
researchers excluded 21 women and their 22 deliveries. 16 of them had undergone
LLETZ, 2 had had more than one conisation, 1 had had previous PTB, and 2 had
multiple gestations. 65 women with a total of 76 deliveries had undergone CKC and
were included in the conisation group. For controls the researchers took the remaining
29,711 singleton deliveries in the study period. 53 women had undergone CKC at the
University Hospital of Graz, 12 at other hospitals. No woman had undergone CKC
during pregnancy
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Complete data in the control group; a small
percentage of incomplete data formost out-
comes in the untreated group
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
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Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single hospital between 1992 to 2002
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? High risk Neither matching nor regression analysis;
the median age at delivery was 30 years
(range 21 to 43) in the treated group vs
28 years (range 14 to 61) in the untreated
group; 73.7% multigravidas in the treated
group vs 49.9% multigravidas in the un-
treated group; no significant difference in
smoking habits
Kristensen 1985
Methods Retrospective cohort study
Comparison group: External - matching for age and parity
Information source - Records of the Data Processing Unit at Odense University Hospi-
tal/Questionnaires (treated group), Records of Odense University Hospital (untreated
group)
Participants Treated group - All women who had conisation performed in the county of Funen
between April 1973 and December 1980 and had a subsequent pregnancy (before April
1982). 85 pregnancies (proceeding beyond 28 weeks) of 82 women were finally included
in the analysis
Untreated group - All singleton deliveries at Odense University Hospital between 1978
and 1982. (Odense University Hospital mainly serves the town of Ostense and the
surrounding rural areas)
Interventions Treatment NOS
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); LBW (< 2500 g)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The needed information was obtained
from hospital records. For women having
left the county of Funen, a questionnaire
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was sent about the outcome of probable
pregnancies after treatment; replies were re-
ceived from all patients
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? High risk The type of conisation is not described
Representative intervention group? Low risk All eligible women from the county of Fu-
nen that had treatment for CIN between
April 1973 to December 1980 (a popula-
tion-based study)
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age and parity
Kristensen 1993
Methods Retrospective cohort study
Comparison groups:
A) External - no matching, no regression analysis
B) Internal (self-matching)
Information source - Medical Birth Register, National Register of Hospital Discharges
Participants All women with a permanent address in Denmark with singleton pregnancies who gave
birth to their first infant in 1982 and second infant during the time period 1982 to
1987. For treated group, treatment took place during 1977 to 1987
A) The first and second delivery of the women whose treatment took place before the
first delivery (68 deliveries of 34 women) and the second delivery of the women whose
treatment took place between the first and second delivery (62 deliveries of 62 women)
were comparedwith the first and second delivery of the womenwith no treatment (28124
deliveries of 14062 women)
B) For the 62 women whose treatment took place between the first and second delivery,
the first delivery was compared with the second delivery (self-matching)
Interventions Treatment NOS (CKC, laser, electrocautery)
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (nulliparous); PTB (< 37 weeks) (parous); PTB
(<3 7 weeks) (singleton pregnancies)
Notes In the cohort of 14,233women, 170had cervical conisation: 34before the first childbirth,
62 between the first and second childbirth, and 74 after the second childbirth
Risk of bias
81Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kristensen 1993 (Continued)
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from na-
tional registers
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Unclear risk The type of conisation is not described as
details are not included in the national reg-
istry. Treatment may include CKC, laser or
electrocautery
Representative intervention group? Low risk This is a population-based study and the
treated group is representative of the aver-
age women who undergoes conisation
Representative comparison group? Low risk A) The external comparison group was
drawn from the same source as the treated
group
B) Internal comparison group (self-match-
ing)
Comparability of treatment groups? High risk A) No matching, no regression analysis
B) Internal comparison group (self-match-
ing)
Kuoppala 1986
Methods Retrospective cohort study
Comparison group: External - matching for age, parity, date of delivery (generally same
month) and singleton birth
Information source - Hospital records of University Central Hospital of Tampere
Participants Treated group - Women who had CKC at the University Central Hospital of Tampere
in 1962 to 1979 and had a subsequent pregnancy. Finally, 62 pregnancies lasting more
than 28 weeks were included in the analysis
Untreated group - 62 pregnancies (> 28 weeks) of women from the labour room register
without previous treatment
Interventions CKC
Outcomes PTB (< 37 weeks); CS; instrumental deliveries (ventouse); induction of labour; oxytocin
use; analgesia use NOS; cervical cerclage; perinatal mortality; stillbirth
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Notes The study comprised patients who had cervical conization at the University Central
Hospital of Tampere in 1962 to 1979. A total of 317 women had cone biopsy: 77
between them had 98 pregnancies. Of these pregnancies, 36 lasted less than 28 weeks
and 62 more than 28 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious.
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible women that had CKC at the
Univeristy Hospital of Tampere between
1962 to 1979
Representative comparison group? Low risk The untreated group was pooled from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age, parity, date of delivery
and singleton birth
Larsson 1982
Methods Retrospective cohort study
Comparison group: Internal (pre-treatment pregnancies) with matching for age, parity,
socioeconomic status, smoking, surgical interventions and various diseases
Information source - South Swedish Regional Tumour Registry, hospital records
Participants Treated group - 197 deliveries after CKC
Untreated group - 284 deliveries before CKC
The CKC took place between 1962 and 1976
Interventions CKC
Outcomes PTB (<37weeks); PTB (<37weeks) (singleton pregnancies); PTB (< 37weeks) (multiple
pregnancies); perinatal mortality; stillbirth
Notes 988 women had undergone conization because of dysplasia in varying degree or carci-
noma in situ over the 15-year period 1962 to 1976. 197 women became pregnant with
a total of 635 pregnancies before and after conisation. 37 of the women had not been
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pregnant before the conisation. Number of pregnancies before conisation: 341 (284 de-
liveries). Number of pregnancies after conization: 294 (197 deliveries)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records and registries
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk The treated group was pooled from the
South Swedish Regional Tumour Registry.
The treated group is in all likelihood rep-
resentative of the average women who un-
dergoes CKC (a population-based study)
Representative comparison group? Low risk Internal comparison group (self-matching)
Comparability of treatment groups? Low risk Internal comparison group (self-matching)
with matching for age, parity, socioeco-
nomic status, smoking, surgical interven-
tions and various diseases
Lima 2011
Methods Retrospective cohort study
Comparison group: External - no matching, no regression analysis
Information source - Hospital records of Dr Alfredo Da Costa Maternity, Lisbon
Participants Treated group - 29 women who had undergone LLETZ or LC (LC = 11; LLETZ = 18)
between 2000 to 2005 at Dr Alfredo da Costa Maternity and had a subsequent delivery
at the same hospital
Untreated group - 58 women without previous cervical treatment who delivered at the
same hospital during 2000 to 2005 (the immediate matched delivery before and after
each case)
Interventions LC; LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (D≤ 10 mm); PTB (< 37 weeks) (D> 10 mm);
CS; LBW (< 2500g); Apgar score (<7) (5min)
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious sources of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single hospital during the study period
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? High risk Nomatching or regression analysis for pos-
sible confounders
Ludviksson 1982
Methods Retrospective cohort study
Comparison group: External - matching for age, parity and time of delivery
Information source - Hospital records of the Regional Hospital of Orebro
Participants Treated group - 83 deliveries of 75 women who were below 35 years of age, underwent
a cone biopsy at the Regional Hospital of Orebro between 1964 and 1978 and had later
a pregnancy ending in a delivery. Women who had an elective section were excluded
Untreated group - 79 deliveries of 79 women without previous treatment
Interventions CKC
Outcomes PTB (≤ 3 7weeks); PTB (≤ 33 weeks); PTB (< 30 weeks); PPH (> 600 mL); MOH
(1000 mL)
Notes 780 women below 35 years of age underwent a cone biopsy at the Regional Hospital of
Orebro between 1964 and 1978. Of these 780 women, 79 later had a pregnancy ending
in a delivery. As elective section was performed in four cases of the conized group, the
final number of women in this group was 75 with 83 deliveries, as opposed to 79 in the
control group. The cone depth was almost 2 cm in most operations
Risk of bias
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Ludviksson 1982 (Continued)
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds.
Representative intervention group? Low risk All women < 35 years that underwent CKC
in a Regional Hospital between 1964 and
1978
Representative comparison group? Unclear risk It is unclear how the control group was se-
lected.
Comparability of treatment groups? Low risk Matching for age, parity and time of deliv-
ery
Martyn 2015
Methods Retrospective cohort study
Comparison group: Women with colposcopy but no treatment - matching for age
Information source - Records of the National Maternity Hospital (Mediscan database,
pathology records and other clinical records) and postal questionnaires
Participants Treated group - 297 women who had undergone LLETZ or CKC at the National
Maternity Hospital during 2001 to 2007 and subsequently had a pregnancy (≥ 24 weeks
of gestation)
Untreated group - 204 women who had had colposcopy but no treatment at theNational
Maternity Hospital during 2001 to 2007 and subsequently had a pregnancy (≥ 24 weeks
of gestation)
Inclusion criteria (for both groups): women aged 24 to 40 years
*This is only a subgroup of the study population. The main outcome of the study was
the effect of CKC/LLETZ on subsequent fertility, but we are not studying infertility in
this meta-analysis. Therefore, we restricted the population to the pregnant women with
a pregnancy of at least 24 weeks of gestation (see ”Notes“ below for more details)
Interventions LLETZ; Excision NOS (CKC, multiple LLETZ)
Outcomes PTB ( <37 weeks); PTB (< 37 weeks) (single cone)
Notes 3590 women aged 24 to 40 years, who had attended the colposcopy services in the
National Maternity Hospital between 2001 and 2007, were sent a postal questionnaire
about the fertility and the pregnancies, if any, after colposcopy/CKC/LLETZ (LLETZ:
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Martyn 2015 (Continued)
1729; CKC:66;colposcopy only:1795). 1355 women (37.7%) replied. Of those who
responded, 759 had one LLETZ, 37 had CKC, 22 had more than one LLETZ (in total,
818 had surgery) and 537 women had colposcopy only. i) Of those with surgery, 321
became pregnant: 38 had a gestational age less than 14 weeks and 5 had a gestational
age 14 weeks to < 24 weeks. We excluded from our meta-analysis these women and we
included the remaining 278. ii) Of those with colposcopy only, 228 became pregnant:
23 had a gestational age less than 14 weeks and 1 had a gestational age 14 weeks to < 24
weeks.We excluded from our meta-analysis these women and we included the remaining
204
We included LLETZ and Excision NOS (CKC and multiple LLETZ)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Only 37.7% of the women responded to
the postal questionnaire which was sent to
them
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Questionnaires were used for the ascertain-
ment of the outcomes; there is a risk of re-
call bias and misclassification of the out-
comes
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Only a small percentage of the women re-
sponded to the questionnaire which was
sent to them. The women who replied are
more likely to belong to a higher socioeco-
nomic class
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age; Both groups had col-
poscopy before pregnancy
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Miller 2015
Methods Retrospective cohort study
Comparison group:
A) External
B) Women with prior dysplasia but no treatment
Both had regression analysis for age, parity, race/ethnicity, BMI and cervical length during
pregnancy
Information source - Hospital records of Northwestern Memorial Hospital, Chicago
Participants Treated - 1356 women with prior excisional procedure for cervical dysplasia who under-
went routine cervical length assessment between 18 to 23 6/7 weeks of gestation from
December 2010 through January 2014 at Northwestern Memorial Hospital in Chicago
Untreated - A) 14,149 women with no prior dysplasia and no excisional procedure
B) 3023 women with prior dysplasia but no excisional procedure
Exclusion criteria: women younger than 18 years old, twin pregnancies, women with
unavailable delivery records
Interventions Excision NOS
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton)
Notes At first, 144womenwith treatment before pregnancywere identified.However, 3women
were excluded for having twin pregnancies and six women could not be matched and
therefore were also excluded
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women undergo-
ing routine cervical length assessment in a
single hospital during December 2010 to
January 2014
Representative comparison group? Low risk Both comparison groups were drawn from
the same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for age, parity, race/
ethnicity, BMI and cervical length during
pregnancy
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Moinian 1982
Methods Retrospective cohort study
Comparison group: Internal (pre-treatment pregnancies)
Information source - Hospital records of the East Hospital, Gothenburg
Participants Treated group - all viable pregnancies after CKC (103) of 90 women who had CKC at
the East Hospital, Gothenburg, between 1968 and 1973
Untreated group - all viable pregnancies before CKC (720) of the same women
All miscarriages were excluded
Interventions CKC
Outcomes PTB (< 37 weeks); cervical cerclage
Notes Radical CKC procedure: if the endocervix was involved, the entire endocervical cancel
was excised to the level of the internal os
Between 1968 and 1973, 414 women were treated by cone biopsy at the East Hospi-
tal, Gothenburg, Sweden. 324 women had been pregnant before conisation, with 801
pregnancies between them, and after cone biopsy 90 women became pregnant, with 122
pregnancies
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? High risk Yes, but CKC described as more than usual
radical
Representative intervention group? Low risk All eligible women that had CKC at East
Hospital, Gothenburg, between 1968 and
1973
Representative comparison group? Low risk Internal comparison group (pre-treatment
pregnancies)
Comparability of treatment groups? Low risk Internal comparison group (pre-treatment
pregnancies)
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Noehr 2009a
Methods Retrospective cohort study
Comparison groups:
A) External
B) Women with biopsy but no treatment
Both were unmatched but had regression analysis for age, year of delivery, smoking
during pregnancy and marital status during pregnancy
Information source - Medical Birth Registry, National Patient Registry, Danish Registry
of Pathology, Danish IVF Registry
Participants Treated group - 10,207 deliveries of women who had undergone LLETZ or ablation
(LLETZ = 8180; Ablation = 2027) during 1997 to 2005 and had a subsequent singleton
delivery (21 to 45 weeks of gestation) during 1997 to 2005. Exclusion criteria: women
with previous CKC; deliveries with medical induction before 37 completed weeks of
gestation; infants delivered by CS performed before 37 completed weeks of gestation;
deliveries subsequent to a collum amputation
Untreated group - A) 510,841 singleton deliveries (21 to 45 weeks of gestation during
1997 to 2005) of women without previous cervical procedure (treatment or biopsy) B)
31,630 singleton deliveries (21 to 45 weeks of gestation during 1997 to 2005) of women
without previous treatment but with previous biopsy
Interventions LLETZ; Ablation NOS
Outcomes sPTB (< 37 weeks); sPTB (< 37 weeks) (D ≤ 12 mm); sPTB (< 37 weeks) (D = 13 mm
to 15mm); sPTB (< 37 weeks) (D = 16 mm to 19 mm); sPTB (< 37 weeks) (D ≥ 20
mm); sPTB (< 37 weeks) (single cone); sPTB (< 37 weeks) (repeat cones); sPTB (< 37
weeks) (singleton pregnancies); sPTB (< 32 weeks); sPTB (< 28 weeks)
Notes Of the 552,678 deliveries in the study, 8180 deliveries were subsequent to LLETZ (1
LLETZ: 7907; 2 LLETZ: 255; ≥ 3 LLETZ: 18). Of these 8180 deliveries, 162 were
subsequent to both LLETZ and ablation. The addition of the number of deliveries
subsequent to biopsy, ablation, LLETZ and no procedure (table 3 of the article) gives the
total number of pregnancies (552,678), thus we concluded that the authors subtracted
these 162 deliveries from the ablation group and left them only in the LLETZ group. In
this way, we made sure that we will not make a duplicate extraction of the same deliveries
The Nordic Classification of Surgical Procedures has the same code for LLETZ and LC
and the authors were not able to separate LLETZ fromLC.However, LC has become rare
in Denmark since the introduction of LLETZ and the authors included the pregnancies
with this code in the LLETZ group. In our meta-analysis, we made the same
In a second article, Noehr and colleagues 2009 investigated the association between cone
depth of the LLETZ and the subsequent risk of sPTB (on the same singleton deliveries
as above). Deliveries after LLETZ with no information on cone depth (n = 4302) and
deliveries after two or more LLETZ (n = 273) were not included in the cone depth
analysis
Nohr and colleagues 2007 is an overlapping study, but it was impossible to extract only
the data that was not included in Noehr and colleagues 2009 and we excluded this study
Risk of bias
Bias Authors’ judgement Support for judgement
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Noehr 2009a (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from national
registries
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Unclear risk The Nordic Classification of Surgical Pro-
cedures has the same code for LLETZ and
LC and the authors were not able to sepa-
rate LLETZ fromLC.However, LChas be-
come rare in Denmark since the introduc-
tion of LLETZ and the authors included
all these pregnancies in the LLETZ group
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study Danish women
delivering during 1997 to 2005 (a popula-
tion-based study)
Representative comparison group? Low risk The 2 comparison groups were drawn from
the same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for age, year of delivery,
smoking during pregnancy andmarital sta-
tus during pregnancy
Noehr 2009b
Methods Retrospective cohort study
Comparison group: External - unmatched; regression analysis for age, year of delivery,
smoking during pregnancy, marital status during pregnancy and IVF
Information source - Medical Birth Registry, National Patient Registry, Danish Registry
of Pathology, Danish IVF Registry
Participants Treated group - 166 deliveries of women who had undergone LLETZ during 1997 to
2005 and had a subsequent twin delivery (21 to 45 weeks of gestation) during 1997 to
2005. Exclusion criteria: women with previous CKC; deliveries with medical induction
before 37 completed weeks of gestation; infants delivered by CS performed before 37
completed weeks of gestation; deliveries subsequent to a collum amputation
Untreated group - 9702 twin deliveries (21 to 45 weeks of gestation during 1997 to
2005) of women without previous LLETZ
Interventions LLETZ
Outcomes sPTB (< 37 weeks) (multiple pregnancies); sPTB (< 32 weeks) (multiple pregnancies);
sPTB (< 28 weeks) (multiple pregnancies)
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Noehr 2009b (Continued)
Notes Of the 9868 twin deliveries in the study, 166 were subsequent to LEEP (of which 11
were subsequent to both LEEP and ablation), 43 were subsequent to ablation, 766 were
subsequent to biopsy with no additional cervical procedure, and the remaining 8893
deliveries were not preceded by any cervical procedure. Only 4 (2.4%) of the deliveries
subsequent to LEEP were preceded by more than one LEEP
The Nordic Classification of Surgical Procedures has the same code for LLETZ and LC
and the authors were not able to separate LLETZ from LC. However, LC has become
rare in Denmark since the introduction of LLETZ and the authors included all these
pregnancies in the LLETZ group. In our meta-analysis, we made the same
In contrast to another article of Noehr and colleagues 2009 with the same study design
but about singletons, this one does not give sPTB rate in the group with no cervical
procedure or in the group with biopsy only (gives only adjustedORs). Therefore, we used
the no-LLETZ group (which may have undergone ablation or biopsy before delivery) as
the control group
Nohr 2007 is a duplicate study that includes a proportion of the population that is
presented in Noehr 2009. As there is a possibility of substantial overlap the data from
this study were not used
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from national
registries
Selective reporting (reporting bias) High risk Data are not shown for the group with ab-
lation, for the group with biopsy only and
for the group with no cervical procedure
Other bias Unclear risk The control group is not really untreated
because 43 women in it (0.4%) have un-
dergone ablation prior to delivery
The Nordic Classification of Surgical Pro-
cedures has the same code for LLETZ and
LC and the authors were not able to sep-
arate LLETZ from LC. However, LC has
become rare in Denmark since the intro-
duction of LLETZ and the authors in-
cluded the pregnancies with this code in
the LLETZ group
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study Danish women
delivering during 1997 to 2005 (a popula-
tion-based study)
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Noehr 2009b (Continued)
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for age, year of delivery,
smoking during pregnancy, marital status
during pregnancy and IVF
Ortoft 2010
Methods Retrospective cohort study
Comparison Groups:
A) External
B) Women with HSIL but no treatment
Both had regression analysis for age, parity, smoking status, educational level and marital
status
C) Internal (self-matching)
Information source - the pathology database, hospital records, the Aarhus birth cohort
and questionnaires
Participants Treated group - 758 women who had a conisation between 1989 to 2007 (one conisation
= 721; two conisations = 37) and were identified from the Danish nationwide pathology
database and subsequently had a pregnancy at the University Hospital of Aarhus until
March 2007. Only the first delivery after treatment was included
Untreated group - A) 74,552 deliveries of women without history of conisation or
dysplasia who delivered at the University Hospital of Aarhus during the study period
B) 390 deliveries of women with CIN not treated with conisation who delivered at the
University Hospital of Aarhus during the study period
Inclusion criteria (for both groups): singleton deliveries. Exclusion criteria: missing ges-
tational age or missing birth weight (0 in the treated group; 355 in the untreated group;
women with preterm induced birth (4 in the treated group; 778 in the untreated group)
, preterm acute CS before labour (6 in the treated group; 534 in the untreated group) or
preterm elective CS (2 in the treated group; 348 in the untreated group) were excluded
from the Cox regression
C) Self-matching for 170 women who had one conisation and had a delivery both before
and after the conisation (last child born before versus first child born after the single
conisation)
Interventions CKC; Electroknife; LLETZ
Outcomes sPTB (< 37 weeks); sPTB (< 37 weeks) (single cone); sPTB (< 37 weeks) (repeat cones)
; sPTB (< 37 weeks)(singleton pregnancies); sPTB (< 32 weeks); sPTB (< 28 weeks);
pPROM (< 37 weeks); pPROM (< 32 weeks); pPROM (< 28 weeks); LBW (< 2500 g);
LBW (< 2000 g); LBW (< 1500 g); perinatal mortality; perinatal mortality (<37 weeks)
; perinatal mortality (< 32 weeks); perinatal mortality (< 28 weeks)
Notes Approximately 8% of all Danish births take place at the University Hospital of Aarhus
Most conisation procedures were performed at the University Hospital of Aarhus, but a
small number were performed at specialist clinics in Aarhus or at the County Hospital
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Ortoft 2010 (Continued)
in Odder
From 1989 to 1992, all conisations were performed with the cold-knife procedure, and
from 1992 to 1995 the cold-knife procedure was only used for high conisations and in
pregnant women. After 1995, the cold-knife procedure was omitted, and instead the
electro knife was used when a high conus biopsy was warranted
Of the 710womenwith one conisation (excluding preterm induced birth (n = 4), preterm
acute CS before labour (n = 5) and preterm elective CS (n = 2)) prior to pregnancy, the
conus procedures were distributed as follows: 572 women had LLETZ, 71 women had
an electrosurgical needle procedure (electroknife), and 67 had CKC
18 women had treatment during pregnancy. Because the percentage of the women with
treatment during pregnancy was low (2.5%), we decided to include this study, because
we estimated that these women would not change the results
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk In the untreated external/CIN group, 355
deliveries (0.5%) were excluded because of
missing gestational age or missing birth
weight. In the treated group, no delivery
was excluded because of missing data
14% of the study cohort did not reply to
a questionnaire about, inter alia, previous
pregnancies. These women were not ex-
cluded from the study, but more women
might have been eligible for the internal
comparison group
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Questionnaires for the outcomes of previ-
ous pregnancies; there is a risk of recall bias
and misclassification of the outcome when
self-matching was used
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single university hospital during 1989
to 2007
Representative comparison group? Low risk A) External - B) women with HSIL but no
treatment: The untreated group was drawn
from the same source as the treated group
C) Internal comparison group (self-match-
ing)
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Ortoft 2010 (Continued)
Comparability of treatment groups? Low risk A) External
B) Women with HSIL but no treatment
Both had regression analysis for age, parity,
smoking status, educational level and mar-
ital status
C) Internal comparison group (self-match-
ing)
Paraskevaidis 2002
Methods Retrospective cohort study
Comparison group: External - matching for age, parity, smoking, multiple pregnancies
and history of previous PTBs
Information source - Hospital records of the University Hospital of Ioannina
Participants Treated group - 28 women with stage IA1 cervical carcinoma without vascular or lymph
space involvementwhowere treatedwith LLETZbetween 1990 to 1998 at theUniversity
Hospital of Ioannina and had at least one pregnancy beyond 24 weeks following the
treatment (by 2001)
Untreated group - 28 women who delivered at the same hospital during the same year
without previous treatment of the cervix
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones);
sPTB; CS; precipitous labour (< 2 hours); LBW (< 2500 g); NICU admission
Notes During the period 1990 to 1998, 47 women with microinvasive cervical carcinoma
stage IA1 without vascular or lymph space involvement were managed exclusively with
LLETZ and had clear excisional margins after a single or repeat cone. Of these women,
28 had at least one pregnancy beyond 24 weeks. Of the remaining 19 women, 12 did
not become pregnant by 2001, 6 had first-trimester miscarriage, and one had an elective
TOP
5 cases had LLETZ performed in two steps in a tophat configuration, because of an
endocervically extended lesion. Three women had repeat LLETZ
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hospi-
tal records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
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Paraskevaidis 2002 (Continued)
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study, women having
LLETZ in a single university hospital be-
tween 1990 to 1998
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age, parity, smoking,multiple
pregnancies and history of previous PTBs
Parikh 2008
Methods Retrospective cohort study
Comparison group: External - no matching, no regression analysis
Information source - Hospital records of St. Luke’s Hospital and Health Network
Participants Treatedwomen - 87womenwhohad≥1LLETZand then conceived, underwent cervical
length screening by transvaginal ultrasound during 2001 to 2005 at St. Luke’s Hospital
and Health Network and delivered at the same hospital. Exclusion criteria: women with
other surgical procedures to the cervix (such as laser, CT, CKC, cerclage); other causes
of PTB, such as multiple gestation, major fetal anomaly and preterm induction of labor
resulting from maternal or fetal indication; women delivering in other hospitals
Untreated group - 18,042 singleton births of women without previous treatment who
delivered at the same hospital during 2001 to 2005
Interventions LLETZ
Outcomes PTB (≤ 34 weeks)
Notes A total of 97 patients who had undergone LLETZ were identified during the specified
time period. Of these, 10 patients were lost to follow-up because of delivery outside the
St. Luke’s Hospital and Health Network. Thus 87 patients were included in the LLETZ
group for analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data were obtained from hospital records;
10 patients in the treated group (10.3%)
were lost to follow-up
Selective reporting (reporting bias) Low risk No reporting bias is obvious
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Parikh 2008 (Continued)
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single hospital during 2001 to 2005
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? High risk No matching, no regression analysis
Poon 2012
Methods Prospective cohort study
Comparison group: External - unmatched; regression analysis for parity, race, smoking,
cervical length, previous delivery at term, previous PTB, previous miscarriage and pre-
vious LLETZ (for the prediction of sPTB)
Information source - questionnaires (for the ascertainment of the exposure); maternity
records of the King’s College Hospital and the University Hospital Lewisham/records of
general practitioners (for the ascertainment of the outcomes)
Participants Treated group - 473 pregnant women with a prior LLETZ who underwent routine
antenatal care at King’s College Hospital or University Hospital Lewisham and had
a transvaginal sonographic measurement of the cervical length at 20 to 24 weeks of
gestation, during January 1998 to July 2006
Untreated group - 25,722 pregnant women without previous LLETZ who underwent
routine antenatal care at King’s College Hospital or University Hospital Lewisham and
had a transvaginal sonographic measurement of the cervical length at 20 to 24 weeks of
gestation, during January 1998 to July 2006
Inclusion criteria (for both groups): singleton pregnancies
Exclusion criteria (for both groups): women with major fetal abnormalities, with painful
regular uterine contractions, with a history of ruptured membranes or cervical cerclage
in situ, with a cervical length at 20 to 24 weeks of gestation ≤ 15mm and because of
this treated with a cervical cerclage or prophylactic progesterone
Interventions LLETZ
Outcomes sPTB (< 37 weeks); sPTB (< 34 weeks)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Poon 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from medical
records and from questionnaires which
were completed by all patients
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Questionnaires were used for the ascertain-
ment of the exposure; there is a risk of recall
bias and misclassification of the exposure
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women with ante-
natal care at two hospitals during January
1998 to July 2006
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for parity, race, smok-
ing, cervical length, previous delivery at
term, previous PTB, previous miscarriage
and previous LLETZ (for the prediction of
sPTB)
Raio 1997
Methods Retrospective cohort study
Comparison groups: A) External - matching for age (+/- 1 year), parity, marital status,
social class, smoking habits and previous PTB
B) Internal (self-matching)
Information source - Hospital records of the Department of Obstetrics and Gynecology
of Munsterlingen, Kantonsspital, Switzerland
Participants A) Treated group - 64 women younger than 35 years of age who had undergone LC at the
Department of Obstetrics and Gynecology of Munsterlingen, Kantonsspital, Switzer-
land, from August 1, 1986, to December 31, 1994, and subsequently had a pregnancy
byDecember 31, 1996. Only the first pregnancy after treatment was included. Exclusion
criteria: voluntary termination of pregnancy, twin gestation, first-trimester miscarriage,
fetal death, ectopic pregnancy, second-trimester termination of pregnancy for fetal struc-
tural abnormalities, blighted ovum, and cervical incompetence for previous pregnancy
Untreated group - 64 women who were delivered at the same hospital during the study
period and had not had any surgical procedure of the cervix
B) 26 women of the treated group were parous. For these women, self-matching was also
possible
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Raio 1997 (Continued)
Interventions LC
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); PTB (< 37 weeks) (D <
10 mm); PTB (< 37 weeks) (D ≥ 10 mm); pPROM
Notes The study was conducted at the Department of Obstetrics and Gynecology of Munster-
lingen, Kantonsspital, Switzerland, from August 1, 1986, to December 31, 1994. Laser
conisation was performed in 228 women younger than 35 years of age with CIN. 26
women were lost after treatment. By December 31, 1996, 117 pregnancies occurred in
78 patients who had undergone laser conisation. If women conceived more than once,
only the first subsequent gestation was included in the analysis. 14 women were excluded
because of the following reasons: voluntary termination of pregnancy (n = 4), twin ges-
tation (n = 3), first-trimester miscarriage (n = 2), fetal death (n = 1), ectopic pregnancy
(n=1), second-trimester termination of pregnancy for fetal structural abnormalities (n
= 1), blighted ovum (n = 1), and cervical incompetence for previous pregnancy (n =
1). The remaining 64 women with singleton pregnancies were included in the treated
group. CIN 3 = 33/64 (51.6%); CIN 2 = 22/64 (34.4%); CIN 1 = 9/64 (14%)
Regression analysis for history of PTB, advanced maternal age, smoking, multiparity
and cone height: cone height was the only covariate that remained significant
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of the 228 women who had undergone
LC from August 1, 1986, to December 31,
1994, 26 women (11.4%) were lost after
treatment
Selective reporting (reporting bias) Low risk No reporting bias is obvious.
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds.
Representative intervention group? Low risk All eligible women that had LC in a single
Swiss cantonhospital betweenAugust 1986
to December 1994
Representative comparison group? Low risk A) The untreated group was pooled from
the same source as the treated group
B) Internal comparison group (self-match-
ing)
Comparability of treatment groups? Low risk A) Matching for age (+/- 1 year), parity,
marital status, social class, smoking habits
and previous PTB
99Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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B) Internal comparison group (self-match-
ing)
Reilly 2012
Methods Retrospective cohort study
Comparison groups:
A) External
B) Women with colposcopy +/- punch biopsy but no treatment
Both were unmatched but had regression analysis for maternal age at birth, social de-
privation, smoking status, time interval between screening/colposcopy/treatment and
conception, any history of a previous adverse pregnancy outcome (and gestational age
for LBW outcome)
Information source - the Cervical Screening Wales programme database, the National
Community Child Health Database and All Wales Perinatal Survey
Participants Treated group - all women in Wales aged 20 to 39 years who had a first referral to
colposcopy and received cervical treatment for CIN between April 2001 - March 2004,
and then had a singleton pregnancy of at least 24 weeks until January 2009; n=2202
(single excision:1546; single ablation:534; multiple treatments:82; other:40)
Untreated group - A) all women inWaled aged 20 to 39 years who had a negative cervical
smear between April 2001to March 2004 with no history of abnormal smears, and then
had a singleton pregnancy of at least 24 weeks of gestation until January 2009; n=38983
B) all women in Wales aged 20 to 39 years who had a first referral to colposcopy +/-
punch biopsy (but no cervical treatment) between April 2001 to March 2004, and then
had a singleton pregnancy of at least 24 weeks of gestation until January 2009; n = 2534
Inclusion criteria: only the first pregnancy following the smear, colposcopy, or treatment
Exclusion criteria: women who were pregnant at the time of screening/colposcopy/treat-
ment during the study period; women in the
colposcopy and treatments groups in the study period who had a history of colposcopy
or treatment to the cervix; women who had negative smears up to and during the study
period and a subsequent abnormal smear, colposcopy or treatment during the follow-up
period
Interventions Single excision NOS (LLETZ, CKC); single ablation NOS (LA, CC, CT); multiple
treatments (either multiple excisions, either multiple ablations, or both); other
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones);
PTB (< 37 weeks) (singleton pregnancies); PTB (< 32 weeks); PTB (< 28 weeks); LBW
(< 2500 g)
Notes At the bottom of the table 2 (page 240) it is stated that the percentages are based on
the babies for whom the gestational age and the birth weight was known. However, the
authors do not give more information about how many babies in each category had a
known gestational age and a known birth weight. Thus, i) we calculated the total number
of babies with a known gestational age in each category according to the rate of PTB
< 37 weeks ii) we calculated the total number of babies with a known birth weight in
each category according to the rate of LBW < 2500 g. Because the percentages were
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rounded, this calculation was not very precise. The addition of the numbers of babies
with a known gestational age of all categories diverged from the known number of babies
with a known gestational age given at the bottom of the table. The same for the babies
with a known birth weight. Because the divergence was small, we decided not to make
any other correction
Women that had ’other treatments’ were not included in our meta-analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk For 225 women (0.1% of the total ini-
tial study population) no unique identifier
(such as NHS number or date of birth) was
available and these women were excluded
18,512 women (10.6% of the eligible for
data linkage women) died in the follow-up
period or were no longer Welsh residents
2.6% of the babies had an unknown gesta-
tional age and 0.4% of the babies had an
unknown birth weight
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women having
cervical treatment in Wales (April 2001
to March 2004) and then delivering in
Wales (till January 2009) (a population-
based study)
Representative comparison group? Low risk Both untreated groups were drawn from
the same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for maternal age at
birth, social deprivation, smoking sta-
tus, time interval between screening/col-
poscopy/treatment and conception, any
history of a previous adverse pregnancy
outcome (and gestational age for LBWout-
come
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Methods Retrospective cohort study
Comparison group:Womenwith colposcopy but no treatment - unmatched; regressional
analysis for age, ethnicity, socioeconomic status, smoking in pregnancy, previous obstetric
history, transfer to the National Women’s Hospital and antepartum haemorrhage
Information source - linking the colposcopy service database at National Women’s Hos-
pital (NWH), Auckland, for the years 1988 through 1999 with the obstetric database at
the same hospital for deliveries from 1989 through 2000
Participants Treated group - 652 women whose pregnancy occurred after treatment with LA, LC, or
LLETZ. Inclusion criteria:Women whowere seen and/or treated at the colposcopy clinic
(1988 to 1999), subsequently carried a singleton pregnancy to at least 20 completed
weeks’ gestation, and delivered or had postpartum care at the study hospital (1989
to 2000). Only the first qualifying pregnancy per woman was included in the study.
Exclusion criteria: Women whose prior treatment status was unknown. Women treated
by modes other than LA, LC and LLETZ, and women who had cervical treatments
before 1988
Untreated group - 426 women who had a pregnancy following a visit to the colposcopy
service but before no cervical treatments that may have been administered
A pregnancy was included only if the visit to the colposcopy clinic or treatment occurred
before the first menstrual period was missed (i.e. last menstrual period + 30 days)
Interventions LC; LLETZ; LA
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones);
PTB (< 37 weeks) (singleton pregnancies); PTB (< 37 weeks) (D≤ 10 mm); PTB (< 37
weeks) (D = 11 mm to 16 mm); PTB (< 37 weeks) (D ≥ 17 mm); PTB (< 32 weeks);
sPTB (< 37 weeks); pPROM
Notes From the colposcopy database of 9226 women, 1208 women were found to have had a
singleton live birth of at least 20 weeks’ gestation, by linkage with the obstetric records.
Of these, 27 were excluded for invalid treatments (13 cryotherapy, 8 Cartier biopsies,
and 6 coldknife conisations), 10 for unknown previous treatment status, and 93 because
of previous treatment, leaving a cohort of 1078 women who had given birth following
treatment or their first encounter at the colposcopy clinic. The clinical records of 1020
women (95%) were abstracted in full. Data were obtained from the database for women
whose colposcopy or obstetric records could not be located (4%)
In the treated group, 606 women had one treatment before pregnancy, 44 two treatments
and two three treatments
The proportion of women in treated vs untreated group with histology: HPV/CIN1
(32.1% vs 46.6%); CIN2/3/AIS (61.7% vs 5.2%); Microinvasion (0.9% vs 0%); No
dysplasia/other diagnosis (2% vs 21.1%); none (3.4% vs 27%)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The information was obtained from hos-
pital records; small number of incomplete
data
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Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women that had
LA, LCorLLETZat theNationalWomen’s
Hospital (NWH); NWH is the principal
provider of public colposcopy services and
inpatient obstetric care to women in the
central Auckland area
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Regressional analysis for age, ethnicity, so-
cioeconomic status, smoking in pregnancy,
previous obstetric history, transfer to the
National Women’s Hospital and antepar-
tum haemorrhage
Sagot 1995
Methods Retrospectice cohort study
Comparison group: Internal (pre-treatment pregnancies)
Information source - Hospital records of the Hospital Mere-Enfant, Nantes, France
Participants Treated group - 54 women (53 pregnancies) under 39 years of age who had undergone
LC between 1 July 1982 and 30 June 1992 and had one or more pregnancies after their
operation
Untreated group: 38 women of the treated group (59 pregnancies) who had also a
pregnancy before treatment
Inclusion criteria: Only pregnancies leading to the birth of a child were included
Interventions LC - two different techniques: Before 1986, hand-held laser (10/54) under GA with 2
stitches, cone-shaped 1 cm to 2 cm deep, radius 1 cm to 1.5 cm, LA for haemostasis
- After 1986, micromanipulator (44/54), less radical, cylinder, 0.8 cm to 1.8 cm deep,
radius 0.6 cm to 0.8 cm
Outcomes PTB (< 37 weeks); Threatened PTL; pPROM; CS; chorioamnionitis; cervical cerclage
Notes Between 1 July 1982 and 30 June 1992, 222 women under 39 years of age underwent
CO2 laser conisation for CIN. 27 had subsequent hysterectomy or tubal sterilisation,
and 48 others could not be recontacted. Thus, 147 women were available for study. Of
these 147 women, 54 had a total of 71 pregnancies after the operation. Of these 71
pregnancies, 53 led to the birth of a live child (two sets of twins). These 53 pregnancies
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were included in the treated group. Of the 54 women which made out the treated
group, 38 had also a pregnancy before the operation. These 38 women had a total of 82
pregnancies before the operation. Of these 82 pregnancies, 59 (all monofetal) led to the
birth of a live child. These 59 pregnancies were included in the control group
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Of the 222 women who underwent LC be-
tween 1 July 1982 and 30 June 1992, 48
(21.6%) could not be recontacted
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds.
Representative intervention group? Low risk All women that had LC in a single univer-
sity hospital in France between July 1982
to June 1992
Representative comparison group? Low risk Internal comparison group (pre-treatment
pregnancies)
Comparability of treatment groups? Low risk Internal comparison group (pre-treatment
pregnancies)
Samson 2005
Methods Retrospective cohort study
Comparison group: External - matching for age (+/- 1 year), parity (nulliparous/parous)
, smoking status (yes/no/unknown), year of delivery (+/- 1 year)
Information source - the Provincial Cytology/Colposcopy Registry (information about
all women who have had colposcopy and treatment for CIN in Nova Scotia since 1992)
and the Nova Scotia Atlee Perinatal Database (information about all pregnancies and
deliveries in Nova Scotia carried beyond 20 weeks of gestation since 1988)
Participants Treated group - 571 women who had LLETZ inHalifax County between 1992 and 1999
and then had a subsequent singleton pregnancy of greater than 20 weeks of gestation
with delivery at the IWK Health Centre in Halifax, Nova Scotia. Only the first delivery
after treatment was included
Untreated group - 571 women from Halifax County with no history of cervical surgery
who delivered at the IWK Health Centre beyond 20 weeks of gestation. Each control
was randomly selected from a pool that included all who matched to a specific case
Exclusion criteria (for both groups): Women who had known major risk factors for
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PTB, including previous PTB and multiple gestations. Multiple gestations were analysed
separately. Women who had an indicated PTB for maternal or fetal reasons
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones)
; PTB (< 37 weeks) (singleton pregnancies); PTB (< 37 weeks) (multiple pregnancies);
PTB (< 34 weeks); PTB (< 34 weeks) (multiple pregnancies); pPROM; CS; induction of
labour; oxytocin use; LBW (< 2500 g); NICU admission; perinatal mortality; stillbirth
Notes Using the Provincial Cytology/Colposcopy Registry database, the authors found that
3056 women had a total of 3315 LLETZ in Halifax County between 1992 and 1999.
When the Provincial Cytology/Colposcopy Registry database was linked with the Atlee
Database, 1629 women were matched, indicating that they had a pregnancy and delivery
at some time in their lives. Of the 1629 matches, 876 (54%) had deliveries only before
their LEEP.Of the 753 womenwith deliveries after their LEEP, 122 (16%) were excluded
because they were not Halifax County residents. Additional exclusions were made for
indicated preterm delivery, previous preterm delivery, and missing matching variables
(parity, age, delivery date), constituting another 50 cases in total. Thus, after appropriate
exclusions, there were 581 women who had at least one delivery after their LEEP, 571
singleton, and 10 twin pregnancies. The multiple gestations were excluded from the
primary analysis, leaving 571 women in the study group. The authors then retrieved a
matched comparison group, consisting of 571 women
In a separate analysis, for the 10 twin pregnancies a matched comparison group was
selected in a 5:1 ratio. 5 appropriate matches could not be found for each study patient,
resulting in 35 women in the comparison group
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The informationwas obtained fromofficial
databases; small number of incomplete data
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women having
LLETZ in Halifax County and then deliv-
ering at the IWK Health Centre
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
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Comparability of treatment groups? Low risk Matching for age (+/- 1 year), parity (nul-
liparous/parous), smoking status (yes/no/
unknown), year of delivery (+/- 1 year)
Saunders 1986
Methods Retrospective cohort study
Comparison group: External - matching for age (+/-5 years), parity, race, year of delivery
and singleton pregnancy
Information source - Hospital case notes and contact with local general practitioners
Participants Treated group - 97 pregnancies of 96 women who had previously undergone LA
Exclusion criteria: pregnancies ending in the 1st trimester (miscarriage or TOP); women
having CKC before LA
Untreated group - 97 pregnancies of women booking around 13 to 16 weeks’ gestation,
with no history of treatment and with recorded pregnancy outcomes
Interventions LA
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones);
pPROM; CS; instrumental deliveries (forceps); LBW (< 2500 g); perinatal mortality
Notes By consultinghospital case notes and contacting local general practitioners, it was possible
to identify 100 pregnancies which had progressed beyond the first trimester in a group of
99 women previously treated with by laser vaporisation cone for CIN.Of the 99 patients,
3 had knife cut cone biopsy followed by laser vaporisation employed at a subsequent date
because of recurrent CIN, and because of this were excluded from the main analysis.
Thus, 96 patients with 97 pregnancies were included (1 patient had two consecutive
normal term deliveries)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk A part of the data were obtained from con-
tact with local general practitioners (a non-
systematic approach)
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk Women were selected if they had LA and
subsequent fell pregnant at Sheffield
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Representative comparison group? Low risk The untreated population was drawn from
the same source as the treated group
Comparability of treatment groups? Unclear risk Matching for age (+/-5 years), parity, race,
year of delivery and singleton pregnancy.
Even though it was found that the per-
centage of smokers was much higher in
the treated that the control group (48% vs
26%), the researchers did not match for
smoking
Shanbhag 2009
Methods Retrospective cohort study
Comparison groups:
A) External
B) Women with CIN 3 but no treatment
Both were unmatched but had regression analysis for maternal age at delivery, smoking,
socioeconomic status, year of delivery, birth weight,malpresentation, sPTB and pPROM
Information source - Scottish Cancer Registry, Scottish Morbidity Record, National
Health Service Scotland Information and Statistics Division
Participants Treated group - 1388 women (from the whole Scotland) with CIN 3 diagnosed by
histology, treatedwith excisional (CKC=2; LC=4; LLETZ=1097) or ablative treatment
(LA = 84, cold coagulation = 181, diathermy coagulation = 20) and subsequently having
a first pregnancy that ended between 1980 to 2005
Untreated group - A) 119216 women (from the whole Scotland) without a record of
CIN, whose first pregnancies ended between 1980 to 2005;
B) 87 women (from the whole Scotland) with CIN3 diagnosed by histology who had a
first pregnancy (that ended between 1980 to 2005) without previously receiving treat-
ment for the CIN 3
Inclusion criteria (for all groups): women who delivered between the ages of 20 and 45
years inclusive, at a gestational age of 24 to 43 weeks, neonatal birth weight more than
350 g, and, in case of CIN 3, women who were diagnosed at the age of 20 or older
Interventions Excision NOS (CKC, LC, LLETZ); Ablation (LA, CC, diathermy coagulation)
Outcomes PTB (< 37weeks); sPTB (< 37weeks); pPROM;CS; LBW(< 2500 g); perinatal mortality
Notes For 1638 women (1638/3113 = 52.6%) with CIN 3, the type of therapy (if any) was
not known
Risk of bias
Bias Authors’ judgement Support for judgement
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Incomplete outcome data (attrition bias)
All outcomes
High risk Information was obtained from national
registries. For 52.6% of the treated popu-
lation, the treatment methods (if any) were
not known and these were not included in
the analysis
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the studywomen inScotland
having a delivery during 1980 to 2005 (a
population-based study)
Representative comparison group? Low risk Both untreated groups were drawn from
the same source as the treated group
Comparability of treatment groups? Low risk Regression analysis for maternal age at de-
livery, smoking, socioeconomic status, year
of delivery, birth weight, malpresentation,
sPTB, pPROM
Simoens 2012
Methods Prospective cohort study
Comparison group: External - matching for admittance in the same maternity ward;
regression analysis for age, parity, ethnicity, smoking, education, HIV status
Information source - a centralised web-based database of the four participating Bel-
gian academic hospitals (”Hopital de la Citadelle“ and ”Centre Hospitalier du Bois de
l’Abbaye (CHBAH)“ in Liege, ”Hopital St. Pierre“ and ”Hopital Erasme“ in Brussels);
questionnaires in combination with checking of obstetrical medical files
Participants Treated group - 97 women who had undergone excisional or ablative treatment for CIN
and then delivered at one of the four participating Belgian academic hospitals during
September 2008 to November 2010
Untreated group - 194 women who delivered at one of the four participating Belgian
academic hospitals during September 2008 to November 2010 and who never had
treatment for CIN or a history of CIN (the next two women after each case meeting
these criteria and who delivered in the same maternity ward)
Inclusion criteria: only women with a singleton pregnancy
Exclusion criteria: women with insufficient data on previous treatment, without a non-
exposed cluster, lacking pregnancy outcome data and unexposed women in excess
Interventions LC, LLETZ, Excision NOS (CKC, LC, LLETZ) +/- Ablation NOS (LA, CC, CT)
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Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (D ≤ 10 mm); PTB (< 37 weeks) (D> 10 mm);
PTB (< 37 weeks) (singleton pregnancies); PTB (< 32 weeks); sPTB (< 37 weeks); sPTB
(< 32 weeks); CS; LBW (< 2500 g)
Notes Of the 97 treatedwomen, 81 received an excisional treatment, eight an ablative treatment
and eight an excisional treatment followed by ablation (mixed)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records and questionnaires in combination
with checking of medical files
Selective reporting (reporting bias) Unclear risk The results are presented analytically only
for the following 3 treatment categories: i)
only excision or excision in combination
with ablation ii) LLETZ iii) LC; the re-
maining treatments only had a small num-
ber of patients and were not presented
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
at 4 university hospitals during September
2008 to November 2010
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for admittance in the same ma-
ternity ward; regression analysis for age,
parity, ethnicity, smoking, education, HIV
status
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Methods Retrospective cohort study
Comparison groups:
A) External - matching for age (+/- 2 years), parity and plurality
B) Internal (self-matching)
Both had regression analysis for smoking, marital status and education
Information source - Records of the eight hospitals that participated in this regional
multicentre study (OestfoldHospital Trust, SoerlandetHospital Trust, VestfoldHospital
Trust, Telemark Hospital Trust, Baerum Hospital, Buskerud Hospital Trust, Ringerike
Hospital, Rikshospitalet University Hospital)
Participants Treated group - 742 women who had undergone LC or LLETZ (LC: 609; LLETZ: 133)
during 1990 to 1999 at one of the eight participating hospitals, were 40 years or younger
at the time of operation, subsequently had a pregnancy progressing beyond 16 weeks,
and gave their permission to the researchers to collect information about their pregnancy
from their medical records in the hospital where they delivered. Only the first pregnancy
after treatment was included
Untreated group - A) 742 women without previous treatment who delivered at one of the
eight participating hospitals (the first subsequent after case delivering woman matched
by age, parity and plurality)
B) In the treated group, 419 women had delivered before the treatment as well. Thus, it
is also possible to compare their first pregnancy after treatment with their first pregnancy
before treatment
Interventions Excision NOS (LC, LLETZ)
Outcomes PTB (< 37 weeks); PTB (< 32 weeks); PTB (< 28 weeks); pPROM; LBW (< 2500 g);
LBW (< 1500 g); LBW (< 1000 g); perinatal mortality
Notes Because all women included in this study have been also included in Albrechtsen 2008,
we excluded it from the analyses in which Albrechtsen 2008 has been also included.
A regional, multi-centre, retrospective case-control study was designed to investigate
pregnancy outcome after LC or LLETZ compared to a control group of pregnant women
without such a procedure. Women who underwent either LC or LLETZ in the period
from January 1, 1990 to December 31, 1999, were investigated for reproductive events.
Those who were 40 years of age or younger at the time of operation were contacted in
writing with information about the study and a request for permission to collect relevant
information from their medical records in the hospitals where they had given birth. A
total of 2,393 women were contacted, and 742 women (31%) answered our request.
The non-responding group consisted of both true non-responders who had given birth
after conisation, and patients who had not given birth after conisation. Written consent
was not collected for the controls, since their data were extracted anonymously from the
birth registries of the participating hospitals
In the external treated group, 7 women had a second-trimester miscarriage. In the article,
in the tables with the results, these women were not included
Risk of bias
Bias Authors’ judgement Support for judgement
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Incomplete outcome data (attrition bias)
All outcomes
High risk The women who had undergone LLETZ
or LC were contacted in writing so that
the researchers would obtain their consent
to collect information about their proba-
ble future pregnancies. Only 742 (31%) re-
sponded and gave their consent. The non-
responding group consisted of both true
non-responders who had given birth after
conisation, and patients who had not given
birth after conisation
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk The women who had undergone LLETZ
or LC were contacted in writing so that
the researchers would obtain their consent
to collect information about their proba-
ble future pregnancies. Only 742 (31%) re-
sponded and gave their consent. The non-
responding group consisted of both true
non-responders who had given birth af-
ter conisation, and patients who had not
given birth after conisation. The women
who replied are more likely to have a higher
level of education
Representative comparison group? Low risk A) The untreated group was drawn from
the same source as the treated group
B) Internal comparison group (self-match-
ing)
Comparability of treatment groups? Low risk A)Matching for age (+/-2 years), parity and
plurality
B) Internal comparison group (self-match-
ing)
Both comparison groups had regression
analysis for smoking, marital status and ed-
ucation
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Methods Retrospective cohort study
Comparison group: External - matching for age, parity and obstetric history
Information source - Records of the Zeynep Kamil Women’s Hospital, Istanbul
Participants Treated group - 15 women who had undergone CKC at the Zeynep Kamil Women’s
Hospital during 2005 to 2010 and subsequently had a pregnancy (beyond 20 weeks of
gestation)
Inclusion - 24 women who had a pregnancy (beyond 20 weeks of gestation) without a
history of cervical intervention
Exclusion criteria (for both group) - miscarriages
Interventions CKC
Outcomes PTB (< 37 weeks); pPROM; NICU admission
Notes Among 392 patients who had CKC at Zeynep Kamil Women’s Hospital (a tertiary
referral teaching institution in Istanbul, Turkey) between the years 2005 to 2010, 22
had a subsequent pregnancy. 7 of those pregnancies resulted in miscarriage and were
excluded
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Very small number of the treated group (n
= 15)
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age, parity and obstetric his-
tory
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Spitzer 1995
Methods Retrospective cohort study
Comparison group: Internal (pre-treatment pregnancies) with matching for age and
parity
Information source - Hospital records of the Colposcopy Clinic at Queens Hospital
Centre and every record from the private practice of the authors (for the ascertainment
of the exposure); questionnaires by mail, telephone or in person (for the ascertainment
of the outcomes)
Participants Treated group - 163 livebirths after LC or LA (34 after LC, 129 after LA)
Control group - 112 livebirths before LC or LA (15 before LC, 97 before LA)
Inclusion criteria: Laser surgery during 1979-1989. Women under the age of 40 at the
time of delivery
Exclusion criteria: Pre-treatment or after-treatment intervals, during which women were
not at risk for pregnancy (e.g. they had tubal ligation or hysterectomy, or their husbands
had vasectomies). Pregnancies that were ongoing at the time the women responded to the
questionnaire. After-treatment intervals for which no appropriate pre-treatment interval
was found
Interventions LC; LA
Outcomes PTB (< 37 weeks)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk The researchers used questionnaires to ac-
quire information about previous pregnan-
cies. Of the initial 1069 women fulfilling
the inclusion criteria, only 512 (47.9%) re-
sponded
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Questionnaires were used for the ascertain-
ment of the outcomes of previous pregnan-
cies. There is a risk of recall bias and mis-
classification of the outcome
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Almost half of the women did not reply to
the questionnaires. Thewomen that replied
are more likely to have a higher educational
level
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Representative comparison group? Low risk Internal comparison group (pre-treatment
pregnancies) with matching for age and
parity
Comparability of treatment groups? Low risk Internal comparison group (pre-treatment
pregnancies) with matching for age and
parity
Stout 2015
Methods Retrospective cohort study
Comparison groups:
A) Women with cervical cytology/punch biopsy - matching for age, hospital site and
calendar year of cervical procedure (LLETZ, cervical cytology, punch biopsy)
B) Internal (pre-treatment pregnancies)
Information source - electronic pathology databases of several tertiary and community
hospitals; structured phone interviews in combination with checking of medical records
Participants Treated group - 598 women who had undergone LLETZ at the participating tertiary
and community hospitals between 1996 and 2006 and subsequently had a pregnancy
Untreated group - A) 1129 women who had undergone cervical cytology (580) or
cervical punch biopsy (549) at the participating hospitals during the same period and
subsequently had a pregnancy
B) Internal (pre-treatment pregnancies of the women with LLETZ)
Inclusion criteria (for all groups):only the first singleton pregnancy beyond 20 weeks of
delivery following the cervical procedure
Exclusion criteria (for all groups): women with a history of CKC; women without ges-
tational age of delivery recorded; women with a cervical procedure outside the partici-
pating hospitals; women with medically indicated PTB (e.g. pre-eclampsia, intrauterine
growth restriction, non-reassuring fetal testing)
Interventions LLETZ
Outcomes sPTB (< 37 weeks); sPTB (< 37 weeks) (singleton pregnancies); sPTB (< 34 weeks)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The gestation age at delivery was unknown
for < 6% of the population
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
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Stout 2015 (Continued)
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women having
LLETZ at several hospitals during 1996 to
2006
Representative comparison group? Low risk A) The untreated group was drawn from
the same source as the treated group
B) Internal comparison group (pre-treat-
ment pregnancies)
Comparability of treatment groups? Low risk A) The untreated group was women with
cervical cytology/punch biopsy matched
for age, hospital site and calendar year of
cervical procedure
B) Internal comparison group (pre-treat-
ment pregnancies)
Tan 2004
Methods Retrospective cohort study
Comparison group: External - matching for age and parity
Information source - Hospital records of Basildon District Hospital
Participants Treated group - 119 women 35 years old or younger who had undergone LLETZ and
delivered in Basildon District Hospital, between 1995 and 1998. Only first pregnancies
following treatment were included
Control group - 119 women who had not had colposcopy/LLETZ and delivered in
Basildon District Hospital between 1995 and 1998
Interventions LLETZ
Outcomes PTB (< 37 weeks); CS; instrumental deliveries (ventouse/forceps); prolonged labour (>
12 hours); induction of labour; oxytocin use; epidural use; pethidine use
Notes 168 women 35 years old or younger had undergone LLETZ and delivered in Basildon
District Hospital, between 1995 and 1998. Of these, 119 women were included in the
treated group and the others were excluded, because their notes could not be retrieved
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk 168 women were eligible for the study. Of
these, 49 (29.2%) were excluded because
their notes could not be retrieved, with no
further details given by the authors
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Tan 2004 (Continued)
Selective reporting (reporting bias) Low risk No reporting bias is obvious.
Other bias High risk There are some contradictions in the pre-
sented data; e.g. although it is stated that
there are 14/119 and 11/119 miscarriages
in the treated and untreated group, respec-
tively, it later presents the mode of delivery
in 119 women in each group
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds.
Representative intervention group? Low risk All eligible women delivering in a single
hospital between 1995 and 1998
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Unclear risk Matching for age and parity. Smoking was
higher in the treated group (52.3%) than
in the untreated group (24.4%)
Turlington 1996
Methods Retrospective cohort study
Comparison group: Women with colposcopically directed biopsy but no treatment -
regression analysis for age
Information source - Hospital records of New Havover Regional Medical Center, tele-
phone interviews/mail-in questionnaires (for reproductive history since their visit to the
colposcopy clinic)
Participants Treated group - 15women between the ages of 16 and 40whowere treatedwith LEEP for
CIN at New Havover Regional Medical Center, Wilmington, North Carolina, between
1991 and 1992, and then had a pregnancy which led to delivery
Untreated group - 15 women of the same range of age who had been seen in the col-
poscopy clinic during the same period for abnormal smear but who did not receive ex-
cisional or ablative therapy, and then had a pregnancy which led to delivery
Exclusion criteria: Women who were anatomically unable to become pregnant as a result
of permanent sterilization or hysterectomy
Interventions LLETZ
Outcomes Stillbirth
Notes Between January 1991 and December 1992, 647 women were evaluated and treated for
abnormal cervical cytologic smears in the colposcopy clinic at New Hanover Regional
Medical Centerm a 630-bed hospital in Wilmington, North Carolina, that serves as a
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Turlington 1996 (Continued)
referral centre for southeastern North Carolina. Using telephone interviews and mail-
in questionnaires, 158 women between the ages of 16 and 40 who had undergone
colposcopy for abnormal smears were contacted and questioned about their reproductive
history since their visit to the colposcopy clinic (79 destined for the treated group and
79 destined for the control group). In the treated group, 54 women replied and were
included in the analysis. In the control group, 57 women replied and were included in
the analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Of the 158 women surveyed, 111 (70.
3%) responded to the questionnaire or tele-
phone interview; 29.7% did not reply
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Questionnaires and telephone interviews
were used for the ascertainment of the out-
come; there is a risk of recall bias and mis-
classification of the outcome
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Questionnaires or telephone interviews
were used for the selection of the treated
group; the women who replied are more
likely to belong to a higher socioeconomic
class
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk The untreated group was taken from
women that were seen in the colposcopy
clinic; regression analysis for age
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van de Vijner 2010
Methods Retrospective cohort study
Comparison group: External - matching for age (+/-2 years), parity and year of delivery
(+/-2 years)
Information source - electronic and paper patient files at the University Hospital of
Leuven and questionnaires
Participants Treated group - 55 pregnancies (beyond 22 weeks of gestation) of 43 women who had
undergone LLETZ (40 patients; 50 pregnancies) or LC (3 patients, 5 pregnancies) during
1999 to 2003 at the University Hospital of Leuven and subsequently delivered before
2007. Exclusion criteria: pregnancies that resulted in a miscarriage
Untreated group - 55 pregnancies of 54 women who had no intervention on the cervix
or were never diagnosed with CIN
Interventions Excision NOS (LC, LLETZ)
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones)
; PTB (< 37 weeks) (singleton pregnancies); PTB (< 37 weeks) (multiple pregnancies)
; PTB (< 34 weeks); threatened PTL; pPROM; CS; instrumental delivery (ventouse/
forceps); induction of labour; oxytocin use; LBW (< 2500 g); NICU admission; perinatal
mortality; stillbirth
Notes 599 women underwent a conisation of the cervix (LLETZ, laser or cold knife) between
1 January 1999 and 31 December 2003 in the University Hospital in Leuven. In this
group, 47 women could be identified who became pregnant after the intervention and
delivered before 1 January 2007. The study concerned 72 pregnancies. Seventeen (23.
6%) resulted in a miscarriage and were excluded. Finally, the treated group consisted of
55 evolutive pregnancies (delivery after 22 weeks of gestation) in 43 women. There were
nine women with two and two women with three subsequent pregnancies
2 women in the treated group had two conisations (4 pregnancies)
In the control group there were 3 twin pregnancies. In the control group there was one
twin pregnancy
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Questionnaires were sent to 599 women
to identify who of them became pregnant
after the intervention. The authors do not
give information about how many replied;
they just write that 47 of them fell pregnant
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk In some outcomes the population increases
and there is no description where these
additional pregnancies come from (e.g.
NICU admission 15/58 in the treated
group vs 9/58 in the untreated group, al-
118Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
van de Vijner 2010 (Continued)
though the treated group consists of 55
pregnancies and so does the untreated
group)
The use of questionnaires for the outcomes
increases the risk of recall and misclassifi-
cation bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Unclear risk There may be women that did not reply to
the questionnaire. This information is not
provided by the authors
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Unclear risk Matching for age (+/-2 years), parity and
year of delivery (+/-2 years). The treated
group, in comparison with the untreated
group, hadmore sexual partners (4.6 vs 2.5)
and smoked more before pregnancy (50%
vs 20.4%). Differences in smoking during
pregnancy, socioeconomic status and edu-
cation level were not statistically significant
Van Hentenryck 2012
Methods Retrospective cohort study
Comparison group: External - matching for age at delivery, parity, smoking, history of
gestation and HIV status
Information source - the electronic databases of the Gynecopathologic and Obstetrics
Departments of Erasme University Hospital, Belgium
Participants Treated group - 106 deliveries of 88 women who had undergone excisional treatment
for CIN at the Erasme University Hospital between 1999 to 2010 and then delivered at
the same hospital between 2000 to 2010 (CKC = 14; LC = 33; LLETZ = 40; unknown
= 1)
Untreated group - 212 deliveries of 176 women who delivered at the Erasme University
Hospital between 2000 to 2010 without previous excision (the first preceding and fol-
lowing women after each case fulfilling the matching criteria)
Interventions Excision NOC (CKC, LC, LLETZ)
Outcomes PTB (< 37 weeks); PTB (< 34 weeks); threatened PTL; pPROM; chorioamnionitis;
CS; instrumental deliveries (ventouse); induction of labour; LBW (< 2500 g); NICU
admission
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Van Hentenryck 2012 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk There were inconsistencies in the numbers
reported in the tables and the text
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women under-
going excisional treatment (1999 to 2010)
and delivering (2000 to 2010) at a single
university hospital
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age at delivery, parity, smok-
ing, history of gestation, HIV status
van Rooijen 1999
Methods Retrospective cohort study
Comparison group: External - matching for age (+/- 3 years), parity and year of delivery
(same year)
Information source - Hospital records of Karolinska Hospital in Stockholm
Participants Treated group - 236 women who had undergone LA and delivered in Karolinska Hos-
pital in Stockholm, between 1982 and 1992. Only first delivery after treatment was in-
cluded.Women who had undergone previous conisation (8) or reoperation with cervical
conisation before pregnancy (11) were excluded
Untreated group - 472 women (2 controls for each case) without previous treatment
who delivered in the same hospital during the same period. The controls were selected
from the birth registry of the hospital
Interventions LA
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); CS; APH; LBW (< 2500 g); LBW
(< 2000 g); LBW (< 1500 g); LBW (< 1000 g)
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van Rooijen 1999 (Continued)
Notes During the 11-year period 1982 to 1992 a total of 1828 women underwent laser vapor-
ization of the uterine cervix at the Department of Obstetrics and Gynaecology, Karolin-
ska Hospital in Stockholm. Until the end of 1992, 298 of these women gave birth to
at least one child after operation. 62 of them were excluded from the study because of
previous conisation (8), reoperation with cervical conization before pregnancy (11) or
because of incomplete data in their charts (43). The remaining 236 women were in-
cluded in the treated group
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk 279 women were eligible for the study. Of
these, 46 (16.5%) were excluded because
of incomplete data in their charts
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in a single hospital between 1982 to 1992
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age (+/- 3 years), parity, year
of delivery (same year)
Weber 1979
Methods Retrospective cohort study
Comparison group: External - matching for age
Information source - interview (about previous CKC, age, previous pregnancies, educa-
tion, employment and smoking habits), hospital records (about current pregnancy)
Participants Treated group - 44 women with CKC in the past were delivered at Fredriksberg Hospital
and Rigshospitalet during March 1974 and December 1975. All pregnancies (48) of
these women after CKC were included in the treated group (even if these were not the
current ones)
Untreated group - All pregnancies (48) of the age-matched women after the date of the
CKC of the cases (even if these were not the current ones). The age-matched women
were delivered at the same hospital and had not had treatment for CIN in the past
121Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Weber 1979 (Continued)
Interventions CKC
Outcomes LBW (<2500g)
Notes During March 1974 and December 1975, 7327 women were delivered at Fredriksberg
Hospital and Rigshospitalet. At their first contact with the antenatal clinics all patients
were interviewed by specially employed and trained staff. 44 stated a previous conisation.
17 of the 44 women had had one or more pregnancies between the CKC and the current
pregnancy. In total, 5 different treated-control groups were chosen and five different
comparisons were described. We decided to include in our analysis only one of them
(described above), in order to avoid a duplicate extraction and analysis of the same
participants (patients)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk All eligible for the study women were in-
terviewed; the information about the out-
come was obtained from hospital records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias High risk Interviews were used to pool information
about previous CKC. There is a risk of re-
call bias and misclassification of exposure
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women delivering
in two hospitals during March 1974 toDe-
cember 1975
Representative comparison group? Low risk The untreated group was drawn from the
same source as the treated group
Comparability of treatment groups? Low risk Matching for age
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Werner 2010
Methods Retrospective cohort study
Comparison groups: A) External
B) Internal (pre-treatment pregnancies)
Both had regression analysis for age, parity and race
Information source - records of Parkland Health & Hospital System
Participants Treated group - 511 women who had undergone LLETZ at the ParklandHospital during
January 1992-May 2008 and subsequently had a pregnancy at the same hospital
Untreated group - A) 240,348 women who delivered at the Parkland Hospital without
previous LLETZ
B) Internal population of women that had pregnancies before LLETZ (n = 842)
Inclusion criteria (for all groups): Only singletons were included
Interventions LLETZ
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (singleton pregnancies); sPTB (< 37 weeks);
pPROM; perinatal mortality; stillbirth
Notes Perinatal mortality was defined as the addition of stillbirths and neonatal deaths up to
28 days of life
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women having
LLETZ and then delivering in a single hos-
pital during January 1992 to May 2008
Representative comparison group? Low risk A) The untreated group was drawn from
the same source as the treated group
B) Internal comparison group (pre-treat-
ment pregnancies)
Comparability of treatment groups? Low risk A) Regression analysis for age, parity and
race
B) Internal comparison group (pre-treat-
ment pregnancies)
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Wuntakal 2013
Methods Retrospective cohort study
Comparison groups:
A) Women with punch biopsy but no treatment
B) Internal (pre-treatment pregnancies)
Both had regression analysis for parity, ethnicity and deprivation
Information source - the Pathology and Obstetric databases of the Whipps Cross Uni-
versity Hospital
Participants Treated group - 261 deliveries of women who had undergone excisional treatment for
CIN (LLETZ, LC, CKC) during 1995 to 2009 at theWhipps Cross University Hospital
and subsequently delivered at the same hospital
Untreated group - A) 257 deliveries of womenwhohad only punch biopsy before delivery
B) The treated group had 181 deliveries before the treatment. These deliveries can be
compared with the deliveries after the treatment
Inclusion criteria (for all groups): singleton pregnancies with a gestational age of 26 to
42 weeks of gestation. Exclusion criteria: antepartum stillbirths
Interventions Excision NOS (CKC, LC, LLETZ)
Outcomes PTB (< 37 weeks); PTB (< 37 weeks) (single cone); PTB (< 37 weeks) (repeat cones)
; PTB (< 33 weeks); pPROM; CS; instrumental deliveries (ventouse/forceps); LBW (<
2500 g)
Notes The patients of this study are also included in the paper by Castanon and colleagues
BMJ 2012. As this is a duplicate study we only included in the analysis the outcomes
that were not presented in Castanon 2012. The outcomes on PTB < 37 weeks and PTB
< 33 weeks were not included in the analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information was obtained from hospital
records
Selective reporting (reporting bias) Low risk No reporting bias is obvious
Other bias Low risk No other obvious source of bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All eligible for the study women having
treatment and delivering in a single univer-
sity hospital during 1995 to 2009
Representative comparison group? Low risk A) The untreated group was drawn from
the same source as the treated group
B) Internal comparison group (pre-treat-
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ment pregnancies)
Comparability of treatment groups? Low risk A) Women with punch biopsy only
B) Internal comparison group (pre-treat-
ment pregnancies)
Both had regression analysis for parity, eth-
nicity and deprivation
APH: antepartum haemorrhage; BMI: body mass index; CIN: cervical intra-epithelial neoplasia; CKC: cold knife conisation; CS:
caesarean Section; CT: cryotherapy; FCBE: Fischer cone biopsy excisor; LA: laser ablation; LBW: low birth weight; LC: laser
conisation; LLETZ: large loop excision of the transformation zone;MOH:major obstetric haemorrhage;NICU: neonatal intensive
care unit;NOS: not otherwise specified;PPH: Postpartum haemorrhage; pPROM: preterm premature rupture of membranes; PTB:
preterm birth; PTL: preterm labour; RD: radical diathermy; sPTB: spontaneous preterm birth; TOP: termination of pregnancy
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Al-Halal 2013 Comparison of women with CIN (+/-treatment) versus general population. We could not include this in
any comparison as we had no information as to whether women with CIN had or not treatment and the
increase in the PTB could be attributed to either
Althuisius 2001 No untreated comparison group
Berghella 2004 No untreated comparison group
Berretta 2013 No untreated comparison group
Bull-Phelps 2007 No untreated comparison group
Chevreau 2017 No untreated comparison group
Ciavattini 2014 Both the treated and untreated group consisted of a high-risk population (women that conceived via
assisted reproductive technology (ART))
Ciavattini 2015 This study reports the miscarriage rates in the treated and untreated group but none of the outcomes that
we are studying
Conner 2013 No untreated comparison group
Ferenczy 1995 No untreated comparison group
Gentry 2000 This study reports the cervical length before and after LLETZ (self-matching), but we do not study this
outcome
125Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Gordon 1991 No untreated comparison group
Gronroos 1979 No untreated comparison group
Kalliala 2012 This study reports the Incidence of any pregnancy, livebirths, miscarriages, extrauterine pregnancies, molar
pregnancies, and
terminations of pregnancies (TOPs), but none of the outcomes that we are studying
Khalid 2012 No untreated comparison group
Kim 2016 No untreated comparison group
Kindinger 2016 No untreated comparison group
Kullander 1971 No untreated comparison group
Leiman 1980 No untreated comparison group
Liu 2014 No untreated comparison group
Liverani 2016 No untreated comparison group
Macvicar 1968 No untreated comparison group
Mariya 2016 No untreated comparison group
Masamoto 2008 No untreated comparison group
Michelin 2009 No untreated comparison group
Mitsuhashi 2000 1) Treatment during pregnancy
2) No untreated comparison group
Monaghan 1982 No untreated comparison group
Naleway 2015 This study reports the percentage of the women that fell pregnant in the treated and untreated group but
not the pregnancy outcomes
Nam 2010 No untreated comparison group
Novikova 1994 No untreated comparison group
Patrelli 2008 No untreated comparison group
Pils 2014 The untreated comparison group was high risk: consisted only of women with a history of second-trimester
miscarriage
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Pinborg 2015 Both treated and untreated groups consisted of a high-risk population (women that conceived via assisted
reproductive technology (ART))
Radha Bai Prabhu 2010 No untreated comparison group
Rafaeli-Yehudai 2014 No untreated comparison group (treated women with cerclage versus treated women without cerclage)
Ricciotti 1995 This study reports the cervical length before and after LLETZ (self-matching), but we are not studying
this outcome
Rosen 1991 Treatment during pregnancy
Sangkarat 2014 No untreated comparison group
Seki 2010 1) Treatment during pregnancy
2) No untreated comparison group
Shin 2010 No untreated comparison group (treated women with cerclage versus treated women without cerclage)
Sljivancanin 2013 Treatment during pregnancy
Smaldone 2010 Comparison of women with CIN (+/-treatment) versus general population. We could not include this in
any comparison as we had no information as to whether women with CIN had or not treatment and the
increase in the PTB could be attributed to either
Spracklen 2013 Data only on fertility
Wakita 1990 No untreated comparison group
Watson 2012 Case-control study
Wongtiraporn 2014 No untreated comparison group
Zuo 2011 Comparison of women with CIN (+/-treatment) versus general population. We could not include this in
any comparison as we had no information as to whether women with CIN had or not treatment and the
increase in the PTB could be attributed to either
CIN: cervical intra-epithelial neoplasia; LLETZ: large loop excision of the transformation zone; PTB: preterm birth
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Characteristics of studies awaiting assessment [ordered by study ID]
Aleman 2016
Methods Retrospective cohort study
Participants Women who had undergone conisation at Antwerp University Hospital and subsequently delivered + control group
Interventions Conisation
Outcomes Rates of adverse obstetric outcomes (such as LBW and CS) after conisation and comparison to the control group
Notes Identified after April 2016, week 2; it will be included in the next version of this meta-analysis
Bjorge 2016
Methods Population-based retrospective cohort study
Participants Women from whole of Norway who had undergone treatment for CIN/early invasive cervical cancer during 1998
to 2014 and subsequently had singleton pregnancy + control group
Interventions Treatment for CIN/early invasive cervical cancer
Outcomes Rates of adverse obstetric outcomes (such as PTB) after treatment and comparison to the control group
Notes Identified after April 2016, week 2; it will be included in the next version of this meta-analysis
Brie 2016
Methods Retrospective case-control study
Participants Women who had undergone conisation in a university hospital between January 2002 to January 2012 and subse-
quently delivered + control group
Interventions Conisation
Outcomes Rates of adverse obstetric outcomes (such as PTB < 37 weeks, PTB < 32 weeks, PTB < 28 weeks and PROM) after
treatment and comparison to the control group
Notes Identified after April 2016, week 2; it will be included in the next version of this meta-analysis
He 2007
Methods Retrospective study
Participants Women who underwent conisation from 1999 to 2005 in Peking Union Medical College Hospital
Interventions Conisation
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He 2007 (Continued)
Outcomes Fertility and pregnancy
Notes Article in Chinese - pending translation for inclusion in the next update of this meta-analysis
Jancar 2016
Methods Population-based retrospective cohort study
Participants Women from whole Slovenia who had a singleton pregnancy during 2003 to 2012 and had previously undergone
CKC or LLETZ + control group
Interventions CKC, LLETZ
Outcomes Rates of adverse obstetric outcomes (sPTB < 37 weeks, < 34 weeks, < 32 weeks, < 28 weeks) after treatment and
comparison to the control group
Notes Identified after April 2016, week 2; it will be included in the next version of this meta-analysis
Kalitsaris 1991
Methods Retrospective study
Participants Women who underwent conisation from 1967 to 1989
Interventions Conisation
Outcomes Percentage of attested postoperative pregnancies
Notes Article in Italian - pending translation for inclusion in the next update of this meta-analysis
Kasum 1991
Methods Retrospective
Participants Women with previously made conisation of the uterine cervix
Interventions Conisation
Outcomes Term, deliveries, preterm deliveries and spontaneous abortions
Notes Article in Yogoslavian - pending translation for inclusion in the next update of this meta-analysis
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Lund 1986
Methods
Participants
Interventions
Outcomes
Notes Article in Norwegian - pending translation for inclusion in the next update of this meta-analysis
Praest 1979
Methods
Participants
Interventions
Outcomes
Notes Article in Danish - pending translation for inclusion in the next update of this meta-analysis
Spuhler 1995
Methods Retrospective study
Participants Women followed at our colpolaparotomy surgery clinic
Interventions Laser CO2 therapy
Outcomes Pregnancy and delivery
Notes Article in French - pending translation for inclusion in the next update of this meta-analysis
Zebitay 2017
Methods Population-based multicentric trial
Participants Turkish women with singleton pregnancy during 2007 to 2013 who had previously undergone CKC + control group
Interventions CKC
Outcomes Rates of PTB after CKC and comparison to the control group; data about removed volume and height of the removed
cone and correlation to PTB
Notes Identified after April 2016, week 2; it will be included in the next version of this meta-analysis
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Zornoza-Garcia 2009
Methods Retrospective cohort study
Participants Women treated at the Leon Hospital in Spain, between 1999 and 2007
Interventions Conisation
Outcomes Conception and pregnancy
Notes Article in Spanish - pending translation for inclusion in the next update of this meta-analysis
CIN: cervical intra-epithelial neoplasia; CKC: cold knife conisation; CS: caesarean section; LBW: low birth weight; LLETZ: large loop
excision of the transformation zone; PTB: preterm birth; sPTB: spontaneous preterm birth.
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D A T A A N D A N A L Y S E S
Comparison 1. Maternal Outcomes-PTB
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PTB (<37w) 59 5.242917E6 Risk Ratio (IV, Random, 95% CI) 1.75 [1.57, 1.96]
1.1 Excisional Treatment vs
No Treatment
53 4.599416E6 Risk Ratio (IV, Random, 95% CI) 1.87 [1.64, 2.12]
1.2 Ablative Treatment vs No
Treatment
14 602370 Risk Ratio (IV, Random, 95% CI) 1.35 [1.20, 1.52]
1.3 Treatment NOS vs No
Treatment
2 41131 Risk Ratio (IV, Random, 95% CI) 2.57 [1.39, 4.77]
2 PTB (<37w)-Analysis by
treatment modality
59 5.242917E6 Risk Ratio (IV, Random, 95% CI) 1.78 [1.60, 1.98]
2.1 CKC vs No Treatment 12 39102 Risk Ratio (IV, Random, 95% CI) 2.70 [2.14, 3.40]
2.2 LC vs No Treatment 9 1509 Risk Ratio (IV, Random, 95% CI) 2.11 [1.26, 3.54]
2.3 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 5.83 [3.80, 8.95]
2.4 LLETZ vs No Treatment 25 1.445104E6 Risk Ratio (IV, Random, 95% CI) 1.58 [1.37, 1.81]
2.5 FCBE vs No Treatment 1 71 Risk Ratio (IV, Random, 95% CI) 5.22 [1.09, 24.90]
2.6 LA vs No Treatment 7 4710 Risk Ratio (IV, Random, 95% CI) 1.04 [0.86, 1.26]
2.7 CT vs No Treatment 2 238 Risk Ratio (IV, Random, 95% CI) 1.02 [0.22, 4.77]
2.8 RD vs No Treatment 1 2150 Risk Ratio (IV, Random, 95% CI) 1.62 [1.27, 2.06]
2.9 Excisional Treatment
NOS vs No Treatment
15 3.106231E6 Risk Ratio (IV, Random, 95% CI) 1.90 [1.50, 2.41]
2.10 Ablative Treatment NOS
vs No Treatment
5 595272 Risk Ratio (IV, Random, 95% CI) 1.46 [1.27, 1.66]
2.11 Treatment NOS vs No
Treatment
2 41131 Risk Ratio (IV, Random, 95% CI) 2.57 [1.39, 4.77]
3 PTB (<32-34w) 24 3.793874E6 Risk Ratio (IV, Random, 95% CI) 2.25 [1.79, 2.82]
3.1 Excisional Treatment vs
No Treatment
22 3.666567E6 Risk Ratio (IV, Random, 95% CI) 2.48 [1.92, 3.20]
3.2 Ablative Treatment vs No
Treatment
3 120820 Risk Ratio (IV, Random, 95% CI) 1.59 [1.08, 2.35]
3.3 Treatment NOS vs No
treatment
2 6487 Risk Ratio (IV, Random, 95% CI) 1.65 [1.13, 2.42]
4 PTB (<32-34w)-Analysis by
treatment modality
24 3.793874E6 Risk Ratio (IV, Random, 95% CI) 2.35 [1.88, 2.95]
4.1 CKC vs No Treatment 5 36979 Risk Ratio (IV, Random, 95% CI) 3.07 [1.72, 5.49]
4.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 10.53 [4.33, 25.65]
4.3 LLETZ vs No Treatment 11 791554 Risk Ratio (IV, Random, 95% CI) 2.13 [1.66, 2.75]
4.4 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 1.86 [0.08, 43.87]
4.5 Excisional Treatment
NOS vs No Treatment
9 2.830635E6 Risk Ratio (IV, Random, 95% CI) 2.94 [1.82, 4.77]
4.6 Ablative Treatment NOS
vs No Treatment
2 120762 Risk Ratio (IV, Random, 95% CI) 1.59 [1.08, 2.35]
4.7 Treatment NOS vs No
treatment
2 6487 Risk Ratio (IV, Random, 95% CI) 1.65 [1.13, 2.42]
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5 PTB (<28-30w) 8 3.910629E6 Risk Ratio (IV, Random, 95% CI) 2.23 [1.55, 3.22]
5.1 Excisional Treatment vs
No Treatment
7 3.337003E6 Risk Ratio (IV, Random, 95% CI) 2.81 [1.91, 4.15]
5.2 Ablative Treatment vs No
Treatment
3 568217 Risk Ratio (IV, Random, 95% CI) 1.38 [0.81, 2.36]
5.3 Treatment NOS vs No
Treatment
1 5409 Risk Ratio (IV, Random, 95% CI) 1.75 [1.05, 2.91]
6 PTB (<28-30w)-Analysis by
treatment modality
8 3.910629E6 Risk Ratio (IV, Random, 95% CI) 2.43 [1.69, 3.49]
6.1 CKC vs No Treatment 2 7118 Risk Ratio (IV, Random, 95% CI) 4.52 [0.83, 24.54]
6.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 14.74 [4.50, 48.32]
6.3 LLETZ vs No Treatment 3 502778 Risk Ratio (IV, Random, 95% CI) 2.57 [1.97, 3.35]
6.4 Excisional Treatment
NOS vs No treatment
3 2.819708E6 Risk Ratio (IV, Random, 95% CI) 2.54 [1.30, 4.99]
6.5 Ablative Treatment NOS
vs No Treatment
3 568217 Risk Ratio (IV, Random, 95% CI) 1.38 [0.81, 2.36]
6.6 Treatment NOS vs No
Treatment
1 5409 Risk Ratio (IV, Random, 95% CI) 1.75 [1.05, 2.91]
7 PTB (≤34w) 15 424567 Risk Ratio (IV, Random, 95% CI) 2.59 [1.78, 3.77]
7.1 Excisional Treatment vs
No Treatment
15 424509 Risk Ratio (IV, Random, 95% CI) 2.61 [1.78, 3.83]
7.2 Ablative Treatment vs No
Treatment
1 58 Risk Ratio (IV, Random, 95% CI) 1.86 [0.08, 43.87]
8 PTB (≤34w)-Analysis by
treatment modality
15 424567 Risk Ratio (IV, Random, 95% CI) 2.56 [1.78, 3.69]
8.1 CKC vs No Treatment 4 30023 Risk Ratio (IV, Random, 95% CI) 2.85 [1.50, 5.41]
8.2 LLETZ vs No Treatment 9 289218 Risk Ratio (IV, Random, 95% CI) 1.83 [1.41, 2.39]
8.3 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 1.86 [0.08, 43.87]
8.4 Excisional Treatment
NOS vs No Treatment
4 105268 Risk Ratio (IV, Random, 95% CI) 7.30 [4.17, 12.80]
9 PTB (<32-33w) 10 3.369685E6 Risk Ratio (IV, Random, 95% CI) 2.08 [1.55, 2.79]
9.1 Excisional Treatment vs
No Treatment
8 3.242436E6 Risk Ratio (IV, Random, 95% CI) 2.43 [1.70, 3.47]
9.2 Ablative Treatment vs No
Treatment
2 120762 Risk Ratio (IV, Random, 95% CI) 1.59 [1.08, 2.35]
9.3 Treatment NOS vs No
treatment
2 6487 Risk Ratio (IV, Random, 95% CI) 1.65 [1.13, 2.42]
10 PTB (<32-33w)-Analysis by
treatment modality
10 3.369685E6 Risk Ratio (IV, Random, 95% CI) 2.26 [1.70, 3.01]
10.1 CKC vs No Treatment 1 6956 Risk Ratio (IV, Random, 95% CI) 4.38 [1.08, 17.65]
10.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 10.53 [4.33, 25.65]
10.3 LLETZ vs No Treatment 3 502714 Risk Ratio (IV, Random, 95% CI) 2.74 [2.30, 3.26]
10.4 Excisional Treatment
NOS vs No Treatment
5 2.725367E6 Risk Ratio (IV, Random, 95% CI) 2.09 [1.20, 3.63]
10.5 Ablative Treatment NOS
vs No Treatment
2 120762 Risk Ratio (IV, Random, 95% CI) 1.59 [1.08, 2.35]
10.6 Treatment NOS vs No
treatment
2 6487 Risk Ratio (IV, Random, 95% CI) 1.65 [1.13, 2.42]
11 PTB (<30w) 1 162 Risk Ratio (IV, Random, 95% CI) 2.86 [0.12, 69.11]
11.1 Excisional Treatment vs
No Treatment
1 162 Risk Ratio (IV, Random, 95% CI) 2.86 [0.12, 69.11]
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12 PTB (<30w)-Analysis by
treatment modality
1 162 Risk Ratio (IV, Random, 95% CI) 2.86 [0.12, 69.11]
12.1 CKC vs No Treatment 1 162 Risk Ratio (IV, Random, 95% CI) 2.86 [0.12, 69.11]
13 PTB (<28w) 7 3.910467E6 Risk Ratio (IV, Random, 95% CI) 2.22 [1.54, 3.22]
13.1 Excisional Treatment vs
No Treatment
6 3.336841E6 Risk Ratio (IV, Random, 95% CI) 2.81 [1.89, 4.18]
13.2 Ablative treatment vs No
Treatment
3 568217 Risk Ratio (IV, Random, 95% CI) 1.38 [0.81, 2.36]
13.3 Treatment NOS vs No
Treatment
1 5409 Risk Ratio (IV, Random, 95% CI) 1.75 [1.05, 2.91]
14 PTB (<28w)-Analysis by
treatment modality
6 3.905058E6 Risk Ratio (IV, Random, 95% CI) 2.52 [1.71, 3.72]
14.1 CKC vs No Treatment 1 6956 Risk Ratio (IV, Random, 95% CI) 5.41 [0.74, 39.84]
14.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 14.74 [4.50, 48.32]
14.3 LLETZ vs No Treatment 3 502778 Risk Ratio (IV, Random, 95% CI) 2.57 [1.97, 3.35]
14.4 Excisional Treatment
NOS vs No treatment
3 2.819708E6 Risk Ratio (IV, Random, 95% CI) 2.54 [1.30, 4.99]
14.5 Ablative Treatment NOS
vs No Treatment
3 568217 Risk Ratio (IV, Random, 95% CI) 1.38 [0.81, 2.36]
15 PTB (<37w)-Nulliparous
women
6 245707 Risk Ratio (IV, Random, 95% CI) 1.92 [1.23, 2.98]
15.1 LC vs No Treatment 2 267 Risk Ratio (IV, Random, 95% CI) 2.18 [1.09, 4.37]
15.2 LLETZ vs No Treatment 3 231344 Risk Ratio (IV, Random, 95% CI) 1.51 [0.76, 3.02]
15.3 Treatment NOS versus
No Treatment
1 14096 Risk Ratio (IV, Random, 95% CI) 3.53 [1.70, 7.33]
16 PTB (<37w)-Parous women 5 339507 Risk Ratio (IV, Random, 95% CI) 2.05 [0.95, 4.43]
16.1 LC vs No Treatment 2 401 Risk Ratio (IV, Random, 95% CI) 2.82 [0.16, 49.84]
16.2 LLETZ vs No Treatment 2 324948 Risk Ratio (IV, Random, 95% CI) 1.20 [0.22, 6.65]
16.3 Treatment NOS vs No
Treatment
1 14158 Risk Ratio (IV, Random, 95% CI) 3.73 [2.23, 6.22]
17 PTB (<37w)-Single cone 17 1.367023E6 Risk Ratio (IV, Random, 95% CI) 1.75 [1.49, 2.06]
17.1 CKC vs No Treatment 3 36783 Risk Ratio (IV, Random, 95% CI) 2.89 [2.08, 4.03]
17.2 LC vs No Treatment 2 657 Risk Ratio (IV, Random, 95% CI) 1.06 [0.54, 2.09]
17.3 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 5.83 [3.80, 8.95]
17.4 LLETZ vs No Treatment 9 1.277874E6 Risk Ratio (IV, Random, 95% CI) 1.74 [1.45, 2.10]
17.5 LA vs No Treatment 4 1421 Risk Ratio (IV, Random, 95% CI) 1.07 [0.66, 1.74]
17.6 Excisional Treatment
NOS vs No Treatment
3 32106 Risk Ratio (IV, Random, 95% CI) 1.88 [1.20, 2.93]
17.7 Ablative Treatment NOS
vs No Treatment
1 10783 Risk Ratio (IV, Random, 95% CI) 1.14 [0.82, 1.57]
18 PTB (<37w)-Repeat cones 11 1.317284E6 Risk Ratio (IV, Random, 95% CI) 3.78 [2.65, 5.39]
18.1 CKC/LA vs No
Treatment
1 99 Risk Ratio (IV, Random, 95% CI) 12.56 [5.11, 30.87]
18.2 LC/LC vs No Treatment 1 270 Risk Ratio (IV, Random, 95% CI) 3.75 [1.70, 8.27]
18.3 LLETZ/LLETZ vs No
Treatment
4 1.202174E6 Risk Ratio (IV, Random, 95% CI) 2.81 [2.33, 3.39]
18.4 LLETZ/Treatment NOS
vs No Treatment
1 298 Risk Ratio (IV, Random, 95% CI) 9.40 [3.53, 25.03]
18.5 Excisional Treatment
NOS/Excisional Treatment
NOS vs No Treatment
3 73651 Risk Ratio (IV, Random, 95% CI) 5.48 [2.68, 11.24]
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18.6 Treatment NOS/
Treatment NOS vs No
Treatment
2 40792 Risk Ratio (IV, Random, 95% CI) 1.71 [1.10, 2.67]
19 PTB (<37w)-Singleton
pregnancies
32 2.18962E6 Risk Ratio (IV, Random, 95% CI) 1.76 [1.57, 1.98]
19.1 CKC vs No Treatment 6 37759 Risk Ratio (IV, Random, 95% CI) 2.89 [2.22, 3.77]
19.2 LC vs No Treatment 4 545 Risk Ratio (IV, Random, 95% CI) 2.54 [1.24, 5.20]
19.3 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 5.83 [3.80, 8.95]
19.4 LLETZ vs No Treatment 18 1.444175E6 Risk Ratio (IV, Random, 95% CI) 1.61 [1.39, 1.87]
19.5 LA vs No Treatment 3 3420 Risk Ratio (IV, Random, 95% CI) 1.10 [0.75, 1.62]
19.6 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 1.86 [0.08, 43.87]
19.7 RD vs No Treatment 1 2150 Risk Ratio (IV, Random, 95% CI) 1.62 [1.27, 2.06]
19.8 Excisional Treatment
NOS vs No Treatment
7 542892 Risk Ratio (IV, Random, 95% CI) 1.42 [1.17, 1.72]
19.9 Ablative Treatment NOS
vs No Treatment
2 110091 Risk Ratio (IV, Random, 95% CI) 1.14 [0.56, 2.32]
19.10 Treatment NOS vs No
Treatment
2 41131 Risk Ratio (IV, Random, 95% CI) 2.57 [1.39, 4.77]
20 PTB (<37w)-Multiple
pregnancies
5 10797 Risk Ratio (IV, Random, 95% CI) 1.14 [0.95, 1.35]
20.1 CKC vs No Treatment 2 84 Risk Ratio (IV, Random, 95% CI) 0.95 [0.49, 1.83]
20.2 LLETZ vs No Treatment 3 10199 Risk Ratio (IV, Random, 95% CI) 1.27 [1.09, 1.47]
20.3 Excisional Treatment
NOS vs No Treatment
1 4 Risk Ratio (IV, Random, 95% CI) 3.5 [0.31, 39.71]
20.4 Ablative Treatment NOS
vs No Treatment
1 510 Risk Ratio (IV, Random, 95% CI) 0.93 [0.72, 1.20]
21 PTB (<32-34w)-Multiple
pregnancies
3 10789 Risk Ratio (IV, Random, 95% CI) 1.68 [0.95, 2.98]
21.1 CKC vs No Treatment 1 80 Risk Ratio (IV, Random, 95% CI) 3.5 [1.29, 9.52]
21.2 LLETZ vs No Treatment 3 10199 Risk Ratio (IV, Random, 95% CI) 1.76 [0.88, 3.50]
21.3 Ablative Treatment NOS
vs No Treatment
1 510 Risk Ratio (IV, Random, 95% CI) 0.85 [0.38, 1.91]
22 PTB (<28w)-Multiple
pregnancies
2 10744 Risk Ratio (IV, Random, 95% CI) 2.43 [1.40, 4.22]
22.1 CKC vs No Treatment 1 80 Risk Ratio (IV, Random, 95% CI) 2.15 [0.09, 49.56]
22.2 LLETZ vs No Treatment 2 10154 Risk Ratio (IV, Random, 95% CI) 2.45 [1.34, 4.47]
22.3 Ablative Treatment NOS
vs No Treatment
1 510 Risk Ratio (IV, Random, 95% CI) 2.32 [0.48, 11.26]
23 PTB (<37w)-Depth≤10-12mm 8 550929 Risk Ratio (IV, Random, 95% CI) 1.54 [1.09, 2.18]
23.1 LC vs No Treatment 1 105 Risk Ratio (IV, Random, 95% CI) 0.52 [0.06, 4.83]
23.2 LLETZ vs No Treatment 3 544907 Risk Ratio (IV, Random, 95% CI) 2.01 [1.28, 3.15]
23.3 Excisional Treatment
NOS vs No Treatment
4 5917 Risk Ratio (IV, Random, 95% CI) 1.20 [0.78, 1.85]
24 PTB (<37w)-Depth≥10-12mm 8 552711 Risk Ratio (IV, Random, 95% CI) 1.93 [1.62, 2.31]
24.1 LC vs No Treatment 1 87 Risk Ratio (IV, Random, 95% CI) 4.64 [1.20, 17.88]
24.2 LLETZ vs No Treatment 3 546134 Risk Ratio (IV, Random, 95% CI) 2.29 [1.57, 3.34]
24.3 Excisional Treatment
NOS vs No Treatment
4 6490 Risk Ratio (IV, Random, 95% CI) 1.68 [1.41, 1.99]
25 PTB (<37w)-Depth≥15-17mm 4 544986 Risk Ratio (IV, Random, 95% CI) 2.77 [1.95, 3.93]
25.1 LC vs No Treatment 1 211 Risk Ratio (IV, Random, 95% CI) 4.92 [2.09, 11.59]
25.2 LLETZ vs No Treatment 2 544248 Risk Ratio (IV, Random, 95% CI) 3.16 [1.54, 6.48]
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25.3 Excisional Treatment
NOS vs No Treatment
1 527 Risk Ratio (IV, Random, 95% CI) 2.03 [1.33, 3.10]
26 PTB (<37w)-Depth≥20mm 3 543750 Risk Ratio (IV, Random, 95% CI) 4.91 [2.06, 11.68]
26.1 LC vs No Treatment 1 192 Risk Ratio (IV, Random, 95% CI) 6.12 [2.57, 14.57]
26.2 LLETZ vs No Treatment 2 543558 Risk Ratio (IV, Random, 95% CI) 4.72 [1.25, 17.80]
27 PTB (<37w)-Volume<6cc 1 550 Risk Ratio (IV, Random, 95% CI) 2.25 [1.09, 4.66]
27.1 LLETZ vs No Treatment 1 550 Risk Ratio (IV, Random, 95% CI) 2.25 [1.09, 4.66]
28 PTB (<37w)-Volume>6cc 1 284 Risk Ratio (IV, Random, 95% CI) 13.90 [5.09, 37.98]
28.1 LLETZ (Volume>6cc) vs
No Treatment
1 284 Risk Ratio (IV, Random, 95% CI) 13.90 [5.09, 37.98]
29 PTB (<37w)-Depth≤10mm 7 7436 Risk Ratio (IV, Random, 95% CI) 1.60 [0.99, 2.59]
29.1 LC vs No Treatment 1 105 Risk Ratio (IV, Random, 95% CI) 0.52 [0.06, 4.83]
29.2 LLETZ vs No Treatment 2 1414 Risk Ratio (IV, Random, 95% CI) 2.72 [1.65, 4.50]
29.3 Excisional Treatment
NOS vs No Treatment
4 5917 Risk Ratio (IV, Random, 95% CI) 1.20 [0.78, 1.85]
30 PTB (<37w)-Depth≤12mm 1 543493 Risk Ratio (IV, Random, 95% CI) 1.56 [1.20, 2.02]
30.1 LLETZ vs No Treatment 1 543493 Risk Ratio (IV, Random, 95% CI) 1.56 [1.20, 2.02]
31 PTB (<37w)-Depth≤15mm 3 545283 Risk Ratio (IV, Random, 95% CI) 1.44 [1.20, 1.73]
31.1 LC vs No Treatment 1 164 Risk Ratio (IV, Random, 95% CI) 0.67 [0.04, 11.18]
31.2 LLETZ vs No Treatment 2 545119 Risk Ratio (IV, Random, 95% CI) 1.44 [1.20, 1.73]
32 PTB (<37w)-Depth≤17mm 1 656 Risk Ratio (IV, Random, 95% CI) 1.14 [0.76, 1.72]
32.1 Excisional Treatment
NOS vs No Treatment
1 656 Risk Ratio (IV, Random, 95% CI) 1.14 [0.76, 1.72]
33 PTB (<37w)-Depth≤15-17mm 4 545939 Risk Ratio (IV, Random, 95% CI) 1.38 [1.17, 1.64]
33.1 LC vs No Treatment 1 164 Risk Ratio (IV, Random, 95% CI) 0.67 [0.04, 11.18]
33.2 LLETZ vs No Treatment 2 545119 Risk Ratio (IV, Random, 95% CI) 1.44 [1.20, 1.73]
33.3 Excisional Treatment
NOS vs No Treatment
1 656 Risk Ratio (IV, Random, 95% CI) 1.14 [0.76, 1.72]
34 PTB (<37w)-Depth≤20mm 3 545992 Risk Ratio (IV, Random, 95% CI) 1.60 [1.38, 1.87]
34.1 LC vs No Treatment 1 183 Risk Ratio (IV, Random, 95% CI) 1.30 [0.28, 5.97]
34.2 LLETZ vs No Treatment 2 545809 Risk Ratio (IV, Random, 95% CI) 1.61 [1.38, 1.87]
35 PTB (<37w)-Depth≥10mm 7 7671 Risk Ratio (IV, Random, 95% CI) 2.12 [1.58, 2.85]
35.1 LC vs No Treatment 1 87 Risk Ratio (IV, Random, 95% CI) 4.64 [1.20, 17.88]
35.2 LLETZ vs No Treatment 2 1094 Risk Ratio (IV, Random, 95% CI) 3.16 [1.80, 5.55]
35.3 Excisional Treatment
NOS vs No Treatment
4 6490 Risk Ratio (IV, Random, 95% CI) 1.68 [1.41, 1.99]
36 PTB (<37w)-Depth≥12mm 1 545040 Risk Ratio (IV, Random, 95% CI) 1.93 [1.66, 2.23]
36.1 LLETZ vs No Treatment 1 545040 Risk Ratio (IV, Random, 95% CI) 1.93 [1.66, 2.23]
37 PTB (<37w)-Depth≥15mm 3 544459 Risk Ratio (IV, Random, 95% CI) 3.49 [1.94, 6.26]
37.1 LC vs No Treatment 1 211 Risk Ratio (IV, Random, 95% CI) 4.92 [2.09, 11.59]
37.2 LLETZ vs No Treatment 2 544248 Risk Ratio (IV, Random, 95% CI) 3.16 [1.54, 6.48]
38 PTB (<37w)-Depth≥17mm 1 527 Risk Ratio (IV, Random, 95% CI) 2.03 [1.33, 3.10]
38.1 Excisional Treatment
NOS vs No Treatment
1 527 Risk Ratio (IV, Random, 95% CI) 2.03 [1.33, 3.10]
39 PTB (<37w)-Depth
10/13-15/16mm
3 544534 Risk Ratio (IV, Random, 95% CI) 1.32 [1.04, 1.66]
39.1 LLETZ vs No Treatment 2 543994 Risk Ratio (IV, Random, 95% CI) 1.32 [1.02, 1.72]
39.2 Excisional Treatment
NOS vs No Treatment
1 540 Risk Ratio (IV, Random, 95% CI) 1.29 [0.79, 2.12]
40 PTB (<37w)-Depth
15/16-19/20mm
3 543608 Risk Ratio (IV, Random, 95% CI) 2.24 [1.73, 2.91]
40.1 LC vs No Treatment 1 169 Risk Ratio (IV, Random, 95% CI) 2.26 [0.50, 10.08]
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40.2 LLETZ vs No Treatment 2 543439 Risk Ratio (IV, Random, 95% CI) 2.53 [1.42, 4.51]
41 PTB (<37w)-Volume<3cc 1 496 Risk Ratio (IV, Random, 95% CI) 2.04 [0.94, 4.41]
41.1 LLETZ vs No Treatment 1 496 Risk Ratio (IV, Random, 95% CI) 2.04 [0.94, 4.41]
42 PTB (<37w)-Volume>3cc 1 338 Risk Ratio (IV, Random, 95% CI) 4.17 [1.77, 9.82]
42.1 LLETZ vs No Treatment 1 338 Risk Ratio (IV, Random, 95% CI) 4.17 [1.77, 9.82]
43 PTB (<37w)-Depth≥10-12mm
vs ≤10-12mm
7 6359 Risk Ratio (IV, Random, 95% CI) 1.54 [1.31, 1.80]
43.1 LC 1 64 Risk Ratio (IV, Random, 95% CI) 8.91 [1.11, 71.73]
43.2 LLETZ 2 836 Risk Ratio (IV, Random, 95% CI) 1.26 [0.74, 2.17]
43.3 Excision NOS 4 5459 Risk Ratio (IV, Random, 95% CI) 1.55 [1.31, 1.83]
44 PTB (<37w)-Depth≥15-17mm
vs ≤15-17mm
4 4275 Risk Ratio (IV, Random, 95% CI) 1.82 [1.47, 2.26]
44.1 LC 1 75 Risk Ratio (IV, Random, 95% CI) 7.02 [0.44, 111.10]
44.2 LLETZ 2 3869 Risk Ratio (IV, Random, 95% CI) 1.86 [1.36, 2.55]
44.3 Excisional Treatment
NOS
1 331 Risk Ratio (IV, Random, 95% CI) 1.78 [1.11, 2.84]
45 PTB (<37w)-Depth≥20mm vs
≤20mm
3 3944 Risk Ratio (IV, Random, 95% CI) 2.79 [1.24, 6.27]
45.1 LC 1 75 Risk Ratio (IV, Random, 95% CI) 4.71 [1.13, 19.62]
45.2 LLETZ 2 3869 Risk Ratio (IV, Random, 95% CI) 2.47 [0.94, 6.51]
46 PTB (<37w)-Volume>3cc vs
<3cc
1 278 Risk Ratio (IV, Random, 95% CI) 2.04 [0.95, 4.39]
46.1 LLETZ 1 278 Risk Ratio (IV, Random, 95% CI) 2.04 [0.95, 4.39]
47 PTB (<37w)-Volume>6cc vs
<6cc
1 278 Risk Ratio (IV, Random, 95% CI) 6.18 [2.53, 15.13]
47.1 LLETZ 1 278 Risk Ratio (IV, Random, 95% CI) 6.18 [2.53, 15.13]
48 PTB (<37w)-Depth
11/13-15/16mm vs
≤10-12mm
3 2600 Risk Ratio (IV, Random, 95% CI) 0.92 [0.67, 1.25]
48.1 LLETZ 2 2370 Risk Ratio (IV, Random, 95% CI) 0.83 [0.58, 1.17]
48.2 Excisional Treatment
NOS
1 230 Risk Ratio (IV, Random, 95% CI) 1.31 [0.68, 2.50]
49 PTB (<37w)-Depth 16-19mm
vs 13-15mm
1 1768 Risk Ratio (IV, Random, 95% CI) 1.65 [1.12, 2.43]
49.1 LLETZ 1 1768 Risk Ratio (IV, Random, 95% CI) 1.65 [1.12, 2.43]
50 PTB (<37w)-Depth≥20mm vs
15/16-19/20mm
3 1560 Risk Ratio (IV, Random, 95% CI) 1.46 [0.95, 2.23]
50.1 LC 1 61 Risk Ratio (IV, Random, 95% CI) 2.71 [0.67, 10.96]
50.2 LLETZ 2 1499 Risk Ratio (IV, Random, 95% CI) 1.40 [0.84, 2.36]
51 PTB (<37w)-Untreated
External Comparison Group
44 5.192047E6 Risk Ratio (IV, Random, 95% CI) 1.92 [1.70, 2.16]
51.1 CKC 7 37370 Risk Ratio (IV, Random, 95% CI) 3.28 [2.44, 4.42]
51.2 LC 6 1126 Risk Ratio (IV, Random, 95% CI) 2.39 [1.24, 4.61]
51.3 NETZ 1 7361 Risk Ratio (IV, Random, 95% CI) 5.82 [3.79, 8.94]
51.4 LLETZ 19 1.414769E6 Risk Ratio (IV, Random, 95% CI) 1.72 [1.48, 2.00]
51.5 LA] 4 1258 Risk Ratio (IV, Random, 95% CI) 1.27 [0.67, 2.40]
51.6 CT 1 58 Risk Ratio (IV, Random, 95% CI) 1.86 [0.08, 43.87]
51.7 Excisional Treatment
NOS
12 3.100025E6 Risk Ratio (IV, Random, 95% CI) 1.91 [1.50, 2.44]
51.8 Ablative Treatment NOS 5 588949 Risk Ratio (IV, Random, 95% CI) 1.45 [1.26, 1.67]
51.9 Treatment NOS 2 41131 Risk Ratio (IV, Random, 95% CI) 2.57 [1.39, 4.77]
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52 PTB (<37w)-Untreated
Internal Comparison Group
(self-matching)
8 2987 Risk Ratio (IV, Random, 95% CI) 1.59 [1.19, 2.13]
52.1 LC 2 354 Risk Ratio (IV, Random, 95% CI) 1.30 [0.56, 3.06]
52.2 LLETZ 1 516 Risk Ratio (IV, Random, 95% CI) 1.82 [1.04, 3.21]
52.3 FCBE 1 71 Risk Ratio (IV, Random, 95% CI) 5.22 [1.09, 24.90]
52.4 Excisional Treatment
NOS
3 1922 Risk Ratio (IV, Random, 95% CI) 1.46 [0.89, 2.39]
52.5 Treatment NOS 1 124 Risk Ratio (IV, Random, 95% CI) 2.0 [0.73, 5.51]
53 PTB (<37w)-Untreated
Internal Comparison Group
(pre-treatment pregnancies)
13 83404 Risk Ratio (IV, Random, 95% CI) 1.39 [0.98, 1.96]
53.1 CKC 3 1430 Risk Ratio (IV, Random, 95% CI) 1.79 [0.81, 3.95]
53.2 LC 2 161 Risk Ratio (IV, Random, 95% CI) 1.65 [0.11, 23.58]
53.3 LLETZ 4 3207 Risk Ratio (IV, Random, 95% CI) 1.13 [0.66, 1.94]
53.4 LA 1 226 Risk Ratio (IV, Random, 95% CI) 1.20 [0.57, 2.53]
53.5 CT 1 180 Risk Ratio (IV, Random, 95% CI) 0.85 [0.15, 4.94]
53.6 Excisional NOS 3 78200 Risk Ratio (IV, Random, 95% CI) 1.65 [0.88, 3.08]
54 PTB (<37w)-Untreated
Colposcopy+/-CIN+/-Biopsy
Comparison Group
13 74958 Risk Ratio (IV, Random, 95% CI) 1.27 [1.14, 1.41]
54.1 CKC 2 265 Risk Ratio (IV, Random, 95% CI) 1.76 [1.01, 3.08]
54.2 LC 1 177 Risk Ratio (IV, Random, 95% CI) 1.52 [0.74, 3.15]
54.3 LLETZ 9 39249 Risk Ratio (IV, Random, 95% CI) 1.33 [1.11, 1.60]
54.4 LA 2 3326 Risk Ratio (IV, Random, 95% CI) 1.05 [0.84, 1.31]
54.5 RD 1 2150 Risk Ratio (IV, Random, 95% CI) 1.62 [1.27, 2.06]
54.6 Excisional Treatment
NOS
5 20321 Risk Ratio (IV, Random, 95% CI) 1.23 [1.07, 1.41]
54.7 Ablative Treatment NOS 2 9470 Risk Ratio (IV, Random, 95% CI) 1.00 [0.74, 1.36]
55 PTB (<37w)-Untreated HSIL
Comparison Group
3 3764 Risk Ratio (IV, Random, 95% CI) 1.37 [0.85, 2.19]
55.1 CKC 1 103 Risk Ratio (IV, Random, 95% CI) 3.76 [0.48, 29.39]
55.2 NETZ 1 109 Risk Ratio (IV, Random, 95% CI) 4.55 [1.11, 18.66]
55.3 LLETZ 1 881 Risk Ratio (IV, Random, 95% CI) 2.48 [1.35, 4.55]
55.4 Excisional Treatment
NOS
2 2274 Risk Ratio (IV, Random, 95% CI) 1.06 [0.71, 1.59]
55.5 Ablative Treatment NOS 2 397 Risk Ratio (IV, Random, 95% CI) 0.68 [0.28, 1.68]
56 PTB (<37w)-All Comparison
Groups
58 5.292724E6 Risk Ratio (IV, Random, 95% CI) 1.76 [1.58, 1.97]
56.1 Treatment vs Untreated
External Comparison Group
43 5.165466E6 Risk Ratio (IV, Random, 95% CI) 1.97 [1.71, 2.26]
56.2 Treatment vs Untreated
Internal Comparison Group
(pre-treatment pregnancies)
13 62519 Risk Ratio (IV, Random, 95% CI) 1.66 [1.24, 2.22]
56.3 Treatment vs Untreated
Internal Comparison Group
(self-matching)
6 1263 Risk Ratio (IV, Random, 95% CI) 1.91 [1.19, 3.08]
56.4 Treatment vs Untreated
Colposcopy+/-CIN+/-Biopsy
Comparison Group
12 62702 Risk Ratio (IV, Random, 95% CI) 1.33 [1.17, 1.50]
56.5 Treatment vs Untreated
HSIL Comparison Group
3 774 Risk Ratio (IV, Random, 95% CI) 1.46 [0.62, 3.42]
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57 PTB (<37w)-Untreated
High-risk Population vs
General Population
15 4.357998E6 Risk Ratio (IV, Random, 95% CI) 1.24 [1.14, 1.34]
57.1 Pre-treatment
pregnancies vs General
Population
10 3.132723E6 Risk Ratio (IV, Random, 95% CI) 1.23 [1.07, 1.42]
57.2 Untreated Colposcopy+/
-CIN+/-Biopsy vs General
Population
4 1.046823E6 Risk Ratio (IV, Random, 95% CI) 1.22 [1.11, 1.34]
57.3 Untreated HSIL vs
General Population
3 178452 Risk Ratio (IV, Random, 95% CI) 1.40 [0.94, 2.10]
58 PTB (<37w)-Depth≤10-12mm
vs Untreated External
Comparison Group
6 1.026243E6 Risk Ratio (IV, Random, 95% CI) 1.64 [1.11, 2.42]
58.1 LCp 1 105 Risk Ratio (IV, Random, 95% CI) 0.52 [0.06, 4.83]
58.2 LLETZ 2 512896 Risk Ratio (IV, Random, 95% CI) 2.06 [1.10, 3.84]
58.3 Excisional Treatment
NOS
3 513242 Risk Ratio (IV, Random, 95% CI) 1.57 [0.72, 3.41]
59 PTB (<37w)-Depth≤10-12mm
vs Untreated Internal
Comparison Group
2 3550 Risk Ratio (IV, Random, 95% CI) 0.90 [0.71, 1.14]
59.1 LC 1 70 Risk Ratio (IV, Random, 95% CI) 0.71 [0.05, 10.85]
59.2 Excisional Treatment
NOS
1 3480 Risk Ratio (IV, Random, 95% CI) 0.90 [0.71, 1.14]
60 PTB (<37w)-Depth≤10-12mm
vs Untreated
Colposcopy+/-CIN+/-Biopsy
4 43145 Risk Ratio (IV, Random, 95% CI) 1.11 [0.85, 1.43]
60.1 LLETZ 2 33033 Risk Ratio (IV, Random, 95% CI) 1.38 [0.94, 2.02]
60.2 Excisional Treatment
NOS
2 10112 Risk Ratio (IV, Random, 95% CI) 0.93 [0.80, 1.09]
61 PTB (<37w)-Depth≤15-17mm
vs Untreated External
Comparison Group
2 513145 Risk Ratio (IV, Random, 95% CI) 1.43 [1.19, 1.73]
61.1 LC 1 164 Risk Ratio (IV, Random, 95% CI) 0.67 [0.04, 11.18]
61.2 LLETZ 1 512981 Risk Ratio (IV, Random, 95% CI) 1.44 [1.19, 1.74]
62 PTB (<37w)-Depth≤15-17mm
vs Untreated
Colposcopy+/-CIN+/-Biopsy
3 34934 Risk Ratio (IV, Random, 95% CI) 1.18 [1.00, 1.40]
62.1 LLETZ 2 34278 Risk Ratio (IV, Random, 95% CI) 1.30 [0.85, 1.98]
62.2 Excisional Treatment
NOS
1 656 Risk Ratio (IV, Random, 95% CI) 1.14 [0.76, 1.72]
63 PTB (<37w)-Depth≤20mm
vs Untreated External
Comparison Group
2 513814 Risk Ratio (IV, Random, 95% CI) 1.60 [1.37, 1.87]
63.1 LC 1 183 Risk Ratio (IV, Random, 95% CI) 1.30 [0.28, 5.97]
63.2 LLETZ 1 513631 Risk Ratio (IV, Random, 95% CI) 1.61 [1.37, 1.88]
64 PTB (<37w)-Depth≤20mm
vs Untreated
Colposcopy+/-CIN+/-Biopsy
2 34968 Risk Ratio (IV, Random, 95% CI) 1.52 [0.92, 2.51]
64.1 LLETZ 2 34968 Risk Ratio (IV, Random, 95% CI) 1.52 [0.92, 2.51]
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65 PTB (<37w)-Depth≥10-12mm
vs Untreated External
Comparison Group
6 1.027812E6 Risk Ratio (IV, Random, 95% CI) 1.96 [1.66, 2.32]
65.1 LC 1 87 Risk Ratio (IV, Random, 95% CI) 4.64 [1.20, 17.88]
65.2 LLETZ 2 514051 Risk Ratio (IV, Random, 95% CI) 2.40 [1.30, 4.43]
65.3 Excisional Treatment
NOS
3 513674 Risk Ratio (IV, Random, 95% CI) 1.82 [1.49, 2.22]
66 PTB (<37w)-Depth≥10-12mm
vs Untreated Internal
Comparison Group
2 3944 Risk Ratio (IV, Random, 95% CI) 2.05 [0.56, 7.48]
66.1 LC 1 52 Risk Ratio (IV, Random, 95% CI) 6.30 [0.79, 50.27]
66.2 Excisional Treatment
NOS
1 3892 Risk Ratio (IV, Random, 95% CI) 1.39 [1.12, 1.73]
67 PTB (<37w)-Depth≥10-12mm
vs Untreated
Colposcopy+/-CIN+/-Biopsy
4 45275 Risk Ratio (IV, Random, 95% CI) 1.52 [1.37, 1.68]
67.1 LLETZ 2 34652 Risk Ratio (IV, Random, 95% CI) 1.80 [1.13, 2.87]
67.2 Excisional Treatment
NOS
2 10623 Risk Ratio (IV, Random, 95% CI) 1.46 [1.29, 1.65]
68 PTB (<37w)-Depth≥15-17mm
vs Untreated External
Comparison Group
2 512503 Risk Ratio (IV, Random, 95% CI) 3.04 [1.62, 5.73]
68.1 LC 1 211 Risk Ratio (IV, Random, 95% CI) 4.92 [2.09, 11.59]
68.2 LLETZ 1 512292 Risk Ratio (IV, Random, 95% CI) 2.45 [2.06, 2.91]
69 PTB (<37w)-Depth≥15-17mm
vs Untreated
Colposcopy+/-CIN+/-Biopsy
3 33934 Risk Ratio (IV, Random, 95% CI) 2.30 [1.57, 3.35]
69.1 LLETZ 2 33407 Risk Ratio (IV, Random, 95% CI) 2.92 [1.14, 7.46]
69.2 Excisional Treatment
NOS
1 527 Risk Ratio (IV, Random, 95% CI) 2.03 [1.33, 3.10]
70 PTB (<37w)-Depth≥20mm
vs Untreated External
Comparison Group
2 511834 Risk Ratio (IV, Random, 95% CI) 3.63 [1.67, 7.90]
70.1 LC 1 192 Risk Ratio (IV, Random, 95% CI) 6.12 [2.57, 14.57]
70.2 LLETZ 1 511642 Risk Ratio (IV, Random, 95% CI) 2.68 [2.15, 3.35]
71 PTB (<37w)-Depth≥20mm
vs Untreated
Colposcopy+/-CIN+/-Biopsy
2 32717 Risk Ratio (IV, Random, 95% CI) 4.32 [0.93, 20.03]
71.1 LLETZ 2 32717 Risk Ratio (IV, Random, 95% CI) 4.32 [0.93, 20.03]
72 PTB (<37w)-Depth
10/13-15/16mm vs Untreated
External Comparison Group
1 511959 Risk Ratio (IV, Random, 95% CI) 1.31 [0.99, 1.72]
72.1 LLETZ 1 511959 Risk Ratio (IV, Random, 95% CI) 1.31 [0.99, 1.72]
73 PTB (<37w)-Depth
10/13-15/16mm vs Untreated
Colposcopy+/-CIN+/-Biopsy
3 33693 Risk Ratio (IV, Random, 95% CI) 1.14 [0.90, 1.44]
73.1 LLETZ 2 33153 Risk Ratio (IV, Random, 95% CI) 1.12 [0.80, 1.57]
73.2 Excisional Treatment
NOS
1 540 Risk Ratio (IV, Random, 95% CI) 1.29 [0.79, 2.12]
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74 PTB (<37w)-Depth
15/16-19/20mm vs Untreated
External Comparison Group
2 511660 Risk Ratio (IV, Random, 95% CI) 2.16 [1.65, 2.84]
74.1 LC 1 169 Risk Ratio (IV, Random, 95% CI) 2.26 [0.50, 10.08]
74.2 LLETZ 1 511491 Risk Ratio (IV, Random, 95% CI) 2.16 [1.64, 2.84]
75 PTB (<37w)-Depth
15/16-19/20mm vs Untreated
Colposcopy+/-CIN+/-Biopsy
2 32598 Risk Ratio (IV, Random, 95% CI) 2.38 [1.04, 5.42]
75.1 LLETZ 2 32598 Risk Ratio (IV, Random, 95% CI) 2.38 [1.04, 5.42]
Comparison 2. Other maternal Outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 sPTB (<37w) 14 1.024731E6 Risk Ratio (IV, Random, 95% CI) 1.76 [1.47, 2.11]
1.1 CKC vs No Treatment 3 7320 Risk Ratio (IV, Random, 95% CI) 3.53 [2.05, 6.05]
1.2 LC vs No Treatment 2 222 Risk Ratio (IV, Random, 95% CI) 1.40 [0.51, 3.81]
1.3 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 5.83 [3.80, 8.95]
1.4 LLETZ vs No Treatment 11 773123 Risk Ratio (IV, Random, 95% CI) 1.60 [1.22, 2.08]
1.5 LA vs No Treatment 1 356 Risk Ratio (IV, Random, 95% CI) 0.95 [0.34, 2.68]
1.6 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 1.86 [0.08, 43.87]
1.7 Excisional Treatment
NOS vs No Treatment
2 95985 Risk Ratio (IV, Random, 95% CI) 1.70 [1.17, 2.46]
1.8 Ablative Treatment NOS
vs No Treatment
2 134720 Risk Ratio (IV, Random, 95% CI) 1.42 [1.20, 1.70]
1.9 Treatment NOS vs No
Treatment
1 5548 Risk Ratio (IV, Random, 95% CI) 1.30 [1.00, 1.69]
2 sPTB (<32-34w) 7 655675 Risk Ratio (IV, Random, 95% CI) 2.63 [1.91, 3.62]
2.1 CKC vs No Treatment 2 6990 Risk Ratio (IV, Random, 95% CI) 4.38 [1.08, 17.65]
2.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 10.53 [4.33, 25.65]
2.3 LLETZ vs No Treatment 6 530985 Risk Ratio (IV, Random, 95% CI) 2.37 [1.82, 3.08]
2.4 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 1.86 [0.08, 43.87]
2.5 Excisional Treatment
NOS vs No Treatment
1 264 Risk Ratio (IV, Random, 95% CI) 13.92 [0.73, 266.57]
2.6 Ablative Treatment NOS
vs No Treatment
1 109979 Risk Ratio (IV, Random, 95% CI) 1.57 [0.97, 2.53]
3 sPTB (<28w) 2 626670 Risk Ratio (IV, Random, 95% CI) 3.18 [1.64, 6.16]
3.1 CKC vs No Treatment 1 6956 Risk Ratio (IV, Random, 95% CI) 5.41 [0.74, 39.84]
3.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 14.74 [4.50, 48.32]
3.3 LLETZ vs No Treatment 2 502336 Risk Ratio (IV, Random, 95% CI) 2.57 [1.96, 3.36]
3.4 Ablative Treatment NOS
vs No Treatment
1 109979 Risk Ratio (IV, Random, 95% CI) 1.22 [0.54, 2.74]
4 pPROM (<37w) 21 477011 Risk Ratio (IV, Random, 95% CI) 2.36 [1.76, 3.17]
4.1 CKC vs No Treatment 4 36733 Risk Ratio (IV, Random, 95% CI) 4.11 [2.05, 8.25]
4.2 LC vs No Treatment 4 635 Risk Ratio (IV, Random, 95% CI) 1.89 [0.97, 3.66]
4.3 NETZ vs No Treatment 1 7279 Risk Ratio (IV, Random, 95% CI) 8.83 [5.39, 14.46]
4.4 LLETZ vs No Treatment 8 302974 Risk Ratio (IV, Random, 95% CI) 2.15 [1.48, 3.12]
4.5 LA vs No Treatment 2 548 Risk Ratio (IV, Random, 95% CI) 1.62 [0.74, 3.55]
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4.6 CT vs No Treatment 1 180 Risk Ratio (IV, Random, 95% CI) 1.13 [0.21, 6.00]
4.7 Excisional Treatment
NOS vs No Treatment
5 98372 Risk Ratio (IV, Random, 95% CI) 2.66 [1.13, 6.24]
4.8 Ablative Treatment NOS
vs No Treatment
1 24742 Risk Ratio (IV, Random, 95% CI) 1.47 [1.01, 2.15]
4.9 Treatment NOS vs No
Treatment
1 5548 Risk Ratio (IV, Random, 95% CI) 1.44 [1.05, 1.97]
5 pPROM (<32w) 1 72788 Risk Ratio (IV, Random, 95% CI) 8.30 [2.03, 33.98]
5.1 CKC vs No Treatment 1 6842 Risk Ratio (IV, Random, 95% CI) 5.32 [0.72, 39.19]
5.2 NETZ vs No Treatment 1 7279 Risk Ratio (IV, Random, 95% CI) 25.38 [9.80, 65.74]
5.3 LLETZ vs No Treatment 1 58667 Risk Ratio (IV, Random, 95% CI) 3.74 [1.66, 8.41]
6 pPROM (<28w) 1 72788 Risk Ratio (IV, Random, 95% CI) 9.09 [1.04, 79.18]
6.1 CKC vs No Treatment 1 6842 Risk Ratio (IV, Random, 95% CI) 6.64 [0.38, 115.16]
6.2 NETZ vs No Treatment 1 7279 Risk Ratio (IV, Random, 95% CI) 43.51 [11.48, 164.
86]
6.3 LLETZ vs No Treatment 1 58667 Risk Ratio (IV, Random, 95% CI) 1.81 [0.25, 13.08]
7 Threatened PTB 5 903 Risk Ratio (IV, Random, 95% CI) 2.44 [1.37, 4.33]
7.1 CKC vs No Treatment 1 126 Risk Ratio (IV, Random, 95% CI) 1.40 [0.45, 4.34]
7.2 LC vs No Treatment 1 112 Risk Ratio (IV, Random, 95% CI) 1.56 [0.53, 4.62]
7.3 LLETZ vs No Treatment 1 237 Risk Ratio (IV, Random, 95% CI) 4.0 [0.75, 21.37]
7.4 Excisional Treatment
NOS vs No Treatment
2 428 Risk Ratio (IV, Random, 95% CI) 4.51 [1.68, 12.06]
8 Chorioamnionitis 4 29198 Risk Ratio (IV, Random, 95% CI) 3.43 [1.36, 8.64]
8.1 CKC vs No Treatment 1 28531 Risk Ratio (IV, Random, 95% CI) 2.39 [0.61, 9.43]
8.2 LC vs No Treatment 1 112 Risk Ratio (IV, Random, 95% CI) 3.33 [0.14, 80.11]
8.3 LLETZ vs No Treatment 1 237 Risk Ratio (IV, Random, 95% CI) 10.00 [1.19, 84.15]
8.4 Excisional Treatment
NOS vs No Treatment
1 318 Risk Ratio (IV, Random, 95% CI) 3.0 [0.51, 17.68]
9 Caeserean Section 36 272360 Risk Ratio (IV, Random, 95% CI) 1.06 [0.98, 1.14]
9.1 CKC vs No Treatment 6 30462 Risk Ratio (IV, Random, 95% CI) 1.24 [0.91, 1.68]
9.2 LC vs No Treatment 5 1038 Risk Ratio (IV, Random, 95% CI) 1.38 [0.90, 2.11]
9.3 LLETZ vs No Treatment 14 5436 Risk Ratio (IV, Random, 95% CI) 1.04 [0.94, 1.15]
9.4 LA vs No Treatment 4 1258 Risk Ratio (IV, Random, 95% CI) 0.86 [0.61, 1.20]
9.5 CT vs No Treatment 2 238 Risk Ratio (IV, Random, 95% CI) 2.47 [1.02, 6.01]
9.6 Excisional Treatment
NOS vs No Treatment
9 203532 Risk Ratio (IV, Random, 95% CI) 1.03 [0.89, 1.20]
9.7 Ablative Treatment NOS
vs No Treatment
2 24848 Risk Ratio (IV, Random, 95% CI) 1.38 [0.42, 4.58]
9.8 Treatment NOS vs No
Treatment
1 5548 Risk Ratio (IV, Random, 95% CI) 1.13 [1.00, 1.27]
10 Instrumental Deliveries
(ventouse/forceps)
16 9588 Risk Ratio (IV, Random, 95% CI) 0.97 [0.88, 1.08]
10.1 CKC vs No Treatment 2 454 Risk Ratio (IV, Random, 95% CI) 1.33 [0.66, 2.70]
10.2 LC vs No Treatment 2 668 Risk Ratio (IV, Random, 95% CI) 1.16 [0.65, 2.07]
10.3 LLETZ vs No Treatment 6 1418 Risk Ratio (IV, Random, 95% CI) 0.89 [0.68, 1.17]
10.4 LA vs No Treatment 3 550 Risk Ratio (IV, Random, 95% CI) 0.94 [0.62, 1.41]
10.5 Excisional Treatment
NOS vs No Treatment
3 950 Risk Ratio (IV, Random, 95% CI) 0.71 [0.46, 1.10]
10.6 Treatment NOS vs No
Treatment
1 5548 Risk Ratio (IV, Random, 95% CI) 1.01 [0.89, 1.15]
11 Precipitous Labour (<2hours) 5 1059 Risk Ratio (IV, Random, 95% CI) 1.26 [0.80, 1.96]
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11.1 CKC vs No Treatment 2 289 Risk Ratio (IV, Random, 95% CI) 1.24 [0.47, 3.27]
11.2 LLETZ vs No Treatment 4 770 Risk Ratio (IV, Random, 95% CI) 1.26 [0.76, 2.08]
12 Prolonged labour (>12hours) 7 1854 Risk Ratio (IV, Random, 95% CI) 1.25 [0.92, 1.69]
12.1 CKC vs No Treatment 2 325 Risk Ratio (IV, Random, 95% CI) 1.99 [0.89, 4.45]
12.2 LC vs No Treatment 1 500 Risk Ratio (IV, Random, 95% CI) 0.92 [0.41, 2.04]
12.3 LLETZ vs No Treatment 4 673 Risk Ratio (IV, Random, 95% CI) 0.96 [0.55, 1.70]
12.4 LA vs No Treatment 2 356 Risk Ratio (IV, Random, 95% CI) 1.41 [0.88, 2.26]
13 Induction of Labour 11 4668 Risk Ratio (IV, Random, 95% CI) 1.01 [0.89, 1.15]
13.1 CKC vs No Treatment 2 137 Risk Ratio (IV, Random, 95% CI) 1.11 [0.54, 2.29]
13.2 LLETZ vs No treatment 8 4056 Risk Ratio (IV, Random, 95% CI) 0.99 [0.82, 1.20]
13.3 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 0.61 [0.22, 1.66]
13.4 Excisional Treatment
NOS vs No Treatment
2 417 Risk Ratio (IV, Random, 95% CI) 0.90 [0.64, 1.28]
14 Oxytocin Use 6 2006 Risk Ratio (IV, Random, 95% CI) 0.90 [0.64, 1.26]
14.1 CKC vs No Treatment 1 103 Risk Ratio (IV, Random, 95% CI) 0.98 [0.59, 1.63]
14.2 LLETZ vs No Treatment 4 1804 Risk Ratio (IV, Random, 95% CI) 0.76 [0.43, 1.34]
14.3 Excisional Treatment
NOS vs No Treatment
1 99 Risk Ratio (IV, Random, 95% CI) 1.18 [0.67, 2.05]
15 Epidural Use 5 105488 Risk Ratio (IV, Random, 95% CI) 1.02 [0.68, 1.53]
15.1 LLETZ vs No Treatment 4 818 Risk Ratio (IV, Random, 95% CI) 0.86 [0.64, 1.16]
15.2 Excisional Treatment
NOS vs No Treatment
1 104670 Risk Ratio (IV, Random, 95% CI) 1.79 [1.29, 2.50]
16 Pethidine Use 2 394 Risk Ratio (IV, Random, 95% CI) 0.94 [0.72, 1.24]
16.1 LLETZ vs No treatment 2 394 Risk Ratio (IV, Random, 95% CI) 0.94 [0.72, 1.24]
17 Analgesia Use NOS 1 103 Risk Ratio (IV, Random, 95% CI) 1.11 [0.62, 1.98]
17.1 CKC vs No Treatment 1 103 Risk Ratio (IV, Random, 95% CI) 1.11 [0.62, 1.98]
18 Cervical stenosis 2 680 Risk Ratio (IV, Random, 95% CI) 2.26 [0.24, 21.59]
18.1 LC vs No Treatment 1 500 Risk Ratio (IV, Random, 95% CI) 3.0 [0.12, 73.29]
18.2 CT vs No Treatment 1 180 Risk Ratio (IV, Random, 95% CI) 1.71 [0.07, 41.31]
19 Antepartum Haemorrhage 4 1245 Risk Ratio (IV, Random, 95% CI) 1.11 [0.40, 3.12]
19.1 CKC vs No Treatment 1 34 Risk Ratio (IV, Random, 95% CI) 1.24 [0.26, 5.83]
19.2 LC vs No Treatment 1 168 Risk Ratio (IV, Random, 95% CI) 17.84 [0.98, 325.68]
19.3 LLETZ vs No Treatment 2 277 Risk Ratio (IV, Random, 95% CI) 0.52 [0.16, 1.67]
19.4 LA vs No Treatment 1 708 Risk Ratio (IV, Random, 95% CI) 8.00 [0.90, 71.18]
19.5 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 0.41 [0.07, 2.25]
20 Postpartum Haemorrhage
(>600ml)
1 149 Risk Ratio (IV, Random, 95% CI) 4.60 [1.38, 15.36]
20.1 CKC vs No Treatment 1 149 Risk Ratio (IV, Random, 95% CI) 4.60 [1.38, 15.36]
21 Massive Obstetric
Haemorrhage (>1000ml)
1 149 Risk Ratio (IV, Random, 95% CI) 3.95 [0.45, 34.48]
21.1 CKC vs No Treatment 1 149 Risk Ratio (IV, Random, 95% CI) 3.95 [0.45, 34.48]
22 Cervical cerclage 8 141300 Risk Ratio (IV, Random, 95% CI) 14.29 [2.85, 71.65]
22.1 CKC vs No Treatment 3 30744 Risk Ratio (IV, Random, 95% CI) 31.42 [2.32, 426.22]
22.2 LC vs No Treatment 1 112 Risk Ratio (IV, Random, 95% CI) 6.68 [0.83, 53.69]
22.3 LLETZ vs No Treatment 1 56 Risk Ratio (IV, Random, 95% CI) 11.00 [0.64, 189.96]
22.4 Excisional Treatment
NOS vs No Treatment
2 104840 Risk Ratio (IV, Random, 95% CI) 42.45 [28.99, 62.16]
22.5 Treatment NOS vs No
Treatment
1 5548 Risk Ratio (IV, Random, 95% CI) 2.16 [1.24, 3.76]
143Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 3. Neonatal Outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 LBW (<2500g) 30 1.348206E6 Risk Ratio (IV, Random, 95% CI) 1.81 [1.58, 2.07]
1.1 CKC vs No Treatment 5 30304 Risk Ratio (IV, Random, 95% CI) 2.51 [1.78, 3.53]
1.2 LC vs No Treatment 4 786 Risk Ratio (IV, Random, 95% CI) 1.76 [0.72, 4.35]
1.3 LLETZ vs No Treatment 12 3357 Risk Ratio (IV, Random, 95% CI) 2.11 [1.51, 2.94]
1.4 LA vs No Treatment 4 1104 Risk Ratio (IV, Random, 95% CI) 1.07 [0.59, 1.92]
1.5 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 3.67 [0.47, 28.47]
1.6 Excisional Treatment
NOS vs No Treatment
10 823648 Risk Ratio (IV, Random, 95% CI) 2.01 [1.62, 2.49]
1.7 Ablative Treatment NOS
vs No Treatment
4 483402 Risk Ratio (IV, Random, 95% CI) 1.36 [1.19, 1.55]
1.8 Treatment NOS vs No
Treatment
1 5547 Risk Ratio (IV, Random, 95% CI) 1.35 [1.14, 1.60]
2 LBW (<2000g) 3 74981 Risk Ratio (IV, Random, 95% CI) 2.49 [0.97, 6.36]
2.1 LC vs No Treatment 1 181 Risk Ratio (IV, Random, 95% CI) 4.46 [1.36, 14.59]
2.2 LA vs No Treatment 2 772 Risk Ratio (IV, Random, 95% CI) 0.95 [0.39, 2.29]
2.3 Excisional Treatment
NOS vs No Treatment
1 74028 Risk Ratio (IV, Random, 95% CI) 4.60 [3.32, 6.37]
3 LBW (<1500g) 5 76836 Risk Ratio (IV, Random, 95% CI) 3.00 [1.54, 5.85]
3.1 LC vs No Treatment 1 181 Risk Ratio (IV, Random, 95% CI) 12.75 [1.53, 106.44]
3.2 LLETZ vs No Treatment 1 378 Risk Ratio (IV, Random, 95% CI) 7.0 [0.36, 134.59]
3.3 LA vs No Treatment 2 772 Risk Ratio (IV, Random, 95% CI) 0.68 [0.16, 2.80]
3.4 Excisional Treatment
NOS vs No Treatment
2 75505 Risk Ratio (IV, Random, 95% CI) 3.34 [2.02, 5.54]
4 LBW (<1000g) 2 2185 Risk Ratio (IV, Random, 95% CI) 2.09 [0.06, 74.71]
4.1 LA vs No Treatment 1 708 Risk Ratio (IV, Random, 95% CI) 0.29 [0.01, 5.50]
4.2 Excisional Treatment
NOS vs No Treatment
1 1477 Risk Ratio (IV, Random, 95% CI) 11.10 [1.44, 85.79]
5 NICU Admission 8 2557 Risk Ratio (IV, Random, 95% CI) 1.45 [1.16, 1.81]
5.1 CKC vs No Treatment 2 71 Risk Ratio (IV, Random, 95% CI) 1.40 [0.52, 3.75]
5.2 LLETZ vs No Treatment 5 1994 Risk Ratio (IV, Random, 95% CI) 1.42 [1.01, 1.99]
5.3 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 2.44 [0.29, 20.49]
5.4 Excisional Treatment
NOS vs No Treatment
2 434 Risk Ratio (IV, Random, 95% CI) 1.76 [1.13, 2.75]
6 Perinatal Mortality 23 1.659433E6 Risk Ratio (IV, Random, 95% CI) 1.51 [1.13, 2.03]
6.1 CKC vs No Treatment 7 50588 Risk Ratio (IV, Random, 95% CI) 1.46 [0.83, 2.57]
6.2 LC vs No Treatment 3 906 Risk Ratio (IV, Random, 95% CI) 1.89 [0.26, 13.87]
6.3 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 9.99 [3.13, 31.92]
6.4 LLETZ vs No Treatment 7 302271 Risk Ratio (IV, Random, 95% CI) 1.53 [0.88, 2.67]
6.5 LA vs No Treatment 2 258 Risk Ratio (IV, Random, 95% CI) 3.0 [0.12, 72.74]
6.6 CT vs No Treatment 2 238 Risk Ratio (IV, Random, 95% CI) 0.19 [0.01, 4.59]
6.7 Excisional Treatment
NOS vs No Treatment
5 820028 Risk Ratio (IV, Random, 95% CI) 1.85 [1.02, 3.36]
6.8 Ablative Treatment NOS
vs No Treatment
2 472197 Risk Ratio (IV, Random, 95% CI) 0.69 [0.42, 1.13]
6.9 Treatment NOS vs No
Treatment
1 5548 Risk Ratio (IV, Random, 95% CI) 1.00 [0.63, 1.58]
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7 Perinatal Mortality (<37w) 1 73992 Risk Ratio (IV, Random, 95% CI) 9.40 [2.01, 43.89]
7.1 CKC vs No Treatment 1 6956 Risk Ratio (IV, Random, 95% CI) 5.33 [0.31, 90.71]
7.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 30.96 [8.71, 110.13]
7.3 LLETZ vs No Treatment 1 59637 Risk Ratio (IV, Random, 95% CI) 3.92 [1.24, 12.38]
8 Perinatal Mortality (<32w) 1 73992 Risk Ratio (IV, Random, 95% CI) 12.81 [2.70, 60.87]
8.1 CKC vs No Treatment 1 6956 Risk Ratio (IV, Random, 95% CI) 6.75 [0.39, 117.10]
8.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 44.23 [11.67, 167.
61]
8.3 LLETZ vs No Treatment 1 59637 Risk Ratio (IV, Random, 95% CI) 5.43 [1.71, 17.30]
9 Perinatal Mortality (<28w) 1 73992 Risk Ratio (IV, Random, 95% CI) 13.76 [2.37, 79.89]
9.1 CKC vs No Treatment 1 6956 Risk Ratio (IV, Random, 95% CI) 9.21 [0.51, 164.95]
9.2 NETZ vs No Treatment 1 7399 Risk Ratio (IV, Random, 95% CI) 51.61 [13.17, 202.
29]
9.3 LLETZ vs No Treatment 1 59637 Risk Ratio (IV, Random, 95% CI) 4.49 [1.09, 18.45]
10 Stillbirth 12 249855 Risk Ratio (IV, Random, 95% CI) 0.98 [0.63, 1.52]
10.1 CKC vs No Treatment 3 935 Risk Ratio (IV, Random, 95% CI) 1.61 [0.48, 5.40]
10.2 LC vs No Treatment 2 725 Risk Ratio (IV, Random, 95% CI) 0.33 [0.03, 3.18]
10.3 LLETZ vs No Treatment 4 242473 Risk Ratio (IV, Random, 95% CI) 1.42 [0.62, 3.26]
10.4 LA vs No Treatment 1 64 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
10.5 Excisional Treatment
NOS vs No Treatment
1 110 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
10.6 Treatment NOS vs No
Treatment
1 5548 Risk Ratio (IV, Random, 95% CI) 0.77 [0.42, 1.40]
11 Apgar score (≤5)(1min) 1 225 Risk Ratio (IV, Random, 95% CI) 0.57 [0.12, 2.68]
11.1 LC vs No Treatment 1 225 Risk Ratio (IV, Random, 95% CI) 0.57 [0.12, 2.68]
12 Apgar score (<7)(1min) 1 152 Risk Ratio (IV, Random, 95% CI) 0.63 [0.07, 5.71]
12.1 LLETZ vs No Treatment 1 87 Risk Ratio (IV, Random, 95% CI) 0.16 [0.01, 3.30]
12.2 CKC vs No Treatment 1 65 Risk Ratio (IV, Random, 95% CI) 1.61 [0.15, 16.90]
13 Apgar score (<7)(5min) 2 297 Risk Ratio (IV, Random, 95% CI) 0.82 [0.19, 3.59]
13.1 CKC vs No Treatment 1 32 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
13.2 LLETZ vs No Treatment 1 120 Risk Ratio (IV, Random, 95% CI) 0.93 [0.16, 5.37]
13.3 CT vs No Treatment 1 58 Risk Ratio (IV, Random, 95% CI) 0.61 [0.04, 9.28]
13.4 Excisional Treatment
NOS vs No Treatment
1 87 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 Maternal Outcomes-PTB, Outcome 1 PTB (<37w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 1 PTB (<37w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment vs No Treatment
Albrechtsen 2008 2368/14882 126466/2155505 2.8 % 2.71 [ 2.61, 2.82 ]
Andersen 1999 14/75 10/150 1.2 % 2.80 [ 1.31, 6.00 ]
Andia 2011 19/189 10/189 1.3 % 1.90 [ 0.91, 3.98 ]
Anwar 2016 5/23 2/48 0.4 % 5.22 [ 1.09, 24.90 ]
Bekassy 1996 20/250 20/250 1.6 % 1.00 [ 0.55, 1.81 ]
Blomfield 1993 7/40 9/80 1.0 % 1.56 [ 0.62, 3.87 ]
Braet 1994 10/78 4/78 0.7 % 2.50 [ 0.82, 7.63 ]
Bruinsma 2007 22/140 23/254 1.7 % 1.74 [ 1.00, 3.00 ]
Buller 1982 3/47 6/79 0.6 % 0.84 [ 0.22, 3.20 ]
Castanon 2012 449/4776 34739/517923 2.7 % 1.40 [ 1.28, 1.53 ]
Crane 2006 14/96 1/59 0.3 % 8.60 [ 1.16, 63.75 ]
Cruickshank 1995 14/147 15/295 1.3 % 1.87 [ 0.93, 3.78 ]
El-Bastawissi 1999 118/852 28/250 2.1 % 1.24 [ 0.84, 1.82 ]
Fischer 2010 19/85 3/85 0.7 % 6.33 [ 1.95, 20.61 ]
Frega 2013 26/406 19/379 1.6 % 1.28 [ 0.72, 2.27 ]
Frey 2013 111/598 178/1140 2.5 % 1.19 [ 0.96, 1.47 ]
Gunasekera 1992 0/22 0/22 Not estimable
Guo 2013 24/84 14/68 1.6 % 1.39 [ 0.78, 2.47 ]
Haffenden 1993 15/152 14/152 1.3 % 1.07 [ 0.54, 2.14 ]
Hagen 1993 21/56 7/112 1.2 % 6.00 [ 2.71, 13.26 ]
Heinonen 2013 547/7636 30151/658179 2.7 % 1.56 [ 1.44, 1.70 ]
Himes 2007 11/114 127/962 1.6 % 0.73 [ 0.41, 1.31 ]
Jakobsson 2007 222/2063 12211/261994 2.7 % 2.31 [ 2.04, 2.62 ]
Jones 1979 12/66 14/264 1.3 % 3.43 [ 1.66, 7.06 ]
Kirn 2015 16/135 11/135 1.3 % 1.45 [ 0.70, 3.02 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Kitson 2014 25/278 10/278 1.3 % 2.50 [ 1.22, 5.11 ]
Klaritsch 2006 17/76 1961/29686 2.0 % 3.39 [ 2.22, 5.16 ]
Kuoppala 1986 4/62 1/62 0.2 % 4.00 [ 0.46, 34.78 ]
Larsson 1982 33/197 16/284 1.6 % 2.97 [ 1.68, 5.25 ]
Lima 2011 6/29 3/58 0.6 % 4.00 [ 1.08, 14.86 ]
Ludviksson 1982 11/83 3/79 0.6 % 3.49 [ 1.01, 12.05 ]
Martyn 2015 25/297 6/204 1.0 % 2.86 [ 1.20, 6.85 ]
Miller 2015 114/1356 1102/17172 2.6 % 1.31 [ 1.09, 1.58 ]
Moinian 1982 3/103 16/720 0.6 % 1.31 [ 0.39, 4.42 ]
Noehr 2009a 530/8180 14758/434520 2.7 % 1.91 [ 1.75, 2.07 ]
Ortoft 2010 79/710 3010/73282 2.5 % 2.71 [ 2.19, 3.34 ]
Paraskevaidis 2002 11/28 3/28 0.7 % 3.67 [ 1.14, 11.75 ]
Poon 2012 41/473 1156/25772 2.3 % 1.93 [ 1.43, 2.60 ]
Raio 1997 6/64 3/64 0.6 % 2.00 [ 0.52, 7.65 ]
Reilly 2012 146/1521 1816/29978 2.6 % 1.58 [ 1.35, 1.86 ]
Sadler 2004 64/383 52/426 2.2 % 1.37 [ 0.98, 1.92 ]
Sagot 1995 6/53 1/59 0.3 % 6.68 [ 0.83, 53.69 ]
Samson 2005 44/558 14/558 1.6 % 3.14 [ 1.74, 5.67 ]
Shanbhag 2009 129/1103 6682/94846 2.6 % 1.66 [ 1.41, 1.96 ]
Simoens 2012 19/88 16/176 1.5 % 2.38 [ 1.29, 4.39 ]
Sozen 2014 7/15 3/24 0.7 % 3.73 [ 1.14, 12.26 ]
Spitzer 1995 2/34 2/15 0.3 % 0.44 [ 0.07, 2.84 ]
Stout 2015 115/598 178/1129 2.5 % 1.22 [ 0.99, 1.51 ]
Tan 2004 13/119 11/119 1.2 % 1.18 [ 0.55, 2.53 ]
van de Vijner 2010 14/55 2/55 0.5 % 7.00 [ 1.67, 29.36 ]
Van Hentenryck 2012 19/106 13/212 1.4 % 2.92 [ 1.50, 5.69 ]
Werner 2010 35/511 17445/240348 2.3 % 0.94 [ 0.69, 1.30 ]
Wuntakal 2013 42/261 22/257 1.8 % 1.88 [ 1.16, 3.06 ]
Subtotal (95% CI) 50353 4549063 76.9 % 1.87 [ 1.64, 2.12 ]
Total events: 5647 (Treated), 252387 (Untreated)
Heterogeneity: Tau2 = 0.12; Chi2 = 527.23, df = 51 (P<0.00001); I2 =90%
Test for overall effect: Z = 9.65 (P < 0.00001)
2 Ablative Treatment vs No Treatment
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Anderson 1984 7/68 5/70 0.8 % 1.44 [ 0.48, 4.32 ]
Bruinsma 2007 201/1765 286/3230 2.6 % 1.29 [ 1.08, 1.53 ]
Crane 2006 1/36 0/22 0.1 % 1.86 [ 0.08, 43.87 ]
El-Bastawissi 1999 4/72 2/22 0.4 % 0.61 [ 0.12, 3.12 ]
Gunasekera 1992 2/109 1/109 0.2 % 2.00 [ 0.18, 21.73 ]
Hemmingsson 1982 3/115 2/65 0.4 % 0.85 [ 0.15, 4.94 ]
Jakobsson 2007 261/3576 20791/446099 2.7 % 1.57 [ 1.39, 1.76 ]
Noehr 2009a 95/2027 3666/107951 2.6 % 1.38 [ 1.13, 1.68 ]
Reilly 2012 36/522 622/10261 2.3 % 1.14 [ 0.82, 1.57 ]
Sadler 2004 23/223 19/158 1.6 % 0.86 [ 0.48, 1.52 ]
Saunders 1986 14/97 6/97 1.0 % 2.33 [ 0.94, 5.82 ]
Shanbhag 2009 34/285 1723/24457 2.3 % 1.69 [ 1.23, 2.33 ]
Spitzer 1995 16/129 10/97 1.2 % 1.20 [ 0.57, 2.53 ]
van Rooijen 1999 14/236 38/472 1.6 % 0.74 [ 0.41, 1.33 ]
Subtotal (95% CI) 9260 593110 19.6 % 1.35 [ 1.20, 1.52 ]
Total events: 711 (Treated), 27171 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 17.46, df = 13 (P = 0.18); I2 =26%
Test for overall effect: Z = 5.00 (P < 0.00001)
3 Treatment NOS vs No Treatment
Kristensen 1985 9/85 755/12792 1.5 % 1.79 [ 0.96, 3.34 ]
Kristensen 1993 19/130 1213/28124 2.0 % 3.39 [ 2.23, 5.15 ]
Subtotal (95% CI) 215 40916 3.5 % 2.57 [ 1.39, 4.77 ]
Total events: 28 (Treated), 1968 (Untreated)
Heterogeneity: Tau2 = 0.13; Chi2 = 2.76, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 3.00 (P = 0.0027)
Total (95% CI) 59828 5183089 100.0 % 1.75 [ 1.57, 1.96 ]
Total events: 6386 (Treated), 281526 (Untreated)
Heterogeneity: Tau2 = 0.12; Chi2 = 642.43, df = 67 (P<0.00001); I2 =90%
Test for overall effect: Z = 9.84 (P < 0.00001)
Test for subgroup differences: Chi2 = 15.52, df = 2 (P = 0.00), I2 =87%
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Analysis 1.2. Comparison 1 Maternal Outcomes-PTB, Outcome 2 PTB (<37w)-Analysis by treatment
modality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 2 PTB (<37w)-Analysis by treatment modality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Jones 1979 12/66 14/264 1.2 % 3.43 [ 1.66, 7.06 ]
Ludviksson 1982 11/83 3/79 0.6 % 3.49 [ 1.01, 12.05 ]
Moinian 1982 3/103 16/720 0.6 % 1.31 [ 0.39, 4.42 ]
Buller 1982 3/47 6/79 0.5 % 0.84 [ 0.22, 3.20 ]
Larsson 1982 33/197 16/284 1.5 % 2.97 [ 1.68, 5.25 ]
Kuoppala 1986 4/62 1/62 0.2 % 4.00 [ 0.46, 34.78 ]
Klaritsch 2006 17/76 1961/29686 1.8 % 3.39 [ 2.22, 5.16 ]
Crane 2006 4/21 0/13 0.1 % 5.73 [ 0.33, 98.41 ]
Bruinsma 2007 11/71 12/129 1.1 % 1.67 [ 0.77, 3.58 ]
Ortoft 2010 7/67 283/6889 1.2 % 2.54 [ 1.25, 5.17 ]
Guo 2013 14/36 6/29 1.0 % 1.88 [ 0.83, 4.28 ]
Sozen 2014 7/15 3/24 0.6 % 3.73 [ 1.14, 12.26 ]
Subtotal (95% CI) 844 38258 10.5 % 2.70 [ 2.14, 3.40 ]
Total events: 126 (Treated), 2321 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 9.07, df = 11 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 8.42 (P < 0.00001)
2 LC vs No Treatment
Hagen 1993 21/56 7/112 1.1 % 6.00 [ 2.71, 13.26 ]
Spitzer 1995 2/34 2/15 0.3 % 0.44 [ 0.07, 2.84 ]
Sagot 1995 6/53 1/59 0.2 % 6.68 [ 0.83, 53.69 ]
Bekassy 1996 20/250 20/250 1.4 % 1.00 [ 0.55, 1.81 ]
Raio 1997 6/64 3/64 0.5 % 2.00 [ 0.52, 7.65 ]
Andersen 1999 14/75 10/150 1.1 % 2.80 [ 1.31, 6.00 ]
Sadler 2004 20/105 14/117 1.4 % 1.59 [ 0.85, 2.99 ]
Lima 2011 2/11 1/22 0.2 % 4.00 [ 0.41, 39.45 ]
Simoens 2012 5/24 5/48 0.7 % 2.00 [ 0.64, 6.25 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 672 837 6.9 % 2.11 [ 1.26, 3.54 ]
Total events: 96 (Treated), 63 (Untreated)
Heterogeneity: Tau2 = 0.30; Chi2 = 17.99, df = 8 (P = 0.02); I2 =56%
Test for overall effect: Z = 2.84 (P = 0.0045)
3 NETZ vs No Treatment
Ortoft 2010 17/71 301/7328 1.8 % 5.83 [ 3.80, 8.95 ]
Subtotal (95% CI) 71 7328 1.8 % 5.83 [ 3.80, 8.95 ]
Total events: 17 (Treated), 301 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.05 (P < 0.00001)
4 LLETZ vs No Treatment
Gunasekera 1992 0/22 0/22 Not estimable
Blomfield 1993 7/40 9/80 0.9 % 1.56 [ 0.62, 3.87 ]
Haffenden 1993 15/152 14/152 1.2 % 1.07 [ 0.54, 2.14 ]
Braet 1994 10/78 4/78 0.7 % 2.50 [ 0.82, 7.63 ]
Cruickshank 1995 14/147 15/295 1.2 % 1.87 [ 0.93, 3.78 ]
Paraskevaidis 2002 11/28 3/28 0.6 % 3.67 [ 1.14, 11.75 ]
Tan 2004 13/119 11/119 1.1 % 1.18 [ 0.55, 2.53 ]
Sadler 2004 44/278 38/309 1.9 % 1.29 [ 0.86, 1.93 ]
Samson 2005 44/558 14/558 1.4 % 3.14 [ 1.74, 5.67 ]
Crane 2006 10/75 1/46 0.3 % 6.13 [ 0.81, 46.36 ]
Himes 2007 11/114 127/962 1.4 % 0.73 [ 0.41, 1.31 ]
Bruinsma 2007 11/69 11/125 1.1 % 1.81 [ 0.83, 3.96 ]
Noehr 2009a 530/8180 14758/434520 2.5 % 1.91 [ 1.75, 2.07 ]
Ortoft 2010 55/572 2426/59065 2.2 % 2.34 [ 1.82, 3.02 ]
Werner 2010 35/511 17445/240348 2.1 % 0.94 [ 0.69, 1.30 ]
Andia 2011 19/189 10/189 1.2 % 1.90 [ 0.91, 3.98 ]
Lima 2011 4/18 2/36 0.4 % 4.00 [ 0.81, 19.82 ]
Poon 2012 41/473 1156/25772 2.1 % 1.93 [ 1.43, 2.60 ]
Simoens 2012 12/52 6/104 0.9 % 4.00 [ 1.59, 10.05 ]
Frey 2013 111/598 178/1140 2.3 % 1.19 [ 0.96, 1.47 ]
Guo 2013 10/48 8/39 1.0 % 1.02 [ 0.44, 2.32 ]
Frega 2013 26/406 19/379 1.5 % 1.28 [ 0.72, 2.27 ]
Heinonen 2013 547/7636 30151/658179 2.5 % 1.56 [ 1.44, 1.70 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Stout 2015 115/598 178/1129 2.3 % 1.22 [ 0.99, 1.51 ]
Martyn 2015 20/278 6/191 0.9 % 2.29 [ 0.94, 5.60 ]
Subtotal (95% CI) 21239 1423865 33.7 % 1.58 [ 1.37, 1.81 ]
Total events: 1715 (Treated), 66590 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 77.23, df = 23 (P<0.00001); I2 =70%
Test for overall effect: Z = 6.44 (P < 0.00001)
5 FCBE vs No Treatment
Anwar 2016 5/23 2/48 0.4 % 5.22 [ 1.09, 24.90 ]
Subtotal (95% CI) 23 48 0.4 % 5.22 [ 1.09, 24.90 ]
Total events: 5 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.07 (P = 0.038)
6 LA vs No Treatment
Anderson 1984 7/68 5/70 0.7 % 1.44 [ 0.48, 4.32 ]
Saunders 1986 14/97 6/97 0.9 % 2.33 [ 0.94, 5.82 ]
Gunasekera 1992 2/109 1/109 0.2 % 2.00 [ 0.18, 21.73 ]
Spitzer 1995 16/129 10/97 1.1 % 1.20 [ 0.57, 2.53 ]
van Rooijen 1999 14/236 38/472 1.4 % 0.74 [ 0.41, 1.33 ]
Sadler 2004 23/223 19/158 1.5 % 0.86 [ 0.48, 1.52 ]
Bruinsma 2007 92/1005 163/1840 2.2 % 1.03 [ 0.81, 1.32 ]
Subtotal (95% CI) 1867 2843 8.1 % 1.04 [ 0.86, 1.26 ]
Total events: 168 (Treated), 242 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.51, df = 6 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.37 (P = 0.71)
7 CT vs No Treatment
Hemmingsson 1982 3/115 2/65 0.3 % 0.85 [ 0.15, 4.94 ]
Crane 2006 1/36 0/22 0.1 % 1.86 [ 0.08, 43.87 ]
Subtotal (95% CI) 151 87 0.4 % 1.02 [ 0.22, 4.77 ]
Total events: 4 (Treated), 2 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.18, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.03 (P = 0.98)
8 RD vs No Treatment
Bruinsma 2007 109/760 123/1390 2.2 % 1.62 [ 1.27, 2.06 ]
Subtotal (95% CI) 760 1390 2.2 % 1.62 [ 1.27, 2.06 ]
Total events: 109 (Treated), 123 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.91 (P = 0.000093)
9 Excisional Treatment NOS vs No Treatment
El-Bastawissi 1999 118/852 28/250 1.9 % 1.24 [ 0.84, 1.82 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Jakobsson 2007 222/2063 12211/261994 2.4 % 2.31 [ 2.04, 2.62 ]
Albrechtsen 2008 2368/14882 126466/2155505 2.5 % 2.71 [ 2.61, 2.82 ]
Shanbhag 2009 129/1103 6682/94846 2.4 % 1.66 [ 1.41, 1.96 ]
Fischer 2010 19/85 3/85 0.6 % 6.33 [ 1.95, 20.61 ]
van de Vijner 2010 14/55 2/55 0.5 % 7.00 [ 1.67, 29.36 ]
Van Hentenryck 2012 19/106 13/212 1.3 % 2.92 [ 1.50, 5.69 ]
Simoens 2012 2/12 5/24 0.4 % 0.80 [ 0.18, 3.54 ]
Castanon 2012 449/4776 34739/517923 2.5 % 1.40 [ 1.28, 1.53 ]
Reilly 2012 146/1521 1816/29978 2.4 % 1.58 [ 1.35, 1.86 ]
Wuntakal 2013 42/261 22/257 1.7 % 1.88 [ 1.16, 3.06 ]
Kitson 2014 25/278 10/278 1.2 % 2.50 [ 1.22, 5.11 ]
Miller 2015 114/1356 1102/17172 2.3 % 1.31 [ 1.09, 1.58 ]
Martyn 2015 5/19 0/13 0.1 % 7.70 [ 0.46, 128.32 ]
Kirn 2015 16/135 11/135 1.2 % 1.45 [ 0.70, 3.02 ]
Subtotal (95% CI) 27504 3078727 23.5 % 1.90 [ 1.50, 2.41 ]
Total events: 3688 (Treated), 183110 (Untreated)
Heterogeneity: Tau2 = 0.14; Chi2 = 286.60, df = 14 (P<0.00001); I2 =95%
Test for overall effect: Z = 5.34 (P < 0.00001)
10 Ablative Treatment NOS vs No Treatment
El-Bastawissi 1999 4/72 2/22 0.4 % 0.61 [ 0.12, 3.12 ]
Jakobsson 2007 261/3576 20791/446099 2.5 % 1.57 [ 1.39, 1.76 ]
Shanbhag 2009 34/285 1723/24457 2.1 % 1.69 [ 1.23, 2.33 ]
Noehr 2009a 95/2027 3666/107951 2.3 % 1.38 [ 1.13, 1.68 ]
Reilly 2012 36/522 622/10261 2.1 % 1.14 [ 0.82, 1.57 ]
Subtotal (95% CI) 6482 588790 9.3 % 1.46 [ 1.27, 1.66 ]
Total events: 430 (Treated), 26804 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 5.69, df = 4 (P = 0.22); I2 =30%
Test for overall effect: Z = 5.54 (P < 0.00001)
11 Treatment NOS vs No Treatment
Kristensen 1985 9/85 755/12792 1.4 % 1.79 [ 0.96, 3.34 ]
Kristensen 1993 19/130 1213/28124 1.8 % 3.39 [ 2.23, 5.15 ]
Subtotal (95% CI) 215 40916 3.2 % 2.57 [ 1.39, 4.77 ]
Total events: 28 (Treated), 1968 (Untreated)
Heterogeneity: Tau2 = 0.13; Chi2 = 2.76, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 3.00 (P = 0.0027)
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 59828 5183089 100.0 % 1.78 [ 1.60, 1.98 ]
Total events: 6386 (Treated), 281526 (Untreated)
Heterogeneity: Tau2 = 0.12; Chi2 = 670.06, df = 78 (P<0.00001); I2 =88%
Test for overall effect: Z = 10.46 (P < 0.00001)
Test for subgroup differences: Chi2 = 83.29, df = 10 (P = 0.00), I2 =88%
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Analysis 1.3. Comparison 1 Maternal Outcomes-PTB, Outcome 3 PTB (<32-34w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 3 PTB (<32-34w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment vs No Treatment
Albrechtsen 2008 769/14882 30702/2155505 7.5 % 3.63 [ 3.38, 3.89 ]
Andia 2011 2/189 0/189 0.5 % 5.00 [ 0.24, 103.45 ]
Armarnik 2011 9/53 2720/104617 5.0 % 6.53 [ 3.60, 11.86 ]
Castanon 2012 143/4776 8845/517923 7.3 % 1.75 [ 1.49, 2.06 ]
Crane 2006 3/96 1/59 0.9 % 1.84 [ 0.20, 17.32 ]
Fischer 2010 6/85 0/85 0.6 % 13.00 [ 0.74, 227.20 ]
Guo 2013 5/84 4/68 2.2 % 1.01 [ 0.28, 3.62 ]
Kitson 2014 15/278 4/278 2.8 % 3.75 [ 1.26, 11.16 ]
Klaritsch 2006 7/76 871/29686 4.4 % 3.14 [ 1.55, 6.38 ]
Ludviksson 1982 3/83 0/79 0.6 % 6.67 [ 0.35, 127.03 ]
Noehr 2009a 119/8180 2324/434519 7.2 % 2.72 [ 2.27, 3.27 ]
Ortoft 2010 18/710 495/73282 5.8 % 3.75 [ 2.36, 5.97 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Parikh 2008 3/87 704/18042 2.7 % 0.88 [ 0.29, 2.69 ]
Poon 2012 16/473 336/25772 5.6 % 2.59 [ 1.58, 4.25 ]
Reilly 2012 22/1521 317/29978 6.0 % 1.37 [ 0.89, 2.10 ]
Samson 2005 7/558 2/558 1.7 % 3.50 [ 0.73, 16.77 ]
Simoens 2012 5/88 1/176 1.0 % 10.00 [ 1.19, 84.29 ]
Stout 2015 40/598 51/1129 6.1 % 1.48 [ 0.99, 2.21 ]
van de Vijner 2010 6/55 0/55 0.6 % 13.00 [ 0.75, 225.30 ]
Van Hentenryck 2012 7/106 0/212 0.6 % 29.86 [ 1.72, 517.90 ]
Werner 2010 19/511 5681/240348 5.9 % 1.57 [ 1.01, 2.45 ]
Wuntakal 2013 8/261 7/257 3.1 % 1.13 [ 0.41, 3.06 ]
Subtotal (95% CI) 33750 3632817 78.1 % 2.48 [ 1.92, 3.20 ]
Total events: 1232 (Treated), 53065 (Untreated)
Heterogeneity: Tau2 = 0.17; Chi2 = 129.47, df = 21 (P<0.00001); I2 =84%
Test for overall effect: Z = 6.97 (P < 0.00001)
2 Ablative Treatment vs No Treatment
Crane 2006 1/36 0/22 0.5 % 1.86 [ 0.08, 43.87 ]
Noehr 2009a 17/2027 578/107952 5.7 % 1.57 [ 0.97, 2.53 ]
Reilly 2012 9/522 108/10261 4.6 % 1.64 [ 0.83, 3.21 ]
Subtotal (95% CI) 2585 118235 10.7 % 1.59 [ 1.08, 2.35 ]
Total events: 27 (Treated), 686 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 2 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.35 (P = 0.019)
3 Treatment NOS vs No treatment
Bruinsma 2007 67/1925 65/3484 6.5 % 1.87 [ 1.33, 2.61 ]
Sadler 2004 24/652 13/426 4.6 % 1.21 [ 0.62, 2.34 ]
Subtotal (95% CI) 2577 3910 11.1 % 1.65 [ 1.13, 2.42 ]
Total events: 91 (Treated), 78 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.32, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 2.58 (P = 0.0098)
Total (95% CI) 38912 3754962 100.0 % 2.25 [ 1.79, 2.82 ]
Total events: 1350 (Treated), 53829 (Untreated)
Heterogeneity: Tau2 = 0.18; Chi2 = 154.59, df = 26 (P<0.00001); I2 =83%
Test for overall effect: Z = 6.97 (P < 0.00001)
Test for subgroup differences: Chi2 = 4.94, df = 2 (P = 0.08), I2 =60%
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Analysis 1.4. Comparison 1 Maternal Outcomes-PTB, Outcome 4 PTB (<32-34w)-Analysis by treatment
modality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 4 PTB (<32-34w)-Analysis by treatment modality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 0/21 0/13 Not estimable
Guo 2013 3/36 2/29 1.4 % 1.21 [ 0.22, 6.76 ]
Klaritsch 2006 7/76 871/29686 4.2 % 3.14 [ 1.55, 6.38 ]
Ludviksson 1982 3/83 0/79 0.5 % 6.67 [ 0.35, 127.03 ]
Ortoft 2010 2/67 47/6889 1.9 % 4.38 [ 1.08, 17.65 ]
Subtotal (95% CI) 283 36696 8.0 % 3.07 [ 1.72, 5.49 ]
Total events: 15 (Treated), 920 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.65, df = 3 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 3.78 (P = 0.00016)
2 NETZ vs No Treatment
Ortoft 2010 5/71 49/7328 3.4 % 10.53 [ 4.33, 25.65 ]
Subtotal (95% CI) 71 7328 3.4 % 10.53 [ 4.33, 25.65 ]
Total events: 5 (Treated), 49 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.18 (P < 0.00001)
3 LLETZ vs No Treatment
Andia 2011 2/189 0/189 0.5 % 5.00 [ 0.24, 103.45 ]
Crane 2006 3/75 1/46 0.9 % 1.84 [ 0.20, 17.17 ]
Guo 2013 2/48 2/39 1.2 % 0.81 [ 0.12, 5.51 ]
Kitson 2014 15/278 4/278 2.7 % 3.75 [ 1.26, 11.16 ]
Noehr 2009a 119/8180 2324/434519 6.8 % 2.72 [ 2.27, 3.27 ]
Ortoft 2010 11/572 399/59065 4.8 % 2.85 [ 1.57, 5.15 ]
Parikh 2008 3/87 704/18042 2.6 % 0.88 [ 0.29, 2.69 ]
Poon 2012 16/473 336/25772 5.3 % 2.59 [ 1.58, 4.25 ]
Samson 2005 7/558 2/558 1.6 % 3.50 [ 0.73, 16.77 ]
Stout 2015 40/598 51/1129 5.8 % 1.48 [ 0.99, 2.21 ]
Werner 2010 19/511 5681/240348 5.6 % 1.57 [ 1.01, 2.45 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 11569 779985 37.8 % 2.13 [ 1.66, 2.75 ]
Total events: 237 (Treated), 9504 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 16.63, df = 10 (P = 0.08); I2 =40%
Test for overall effect: Z = 5.85 (P < 0.00001)
4 CT vs No Treatment
Crane 2006 1/36 0/22 0.5 % 1.86 [ 0.08, 43.87 ]
Subtotal (95% CI) 36 22 0.5 % 1.86 [ 0.08, 43.87 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
5 Excisional Treatment NOS vs No Treatment
Albrechtsen 2008 769/14882 30702/2155505 7.1 % 3.63 [ 3.38, 3.89 ]
Armarnik 2011 9/53 2720/104617 4.8 % 6.53 [ 3.60, 11.86 ]
Castanon 2012 143/4776 8845/517923 6.9 % 1.75 [ 1.49, 2.06 ]
Fischer 2010 6/85 0/85 0.6 % 13.00 [ 0.74, 227.20 ]
Reilly 2012 22/1521 317/29978 5.7 % 1.37 [ 0.89, 2.10 ]
Simoens 2012 5/88 1/176 1.0 % 10.00 [ 1.19, 84.29 ]
van de Vijner 2010 6/55 0/55 0.6 % 13.00 [ 0.75, 225.30 ]
Van Hentenryck 2012 7/106 0/212 0.6 % 29.86 [ 1.72, 517.90 ]
Wuntakal 2013 8/261 7/257 3.0 % 1.13 [ 0.41, 3.06 ]
Subtotal (95% CI) 21827 2808808 30.1 % 2.94 [ 1.82, 4.77 ]
Total events: 975 (Treated), 42592 (Untreated)
Heterogeneity: Tau2 = 0.28; Chi2 = 95.02, df = 8 (P<0.00001); I2 =92%
Test for overall effect: Z = 4.39 (P = 0.000012)
6 Ablative Treatment NOS vs No Treatment
Noehr 2009a 17/2027 578/107952 5.4 % 1.57 [ 0.97, 2.53 ]
Reilly 2012 9/522 108/10261 4.4 % 1.64 [ 0.83, 3.21 ]
Subtotal (95% CI) 2549 118213 9.7 % 1.59 [ 1.08, 2.35 ]
Total events: 26 (Treated), 686 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.020)
7 Treatment NOS vs No treatment
Bruinsma 2007 67/1925 65/3484 6.2 % 1.87 [ 1.33, 2.61 ]
Sadler 2004 24/652 13/426 4.4 % 1.21 [ 0.62, 2.34 ]
Subtotal (95% CI) 2577 3910 10.6 % 1.65 [ 1.13, 2.42 ]
Total events: 91 (Treated), 78 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.32, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 2.58 (P = 0.0098)
Total (95% CI) 38912 3754962 100.0 % 2.35 [ 1.88, 2.95 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 1350 (Treated), 53829 (Untreated)
Heterogeneity: Tau2 = 0.18; Chi2 = 161.80, df = 29 (P<0.00001); I2 =82%
Test for overall effect: Z = 7.47 (P < 0.00001)
Test for subgroup differences: Chi2 = 19.40, df = 6 (P = 0.00), I2 =69%
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Analysis 1.5. Comparison 1 Maternal Outcomes-PTB, Outcome 5 PTB (<28-30w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 5 PTB (<28-30w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment vs No Treatment
Ludviksson 1982 1/83 0/79 1.2 % 2.86 [ 0.12, 69.11 ]
Cruickshank 1995 4/147 3/295 4.2 % 2.68 [ 0.61, 11.80 ]
Jakobsson 2007 31/4846 1990/612976 12.3 % 1.97 [ 1.38, 2.81 ]
Albrechtsen 2008 234/14882 7757/2155505 13.6 % 4.37 [ 3.84, 4.97 ]
Noehr 2009a 50/8180 1055/434519 12.8 % 2.52 [ 1.90, 3.34 ]
Ortoft 2010 9/710 206/73282 9.5 % 4.51 [ 2.32, 8.75 ]
Reilly 2012 9/1521 106/29978 9.4 % 1.67 [ 0.85, 3.30 ]
Subtotal (95% CI) 30369 3306634 63.1 % 2.81 [ 1.91, 4.15 ]
Total events: 338 (Treated), 11117 (Untreated)
Heterogeneity: Tau2 = 0.16; Chi2 = 31.42, df = 6 (P = 0.00002); I2 =81%
Test for overall effect: Z = 5.22 (P < 0.00001)
2 Ablative Treatment vs No Treatment
Jakobsson 2007 12/3576 1441/443879 10.4 % 1.03 [ 0.59, 1.82 ]
Noehr 2009a 6/2027 262/107952 8.3 % 1.22 [ 0.54, 2.74 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Reilly 2012 5/522 36/10261 7.3 % 2.73 [ 1.08, 6.93 ]
Subtotal (95% CI) 6125 562092 26.0 % 1.38 [ 0.81, 2.36 ]
Total events: 23 (Treated), 1739 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 3.09, df = 2 (P = 0.21); I2 =35%
Test for overall effect: Z = 1.17 (P = 0.24)
3 Treatment NOS vs No Treatment
Bruinsma 2007 29/1925 30/3484 10.9 % 1.75 [ 1.05, 2.91 ]
Subtotal (95% CI) 1925 3484 10.9 % 1.75 [ 1.05, 2.91 ]
Total events: 29 (Treated), 30 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.16 (P = 0.031)
Total (95% CI) 38419 3872210 100.0 % 2.23 [ 1.55, 3.22 ]
Total events: 390 (Treated), 12886 (Untreated)
Heterogeneity: Tau2 = 0.25; Chi2 = 62.71, df = 10 (P<0.00001); I2 =84%
Test for overall effect: Z = 4.30 (P = 0.000017)
Test for subgroup differences: Chi2 = 5.02, df = 2 (P = 0.08), I2 =60%
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Analysis 1.6. Comparison 1 Maternal Outcomes-PTB, Outcome 6 PTB (<28-30w)-Analysis by treatment
modality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 6 PTB (<28-30w)-Analysis by treatment modality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ludviksson 1982 1/83 0/79 1.2 % 2.86 [ 0.12, 69.11 ]
Ortoft 2010 1/67 19/6889 2.6 % 5.41 [ 0.74, 39.84 ]
Subtotal (95% CI) 150 6968 3.8 % 4.52 [ 0.83, 24.54 ]
Total events: 2 (Treated), 19 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 1.75 (P = 0.081)
2 NETZ vs No Treatment
Ortoft 2010 3/71 21/7328 5.4 % 14.74 [ 4.50, 48.32 ]
Subtotal (95% CI) 71 7328 5.4 % 14.74 [ 4.50, 48.32 ]
Total events: 3 (Treated), 21 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.44 (P < 0.00001)
3 LLETZ vs No Treatment
Cruickshank 1995 4/147 3/295 4.1 % 2.68 [ 0.61, 11.80 ]
Noehr 2009a 50/8180 1055/434519 11.9 % 2.52 [ 1.90, 3.34 ]
Ortoft 2010 5/572 166/59065 7.3 % 3.11 [ 1.28, 7.54 ]
Subtotal (95% CI) 8899 493879 23.2 % 2.57 [ 1.97, 3.35 ]
Total events: 59 (Treated), 1224 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.20, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 6.98 (P < 0.00001)
4 Excisional Treatment NOS vs No treatment
Albrechtsen 2008 234/14882 7757/2155505 12.6 % 4.37 [ 3.84, 4.97 ]
Jakobsson 2007 31/4846 1990/612976 11.4 % 1.97 [ 1.38, 2.81 ]
Reilly 2012 9/1521 106/29978 8.8 % 1.67 [ 0.85, 3.30 ]
Subtotal (95% CI) 21249 2798459 32.8 % 2.54 [ 1.30, 4.99 ]
Total events: 274 (Treated), 9853 (Untreated)
Heterogeneity: Tau2 = 0.31; Chi2 = 23.26, df = 2 (P<0.00001); I2 =91%
Test for overall effect: Z = 2.71 (P = 0.0067)
5 Ablative Treatment NOS vs No Treatment
Jakobsson 2007 12/3576 1441/443879 9.7 % 1.03 [ 0.59, 1.82 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Noehr 2009a 6/2027 262/107952 7.8 % 1.22 [ 0.54, 2.74 ]
Reilly 2012 5/522 36/10261 6.9 % 2.73 [ 1.08, 6.93 ]
Subtotal (95% CI) 6125 562092 24.5 % 1.38 [ 0.81, 2.36 ]
Total events: 23 (Treated), 1739 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 3.09, df = 2 (P = 0.21); I2 =35%
Test for overall effect: Z = 1.17 (P = 0.24)
6 Treatment NOS vs No Treatment
Bruinsma 2007 29/1925 30/3484 10.2 % 1.75 [ 1.05, 2.91 ]
Subtotal (95% CI) 1925 3484 10.2 % 1.75 [ 1.05, 2.91 ]
Total events: 29 (Treated), 30 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.16 (P = 0.031)
Total (95% CI) 38419 3872210 100.0 % 2.43 [ 1.69, 3.49 ]
Total events: 390 (Treated), 12886 (Untreated)
Heterogeneity: Tau2 = 0.27; Chi2 = 68.20, df = 12 (P<0.00001); I2 =82%
Test for overall effect: Z = 4.80 (P < 0.00001)
Test for subgroup differences: Chi2 = 15.36, df = 5 (P = 0.01), I2 =67%
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Analysis 1.7. Comparison 1 Maternal Outcomes-PTB, Outcome 7 PTB (≤34w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 7 PTB (≤34w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment vs No Treatment
Andia 2011 10/189 3/189 5.6 % 3.33 [ 0.93, 11.92 ]
Armarnik 2011 9/53 2720/104617 11.5 % 6.53 [ 3.60, 11.86 ]
Crane 2006 3/96 1/59 2.4 % 1.84 [ 0.20, 17.32 ]
Fischer 2010 6/85 0/85 1.5 % 13.00 [ 0.74, 227.20 ]
Guo 2013 5/84 4/68 5.6 % 1.01 [ 0.28, 3.62 ]
Kitson 2014 15/278 4/278 6.8 % 3.75 [ 1.26, 11.16 ]
Klaritsch 2006 7/76 871/29686 10.3 % 3.14 [ 1.55, 6.38 ]
Ludviksson 1982 3/83 0/79 1.5 % 6.67 [ 0.35, 127.03 ]
Parikh 2008 3/87 704/18042 6.6 % 0.88 [ 0.29, 2.69 ]
Poon 2012 16/473 336/25772 12.7 % 2.59 [ 1.58, 4.25 ]
Samson 2005 7/558 2/558 4.2 % 3.50 [ 0.73, 16.77 ]
Stout 2015 40/598 51/1129 13.7 % 1.48 [ 0.99, 2.21 ]
van de Vijner 2010 6/55 0/55 1.6 % 13.00 [ 0.75, 225.30 ]
Van Hentenryck 2012 7/106 0/212 1.5 % 29.86 [ 1.72, 517.90 ]
Werner 2010 19/511 5681/240348 13.2 % 1.57 [ 1.01, 2.45 ]
Subtotal (95% CI) 3332 421177 98.7 % 2.61 [ 1.78, 3.83 ]
Total events: 156 (Treated), 10377 (Untreated)
Heterogeneity: Tau2 = 0.24; Chi2 = 32.43, df = 14 (P = 0.003); I2 =57%
Test for overall effect: Z = 4.92 (P < 0.00001)
2 Ablative Treatment vs No Treatment
Crane 2006 1/36 0/22 1.3 % 1.86 [ 0.08, 43.87 ]
Subtotal (95% CI) 36 22 1.3 % 1.86 [ 0.08, 43.87 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
Total (95% CI) 3368 421199 100.0 % 2.59 [ 1.78, 3.77 ]
Total events: 157 (Treated), 10377 (Untreated)
Heterogeneity: Tau2 = 0.22; Chi2 = 32.45, df = 15 (P = 0.01); I2 =54%
Test for overall effect: Z = 5.00 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.04, df = 1 (P = 0.84), I2 =0.0%
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Analysis 1.8. Comparison 1 Maternal Outcomes-PTB, Outcome 8 PTB (≤34w)-Analysis by treatment
modality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 8 PTB (≤34w)-Analysis by treatment modality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 0/21 0/13 Not estimable
Guo 2013 3/36 2/29 3.5 % 1.21 [ 0.22, 6.76 ]
Klaritsch 2006 7/76 871/29686 10.2 % 3.14 [ 1.55, 6.38 ]
Ludviksson 1982 3/83 0/79 1.4 % 6.67 [ 0.35, 127.03 ]
Subtotal (95% CI) 216 29807 15.1 % 2.85 [ 1.50, 5.41 ]
Total events: 13 (Treated), 873 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.35, df = 2 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 3.21 (P = 0.0013)
2 LLETZ vs No Treatment
Andia 2011 10/189 3/189 5.5 % 3.33 [ 0.93, 11.92 ]
Crane 2006 3/75 1/46 2.3 % 1.84 [ 0.20, 17.17 ]
Guo 2013 2/48 2/39 3.0 % 0.81 [ 0.12, 5.51 ]
Kitson 2014 15/278 4/278 6.7 % 3.75 [ 1.26, 11.16 ]
Parikh 2008 3/87 704/18042 6.5 % 0.88 [ 0.29, 2.69 ]
Poon 2012 16/473 336/25772 12.7 % 2.59 [ 1.58, 4.25 ]
Samson 2005 7/558 2/558 4.1 % 3.50 [ 0.73, 16.77 ]
Stout 2015 40/598 51/1129 13.7 % 1.48 [ 0.99, 2.21 ]
Werner 2010 19/511 5681/240348 13.3 % 1.57 [ 1.01, 2.45 ]
Subtotal (95% CI) 2817 286401 67.7 % 1.83 [ 1.41, 2.39 ]
Total events: 115 (Treated), 6784 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 8.93, df = 8 (P = 0.35); I2 =10%
Test for overall effect: Z = 4.52 (P < 0.00001)
3 CT vs No Treatment
Crane 2006 1/36 0/22 1.2 % 1.86 [ 0.08, 43.87 ]
Subtotal (95% CI) 36 22 1.2 % 1.86 [ 0.08, 43.87 ]
Total events: 1 (Treated), 0 (Untreated)
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
4 Excisional Treatment NOS vs No Treatment
Armarnik 2011 9/53 2720/104617 11.4 % 6.53 [ 3.60, 11.86 ]
Fischer 2010 6/85 0/85 1.5 % 13.00 [ 0.74, 227.20 ]
van de Vijner 2010 6/55 0/55 1.5 % 13.00 [ 0.75, 225.30 ]
Van Hentenryck 2012 7/106 0/212 1.5 % 29.86 [ 1.72, 517.90 ]
Subtotal (95% CI) 299 104969 15.9 % 7.30 [ 4.17, 12.80 ]
Total events: 28 (Treated), 2720 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.38, df = 3 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 6.95 (P < 0.00001)
Total (95% CI) 3368 421199 100.0 % 2.56 [ 1.78, 3.69 ]
Total events: 157 (Treated), 10377 (Untreated)
Heterogeneity: Tau2 = 0.21; Chi2 = 32.53, df = 16 (P = 0.01); I2 =51%
Test for overall effect: Z = 5.04 (P < 0.00001)
Test for subgroup differences: Chi2 = 19.45, df = 3 (P = 0.00), I2 =85%
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Analysis 1.9. Comparison 1 Maternal Outcomes-PTB, Outcome 9 PTB (<32-33w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 9 PTB (<32-33w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment vs No Treatment
Albrechtsen 2008 769/14882 30702/2155505 12.6 % 3.63 [ 3.38, 3.89 ]
Andia 2011 2/189 0/189 0.9 % 5.00 [ 0.24, 103.45 ]
Castanon 2012 143/4776 8845/517923 12.2 % 1.75 [ 1.49, 2.06 ]
Noehr 2009a 119/8180 2324/434519 12.1 % 2.72 [ 2.27, 3.27 ]
Ortoft 2010 18/710 495/73282 9.6 % 3.75 [ 2.36, 5.97 ]
Reilly 2012 22/1521 317/29978 10.0 % 1.37 [ 0.89, 2.10 ]
Simoens 2012 5/88 1/176 1.6 % 10.00 [ 1.19, 84.29 ]
Wuntakal 2013 8/261 7/257 5.1 % 1.13 [ 0.41, 3.06 ]
Subtotal (95% CI) 30607 3211829 64.3 % 2.43 [ 1.70, 3.47 ]
Total events: 1086 (Treated), 42691 (Untreated)
Heterogeneity: Tau2 = 0.17; Chi2 = 88.34, df = 7 (P<0.00001); I2 =92%
Test for overall effect: Z = 4.87 (P < 0.00001)
2 Ablative Treatment vs No Treatment
Noehr 2009a 17/2027 578/107952 9.5 % 1.57 [ 0.97, 2.53 ]
Reilly 2012 9/522 108/10261 7.6 % 1.64 [ 0.83, 3.21 ]
Subtotal (95% CI) 2549 118213 17.1 % 1.59 [ 1.08, 2.35 ]
Total events: 26 (Treated), 686 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.020)
3 Treatment NOS vs No treatment
Bruinsma 2007 67/1925 65/3484 10.9 % 1.87 [ 1.33, 2.61 ]
Sadler 2004 24/652 13/426 7.7 % 1.21 [ 0.62, 2.34 ]
Subtotal (95% CI) 2577 3910 18.6 % 1.65 [ 1.13, 2.42 ]
Total events: 91 (Treated), 78 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.32, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 2.58 (P = 0.0098)
Total (95% CI) 35733 3333952 100.0 % 2.08 [ 1.55, 2.79 ]
Total events: 1203 (Treated), 43455 (Untreated)
Heterogeneity: Tau2 = 0.18; Chi2 = 115.26, df = 11 (P<0.00001); I2 =90%
Test for overall effect: Z = 4.89 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.10, df = 2 (P = 0.21), I2 =35%
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Analysis 1.10. Comparison 1 Maternal Outcomes-PTB, Outcome 10 PTB (<32-33w)-Analysis by treatment
modality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 10 PTB (<32-33w)-Analysis by treatment modality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 2/67 47/6889 3.1 % 4.38 [ 1.08, 17.65 ]
Subtotal (95% CI) 67 6889 3.1 % 4.38 [ 1.08, 17.65 ]
Total events: 2 (Treated), 47 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.07 (P = 0.038)
2 NETZ vs No Treatment
Ortoft 2010 5/71 49/7328 5.5 % 10.53 [ 4.33, 25.65 ]
Subtotal (95% CI) 71 7328 5.5 % 10.53 [ 4.33, 25.65 ]
Total events: 5 (Treated), 49 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.18 (P < 0.00001)
3 LLETZ vs No Treatment
Andia 2011 2/189 0/189 0.8 % 5.00 [ 0.24, 103.45 ]
Noehr 2009a 119/8180 2324/434519 11.1 % 2.72 [ 2.27, 3.27 ]
Ortoft 2010 11/572 399/59065 7.8 % 2.85 [ 1.57, 5.15 ]
Subtotal (95% CI) 8941 493773 19.8 % 2.74 [ 2.30, 3.26 ]
Total events: 132 (Treated), 2723 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.17, df = 2 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 11.31 (P < 0.00001)
4 Excisional Treatment NOS vs No Treatment
Albrechtsen 2008 769/14882 30702/2155505 11.6 % 3.63 [ 3.38, 3.89 ]
Castanon 2012 143/4776 8845/517923 11.2 % 1.75 [ 1.49, 2.06 ]
Reilly 2012 22/1521 317/29978 9.3 % 1.37 [ 0.89, 2.10 ]
Simoens 2012 5/88 1/176 1.6 % 10.00 [ 1.19, 84.29 ]
Wuntakal 2013 8/261 7/257 4.8 % 1.13 [ 0.41, 3.06 ]
Subtotal (95% CI) 21528 2703839 38.5 % 2.09 [ 1.20, 3.63 ]
Total events: 947 (Treated), 39872 (Untreated)
Heterogeneity: Tau2 = 0.28; Chi2 = 85.24, df = 4 (P<0.00001); I2 =95%
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 2.61 (P = 0.0091)
5 Ablative Treatment NOS vs No Treatment
Noehr 2009a 17/2027 578/107952 8.8 % 1.57 [ 0.97, 2.53 ]
Reilly 2012 9/522 108/10261 7.1 % 1.64 [ 0.83, 3.21 ]
Subtotal (95% CI) 2549 118213 15.9 % 1.59 [ 1.08, 2.35 ]
Total events: 26 (Treated), 686 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.020)
6 Treatment NOS vs No treatment
Bruinsma 2007 67/1925 65/3484 10.1 % 1.87 [ 1.33, 2.61 ]
Sadler 2004 24/652 13/426 7.2 % 1.21 [ 0.62, 2.34 ]
Subtotal (95% CI) 2577 3910 17.2 % 1.65 [ 1.13, 2.42 ]
Total events: 91 (Treated), 78 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.32, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 2.58 (P = 0.0098)
Total (95% CI) 35733 3333952 100.0 % 2.26 [ 1.70, 3.01 ]
Total events: 1203 (Treated), 43455 (Untreated)
Heterogeneity: Tau2 = 0.18; Chi2 = 122.30, df = 13 (P<0.00001); I2 =89%
Test for overall effect: Z = 5.56 (P < 0.00001)
Test for subgroup differences: Chi2 = 21.59, df = 5 (P = 0.00), I2 =77%
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Analysis 1.11. Comparison 1 Maternal Outcomes-PTB, Outcome 11 PTB (<30w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 11 PTB (<30w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment vs No Treatment
Ludviksson 1982 1/83 0/79 100.0 % 2.86 [ 0.12, 69.11 ]
Total (95% CI) 83 79 100.0 % 2.86 [ 0.12, 69.11 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Maternal Outcomes-PTB, Outcome 12 PTB (<30w)-Analysis by treatment
modality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 12 PTB (<30w)-Analysis by treatment modality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ludviksson 1982 1/83 0/79 100.0 % 2.86 [ 0.12, 69.11 ]
Total (95% CI) 83 79 100.0 % 2.86 [ 0.12, 69.11 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Maternal Outcomes-PTB, Outcome 13 PTB (<28w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 13 PTB (<28w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment vs No Treatment
Albrechtsen 2008 234/14882 7757/2155505 13.7 % 4.37 [ 3.84, 4.97 ]
Cruickshank 1995 4/147 3/295 4.3 % 2.68 [ 0.61, 11.80 ]
Jakobsson 2007 31/4846 1990/612976 12.4 % 1.97 [ 1.38, 2.81 ]
Noehr 2009a 50/8180 1055/434519 12.9 % 2.52 [ 1.90, 3.34 ]
Ortoft 2010 9/710 206/73282 9.7 % 4.51 [ 2.32, 8.75 ]
Reilly 2012 9/1521 106/29978 9.5 % 1.67 [ 0.85, 3.30 ]
Subtotal (95% CI) 30286 3306555 62.6 % 2.81 [ 1.89, 4.18 ]
Total events: 337 (Treated), 11117 (Untreated)
Heterogeneity: Tau2 = 0.17; Chi2 = 31.40, df = 5 (P<0.00001); I2 =84%
Test for overall effect: Z = 5.09 (P < 0.00001)
2 Ablative treatment vs No Treatment
Jakobsson 2007 12/3576 1441/443879 10.5 % 1.03 [ 0.59, 1.82 ]
Noehr 2009a 6/2027 262/107952 8.4 % 1.22 [ 0.54, 2.74 ]
Reilly 2012 5/522 36/10261 7.4 % 2.73 [ 1.08, 6.93 ]
Subtotal (95% CI) 6125 562092 26.4 % 1.38 [ 0.81, 2.36 ]
Total events: 23 (Treated), 1739 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 3.09, df = 2 (P = 0.21); I2 =35%
Test for overall effect: Z = 1.17 (P = 0.24)
3 Treatment NOS vs No Treatment
Bruinsma 2007 29/1925 30/3484 11.1 % 1.75 [ 1.05, 2.91 ]
Subtotal (95% CI) 1925 3484 11.1 % 1.75 [ 1.05, 2.91 ]
Total events: 29 (Treated), 30 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.16 (P = 0.031)
Total (95% CI) 38336 3872131 100.0 % 2.22 [ 1.54, 3.22 ]
Total events: 389 (Treated), 12886 (Untreated)
Heterogeneity: Tau2 = 0.26; Chi2 = 62.70, df = 9 (P<0.00001); I2 =86%
Test for overall effect: Z = 4.22 (P = 0.000024)
Test for subgroup differences: Chi2 = 4.90, df = 2 (P = 0.09), I2 =59%
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Analysis 1.14. Comparison 1 Maternal Outcomes-PTB, Outcome 14 PTB (<28w)-Analysis by treatment
modality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 14 PTB (<28w)-Analysis by treatment modality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 1/67 19/6889 3.0 % 5.41 [ 0.74, 39.84 ]
Subtotal (95% CI) 67 6889 3.0 % 5.41 [ 0.74, 39.84 ]
Total events: 1 (Treated), 19 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.66 (P = 0.097)
2 NETZ vs No Treatment
Ortoft 2010 3/71 21/7328 6.1 % 14.74 [ 4.50, 48.32 ]
Subtotal (95% CI) 71 7328 6.1 % 14.74 [ 4.50, 48.32 ]
Total events: 3 (Treated), 21 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.44 (P < 0.00001)
3 LLETZ vs No Treatment
Cruickshank 1995 4/147 3/295 4.6 % 2.68 [ 0.61, 11.80 ]
Noehr 2009a 50/8180 1055/434519 13.3 % 2.52 [ 1.90, 3.34 ]
Ortoft 2010 5/572 166/59065 8.2 % 3.11 [ 1.28, 7.54 ]
Subtotal (95% CI) 8899 493879 26.2 % 2.57 [ 1.97, 3.35 ]
Total events: 59 (Treated), 1224 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.20, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 6.98 (P < 0.00001)
4 Excisional Treatment NOS vs No treatment
Albrechtsen 2008 234/14882 7757/2155505 14.1 % 4.37 [ 3.84, 4.97 ]
Jakobsson 2007 31/4846 1990/612976 12.8 % 1.97 [ 1.38, 2.81 ]
Reilly 2012 9/1521 106/29978 10.0 % 1.67 [ 0.85, 3.30 ]
Subtotal (95% CI) 21249 2798459 36.9 % 2.54 [ 1.30, 4.99 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 274 (Treated), 9853 (Untreated)
Heterogeneity: Tau2 = 0.31; Chi2 = 23.26, df = 2 (P<0.00001); I2 =91%
Test for overall effect: Z = 2.71 (P = 0.0067)
5 Ablative Treatment NOS vs No Treatment
Jakobsson 2007 12/3576 1441/443879 11.0 % 1.03 [ 0.59, 1.82 ]
Noehr 2009a 6/2027 262/107952 8.9 % 1.22 [ 0.54, 2.74 ]
Reilly 2012 5/522 36/10261 7.9 % 2.73 [ 1.08, 6.93 ]
Subtotal (95% CI) 6125 562092 27.7 % 1.38 [ 0.81, 2.36 ]
Total events: 23 (Treated), 1739 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 3.09, df = 2 (P = 0.21); I2 =35%
Test for overall effect: Z = 1.17 (P = 0.24)
Total (95% CI) 36411 3868647 100.0 % 2.52 [ 1.71, 3.72 ]
Total events: 360 (Treated), 12856 (Untreated)
Heterogeneity: Tau2 = 0.27; Chi2 = 61.70, df = 10 (P<0.00001); I2 =84%
Test for overall effect: Z = 4.66 (P < 0.00001)
Test for subgroup differences: Chi2 = 13.92, df = 4 (P = 0.01), I2 =71%
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Analysis 1.15. Comparison 1 Maternal Outcomes-PTB, Outcome 15 PTB (<37w)-Nulliparous women.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 15 PTB (<37w)-Nulliparous women
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Bekassy 1996 11/102 7/102 12.6 % 1.57 [ 0.63, 3.89 ]
Hagen 1993 8/21 5/42 11.5 % 3.20 [ 1.19, 8.59 ]
Subtotal (95% CI) 123 144 24.1 % 2.18 [ 1.09, 4.37 ]
Total events: 19 (Treated), 12 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.08, df = 1 (P = 0.30); I2 =8%
Test for overall effect: Z = 2.20 (P = 0.028)
2 LLETZ vs No Treatment
Andia 2011 16/153 17/146 17.2 % 0.90 [ 0.47, 1.71 ]
Frega 2013 26/406 19/379 18.6 % 1.28 [ 0.72, 2.27 ]
Jakobsson 2009 44/364 10575/229896 24.5 % 2.63 [ 1.99, 3.47 ]
Subtotal (95% CI) 923 230421 60.3 % 1.51 [ 0.76, 3.02 ]
Total events: 86 (Treated), 10611 (Untreated)
Heterogeneity: Tau2 = 0.31; Chi2 = 11.98, df = 2 (P = 0.003); I2 =83%
Test for overall effect: Z = 1.17 (P = 0.24)
3 Treatment NOS versus No Treatment
Kristensen 1993 6/34 702/14062 15.6 % 3.53 [ 1.70, 7.33 ]
Subtotal (95% CI) 34 14062 15.6 % 3.53 [ 1.70, 7.33 ]
Total events: 6 (Treated), 702 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.39 (P = 0.00069)
Total (95% CI) 1080 244627 100.0 % 1.92 [ 1.23, 2.98 ]
Total events: 111 (Treated), 11325 (Untreated)
Heterogeneity: Tau2 = 0.19; Chi2 = 15.08, df = 5 (P = 0.01); I2 =67%
Test for overall effect: Z = 2.90 (P = 0.0037)
Test for subgroup differences: Chi2 = 2.74, df = 2 (P = 0.25), I2 =27%
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Analysis 1.16. Comparison 1 Maternal Outcomes-PTB, Outcome 16 PTB (<37w)-Parous women.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 16 PTB (<37w)-Parous women
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Bekassy 1996 9/148 13/148 20.6 % 0.69 [ 0.31, 1.57 ]
Hagen 1993 13/35 2/70 14.0 % 13.00 [ 3.10, 54.45 ]
Subtotal (95% CI) 183 218 34.6 % 2.82 [ 0.16, 49.84 ]
Total events: 22 (Treated), 15 (Untreated)
Heterogeneity: Tau2 = 3.95; Chi2 = 12.14, df = 1 (P = 0.00049); I2 =92%
Test for overall effect: Z = 0.71 (P = 0.48)
2 LLETZ vs No Treatment
Andia 2011 3/36 8/43 15.8 % 0.45 [ 0.13, 1.56 ]
Jakobsson 2009 31/258 14998/324611 25.6 % 2.60 [ 1.87, 3.62 ]
Subtotal (95% CI) 294 324654 41.4 % 1.20 [ 0.22, 6.65 ]
Total events: 34 (Treated), 15006 (Untreated)
Heterogeneity: Tau2 = 1.33; Chi2 = 7.10, df = 1 (P = 0.01); I2 =86%
Test for overall effect: Z = 0.21 (P = 0.83)
3 Treatment NOS vs No Treatment
Kristensen 1993 13/96 511/14062 24.0 % 3.73 [ 2.23, 6.22 ]
Subtotal (95% CI) 96 14062 24.0 % 3.73 [ 2.23, 6.22 ]
Total events: 13 (Treated), 511 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.03 (P < 0.00001)
Total (95% CI) 573 338934 100.0 % 2.05 [ 0.95, 4.43 ]
Total events: 69 (Treated), 15532 (Untreated)
Heterogeneity: Tau2 = 0.58; Chi2 = 24.15, df = 4 (P = 0.00007); I2 =83%
Test for overall effect: Z = 1.82 (P = 0.069)
Test for subgroup differences: Chi2 = 1.56, df = 2 (P = 0.46), I2 =0.0%
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Analysis 1.17. Comparison 1 Maternal Outcomes-PTB, Outcome 17 PTB (<37w)-Single cone.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 17 PTB (<37w)-Single cone
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Guo 2013 14/36 6/29 2.7 % 1.88 [ 0.83, 4.28 ]
Klaritsch 2006 17/76 1961/29686 5.5 % 3.39 [ 2.22, 5.16 ]
Ortoft 2010 7/67 283/6889 3.3 % 2.54 [ 1.25, 5.17 ]
Subtotal (95% CI) 179 36604 11.5 % 2.89 [ 2.08, 4.03 ]
Total events: 38 (Treated), 2250 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.72, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 6.28 (P < 0.00001)
2 LC vs No Treatment
Bekassy 1996 14/230 20/250 3.6 % 0.76 [ 0.39, 1.47 ]
Sadler 2004 20/105 9/72 3.2 % 1.52 [ 0.74, 3.15 ]
Subtotal (95% CI) 335 322 6.8 % 1.06 [ 0.54, 2.09 ]
Total events: 34 (Treated), 29 (Untreated)
Heterogeneity: Tau2 = 0.12; Chi2 = 1.92, df = 1 (P = 0.17); I2 =48%
Test for overall effect: Z = 0.16 (P = 0.87)
3 NETZ vs No Treatment
Ortoft 2010 17/71 301/7328 5.4 % 5.83 [ 3.80, 8.95 ]
Subtotal (95% CI) 71 7328 5.4 % 5.83 [ 3.80, 8.95 ]
Total events: 17 (Treated), 301 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.05 (P < 0.00001)
4 LLETZ vs No Treatment
Frega 2013 26/406 19/379 4.2 % 1.28 [ 0.72, 2.27 ]
Guo 2013 10/48 8/39 2.7 % 1.02 [ 0.44, 2.32 ]
Heinonen 2013 444/6766 30151/658179 8.4 % 1.43 [ 1.31, 1.57 ]
Martyn 2015 20/278 6/204 2.4 % 2.45 [ 1.00, 5.98 ]
Noehr 2009a 499/7907 18424/542471 8.4 % 1.86 [ 1.70, 2.03 ]
Ortoft 2010 55/572 2426/59065 7.1 % 2.34 [ 1.82, 3.02 ]
Paraskevaidis 2002 9/25 3/28 1.5 % 3.36 [ 1.02, 11.05 ]
Sadler 2004 44/278 24/196 5.1 % 1.29 [ 0.81, 2.05 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Samson 2005 32/475 14/558 3.9 % 2.69 [ 1.45, 4.97 ]
Subtotal (95% CI) 16755 1261119 43.7 % 1.74 [ 1.45, 2.10 ]
Total events: 1139 (Treated), 51075 (Untreated)
Heterogeneity: Tau2 = 0.04; Chi2 = 31.41, df = 8 (P = 0.00012); I2 =75%
Test for overall effect: Z = 5.81 (P < 0.00001)
5 LA vs No Treatment
Anderson 1984 7/68 5/70 1.8 % 1.44 [ 0.48, 4.32 ]
Sadler 2004 23/223 19/158 4.2 % 0.86 [ 0.48, 1.52 ]
Saunders 1986 14/97 6/97 2.3 % 2.33 [ 0.94, 5.82 ]
van Rooijen 1999 14/236 38/472 4.0 % 0.74 [ 0.41, 1.33 ]
Subtotal (95% CI) 624 797 12.3 % 1.07 [ 0.66, 1.74 ]
Total events: 58 (Treated), 68 (Untreated)
Heterogeneity: Tau2 = 0.10; Chi2 = 5.02, df = 3 (P = 0.17); I2 =40%
Test for overall effect: Z = 0.28 (P = 0.78)
6 Excisional Treatment NOS vs No Treatment
Reilly 2012 146/1521 1816/29978 8.0 % 1.58 [ 1.35, 1.86 ]
van de Vijner 2010 14/51 2/55 1.1 % 7.55 [ 1.80, 31.60 ]
Wuntakal 2013 37/244 22/257 4.8 % 1.77 [ 1.08, 2.91 ]
Subtotal (95% CI) 1816 30290 13.9 % 1.88 [ 1.20, 2.93 ]
Total events: 197 (Treated), 1840 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 4.63, df = 2 (P = 0.10); I2 =57%
Test for overall effect: Z = 2.77 (P = 0.0055)
7 Ablative Treatment NOS vs No Treatment
Reilly 2012 36/522 622/10261 6.4 % 1.14 [ 0.82, 1.57 ]
Subtotal (95% CI) 522 10261 6.4 % 1.14 [ 0.82, 1.57 ]
Total events: 36 (Treated), 622 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.44)
Total (95% CI) 20302 1346721 100.0 % 1.75 [ 1.49, 2.06 ]
Total events: 1519 (Treated), 56185 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 105.00, df = 22 (P<0.00001); I2 =79%
Test for overall effect: Z = 6.75 (P < 0.00001)
Test for subgroup differences: Chi2 = 50.99, df = 6 (P = 0.00), I2 =88%
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Analysis 1.18. Comparison 1 Maternal Outcomes-PTB, Outcome 18 PTB (<37w)-Repeat cones.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 18 PTB (<37w)-Repeat cones
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC/LA vs No Treatment
Saunders 1986 2/2 6/97 7.5 % 12.56 [ 5.11, 30.87 ]
Subtotal (95% CI) 2 97 7.5 % 12.56 [ 5.11, 30.87 ]
Total events: 2 (Treated), 6 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.52 (P < 0.00001)
2 LC/LC vs No Treatment
Bekassy 1996 6/20 20/250 8.4 % 3.75 [ 1.70, 8.27 ]
Subtotal (95% CI) 20 250 8.4 % 3.75 [ 1.70, 8.27 ]
Total events: 6 (Treated), 20 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.28 (P = 0.0010)
3 LLETZ/LLETZ vs No Treatment
Heinonen 2013 103/870 30151/658179 13.9 % 2.58 [ 2.16, 3.10 ]
Noehr 2009a 31/273 18424/542471 12.8 % 3.34 [ 2.40, 4.66 ]
Paraskevaidis 2002 2/3 3/28 4.7 % 6.22 [ 1.64, 23.66 ]
Samson 2005 3/49 8/301 5.0 % 2.30 [ 0.63, 8.39 ]
Subtotal (95% CI) 1195 1200979 36.4 % 2.81 [ 2.33, 3.39 ]
Total events: 139 (Treated), 48586 (Untreated)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.28, df = 3 (P = 0.35); I2 =9%
Test for overall effect: Z = 10.84 (P < 0.00001)
4 LLETZ/Treatment NOS vs No Treatment
Samson 2005 9/41 6/257 6.9 % 9.40 [ 3.53, 25.03 ]
Subtotal (95% CI) 41 257 6.9 % 9.40 [ 3.53, 25.03 ]
Total events: 9 (Treated), 6 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.49 (P < 0.00001)
5 Excisional Treatment NOS/Excisional Treatment NOS vs No Treatment
Ortoft 2010 12/36 3010/73282 11.6 % 8.12 [ 5.11, 12.90 ]
van de Vijner 2010 0/4 2/55 1.4 % 2.24 [ 0.12, 40.52 ]
Wuntakal 2013 5/17 22/257 8.0 % 3.44 [ 1.49, 7.94 ]
Subtotal (95% CI) 57 73594 21.0 % 5.48 [ 2.68, 11.24 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 17 (Treated), 3034 (Untreated)
Heterogeneity: Tau2 = 0.18; Chi2 = 3.63, df = 2 (P = 0.16); I2 =45%
Test for overall effect: Z = 4.65 (P < 0.00001)
6 Treatment NOS/Treatment NOS vs No Treatment
Reilly 2012 8/81 2438/40239 9.6 % 1.63 [ 0.84, 3.15 ]
Sadler 2004 10/46 52/426 10.2 % 1.78 [ 0.97, 3.26 ]
Subtotal (95% CI) 127 40665 19.8 % 1.71 [ 1.10, 2.67 ]
Total events: 18 (Treated), 2490 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 2.36 (P = 0.018)
Total (95% CI) 1442 1315842 100.0 % 3.78 [ 2.65, 5.39 ]
Total events: 191 (Treated), 54142 (Untreated)
Heterogeneity: Tau2 = 0.23; Chi2 = 43.33, df = 11 (P<0.00001); I2 =75%
Test for overall effect: Z = 7.33 (P < 0.00001)
Test for subgroup differences: Chi2 = 24.57, df = 5 (P = 0.00), I2 =80%
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Analysis 1.19. Comparison 1 Maternal Outcomes-PTB, Outcome 19 PTB (<37w)-Singleton pregnancies.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 19 PTB (<37w)-Singleton pregnancies
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Bruinsma 2007 11/71 12/129 1.5 % 1.67 [ 0.77, 3.58 ]
Crane 2006 4/21 0/13 0.2 % 5.73 [ 0.33, 98.41 ]
Jones 1979 12/66 14/264 1.6 % 3.43 [ 1.66, 7.06 ]
Klaritsch 2006 17/76 1961/29686 2.9 % 3.39 [ 2.22, 5.16 ]
Larsson 1982 33/194 16/283 2.2 % 3.01 [ 1.70, 5.31 ]
Ortoft 2010 6/67 283/6889 1.5 % 2.18 [ 1.01, 4.72 ]
Subtotal (95% CI) 495 37264 9.9 % 2.89 [ 2.22, 3.77 ]
Total events: 83 (Treated), 2286 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.51, df = 5 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 7.84 (P < 0.00001)
2 LC vs No Treatment
Hagen 1993 21/56 7/112 1.5 % 6.00 [ 2.71, 13.26 ]
Raio 1997 6/64 3/64 0.6 % 2.00 [ 0.52, 7.65 ]
Sadler 2004 20/105 9/72 1.6 % 1.52 [ 0.74, 3.15 ]
Simoens 2012 5/24 5/48 0.8 % 2.00 [ 0.64, 6.25 ]
Subtotal (95% CI) 249 296 4.6 % 2.54 [ 1.24, 5.20 ]
Total events: 52 (Treated), 24 (Untreated)
Heterogeneity: Tau2 = 0.29; Chi2 = 6.70, df = 3 (P = 0.08); I2 =55%
Test for overall effect: Z = 2.55 (P = 0.011)
3 NETZ vs No Treatment
Ortoft 2010 17/71 301/7328 2.9 % 5.83 [ 3.80, 8.95 ]
Subtotal (95% CI) 71 7328 2.9 % 5.83 [ 3.80, 8.95 ]
Total events: 17 (Treated), 301 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.05 (P < 0.00001)
4 LLETZ vs No Treatment
Andia 2011 19/189 10/189 1.6 % 1.90 [ 0.91, 3.98 ]
Braet 1994 10/78 4/78 0.9 % 2.50 [ 0.82, 7.63 ]
Bruinsma 2007 11/69 11/125 1.5 % 1.81 [ 0.83, 3.96 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Crane 2006 10/75 1/46 0.3 % 6.13 [ 0.81, 46.36 ]
Cruickshank 1995 14/147 15/295 1.7 % 1.87 [ 0.93, 3.78 ]
Frega 2013 26/406 19/379 2.2 % 1.28 [ 0.72, 2.27 ]
Frey 2013 111/598 178/1140 4.1 % 1.19 [ 0.96, 1.47 ]
Heinonen 2013 547/7636 30151/658179 4.7 % 1.56 [ 1.44, 1.70 ]
Himes 2007 11/114 127/962 2.1 % 0.73 [ 0.41, 1.31 ]
Kitson 2014 25/278 10/278 1.7 % 2.50 [ 1.22, 5.11 ]
Noehr 2009a 530/8180 14758/434520 4.6 % 1.91 [ 1.75, 2.07 ]
Ortoft 2010 55/572 2426/59065 3.9 % 2.34 [ 1.82, 3.02 ]
Poon 2012 41/473 1156/25772 3.6 % 1.93 [ 1.43, 2.60 ]
Sadler 2004 44/278 24/196 2.7 % 1.29 [ 0.81, 2.05 ]
Samson 2005 44/558 14/558 2.1 % 3.14 [ 1.74, 5.67 ]
Simoens 2012 12/52 6/104 1.2 % 4.00 [ 1.59, 10.05 ]
Stout 2015 115/598 178/1129 4.1 % 1.22 [ 0.99, 1.51 ]
Werner 2010 35/511 17445/240348 3.5 % 0.94 [ 0.69, 1.30 ]
Subtotal (95% CI) 20812 1423363 46.3 % 1.61 [ 1.39, 1.87 ]
Total events: 1660 (Treated), 66533 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 71.07, df = 17 (P<0.00001); I2 =76%
Test for overall effect: Z = 6.28 (P < 0.00001)
5 LA vs No Treatment
Bruinsma 2007 92/1005 163/1840 3.9 % 1.03 [ 0.81, 1.32 ]
Sadler 2004 23/223 19/158 2.2 % 0.86 [ 0.48, 1.52 ]
Saunders 1986 14/97 6/97 1.2 % 2.33 [ 0.94, 5.82 ]
Subtotal (95% CI) 1325 2095 7.3 % 1.10 [ 0.75, 1.62 ]
Total events: 129 (Treated), 188 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 3.43, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 0.49 (P = 0.62)
6 CT vs No Treatment
Crane 2006 1/36 0/22 0.1 % 1.86 [ 0.08, 43.87 ]
Subtotal (95% CI) 36 22 0.1 % 1.86 [ 0.08, 43.87 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
7 RD vs No Treatment
Bruinsma 2007 109/760 123/1390 3.9 % 1.62 [ 1.27, 2.06 ]
Subtotal (95% CI) 760 1390 3.9 % 1.62 [ 1.27, 2.06 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 109 (Treated), 123 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.91 (P = 0.000093)
8 Excisional Treatment NOS vs No Treatment
Castanon 2012 449/4776 34739/517923 4.6 % 1.40 [ 1.28, 1.53 ]
El-Bastawissi 1999 118/852 26/231 3.0 % 1.23 [ 0.83, 1.83 ]
Fischer 2010 19/85 3/85 0.8 % 6.33 [ 1.95, 20.61 ]
Kirn 2015 16/135 11/135 1.6 % 1.45 [ 0.70, 3.02 ]
Miller 2015 114/1356 1102/17172 4.2 % 1.31 [ 1.09, 1.58 ]
Simoens 2012 2/12 5/24 0.5 % 0.80 [ 0.18, 3.54 ]
van de Vijner 2010 11/52 2/54 0.5 % 5.71 [ 1.33, 24.54 ]
Subtotal (95% CI) 7268 535624 15.4 % 1.42 [ 1.17, 1.72 ]
Total events: 729 (Treated), 35888 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 11.29, df = 6 (P = 0.08); I2 =47%
Test for overall effect: Z = 3.56 (P = 0.00036)
9 Ablative Treatment NOS vs No Treatment
El-Bastawissi 1999 4/72 4/41 0.6 % 0.57 [ 0.15, 2.16 ]
Noehr 2009a 95/2027 3666/107951 4.2 % 1.38 [ 1.13, 1.68 ]
Subtotal (95% CI) 2099 107992 4.8 % 1.14 [ 0.56, 2.32 ]
Total events: 99 (Treated), 3670 (Untreated)
Heterogeneity: Tau2 = 0.16; Chi2 = 1.66, df = 1 (P = 0.20); I2 =40%
Test for overall effect: Z = 0.37 (P = 0.71)
10 Treatment NOS vs No Treatment
Kristensen 1985 9/85 755/12792 2.0 % 1.79 [ 0.96, 3.34 ]
Kristensen 1993 19/130 1213/28124 2.9 % 3.39 [ 2.23, 5.15 ]
Subtotal (95% CI) 215 40916 4.9 % 2.57 [ 1.39, 4.77 ]
Total events: 28 (Treated), 1968 (Untreated)
Heterogeneity: Tau2 = 0.13; Chi2 = 2.76, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 3.00 (P = 0.0027)
Total (95% CI) 33330 2156290 100.0 % 1.76 [ 1.57, 1.98 ]
Total events: 2907 (Treated), 110981 (Untreated)
Heterogeneity: Tau2 = 0.07; Chi2 = 199.50, df = 44 (P<0.00001); I2 =78%
Test for overall effect: Z = 9.70 (P < 0.00001)
Test for subgroup differences: Chi2 = 59.43, df = 9 (P = 0.00), I2 =85%
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Analysis 1.20. Comparison 1 Maternal Outcomes-PTB, Outcome 20 PTB (<37w)-Multiple pregnancies.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 20 PTB (<37w)-Multiple pregnancies
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ehsanipoor 2014 5/10 37/70 6.3 % 0.95 [ 0.49, 1.83 ]
Larsson 1982 0/3 0/1 Not estimable
Subtotal (95% CI) 13 71 6.3 % 0.95 [ 0.49, 1.83 ]
Total events: 5 (Treated), 37 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
2 LLETZ vs No Treatment
Ehsanipoor 2014 21/36 135/250 22.6 % 1.08 [ 0.80, 1.46 ]
Noehr 2009b 72/166 3156/9702 40.1 % 1.33 [ 1.12, 1.59 ]
Samson 2005 4/10 10/35 3.4 % 1.40 [ 0.56, 3.52 ]
Subtotal (95% CI) 212 9987 66.1 % 1.27 [ 1.09, 1.47 ]
Total events: 97 (Treated), 3301 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.46, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 3.09 (P = 0.0020)
3 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 3/3 0/1 0.5 % 3.50 [ 0.31, 39.71 ]
Subtotal (95% CI) 3 1 0.5 % 3.50 [ 0.31, 39.71 ]
Total events: 3 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
4 Ablative Treatment NOS vs No Treatment
Ehsanipoor 2014 32/64 240/446 27.0 % 0.93 [ 0.72, 1.20 ]
Subtotal (95% CI) 64 446 27.0 % 0.93 [ 0.72, 1.20 ]
Total events: 32 (Treated), 240 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 292 10505 100.0 % 1.14 [ 0.95, 1.35 ]
Total events: 137 (Treated), 3578 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 6.74, df = 5 (P = 0.24); I2 =26%
Test for overall effect: Z = 1.44 (P = 0.15)
Test for subgroup differences: Chi2 = 5.28, df = 3 (P = 0.15), I2 =43%
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Analysis 1.21. Comparison 1 Maternal Outcomes-PTB, Outcome 21 PTB (<32-34w)-Multiple pregnancies.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 21 PTB (<32-34w)-Multiple pregnancies
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ehsanipoor 2014 4/10 8/70 18.4 % 3.50 [ 1.29, 9.52 ]
Subtotal (95% CI) 10 70 18.4 % 3.50 [ 1.29, 9.52 ]
Total events: 4 (Treated), 8 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.45 (P = 0.014)
2 LLETZ vs No Treatment
Ehsanipoor 2014 3/36 27/250 15.7 % 0.77 [ 0.25, 2.41 ]
Noehr 2009b 23/166 629/9702 35.1 % 2.14 [ 1.45, 3.15 ]
Samson 2005 2/10 2/35 7.9 % 3.50 [ 0.56, 21.81 ]
Subtotal (95% CI) 212 9987 58.8 % 1.76 [ 0.88, 3.50 ]
Total events: 28 (Treated), 658 (Untreated)
Heterogeneity: Tau2 = 0.16; Chi2 = 3.14, df = 2 (P = 0.21); I2 =36%
Test for overall effect: Z = 1.61 (P = 0.11)
3 Ablative Treatment NOS vs No Treatment
Ehsanipoor 2014 6/64 49/446 22.9 % 0.85 [ 0.38, 1.91 ]
Subtotal (95% CI) 64 446 22.9 % 0.85 [ 0.38, 1.91 ]
Total events: 6 (Treated), 49 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
Total (95% CI) 286 10503 100.0 % 1.68 [ 0.95, 2.98 ]
Total events: 38 (Treated), 715 (Untreated)
Heterogeneity: Tau2 = 0.20; Chi2 = 8.36, df = 4 (P = 0.08); I2 =52%
Test for overall effect: Z = 1.78 (P = 0.076)
Test for subgroup differences: Chi2 = 4.76, df = 2 (P = 0.09), I2 =58%
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Analysis 1.22. Comparison 1 Maternal Outcomes-PTB, Outcome 22 PTB (<28w)-Multiple pregnancies.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 22 PTB (<28w)-Multiple pregnancies
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ehsanipoor 2014 0/10 1/70 3.1 % 2.15 [ 0.09, 49.56 ]
Subtotal (95% CI) 10 70 3.1 % 2.15 [ 0.09, 49.56 ]
Total events: 0 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
2 LLETZ vs No Treatment
Ehsanipoor 2014 0/36 4/250 3.6 % 0.75 [ 0.04, 13.72 ]
Noehr 2009b 10/166 226/9702 81.0 % 2.59 [ 1.40, 4.78 ]
Subtotal (95% CI) 202 9952 84.6 % 2.45 [ 1.34, 4.47 ]
Total events: 10 (Treated), 230 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.66, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 2.93 (P = 0.0034)
3 Ablative Treatment NOS vs No Treatment
Ehsanipoor 2014 2/64 6/446 12.3 % 2.32 [ 0.48, 11.26 ]
Subtotal (95% CI) 64 446 12.3 % 2.32 [ 0.48, 11.26 ]
Total events: 2 (Treated), 6 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.30)
Total (95% CI) 276 10468 100.0 % 2.43 [ 1.40, 4.22 ]
Total events: 12 (Treated), 237 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.67, df = 3 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 3.14 (P = 0.0017)
Test for subgroup differences: Chi2 = 0.01, df = 2 (P = 1.00), I2 =0.0%
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Analysis 1.23. Comparison 1 Maternal Outcomes-PTB, Outcome 23 PTB (<37w)-Depth≤10-12mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 23 PTB (<37w)-Depth≤10-12mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Raio 1997 1/41 3/64 2.2 % 0.52 [ 0.06, 4.83 ]
Subtotal (95% CI) 41 64 2.2 % 0.52 [ 0.06, 4.83 ]
Total events: 1 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
2 LLETZ vs No Treatment
Kitson 2014 8/103 10/278 9.5 % 2.16 [ 0.88, 5.32 ]
Noehr 2009a 54/1022 18424/542471 23.2 % 1.56 [ 1.20, 2.02 ]
Samson 2005 36/475 14/558 14.7 % 3.02 [ 1.65, 5.53 ]
Subtotal (95% CI) 1600 543307 47.4 % 2.01 [ 1.28, 3.15 ]
Total events: 98 (Treated), 18448 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 4.12, df = 2 (P = 0.13); I2 =51%
Test for overall effect: Z = 3.03 (P = 0.0025)
3 Excisional Treatment NOS vs No Treatment
Castanon 2012 173/2307 210/2917 24.6 % 1.04 [ 0.86, 1.26 ]
Lima 2011 4/15 3/58 5.1 % 5.16 [ 1.29, 20.60 ]
Sadler 2004 14/116 52/426 15.9 % 0.99 [ 0.57, 1.72 ]
Simoens 2012 3/26 4/52 4.9 % 1.50 [ 0.36, 6.21 ]
Subtotal (95% CI) 2464 3453 50.4 % 1.20 [ 0.78, 1.85 ]
Total events: 194 (Treated), 269 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 5.32, df = 3 (P = 0.15); I2 =44%
Test for overall effect: Z = 0.85 (P = 0.39)
Total (95% CI) 4105 546824 100.0 % 1.54 [ 1.09, 2.18 ]
Total events: 293 (Treated), 18720 (Untreated)
Heterogeneity: Tau2 = 0.12; Chi2 = 20.93, df = 7 (P = 0.004); I2 =67%
Test for overall effect: Z = 2.46 (P = 0.014)
Test for subgroup differences: Chi2 = 3.48, df = 2 (P = 0.18), I2 =43%
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Analysis 1.24. Comparison 1 Maternal Outcomes-PTB, Outcome 24 PTB (<37w)-Depth≥10-12mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 24 PTB (<37w)-Depth≥10-12mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Raio 1997 5/23 3/64 1.7 % 4.64 [ 1.20, 17.88 ]
Subtotal (95% CI) 23 64 1.7 % 4.64 [ 1.20, 17.88 ]
Total events: 5 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.23 (P = 0.026)
2 LLETZ vs No Treatment
Kitson 2014 17/175 10/278 5.0 % 2.70 [ 1.27, 5.76 ]
Noehr 2009a 168/2569 18424/542471 35.3 % 1.93 [ 1.66, 2.23 ]
Samson 2005 8/83 14/558 4.2 % 3.84 [ 1.66, 8.88 ]
Subtotal (95% CI) 2827 543307 44.5 % 2.29 [ 1.57, 3.34 ]
Total events: 193 (Treated), 18448 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 3.19, df = 2 (P = 0.20); I2 =37%
Test for overall effect: Z = 4.29 (P = 0.000018)
3 Excisional Treatment NOS vs No Treatment
Castanon 2012 316/2719 210/2917 33.1 % 1.61 [ 1.37, 1.91 ]
Lima 2011 2/14 3/58 1.1 % 2.76 [ 0.51, 14.99 ]
Sadler 2004 43/215 52/426 15.7 % 1.64 [ 1.13, 2.37 ]
Simoens 2012 12/47 7/94 4.0 % 3.43 [ 1.45, 8.13 ]
Subtotal (95% CI) 2995 3495 53.8 % 1.68 [ 1.41, 1.99 ]
Total events: 373 (Treated), 272 (Untreated)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.17, df = 3 (P = 0.37); I2 =5%
Test for overall effect: Z = 5.91 (P < 0.00001)
Total (95% CI) 5845 546866 100.0 % 1.93 [ 1.62, 2.31 ]
Total events: 571 (Treated), 18723 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 11.09, df = 7 (P = 0.13); I2 =37%
Test for overall effect: Z = 7.19 (P < 0.00001)
Test for subgroup differences: Chi2 = 4.10, df = 2 (P = 0.13), I2 =51%
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Analysis 1.25. Comparison 1 Maternal Outcomes-PTB, Outcome 25 PTB (<37w)-Depth≥15-17mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 25 PTB (<37w)-Depth≥15-17mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 14/61 7/150 12.5 % 4.92 [ 2.09, 11.59 ]
Subtotal (95% CI) 61 150 12.5 % 4.92 [ 2.09, 11.59 ]
Total events: 14 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.64 (P = 0.00027)
2 LLETZ vs No Treatment
Kitson 2014 9/48 10/278 12.8 % 5.21 [ 2.23, 12.16 ]
Noehr 2009a 119/1451 18424/542471 45.5 % 2.41 [ 2.03, 2.87 ]
Subtotal (95% CI) 1499 542749 58.3 % 3.16 [ 1.54, 6.48 ]
Total events: 128 (Treated), 18434 (Untreated)
Heterogeneity: Tau2 = 0.20; Chi2 = 3.04, df = 1 (P = 0.08); I2 =67%
Test for overall effect: Z = 3.14 (P = 0.0017)
3 Excisional Treatment NOS vs No Treatment
Sadler 2004 25/101 52/426 29.1 % 2.03 [ 1.33, 3.10 ]
Subtotal (95% CI) 101 426 29.1 % 2.03 [ 1.33, 3.10 ]
Total events: 25 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.26 (P = 0.0011)
Total (95% CI) 1661 543325 100.0 % 2.77 [ 1.95, 3.93 ]
Total events: 167 (Treated), 18493 (Untreated)
Heterogeneity: Tau2 = 0.06; Chi2 = 6.36, df = 3 (P = 0.10); I2 =53%
Test for overall effect: Z = 5.71 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.71, df = 2 (P = 0.16), I2 =46%
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Analysis 1.26. Comparison 1 Maternal Outcomes-PTB, Outcome 26 PTB (<37w)-Depth≥20mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 26 PTB (<37w)-Depth≥20mm
Study or subgroup Treatment Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 12/42 7/150 30.7 % 6.12 [ 2.57, 14.57 ]
Subtotal (95% CI) 42 150 30.7 % 6.12 [ 2.57, 14.57 ]
Total events: 12 (Treatment), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.10 (P = 0.000042)
2 LLETZ vs No Treatment
Kitson 2014 3/8 10/278 26.2 % 10.43 [ 3.53, 30.76 ]
Noehr 2009a 72/801 18424/542471 43.1 % 2.65 [ 2.12, 3.30 ]
Subtotal (95% CI) 809 542749 69.3 % 4.72 [ 1.25, 17.80 ]
Total events: 75 (Treatment), 18434 (Untreated)
Heterogeneity: Tau2 = 0.78; Chi2 = 5.92, df = 1 (P = 0.01); I2 =83%
Test for overall effect: Z = 2.29 (P = 0.022)
Total (95% CI) 851 542899 100.0 % 4.91 [ 2.06, 11.68 ]
Total events: 87 (Treatment), 18441 (Untreated)
Heterogeneity: Tau2 = 0.44; Chi2 = 8.88, df = 2 (P = 0.01); I2 =77%
Test for overall effect: Z = 3.59 (P = 0.00033)
Test for subgroup differences: Chi2 = 0.10, df = 1 (P = 0.75), I2 =0.0%
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Analysis 1.27. Comparison 1 Maternal Outcomes-PTB, Outcome 27 PTB (<37w)-Volume<6cc.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 27 PTB (<37w)-Volume<6cc
Study or subgroup Treated Volume<6cc Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Kitson 2014 22/272 10/278 100.0 % 2.25 [ 1.09, 4.66 ]
Total (95% CI) 272 278 100.0 % 2.25 [ 1.09, 4.66 ]
Total events: 22 (Treated Volume<6cc), 10 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
Test for subgroup differences: Not applicable
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Analysis 1.28. Comparison 1 Maternal Outcomes-PTB, Outcome 28 PTB (<37w)-Volume>6cc.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 28 PTB (<37w)-Volume>6cc
Study or subgroup Treated Volume>6cc Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ (Volume>6cc) vs No Treatment
Kitson 2014 3/6 10/278 100.0 % 13.90 [ 5.09, 37.98 ]
Total (95% CI) 6 278 100.0 % 13.90 [ 5.09, 37.98 ]
Total events: 3 (Treated Volume>6cc), 10 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.13 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.29. Comparison 1 Maternal Outcomes-PTB, Outcome 29 PTB (<37w)-Depth≤10mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 29 PTB (<37w)-Depth≤10mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Raio 1997 1/41 3/64 4.0 % 0.52 [ 0.06, 4.83 ]
Subtotal (95% CI) 41 64 4.0 % 0.52 [ 0.06, 4.83 ]
Total events: 1 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
2 LLETZ vs No Treatment
Kitson 2014 8/103 10/278 14.0 % 2.16 [ 0.88, 5.32 ]
Samson 2005 36/475 14/558 19.1 % 3.02 [ 1.65, 5.53 ]
Subtotal (95% CI) 578 836 33.1 % 2.72 [ 1.65, 4.50 ]
Total events: 44 (Treated), 24 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.37, df = 1 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 3.91 (P = 0.000094)
3 Excisional Treatment NOS vs No Treatment
Castanon 2012 173/2307 210/2917 26.3 % 1.04 [ 0.86, 1.26 ]
Lima 2011 4/15 3/58 8.4 % 5.16 [ 1.29, 20.60 ]
Sadler 2004 14/116 52/426 20.2 % 0.99 [ 0.57, 1.72 ]
Simoens 2012 3/26 4/52 8.1 % 1.50 [ 0.36, 6.21 ]
Subtotal (95% CI) 2464 3453 62.9 % 1.20 [ 0.78, 1.85 ]
Total events: 194 (Treated), 269 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 5.32, df = 3 (P = 0.15); I2 =44%
Test for overall effect: Z = 0.85 (P = 0.39)
Total (95% CI) 3083 4353 100.0 % 1.60 [ 0.99, 2.59 ]
Total events: 239 (Treated), 296 (Untreated)
Heterogeneity: Tau2 = 0.22; Chi2 = 17.96, df = 6 (P = 0.01); I2 =67%
Test for overall effect: Z = 1.93 (P = 0.054)
Test for subgroup differences: Chi2 = 6.91, df = 2 (P = 0.03), I2 =71%
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Analysis 1.30. Comparison 1 Maternal Outcomes-PTB, Outcome 30 PTB (<37w)-Depth≤12mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 30 PTB (<37w)-Depth≤12mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Noehr 2009a 54/1022 18424/542471 100.0 % 1.56 [ 1.20, 2.02 ]
Total (95% CI) 1022 542471 100.0 % 1.56 [ 1.20, 2.02 ]
Total events: 54 (Treated), 18424 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.33 (P = 0.00086)
Test for subgroup differences: Not applicable
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Analysis 1.31. Comparison 1 Maternal Outcomes-PTB, Outcome 31 PTB (<37w)-Depth≤15mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 31 PTB (<37w)-Depth≤15mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 0/14 7/150 0.4 % 0.67 [ 0.04, 11.18 ]
Subtotal (95% CI) 14 150 0.4 % 0.67 [ 0.04, 11.18 ]
Total events: 0 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
2 LLETZ vs No Treatment
Kitson 2014 16/230 10/278 5.6 % 1.93 [ 0.89, 4.18 ]
Noehr 2009a 103/2140 18424/542471 93.9 % 1.42 [ 1.17, 1.71 ]
Subtotal (95% CI) 2370 542749 99.6 % 1.44 [ 1.20, 1.73 ]
Total events: 119 (Treated), 18434 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 3.91 (P = 0.000092)
Total (95% CI) 2384 542899 100.0 % 1.44 [ 1.20, 1.73 ]
Total events: 119 (Treated), 18441 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.87, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 3.89 (P = 0.00010)
Test for subgroup differences: Chi2 = 0.28, df = 1 (P = 0.59), I2 =0.0%
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Analysis 1.32. Comparison 1 Maternal Outcomes-PTB, Outcome 32 PTB (<37w)-Depth≤17mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 32 PTB (<37w)-Depth≤17mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment NOS vs No Treatment
Sadler 2004 32/230 52/426 100.0 % 1.14 [ 0.76, 1.72 ]
Total (95% CI) 230 426 100.0 % 1.14 [ 0.76, 1.72 ]
Total events: 32 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 1.33. Comparison 1 Maternal Outcomes-PTB, Outcome 33 PTB (<37w)-Depth≤15-17mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 33 PTB (<37w)-Depth≤15-17mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 0/14 7/150 0.4 % 0.67 [ 0.04, 11.18 ]
Subtotal (95% CI) 14 150 0.4 % 0.67 [ 0.04, 11.18 ]
Total events: 0 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
2 LLETZ vs No Treatment
Kitson 2014 16/230 10/278 4.7 % 1.93 [ 0.89, 4.18 ]
Noehr 2009a 103/2140 18424/542471 78.3 % 1.42 [ 1.17, 1.71 ]
Subtotal (95% CI) 2370 542749 83.0 % 1.44 [ 1.20, 1.73 ]
Total events: 119 (Treated), 18434 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 3.91 (P = 0.000092)
3 Excisional Treatment NOS vs No Treatment
Sadler 2004 32/230 52/426 16.6 % 1.14 [ 0.76, 1.72 ]
Subtotal (95% CI) 230 426 16.6 % 1.14 [ 0.76, 1.72 ]
Total events: 32 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Total (95% CI) 2614 543325 100.0 % 1.38 [ 1.17, 1.64 ]
Total events: 151 (Treated), 18493 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.90, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 3.80 (P = 0.00014)
Test for subgroup differences: Chi2 = 1.31, df = 2 (P = 0.52), I2 =0.0%
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Analysis 1.34. Comparison 1 Maternal Outcomes-PTB, Outcome 34 PTB (<37w)-Depth≤20mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 34 PTB (<37w)-Depth≤20mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 2/33 7/150 1.0 % 1.30 [ 0.28, 5.97 ]
Subtotal (95% CI) 33 150 1.0 % 1.30 [ 0.28, 5.97 ]
Total events: 2 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.74)
2 LLETZ vs No Treatment
Kitson 2014 22/270 10/278 4.4 % 2.27 [ 1.09, 4.69 ]
Noehr 2009a 150/2790 18424/542471 94.6 % 1.58 [ 1.35, 1.85 ]
Subtotal (95% CI) 3060 542749 99.0 % 1.61 [ 1.38, 1.87 ]
Total events: 172 (Treated), 18434 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.89, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 6.09 (P < 0.00001)
Total (95% CI) 3093 542899 100.0 % 1.60 [ 1.38, 1.87 ]
Total events: 174 (Treated), 18441 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.96, df = 2 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 6.10 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.78), I2 =0.0%
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Analysis 1.35. Comparison 1 Maternal Outcomes-PTB, Outcome 35 PTB (<37w)-Depth≥10mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 35 PTB (<37w)-Depth≥10mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Raio 1997 5/23 3/64 4.3 % 4.64 [ 1.20, 17.88 ]
Subtotal (95% CI) 23 64 4.3 % 4.64 [ 1.20, 17.88 ]
Total events: 5 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.23 (P = 0.026)
2 LLETZ vs No Treatment
Kitson 2014 17/175 10/278 11.2 % 2.70 [ 1.27, 5.76 ]
Samson 2005 8/83 14/558 9.6 % 3.84 [ 1.66, 8.88 ]
Subtotal (95% CI) 258 836 20.8 % 3.16 [ 1.80, 5.55 ]
Total events: 25 (Treated), 24 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.37, df = 1 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 4.02 (P = 0.000059)
3 Excisional Treatment NOS vs No Treatment
Castanon 2012 316/2719 210/2917 37.4 % 1.61 [ 1.37, 1.91 ]
Lima 2011 2/14 3/58 2.8 % 2.76 [ 0.51, 14.99 ]
Sadler 2004 43/215 52/426 25.5 % 1.64 [ 1.13, 2.37 ]
Simoens 2012 12/47 7/94 9.1 % 3.43 [ 1.45, 8.13 ]
Subtotal (95% CI) 2995 3495 74.9 % 1.68 [ 1.41, 1.99 ]
Total events: 373 (Treated), 272 (Untreated)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.17, df = 3 (P = 0.37); I2 =5%
Test for overall effect: Z = 5.91 (P < 0.00001)
Total (95% CI) 3276 4395 100.0 % 2.12 [ 1.58, 2.85 ]
Total events: 403 (Treated), 299 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 10.28, df = 6 (P = 0.11); I2 =42%
Test for overall effect: Z = 5.00 (P < 0.00001)
Test for subgroup differences: Chi2 = 6.43, df = 2 (P = 0.04), I2 =69%
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Analysis 1.36. Comparison 1 Maternal Outcomes-PTB, Outcome 36 PTB (<37w)-Depth≥12mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 36 PTB (<37w)-Depth≥12mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Noehr 2009a 168/2569 18424/542471 100.0 % 1.93 [ 1.66, 2.23 ]
Total (95% CI) 2569 542471 100.0 % 1.93 [ 1.66, 2.23 ]
Total events: 168 (Treated), 18424 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.74 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.37. Comparison 1 Maternal Outcomes-PTB, Outcome 37 PTB (<37w)-Depth≥15mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 37 PTB (<37w)-Depth≥15mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 14/61 7/150 24.7 % 4.92 [ 2.09, 11.59 ]
Subtotal (95% CI) 61 150 24.7 % 4.92 [ 2.09, 11.59 ]
Total events: 14 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.64 (P = 0.00027)
2 LLETZ vs No Treatment
Kitson 2014 9/48 10/278 25.0 % 5.21 [ 2.23, 12.16 ]
Noehr 2009a 119/1451 18424/542471 50.3 % 2.41 [ 2.03, 2.87 ]
Subtotal (95% CI) 1499 542749 75.3 % 3.16 [ 1.54, 6.48 ]
Total events: 128 (Treated), 18434 (Untreated)
Heterogeneity: Tau2 = 0.20; Chi2 = 3.04, df = 1 (P = 0.08); I2 =67%
Test for overall effect: Z = 3.14 (P = 0.0017)
Total (95% CI) 1560 542899 100.0 % 3.49 [ 1.94, 6.26 ]
Total events: 142 (Treated), 18441 (Untreated)
Heterogeneity: Tau2 = 0.17; Chi2 = 5.38, df = 2 (P = 0.07); I2 =63%
Test for overall effect: Z = 4.19 (P = 0.000028)
Test for subgroup differences: Chi2 = 0.60, df = 1 (P = 0.44), I2 =0.0%
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Analysis 1.38. Comparison 1 Maternal Outcomes-PTB, Outcome 38 PTB (<37w)-Depth≥17mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 38 PTB (<37w)-Depth≥17mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional Treatment NOS vs No Treatment
Sadler 2004 25/101 52/426 100.0 % 2.03 [ 1.33, 3.10 ]
Total (95% CI) 101 426 100.0 % 2.03 [ 1.33, 3.10 ]
Total events: 25 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Not applicable
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Analysis 1.39. Comparison 1 Maternal Outcomes-PTB, Outcome 39 PTB (<37w)-Depth 10/13-15/16mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 39 PTB (<37w)-Depth 10/13-15/16mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Kitson 2014 8/127 10/278 6.6 % 1.75 [ 0.71, 4.33 ]
Noehr 2009a 49/1118 18424/542471 71.5 % 1.29 [ 0.98, 1.70 ]
Subtotal (95% CI) 1245 542749 78.0 % 1.32 [ 1.02, 1.72 ]
Total events: 57 (Treated), 18434 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.10 (P = 0.036)
2 Excisional Treatment NOS vs No Treatment
Sadler 2004 18/114 52/426 22.0 % 1.29 [ 0.79, 2.12 ]
Subtotal (95% CI) 114 426 22.0 % 1.29 [ 0.79, 2.12 ]
Total events: 18 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
Total (95% CI) 1359 543175 100.0 % 1.32 [ 1.04, 1.66 ]
Total events: 75 (Treated), 18486 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.41, df = 2 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 2.33 (P = 0.020)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.94), I2 =0.0%
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Analysis 1.40. Comparison 1 Maternal Outcomes-PTB, Outcome 40 PTB (<37w)-Depth 15/16-19/20mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 40 PTB (<37w)-Depth 15/16-19/20mm
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 2/19 7/150 3.0 % 2.26 [ 0.50, 10.08 ]
Subtotal (95% CI) 19 150 3.0 % 2.26 [ 0.50, 10.08 ]
Total events: 2 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.06 (P = 0.29)
2 LLETZ vs No Treatment
Kitson 2014 6/40 10/278 7.4 % 4.17 [ 1.60, 10.85 ]
Noehr 2009a 47/650 18424/542471 89.5 % 2.13 [ 1.62, 2.80 ]
Subtotal (95% CI) 690 542749 97.0 % 2.53 [ 1.42, 4.51 ]
Total events: 53 (Treated), 18434 (Untreated)
Heterogeneity: Tau2 = 0.10; Chi2 = 1.75, df = 1 (P = 0.19); I2 =43%
Test for overall effect: Z = 3.16 (P = 0.0016)
Total (95% CI) 709 542899 100.0 % 2.24 [ 1.73, 2.91 ]
Total events: 55 (Treated), 18441 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.75, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 6.07 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.89), I2 =0.0%
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Analysis 1.41. Comparison 1 Maternal Outcomes-PTB, Outcome 41 PTB (<37w)-Volume<3cc.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 41 PTB (<37w)-Volume<3cc
Study or subgroup Treated Volume<3cc Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Kitson 2014 16/218 10/278 100.0 % 2.04 [ 0.94, 4.41 ]
Total (95% CI) 218 278 100.0 % 2.04 [ 0.94, 4.41 ]
Total events: 16 (Treated Volume<3cc), 10 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.069)
Test for subgroup differences: Not applicable
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Analysis 1.42. Comparison 1 Maternal Outcomes-PTB, Outcome 42 PTB (<37w)-Volume>3cc.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 42 PTB (<37w)-Volume>3cc
Study or subgroup Treated Volume>3cc Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Kitson 2014 9/60 10/278 100.0 % 4.17 [ 1.77, 9.82 ]
Total (95% CI) 60 278 100.0 % 4.17 [ 1.77, 9.82 ]
Total events: 9 (Treated Volume>3cc), 10 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.27 (P = 0.0011)
Test for subgroup differences: Not applicable
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Analysis 1.43. Comparison 1 Maternal Outcomes-PTB, Outcome 43 PTB (<37w)-Depth≥10-12mm vs ≤10-
12mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 43 PTB (<37w)-Depth≥10-12mm vs≤10-12mm
Study or subgroup Depth≥10/12mm Depth≤12/10mm Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Raio 1997 5/23 1/41 0.6 % 8.91 [ 1.11, 71.73 ]
Subtotal (95% CI) 23 41 0.6 % 8.91 [ 1.11, 71.73 ]
Total events: 5 (Depth≥10/12mm), 1 (Depth≤12/10mm)
Heterogeneity: not applicable
Test for overall effect: Z = 2.06 (P = 0.040)
2 LLETZ
Kitson 2014 17/175 8/103 3.9 % 1.25 [ 0.56, 2.80 ]
Samson 2005 8/83 36/475 4.7 % 1.27 [ 0.61, 2.64 ]
Subtotal (95% CI) 258 578 8.6 % 1.26 [ 0.74, 2.17 ]
Total events: 25 (Depth≥10/12mm), 44 (Depth≤12/10mm)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.84 (P = 0.40)
3 Excision NOS
Castanon 2012 316/2719 173/2307 80.0 % 1.55 [ 1.30, 1.85 ]
Lima 2011 2/14 4/15 1.1 % 0.54 [ 0.12, 2.48 ]
Sadler 2004 43/215 14/116 8.0 % 1.66 [ 0.95, 2.90 ]
Simoens 2012 12/47 3/26 1.8 % 2.21 [ 0.69, 7.14 ]
Subtotal (95% CI) 2995 2464 90.9 % 1.55 [ 1.31, 1.83 ]
Total events: 373 (Depth≥10/12mm), 194 (Depth≤12/10mm)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.25, df = 3 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 5.18 (P < 0.00001)
Total (95% CI) 3276 3083 100.0 % 1.54 [ 1.31, 1.80 ]
Total events: 403 (Depth≥10/12mm), 239 (Depth≤12/10mm)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.51, df = 6 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 5.34 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.25, df = 2 (P = 0.20), I2 =38%
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Analysis 1.44. Comparison 1 Maternal Outcomes-PTB, Outcome 44 PTB (<37w)-Depth≥15-17mm vs ≤15-
17mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 44 PTB (<37w)-Depth≥15-17mm vs≤15-17mm
Study or subgroup Depth≥15/17mm Depth≤17/15mm Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 14/61 0/14 0.6 % 7.02 [ 0.44, 111.10 ]
Subtotal (95% CI) 61 14 0.6 % 7.02 [ 0.44, 111.10 ]
Total events: 14 (Depth≥15/17mm), 0 (Depth≤17/15mm)
Heterogeneity: not applicable
Test for overall effect: Z = 1.38 (P = 0.17)
2 LLETZ
Kitson 2014 9/48 16/230 8.1 % 2.70 [ 1.27, 5.74 ]
Noehr 2009a 119/1451 101/2140 70.2 % 1.74 [ 1.34, 2.25 ]
Subtotal (95% CI) 1499 2370 78.3 % 1.86 [ 1.36, 2.55 ]
Total events: 128 (Depth≥15/17mm), 117 (Depth≤17/15mm)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.16, df = 1 (P = 0.28); I2 =14%
Test for overall effect: Z = 3.87 (P = 0.00011)
3 Excisional Treatment NOS
Sadler 2004 25/101 32/230 21.1 % 1.78 [ 1.11, 2.84 ]
Subtotal (95% CI) 101 230 21.1 % 1.78 [ 1.11, 2.84 ]
Total events: 25 (Depth≥15/17mm), 32 (Depth≤17/15mm)
Heterogeneity: not applicable
Test for overall effect: Z = 2.41 (P = 0.016)
Total (95% CI) 1661 2614 100.0 % 1.82 [ 1.47, 2.26 ]
Total events: 167 (Depth≥15/17mm), 149 (Depth≤17/15mm)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.09, df = 3 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 5.48 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.92, df = 2 (P = 0.63), I2 =0.0%
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Analysis 1.45. Comparison 1 Maternal Outcomes-PTB, Outcome 45 PTB (<37w)-Depth≥20mm vs ≤20mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 45 PTB (<37w)-Depth≥20mm vs≤20mm
Study or subgroup Depth≥20mm Depth≤20mm Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 12/42 2/33 20.1 % 4.71 [ 1.13, 19.62 ]
Subtotal (95% CI) 42 33 20.1 % 4.71 [ 1.13, 19.62 ]
Total events: 12 (Depth≥20mm), 2 (Depth≤20mm)
Heterogeneity: not applicable
Test for overall effect: Z = 2.13 (P = 0.033)
2 LLETZ
Kitson 2014 3/8 22/270 29.9 % 4.60 [ 1.73, 12.26 ]
Noehr 2009a 72/801 150/2790 50.0 % 1.67 [ 1.28, 2.19 ]
Subtotal (95% CI) 809 3060 79.9 % 2.47 [ 0.94, 6.51 ]
Total events: 75 (Depth≥20mm), 172 (Depth≤20mm)
Heterogeneity: Tau2 = 0.38; Chi2 = 3.81, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 1.84 (P = 0.066)
Total (95% CI) 851 3093 100.0 % 2.79 [ 1.24, 6.27 ]
Total events: 87 (Depth≥20mm), 174 (Depth≤20mm)
Heterogeneity: Tau2 = 0.32; Chi2 = 5.52, df = 2 (P = 0.06); I2 =64%
Test for overall effect: Z = 2.47 (P = 0.013)
Test for subgroup differences: Chi2 = 0.54, df = 1 (P = 0.46), I2 =0.0%
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Analysis 1.46. Comparison 1 Maternal Outcomes-PTB, Outcome 46 PTB (<37w)-Volume>3cc vs <3cc.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 46 PTB (<37w)-Volume>3cc vs <3cc
Study or subgroup Volume >3/4cc Volume <4/3cc Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 9/60 16/218 100.0 % 2.04 [ 0.95, 4.39 ]
Total (95% CI) 60 218 100.0 % 2.04 [ 0.95, 4.39 ]
Total events: 9 (Volume >3/4cc), 16 (Volume <4/3cc)
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.067)
Test for subgroup differences: Not applicable
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Analysis 1.47. Comparison 1 Maternal Outcomes-PTB, Outcome 47 PTB (<37w)-Volume>6cc vs <6cc.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 47 PTB (<37w)-Volume>6cc vs <6cc
Study or subgroup Volume >6cc Volume <6cc Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 3/6 22/272 100.0 % 6.18 [ 2.53, 15.13 ]
Total (95% CI) 6 272 100.0 % 6.18 [ 2.53, 15.13 ]
Total events: 3 (Volume >6cc), 22 (Volume <6cc)
Heterogeneity: not applicable
Test for overall effect: Z = 3.99 (P = 0.000066)
Test for subgroup differences: Not applicable
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Analysis 1.48. Comparison 1 Maternal Outcomes-PTB, Outcome 48 PTB (<37w)-Depth 11/13-15/16mm vs
≤10-12mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 48 PTB (<37w)-Depth 11/13-15/16mm vs≤10-12mm
Study or subgroup
Depth
11/13-
15/16mm Depth <12/10mm Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 8/127 8/103 10.6 % 0.81 [ 0.32, 2.09 ]
Noehr 2009a 49/1118 54/1022 66.8 % 0.83 [ 0.57, 1.21 ]
Subtotal (95% CI) 1245 1125 77.4 % 0.83 [ 0.58, 1.17 ]
Total events: 57 (Depth 11/13-15/16mm), 62 (Depth <12/10mm)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
2 Excisional Treatment NOS
Sadler 2004 18/114 14/116 22.6 % 1.31 [ 0.68, 2.50 ]
Subtotal (95% CI) 114 116 22.6 % 1.31 [ 0.68, 2.50 ]
Total events: 18 (Depth 11/13-15/16mm), 14 (Depth <12/10mm)
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
Total (95% CI) 1359 1241 100.0 % 0.92 [ 0.67, 1.25 ]
Total events: 75 (Depth 11/13-15/16mm), 76 (Depth <12/10mm)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.49, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Chi2 = 1.49, df = 1 (P = 0.22), I2 =33%
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Analysis 1.49. Comparison 1 Maternal Outcomes-PTB, Outcome 49 PTB (<37w)-Depth 16-19mm vs 13-
15mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 49 PTB (<37w)-Depth 16-19mm vs 13-15mm
Study or subgroup Depth 16-19mm Depth 13-15mm Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Noehr 2009a 47/650 49/1118 100.0 % 1.65 [ 1.12, 2.43 ]
Total (95% CI) 650 1118 100.0 % 1.65 [ 1.12, 2.43 ]
Total events: 47 (Depth 16-19mm), 49 (Depth 13-15mm)
Heterogeneity: not applicable
Test for overall effect: Z = 2.53 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 1.50. Comparison 1 Maternal Outcomes-PTB, Outcome 50 PTB (<37w)-Depth≥20mm vs 15/16-
19/20mm.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 50 PTB (<37w)-Depth≥20mm vs 15/16-19/20mm
Study or subgroup Depth >20mm
Depth
15/16-
19/20mm Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 12/42 2/19 8.9 % 2.71 [ 0.67, 10.96 ]
Subtotal (95% CI) 42 19 8.9 % 2.71 [ 0.67, 10.96 ]
Total events: 12 (Depth >20mm), 2 (Depth 15/16-19/20mm)
Heterogeneity: not applicable
Test for overall effect: Z = 1.40 (P = 0.16)
2 LLETZ
Kitson 2014 3/8 6/40 12.6 % 2.50 [ 0.78, 7.97 ]
Noehr 2009a 72/801 47/650 78.4 % 1.24 [ 0.87, 1.77 ]
Subtotal (95% CI) 809 690 91.1 % 1.40 [ 0.84, 2.36 ]
Total events: 75 (Depth >20mm), 53 (Depth 15/16-19/20mm)
Heterogeneity: Tau2 = 0.05; Chi2 = 1.28, df = 1 (P = 0.26); I2 =22%
Test for overall effect: Z = 1.28 (P = 0.20)
Total (95% CI) 851 709 100.0 % 1.46 [ 0.95, 2.23 ]
Total events: 87 (Depth >20mm), 55 (Depth 15/16-19/20mm)
Heterogeneity: Tau2 = 0.03; Chi2 = 2.25, df = 2 (P = 0.33); I2 =11%
Test for overall effect: Z = 1.72 (P = 0.086)
Test for subgroup differences: Chi2 = 0.75, df = 1 (P = 0.39), I2 =0.0%
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Analysis 1.51. Comparison 1 Maternal Outcomes-PTB, Outcome 51 PTB (<37w)-Untreated External
Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 51 PTB (<37w)-Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC
Crane 2006 4/21 0/13 0.2 % 5.73 [ 0.33, 98.41 ]
Jones 1979 12/66 14/264 1.5 % 3.43 [ 1.66, 7.06 ]
Klaritsch 2006 17/76 1961/29686 2.4 % 3.39 [ 2.22, 5.16 ]
Kuoppala 1986 4/62 1/62 0.3 % 4.00 [ 0.46, 34.78 ]
Ludviksson 1982 11/83 3/79 0.7 % 3.49 [ 1.01, 12.05 ]
Ortoft 2010 7/67 281/6852 1.6 % 2.55 [ 1.25, 5.18 ]
Sozen 2014 7/15 3/24 0.8 % 3.73 [ 1.14, 12.26 ]
Subtotal (95% CI) 390 36980 7.6 % 3.28 [ 2.44, 4.42 ]
Total events: 62 (Treated), 2263 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.76, df = 6 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 7.81 (P < 0.00001)
2 LC
Andersen 1999 14/75 10/150 1.5 % 2.80 [ 1.31, 6.00 ]
Bekassy 1996 20/250 20/250 1.9 % 1.00 [ 0.55, 1.81 ]
Hagen 1993 21/56 7/112 1.4 % 6.00 [ 2.71, 13.26 ]
Lima 2011 2/11 1/22 0.3 % 4.00 [ 0.41, 39.45 ]
Raio 1997 6/64 3/64 0.7 % 2.00 [ 0.52, 7.65 ]
Simoens 2012 5/24 5/48 0.8 % 2.00 [ 0.64, 6.25 ]
Subtotal (95% CI) 480 646 6.5 % 2.39 [ 1.24, 4.61 ]
Total events: 68 (Treated), 46 (Untreated)
Heterogeneity: Tau2 = 0.39; Chi2 = 13.57, df = 5 (P = 0.02); I2 =63%
Test for overall effect: Z = 2.59 (P = 0.0095)
3 NETZ
Ortoft 2010 17/71 300/7290 2.4 % 5.82 [ 3.79, 8.94 ]
Subtotal (95% CI) 71 7290 2.4 % 5.82 [ 3.79, 8.94 ]
Total events: 17 (Treated), 300 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.04 (P < 0.00001)
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
4 LLETZ
Andia 2011 19/190 10/189 1.5 % 1.89 [ 0.90, 3.96 ]
Blomfield 1993 7/40 9/80 1.2 % 1.56 [ 0.62, 3.87 ]
Braet 1994 10/78 4/78 0.9 % 2.50 [ 0.82, 7.63 ]
Crane 2006 10/75 1/46 0.3 % 6.13 [ 0.81, 46.36 ]
Cruickshank 1995 14/147 15/295 1.6 % 1.87 [ 0.93, 3.78 ]
Frega 2013 26/406 19/379 1.9 % 1.28 [ 0.72, 2.27 ]
Frey 2013 111/598 87/588 3.0 % 1.25 [ 0.97, 1.62 ]
Gunasekera 1992 0/22 0/22 Not estimable
Haffenden 1993 15/152 14/152 1.6 % 1.07 [ 0.54, 2.14 ]
Heinonen 2013 547/7636 30151/658179 3.4 % 1.56 [ 1.44, 1.70 ]
Lima 2011 4/18 2/36 0.5 % 4.00 [ 0.81, 19.82 ]
Noehr 2009a 530/8180 13702/409184 3.4 % 1.93 [ 1.78, 2.10 ]
Ortoft 2010 55/572 2414/58757 3.0 % 2.34 [ 1.81, 3.02 ]
Paraskevaidis 2002 11/28 3/28 0.8 % 3.67 [ 1.14, 11.75 ]
Poon 2012 41/473 1156/25772 2.9 % 1.93 [ 1.43, 2.60 ]
Samson 2005 44/558 14/558 1.9 % 3.14 [ 1.74, 5.67 ]
Simoens 2012 12/52 6/104 1.1 % 4.00 [ 1.59, 10.05 ]
Tan 2004 13/119 11/119 1.5 % 1.18 [ 0.55, 2.53 ]
Werner 2010 35/511 17445/240348 2.8 % 0.94 [ 0.69, 1.30 ]
Subtotal (95% CI) 19855 1394914 33.4 % 1.72 [ 1.48, 2.00 ]
Total events: 1504 (Treated), 65063 (Untreated)
Heterogeneity: Tau2 = 0.04; Chi2 = 54.14, df = 17 (P<0.00001); I2 =69%
Test for overall effect: Z = 7.01 (P < 0.00001)
5 LA]
Anderson 1984 7/68 5/70 0.9 % 1.44 [ 0.48, 4.32 ]
Gunasekera 1992 2/109 1/109 0.2 % 2.00 [ 0.18, 21.73 ]
Saunders 1986 14/97 6/97 1.2 % 2.33 [ 0.94, 5.82 ]
van Rooijen 1999 14/236 38/472 1.9 % 0.74 [ 0.41, 1.33 ]
Subtotal (95% CI) 510 748 4.2 % 1.27 [ 0.67, 2.40 ]
Total events: 37 (Treated), 50 (Untreated)
Heterogeneity: Tau2 = 0.16; Chi2 = 4.82, df = 3 (P = 0.19); I2 =38%
Test for overall effect: Z = 0.73 (P = 0.47)
6 CT
Crane 2006 1/36 0/22 0.1 % 1.86 [ 0.08, 43.87 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 36 22 0.1 % 1.86 [ 0.08, 43.87 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
7 Excisional Treatment NOS
Albrechtsen 2008 2368/14882 126466/2155505 3.5 % 2.71 [ 2.61, 2.82 ]
Castanon 2012 449/4776 34153/510660 3.4 % 1.41 [ 1.29, 1.54 ]
El-Bastawissi 1999 118/852 586/7337 3.2 % 1.73 [ 1.44, 2.09 ]
Fischer 2010 19/85 3/85 0.8 % 6.33 [ 1.95, 20.61 ]
Jakobsson 2007 222/2063 12211/261994 3.4 % 2.31 [ 2.04, 2.62 ]
Kirn 2015 16/135 11/135 1.5 % 1.45 [ 0.70, 3.02 ]
Miller 2015 114/1356 905/14149 3.2 % 1.31 [ 1.09, 1.58 ]
Reilly 2012 146/1521 1661/28146 3.3 % 1.63 [ 1.38, 1.91 ]
Shanbhag 2009 129/1103 6672/94777 3.3 % 1.66 [ 1.41, 1.96 ]
Simoens 2012 2/12 5/24 0.6 % 0.80 [ 0.18, 3.54 ]
van de Vijner 2010 14/55 2/55 0.6 % 7.00 [ 1.67, 29.36 ]
Van Hentenryck 2012 19/106 13/212 1.7 % 2.92 [ 1.50, 5.69 ]
Subtotal (95% CI) 26946 3073079 28.4 % 1.91 [ 1.50, 2.44 ]
Total events: 3616 (Treated), 182688 (Untreated)
Heterogeneity: Tau2 = 0.13; Chi2 = 278.82, df = 11 (P<0.00001); I2 =96%
Test for overall effect: Z = 5.19 (P < 0.00001)
8 Ablative Treatment NOS
El-Bastawissi 1999 4/72 51/638 1.0 % 0.69 [ 0.26, 1.87 ]
Jakobsson 2007 261/3576 20791/446099 3.4 % 1.57 [ 1.39, 1.76 ]
Noehr 2009a 95/2027 3404/101657 3.2 % 1.40 [ 1.15, 1.71 ]
Reilly 2012 36/522 568/9634 2.8 % 1.17 [ 0.85, 1.62 ]
Shanbhag 2009 34/285 1720/24439 2.8 % 1.70 [ 1.23, 2.33 ]
Subtotal (95% CI) 6482 582467 13.2 % 1.45 [ 1.26, 1.67 ]
Total events: 430 (Treated), 26534 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 6.11, df = 4 (P = 0.19); I2 =35%
Test for overall effect: Z = 5.26 (P < 0.00001)
9 Treatment NOS
Kristensen 1985 9/85 755/12792 1.8 % 1.79 [ 0.96, 3.34 ]
Kristensen 1993 19/130 1213/28124 2.5 % 3.39 [ 2.23, 5.15 ]
Subtotal (95% CI) 215 40916 4.3 % 2.57 [ 1.39, 4.77 ]
Total events: 28 (Treated), 1968 (Untreated)
Heterogeneity: Tau2 = 0.13; Chi2 = 2.76, df = 1 (P = 0.10); I2 =64%
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 3.00 (P = 0.0027)
Total (95% CI) 54985 5137062 100.0 % 1.92 [ 1.70, 2.16 ]
Total events: 5763 (Treated), 278912 (Untreated)
Heterogeneity: Tau2 = 0.11; Chi2 = 548.19, df = 55 (P<0.00001); I2 =90%
Test for overall effect: Z = 10.59 (P < 0.00001)
Test for subgroup differences: Chi2 = 57.13, df = 8 (P = 0.00), I2 =86%
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Analysis 1.52. Comparison 1 Maternal Outcomes-PTB, Outcome 52 PTB (<37w)-Untreated Internal
Comparison Group (self-matching).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 52 PTB (<37w)-Untreated Internal Comparison Group (self-matching)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Bekassy 1996 9/148 8/148 8.5 % 1.13 [ 0.45, 2.84 ]
Raio 1997 3/29 1/29 1.7 % 3.00 [ 0.33, 27.18 ]
Subtotal (95% CI) 177 177 10.2 % 1.30 [ 0.56, 3.06 ]
Total events: 12 (Treated), 9 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.65, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 0.61 (P = 0.54)
2 LLETZ
Jakobsson 2009 31/258 17/258 18.4 % 1.82 [ 1.04, 3.21 ]
Subtotal (95% CI) 258 258 18.4 % 1.82 [ 1.04, 3.21 ]
Total events: 31 (Treated), 17 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.08 (P = 0.037)
3 FCBE
Anwar 2016 5/23 2/48 3.3 % 5.22 [ 1.09, 24.90 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 23 48 3.3 % 5.22 [ 1.09, 24.90 ]
Total events: 5 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.07 (P = 0.038)
4 Excisional Treatment NOS
Castanon 2012 30/372 32/372 23.0 % 0.94 [ 0.58, 1.51 ]
Ortoft 2010 17/170 8/170 10.6 % 2.13 [ 0.94, 4.79 ]
Sjoborg 2007 57/419 32/419 27.3 % 1.78 [ 1.18, 2.69 ]
Subtotal (95% CI) 961 961 60.8 % 1.46 [ 0.89, 2.39 ]
Total events: 104 (Treated), 72 (Untreated)
Heterogeneity: Tau2 = 0.11; Chi2 = 5.02, df = 2 (P = 0.08); I2 =60%
Test for overall effect: Z = 1.51 (P = 0.13)
5 Treatment NOS
Kristensen 1993 10/62 5/62 7.3 % 2.00 [ 0.73, 5.51 ]
Subtotal (95% CI) 62 62 7.3 % 2.00 [ 0.73, 5.51 ]
Total events: 10 (Treated), 5 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.34 (P = 0.18)
Total (95% CI) 1481 1506 100.0 % 1.59 [ 1.19, 2.13 ]
Total events: 162 (Treated), 105 (Untreated)
Heterogeneity: Tau2 = 0.04; Chi2 = 8.97, df = 7 (P = 0.25); I2 =22%
Test for overall effect: Z = 3.13 (P = 0.0017)
Test for subgroup differences: Chi2 = 2.86, df = 4 (P = 0.58), I2 =0.0%
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Analysis 1.53. Comparison 1 Maternal Outcomes-PTB, Outcome 53 PTB (<37w)-Untreated Internal
Comparison Group (pre-treatment pregnancies).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 53 PTB (<37w)-Untreated Internal Comparison Group (pre-treatment pregnancies)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC
Buller 1982 3/47 6/79 4.2 % 0.84 [ 0.22, 3.20 ]
Larsson 1982 33/197 16/284 8.7 % 2.97 [ 1.68, 5.25 ]
Moinian 1982 3/103 16/720 4.7 % 1.31 [ 0.39, 4.42 ]
Subtotal (95% CI) 347 1083 17.6 % 1.79 [ 0.81, 3.95 ]
Total events: 39 (Treated), 38 (Untreated)
Heterogeneity: Tau2 = 0.24; Chi2 = 3.76, df = 2 (P = 0.15); I2 =47%
Test for overall effect: Z = 1.45 (P = 0.15)
2 LC
Sagot 1995 6/53 1/59 2.2 % 6.68 [ 0.83, 53.69 ]
Spitzer 1995 2/34 2/15 2.6 % 0.44 [ 0.07, 2.84 ]
Subtotal (95% CI) 87 74 4.8 % 1.65 [ 0.11, 23.58 ]
Total events: 8 (Treated), 3 (Untreated)
Heterogeneity: Tau2 = 2.67; Chi2 = 3.63, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 0.37 (P = 0.71)
3 LLETZ
Andia 2011 19/189 25/189 8.7 % 0.76 [ 0.43, 1.33 ]
Cruickshank 1995 14/147 7/133 6.6 % 1.81 [ 0.75, 4.35 ]
Stout 2015 115/598 66/598 10.6 % 1.74 [ 1.32, 2.31 ]
Werner 2010 35/511 78/842 10.0 % 0.74 [ 0.50, 1.08 ]
Subtotal (95% CI) 1445 1762 35.9 % 1.13 [ 0.66, 1.94 ]
Total events: 183 (Treated), 176 (Untreated)
Heterogeneity: Tau2 = 0.23; Chi2 = 16.26, df = 3 (P = 0.001); I2 =82%
Test for overall effect: Z = 0.44 (P = 0.66)
4 LA
Spitzer 1995 16/129 10/97 7.4 % 1.20 [ 0.57, 2.53 ]
Subtotal (95% CI) 129 97 7.4 % 1.20 [ 0.57, 2.53 ]
Total events: 16 (Treated), 10 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.49 (P = 0.63)
5 CT
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Hemmingsson 1982 3/115 2/65 2.9 % 0.85 [ 0.15, 4.94 ]
Subtotal (95% CI) 115 65 2.9 % 0.85 [ 0.15, 4.94 ]
Total events: 3 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.85)
6 Excisional NOS
Albrechtsen 2008 2368/14882 3601/56927 11.3 % 2.52 [ 2.40, 2.64 ]
Castanon 2012 449/4776 98/1173 10.9 % 1.13 [ 0.91, 1.39 ]
Wuntakal 2013 42/261 19/181 9.1 % 1.53 [ 0.92, 2.55 ]
Subtotal (95% CI) 19919 58281 31.4 % 1.65 [ 0.88, 3.08 ]
Total events: 2859 (Treated), 3718 (Untreated)
Heterogeneity: Tau2 = 0.28; Chi2 = 57.04, df = 2 (P<0.00001); I2 =96%
Test for overall effect: Z = 1.56 (P = 0.12)
Total (95% CI) 22042 61362 100.0 % 1.39 [ 0.98, 1.96 ]
Total events: 3108 (Treated), 3947 (Untreated)
Heterogeneity: Tau2 = 0.27; Chi2 = 124.97, df = 13 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.87 (P = 0.061)
Test for subgroup differences: Chi2 = 1.68, df = 5 (P = 0.89), I2 =0.0%
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Analysis 1.54. Comparison 1 Maternal Outcomes-PTB, Outcome 54 PTB (<37w)-Untreated Colposcopy+/-
CIN+/-Biopsy Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 54 PTB (<37w)-Untreated Colposcopy+/-CIN+/-Biopsy Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC
Bruinsma 2007 11/71 12/129 1.6 % 1.67 [ 0.77, 3.58 ]
Guo 2013 14/36 6/29 1.4 % 1.88 [ 0.83, 4.28 ]
Subtotal (95% CI) 107 158 3.0 % 1.76 [ 1.01, 3.08 ]
Total events: 25 (Treated), 18 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 1.98 (P = 0.047)
2 LC
Sadler 2004 20/105 9/72 1.7 % 1.52 [ 0.74, 3.15 ]
Subtotal (95% CI) 105 72 1.7 % 1.52 [ 0.74, 3.15 ]
Total events: 20 (Treated), 9 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.26)
3 LLETZ
Bruinsma 2007 11/69 11/125 1.5 % 1.81 [ 0.83, 3.96 ]
Frey 2013 111/598 91/552 7.0 % 1.13 [ 0.88, 1.45 ]
Guo 2013 10/48 8/39 1.4 % 1.02 [ 0.44, 2.32 ]
Himes 2007 11/114 127/962 2.5 % 0.73 [ 0.41, 1.31 ]
Kitson 2014 25/278 10/278 1.8 % 2.50 [ 1.22, 5.11 ]
Martyn 2015 20/278 6/191 1.2 % 2.29 [ 0.94, 5.60 ]
Noehr 2009a 530/8180 1056/25336 10.6 % 1.55 [ 1.40, 1.72 ]
Sadler 2004 44/278 24/196 3.5 % 1.29 [ 0.81, 2.05 ]
Stout 2015 115/598 178/1129 7.9 % 1.22 [ 0.99, 1.51 ]
Subtotal (95% CI) 10441 28808 37.4 % 1.33 [ 1.11, 1.60 ]
Total events: 877 (Treated), 1511 (Untreated)
Heterogeneity: Tau2 = 0.03; Chi2 = 17.89, df = 8 (P = 0.02); I2 =55%
Test for overall effect: Z = 3.04 (P = 0.0023)
4 LA
Bruinsma 2007 92/1005 163/1940 7.1 % 1.09 [ 0.85, 1.39 ]
Sadler 2004 23/223 19/158 2.6 % 0.86 [ 0.48, 1.52 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 1228 2098 9.7 % 1.05 [ 0.84, 1.31 ]
Total events: 115 (Treated), 182 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.57, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.43 (P = 0.67)
5 RD
Bruinsma 2007 109/760 123/1390 7.2 % 1.62 [ 1.27, 2.06 ]
Subtotal (95% CI) 760 1390 7.2 % 1.62 [ 1.27, 2.06 ]
Total events: 109 (Treated), 123 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.91 (P = 0.000093)
6 Excisional Treatment NOS
Castanon 2012 449/4776 586/7263 10.2 % 1.17 [ 1.04, 1.31 ]
Martyn 2015 5/19 0/13 0.1 % 7.70 [ 0.46, 128.32 ]
Miller 2015 114/1356 197/3023 7.7 % 1.29 [ 1.03, 1.61 ]
Reilly 2012 146/1521 156/1832 7.8 % 1.13 [ 0.91, 1.40 ]
Wuntakal 2013 42/261 22/257 3.3 % 1.88 [ 1.16, 3.06 ]
Subtotal (95% CI) 7933 12388 29.2 % 1.23 [ 1.07, 1.41 ]
Total events: 756 (Treated), 961 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 5.93, df = 4 (P = 0.20); I2 =33%
Test for overall effect: Z = 2.97 (P = 0.0030)
7 Ablative Treatment NOS
Noehr 2009a 95/2027 262/6294 7.5 % 1.13 [ 0.90, 1.42 ]
Reilly 2012 36/522 53/627 4.2 % 0.82 [ 0.54, 1.23 ]
Subtotal (95% CI) 2549 6921 11.7 % 1.00 [ 0.74, 1.36 ]
Total events: 131 (Treated), 315 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.83, df = 1 (P = 0.18); I2 =45%
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 23123 51835 100.0 % 1.27 [ 1.14, 1.41 ]
Total events: 2033 (Treated), 3119 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 46.99, df = 21 (P = 0.00094); I2 =55%
Test for overall effect: Z = 4.48 (P < 0.00001)
Test for subgroup differences: Chi2 = 10.97, df = 6 (P = 0.09), I2 =45%
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Analysis 1.55. Comparison 1 Maternal Outcomes-PTB, Outcome 55 PTB (<37w)-Untreated HSIL
Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 55 PTB (<37w)-Untreated HSIL Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC
Ortoft 2010 7/67 1/36 4.5 % 3.76 [ 0.48, 29.39 ]
Subtotal (95% CI) 67 36 4.5 % 3.76 [ 0.48, 29.39 ]
Total events: 7 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
2 NETZ
Ortoft 2010 17/71 2/38 8.3 % 4.55 [ 1.11, 18.66 ]
Subtotal (95% CI) 71 38 8.3 % 4.55 [ 1.11, 18.66 ]
Total events: 17 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.10 (P = 0.035)
3 LLETZ
Ortoft 2010 55/572 12/309 20.9 % 2.48 [ 1.35, 4.55 ]
Subtotal (95% CI) 572 309 20.9 % 2.48 [ 1.35, 4.55 ]
Total events: 55 (Treated), 12 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.92 (P = 0.0035)
4 Excisional Treatment NOS
El-Bastawissi 1999 118/852 28/250 26.4 % 1.24 [ 0.84, 1.82 ]
Shanbhag 2009 129/1103 10/69 21.2 % 0.81 [ 0.44, 1.46 ]
Subtotal (95% CI) 1955 319 47.6 % 1.06 [ 0.71, 1.59 ]
Total events: 247 (Treated), 38 (Untreated)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.39, df = 1 (P = 0.24); I2 =28%
Test for overall effect: Z = 0.30 (P = 0.76)
5 Ablative Treatment NOS
El-Bastawissi 1999 4/72 2/22 6.7 % 0.61 [ 0.12, 3.12 ]
Shanbhag 2009 34/285 3/18 12.0 % 0.72 [ 0.24, 2.11 ]
Subtotal (95% CI) 357 40 18.6 % 0.68 [ 0.28, 1.68 ]
Total events: 38 (Treated), 5 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.40)
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 3022 742 100.0 % 1.37 [ 0.85, 2.19 ]
Total events: 364 (Treated), 58 (Untreated)
Heterogeneity: Tau2 = 0.18; Chi2 = 12.87, df = 6 (P = 0.05); I2 =53%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Chi2 = 11.18, df = 4 (P = 0.02), I2 =64%
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Analysis 1.56. Comparison 1 Maternal Outcomes-PTB, Outcome 56 PTB (<37w)-All Comparison Groups.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 56 PTB (<37w)-All Comparison Groups
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Treatment vs Untreated External Comparison Group
Albrechtsen 2008 2306/14495 126466/2155505 2.7 % 2.71 [ 2.61, 2.82 ]
Andersen 1999 14/75 10/150 1.2 % 2.80 [ 1.31, 6.00 ]
Anderson 1984 7/68 5/70 0.7 % 1.44 [ 0.48, 4.32 ]
Andia 2011 10/95 10/189 1.0 % 1.99 [ 0.86, 4.61 ]
Bekassy 1996 11/102 20/250 1.3 % 1.35 [ 0.67, 2.71 ]
Blomfield 1993 7/40 9/80 0.9 % 1.56 [ 0.62, 3.87 ]
Braet 1994 10/78 4/78 0.7 % 2.50 [ 0.82, 7.63 ]
Castanon 2012 442/4700 34153/510660 2.7 % 1.41 [ 1.29, 1.54 ]
Crane 2006 15/132 1/81 0.3 % 9.20 [ 1.24, 68.37 ]
Cruickshank 1995 10/101 15/295 1.2 % 1.95 [ 0.90, 4.20 ]
El-Bastawissi 1999 118/896 637/7975 2.5 % 1.65 [ 1.37, 1.98 ]
Fischer 2010 19/85 3/85 0.6 % 6.33 [ 1.95, 20.61 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Frega 2013 26/406 19/379 1.5 % 1.28 [ 0.72, 2.27 ]
Frey 2013 57/309 87/588 2.2 % 1.25 [ 0.92, 1.69 ]
Gunasekera 1992 2/131 1/131 0.2 % 2.00 [ 0.18, 21.79 ]
Haffenden 1993 15/152 14/152 1.3 % 1.07 [ 0.54, 2.14 ]
Hagen 1993 21/56 7/112 1.1 % 6.00 [ 2.71, 13.26 ]
Heinonen 2013 547/7636 30151/658179 2.7 % 1.56 [ 1.44, 1.70 ]
Jakobsson 2007 483/5639 33002/708093 2.7 % 1.84 [ 1.69, 2.00 ]
Jones 1979 12/66 14/264 1.2 % 3.43 [ 1.66, 7.06 ]
Kirn 2015 16/135 11/135 1.2 % 1.45 [ 0.70, 3.02 ]
Klaritsch 2006 17/76 1961/29686 1.9 % 3.39 [ 2.22, 5.16 ]
Kristensen 1985 9/85 755/12792 1.4 % 1.79 [ 0.96, 3.34 ]
Kristensen 1993 9/68 1213/28124 1.5 % 3.07 [ 1.67, 5.65 ]
Kuoppala 1986 4/62 1/62 0.2 % 4.00 [ 0.46, 34.78 ]
Lima 2011 6/29 3/58 0.6 % 4.00 [ 1.08, 14.86 ]
Ludviksson 1982 11/83 3/79 0.6 % 3.49 [ 1.01, 12.05 ]
Noehr 2009a 36/592 17106/510841 2.2 % 1.82 [ 1.32, 2.49 ]
Ortoft 2010 62/537 2995/72899 2.4 % 2.81 [ 2.22, 3.56 ]
Paraskevaidis 2002 11/28 3/28 0.7 % 3.67 [ 1.14, 11.75 ]
Poon 2012 41/473 1156/25772 2.3 % 1.93 [ 1.43, 2.60 ]
Raio 1997 3/35 3/64 0.4 % 1.83 [ 0.39, 8.58 ]
Reilly 2012 171/1918 2229/37780 2.6 % 1.51 [ 1.30, 1.75 ]
Samson 2005 44/558 14/558 1.5 % 3.14 [ 1.74, 5.67 ]
Saunders 1986 14/97 6/97 0.9 % 2.33 [ 0.94, 5.82 ]
Shanbhag 2009 163/1387 8392/119216 2.6 % 1.67 [ 1.44, 1.93 ]
Simoens 2012 19/88 16/176 1.5 % 2.38 [ 1.29, 4.39 ]
Sozen 2014 7/15 3/24 0.6 % 3.73 [ 1.14, 12.26 ]
Tan 2004 13/119 11/119 1.2 % 1.18 [ 0.55, 2.53 ]
van de Vijner 2010 14/55 2/55 0.5 % 7.00 [ 1.67, 29.36 ]
Van Hentenryck 2012 19/106 13/212 1.3 % 2.92 [ 1.50, 5.69 ]
van Rooijen 1999 14/236 38/472 1.5 % 0.74 [ 0.41, 1.33 ]
Werner 2010 35/509 17445/240348 2.2 % 0.95 [ 0.69, 1.30 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 42553 5122913 60.6 % 1.97 [ 1.71, 2.26 ]
Total events: 4870 (Treated), 278007 (Untreated)
Heterogeneity: Tau2 = 0.11; Chi2 = 442.44, df = 42 (P<0.00001); I2 =91%
Test for overall effect: Z = 9.52 (P < 0.00001)
2 Treatment vs Untreated Internal Comparison Group (pre-treatment pregnancies)
Albrechtsen 2008 62/387 3601/56927 2.4 % 2.53 [ 2.01, 3.19 ]
Andia 2011 9/94 25/189 1.2 % 0.72 [ 0.35, 1.49 ]
Buller 1982 3/47 6/79 0.5 % 0.84 [ 0.22, 3.20 ]
Castanon 2012 1/7 66/801 0.3 % 1.73 [ 0.28, 10.80 ]
Cruickshank 1995 4/46 7/133 0.6 % 1.65 [ 0.51, 5.39 ]
Hemmingsson 1982 3/115 2/65 0.3 % 0.85 [ 0.15, 4.94 ]
Larsson 1982 33/197 16/284 1.6 % 2.97 [ 1.68, 5.25 ]
Moinian 1982 3/103 16/720 0.6 % 1.31 [ 0.39, 4.42 ]
Sagot 1995 6/53 1/59 0.2 % 6.68 [ 0.83, 53.69 ]
Spitzer 1995 18/163 12/112 1.3 % 1.03 [ 0.52, 2.05 ]
Stout 2015 40/207 66/598 2.1 % 1.75 [ 1.22, 2.51 ]
Werner 2010 0/2 78/842 0.2 % 1.79 [ 0.14, 22.67 ]
Wuntakal 2013 17/108 19/181 1.5 % 1.50 [ 0.82, 2.76 ]
Subtotal (95% CI) 1529 60990 13.0 % 1.66 [ 1.24, 2.22 ]
Total events: 199 (Treated), 3915 (Untreated)
Heterogeneity: Tau2 = 0.10; Chi2 = 22.87, df = 12 (P = 0.03); I2 =48%
Test for overall effect: Z = 3.37 (P = 0.00074)
3 Treatment vs Untreated Internal Comparison Group (self-matching)
Anwar 2016 5/23 2/48 0.4 % 5.22 [ 1.09, 24.90 ]
Bekassy 1996 9/148 8/148 0.9 % 1.13 [ 0.45, 2.84 ]
Castanon 2012 0/2 32/372 0.2 % 1.91 [ 0.15, 24.54 ]
Kristensen 1993 10/62 5/62 0.8 % 2.00 [ 0.73, 5.51 ]
Ortoft 2010 17/170 8/170 1.1 % 2.13 [ 0.94, 4.79 ]
Raio 1997 2/29 1/29 0.2 % 2.00 [ 0.19, 20.86 ]
Subtotal (95% CI) 434 829 3.6 % 1.91 [ 1.19, 3.08 ]
Total events: 43 (Treated), 56 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.92, df = 5 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 2.67 (P = 0.0077)
4 Treatment vs Untreated Colposcopy+/-CIN+/-Biopsy Comparison Group
Bruinsma 2007 224/1925 309/3484 2.6 % 1.31 [ 1.11, 1.54 ]
Castanon 2012 6/67 586/7263 1.2 % 1.11 [ 0.52, 2.39 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Frey 2013 54/289 91/552 2.2 % 1.13 [ 0.84, 1.54 ]
Guo 2013 24/84 14/68 1.5 % 1.39 [ 0.78, 2.47 ]
Himes 2007 11/114 127/962 1.5 % 0.73 [ 0.41, 1.31 ]
Kitson 2014 25/278 10/278 1.3 % 2.50 [ 1.22, 5.11 ]
Martyn 2015 25/297 6/204 1.0 % 2.86 [ 1.20, 6.85 ]
Noehr 2009a 589/9615 1318/31630 2.7 % 1.47 [ 1.34, 1.62 ]
Reilly 2012 11/125 209/2459 1.5 % 1.04 [ 0.58, 1.85 ]
Sadler 2004 97/652 52/426 2.2 % 1.22 [ 0.89, 1.67 ]
Stout 2015 75/391 178/1129 2.4 % 1.22 [ 0.95, 1.55 ]
Wuntakal 2013 25/153 22/257 1.6 % 1.91 [ 1.12, 3.27 ]
Subtotal (95% CI) 13990 48712 21.7 % 1.33 [ 1.17, 1.50 ]
Total events: 1166 (Treated), 2922 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 17.86, df = 11 (P = 0.08); I2 =38%
Test for overall effect: Z = 4.54 (P < 0.00001)
5 Treatment vs Untreated HSIL Comparison Group
El-Bastawissi 1999 4/28 30/272 0.9 % 1.30 [ 0.49, 3.41 ]
Ortoft 2010 0/3 15/383 0.2 % 3.10 [ 0.22, 43.32 ]
Shanbhag 2009 0/1 13/87 0.2 % 1.63 [ 0.14, 18.89 ]
Subtotal (95% CI) 32 742 1.2 % 1.46 [ 0.62, 3.42 ]
Total events: 4 (Treated), 58 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.38, df = 2 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.87 (P = 0.39)
Total (95% CI) 58538 5234186 100.0 % 1.76 [ 1.58, 1.97 ]
Total events: 6282 (Treated), 284958 (Untreated)
Heterogeneity: Tau2 = 0.11; Chi2 = 619.05, df = 76 (P<0.00001); I2 =88%
Test for overall effect: Z = 10.19 (P < 0.00001)
Test for subgroup differences: Chi2 = 18.22, df = 4 (P = 0.00), I2 =78%
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Analysis 1.57. Comparison 1 Maternal Outcomes-PTB, Outcome 57 PTB (<37w)-Untreated High-risk
Population vs General Population.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 57 PTB (<37w)-Untreated High-risk Population vs General Population
Study or subgroup Pre-Tx/Colpo/HSIL General Population Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Pre-treatment pregnancies vs General Population
Albrechtsen 2008 3601/56927 126466/2155505 15.5 % 1.08 [ 1.04, 1.11 ]
Andia 2011 25/189 10/189 1.2 % 2.50 [ 1.24, 5.06 ]
Bekassy 1996 8/148 20/250 1.0 % 0.68 [ 0.31, 1.50 ]
Castanon 2012 98/1173 4747/70982 8.5 % 1.25 [ 1.03, 1.51 ]
Cruickshank 1995 7/133 15/295 0.8 % 1.04 [ 0.43, 2.48 ]
Jakobsson 2009 17/258 25563/554507 2.6 % 1.43 [ 0.90, 2.26 ]
Kristensen 1993 16/210 1213/28124 2.5 % 1.77 [ 1.10, 2.84 ]
Ortoft 2010 8/170 920/22380 1.3 % 1.14 [ 0.58, 2.26 ]
Raio 1997 1/29 3/64 0.1 % 0.74 [ 0.08, 6.77 ]
Werner 2010 78/842 17445/240348 7.7 % 1.28 [ 1.03, 1.58 ]
Subtotal (95% CI) 60079 3072644 41.3 % 1.23 [ 1.07, 1.42 ]
Total events: 3859 (Pre-Tx/Colpo/HSIL), 176402 (General Population)
Heterogeneity: Tau2 = 0.02; Chi2 = 16.71, df = 9 (P = 0.05); I2 =46%
Test for overall effect: Z = 2.90 (P = 0.0037)
2 Untreated Colposcopy+/-CIN+/-Biopsy vs General Population
Castanon 2012 586/7263 29406/439678 13.8 % 1.21 [ 1.12, 1.30 ]
Miller 2015 197/3023 905/14149 10.4 % 1.02 [ 0.88, 1.18 ]
Noehr 2009a 1318/31630 17106/510841 14.8 % 1.24 [ 1.18, 1.31 ]
Reilly 2012 209/2459 2229/37780 11.0 % 1.44 [ 1.26, 1.65 ]
Subtotal (95% CI) 44375 1002448 50.1 % 1.22 [ 1.11, 1.34 ]
Total events: 2310 (Pre-Tx/Colpo/HSIL), 49646 (General Population)
Heterogeneity: Tau2 = 0.01; Chi2 = 11.74, df = 3 (P = 0.01); I2 =74%
Test for overall effect: Z = 4.22 (P = 0.000025)
3 Untreated HSIL vs General Population
El-Bastawissi 1999 30/272 637/7975 4.1 % 1.38 [ 0.98, 1.95 ]
Ortoft 2010 15/383 2075/50519 2.3 % 0.95 [ 0.58, 1.57 ]
Shanbhag 2009 13/87 8392/119216 2.3 % 2.12 [ 1.29, 3.51 ]
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(. . . Continued)
Study or subgroup Pre-Tx/Colpo/HSIL General Population Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 742 177710 8.7 % 1.40 [ 0.94, 2.10 ]
Total events: 58 (Pre-Tx/Colpo/HSIL), 11104 (General Population)
Heterogeneity: Tau2 = 0.08; Chi2 = 4.94, df = 2 (P = 0.08); I2 =59%
Test for overall effect: Z = 1.65 (P = 0.098)
Total (95% CI) 105196 4252802 100.0 % 1.24 [ 1.14, 1.34 ]
Total events: 6227 (Pre-Tx/Colpo/HSIL), 237152 (General Population)
Heterogeneity: Tau2 = 0.01; Chi2 = 57.36, df = 16 (P<0.00001); I2 =72%
Test for overall effect: Z = 5.09 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.43, df = 2 (P = 0.81), I2 =0.0%
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Analysis 1.58. Comparison 1 Maternal Outcomes-PTB, Outcome 58 PTB (<37w)-Depth≤10-12mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 58 PTB (<37w)-Depth≤10-12mm vs Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LCp
Raio 1997 1/41 3/64 2.8 % 0.52 [ 0.06, 4.83 ]
Subtotal (95% CI) 41 64 2.8 % 0.52 [ 0.06, 4.83 ]
Total events: 1 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
2 LLETZ
Noehr 2009a 54/1022 17106/510841 30.0 % 1.58 [ 1.22, 2.05 ]
Samson 2005 36/475 14/558 19.0 % 3.02 [ 1.65, 5.53 ]
Subtotal (95% CI) 1497 511399 49.0 % 2.06 [ 1.10, 3.84 ]
Total events: 90 (Treated), 17120 (Untreated)
Heterogeneity: Tau2 = 0.15; Chi2 = 3.74, df = 1 (P = 0.05); I2 =73%
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 2.26 (P = 0.024)
3 Excisional Treatment NOS
Castanon 2012 173/2307 34153/510660 33.1 % 1.12 [ 0.97, 1.29 ]
Lima 2011 4/15 3/58 6.5 % 5.16 [ 1.29, 20.60 ]
Simoens 2012 3/26 16/176 8.6 % 1.27 [ 0.40, 4.06 ]
Subtotal (95% CI) 2348 510894 48.1 % 1.57 [ 0.72, 3.41 ]
Total events: 180 (Treated), 34172 (Untreated)
Heterogeneity: Tau2 = 0.28; Chi2 = 4.64, df = 2 (P = 0.10); I2 =57%
Test for overall effect: Z = 1.14 (P = 0.25)
Total (95% CI) 3886 1022357 100.0 % 1.64 [ 1.11, 2.42 ]
Total events: 271 (Treated), 51295 (Untreated)
Heterogeneity: Tau2 = 0.12; Chi2 = 17.99, df = 5 (P = 0.003); I2 =72%
Test for overall effect: Z = 2.47 (P = 0.014)
Test for subgroup differences: Chi2 = 1.47, df = 2 (P = 0.48), I2 =0.0%
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Analysis 1.59. Comparison 1 Maternal Outcomes-PTB, Outcome 59 PTB (<37w)-Depth≤10-12mm vs
Untreated Internal Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 59 PTB (<37w)-Depth≤10-12mm vs Untreated Internal Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Raio 1997 1/41 1/29 0.8 % 0.71 [ 0.05, 10.85 ]
Subtotal (95% CI) 41 29 0.8 % 0.71 [ 0.05, 10.85 ]
Total events: 1 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
2 Excisional Treatment NOS
Castanon 2012 173/2307 98/1173 99.2 % 0.90 [ 0.71, 1.14 ]
Subtotal (95% CI) 2307 1173 99.2 % 0.90 [ 0.71, 1.14 ]
Total events: 173 (Treated), 98 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.89 (P = 0.37)
Total (95% CI) 2348 1202 100.0 % 0.90 [ 0.71, 1.14 ]
Total events: 174 (Treated), 99 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.91 (P = 0.36)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.86), I2 =0.0%
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Analysis 1.60. Comparison 1 Maternal Outcomes-PTB, Outcome 60 PTB (<37w)-Depth≤10-12mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 60 PTB (<37w)-Depth≤10-12mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 8/103 10/278 7.1 % 2.16 [ 0.88, 5.32 ]
Noehr 2009a 54/1022 1318/31630 33.9 % 1.27 [ 0.97, 1.65 ]
Subtotal (95% CI) 1125 31908 41.0 % 1.38 [ 0.94, 2.02 ]
Total events: 62 (Treated), 1328 (Untreated)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 1.66 (P = 0.098)
2 Excisional Treatment NOS
Castanon 2012 173/2307 586/7263 43.5 % 0.93 [ 0.79, 1.09 ]
Sadler 2004 14/116 52/426 15.5 % 0.99 [ 0.57, 1.72 ]
Subtotal (95% CI) 2423 7689 59.0 % 0.93 [ 0.80, 1.09 ]
Total events: 187 (Treated), 638 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.86 (P = 0.39)
Total (95% CI) 3548 39597 100.0 % 1.11 [ 0.85, 1.43 ]
Total events: 249 (Treated), 1966 (Untreated)
Heterogeneity: Tau2 = 0.03; Chi2 = 6.50, df = 3 (P = 0.09); I2 =54%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 3.45, df = 1 (P = 0.06), I2 =71%
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Analysis 1.61. Comparison 1 Maternal Outcomes-PTB, Outcome 61 PTB (<37w)-Depth≤15-17mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 61 PTB (<37w)-Depth≤15-17mm vs Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 0/14 7/150 0.4 % 0.67 [ 0.04, 11.18 ]
Subtotal (95% CI) 14 150 0.4 % 0.67 [ 0.04, 11.18 ]
Total events: 0 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
2 LLETZ
Noehr 2009a 103/2140 17106/510841 99.6 % 1.44 [ 1.19, 1.74 ]
Subtotal (95% CI) 2140 510841 99.6 % 1.44 [ 1.19, 1.74 ]
Total events: 103 (Treated), 17106 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.76 (P = 0.00017)
Total (95% CI) 2154 510991 100.0 % 1.43 [ 1.19, 1.73 ]
Total events: 103 (Treated), 17113 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.28, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 3.74 (P = 0.00019)
Test for subgroup differences: Chi2 = 0.28, df = 1 (P = 0.60), I2 =0.0%
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Analysis 1.62. Comparison 1 Maternal Outcomes-PTB, Outcome 62 PTB (<37w)-Depth≤15-17mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 62 PTB (<37w)-Depth≤15-17mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 16/230 10/278 5.0 % 1.93 [ 0.89, 4.18 ]
Noehr 2009a 103/2140 1318/31630 77.4 % 1.16 [ 0.95, 1.40 ]
Subtotal (95% CI) 2370 31908 82.4 % 1.30 [ 0.85, 1.98 ]
Total events: 119 (Treated), 1328 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 1.61, df = 1 (P = 0.20); I2 =38%
Test for overall effect: Z = 1.21 (P = 0.23)
2 Excisional Treatment NOS
Sadler 2004 32/230 52/426 17.6 % 1.14 [ 0.76, 1.72 ]
Subtotal (95% CI) 230 426 17.6 % 1.14 [ 0.76, 1.72 ]
Total events: 32 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Total (95% CI) 2600 32334 100.0 % 1.18 [ 1.00, 1.40 ]
Total events: 151 (Treated), 1380 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.65, df = 2 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 1.91 (P = 0.056)
Test for subgroup differences: Chi2 = 0.19, df = 1 (P = 0.66), I2 =0.0%
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Analysis 1.63. Comparison 1 Maternal Outcomes-PTB, Outcome 63 PTB (<37w)-Depth≤20mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 63 PTB (<37w)-Depth≤20mm vs Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 2/33 7/150 1.0 % 1.30 [ 0.28, 5.97 ]
Subtotal (95% CI) 33 150 1.0 % 1.30 [ 0.28, 5.97 ]
Total events: 2 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.74)
2 LLETZ
Noehr 2009a 150/2790 17106/510841 99.0 % 1.61 [ 1.37, 1.88 ]
Subtotal (95% CI) 2790 510841 99.0 % 1.61 [ 1.37, 1.88 ]
Total events: 150 (Treated), 17106 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.93 (P < 0.00001)
Total (95% CI) 2823 510991 100.0 % 1.60 [ 1.37, 1.87 ]
Total events: 152 (Treated), 17113 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.07, df = 1 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 5.94 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.79), I2 =0.0%
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Analysis 1.64. Comparison 1 Maternal Outcomes-PTB, Outcome 64 PTB (<37w)-Depth≤20mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 64 PTB (<37w)-Depth≤20mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 22/270 10/278 29.3 % 2.27 [ 1.09, 4.69 ]
Noehr 2009a 150/2790 1318/31630 70.7 % 1.29 [ 1.09, 1.52 ]
Total (95% CI) 3060 31908 100.0 % 1.52 [ 0.92, 2.51 ]
Total events: 172 (Treated), 1328 (Untreated)
Heterogeneity: Tau2 = 0.09; Chi2 = 2.18, df = 1 (P = 0.14); I2 =54%
Test for overall effect: Z = 1.64 (P = 0.10)
Test for subgroup differences: Not applicable
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Analysis 1.65. Comparison 1 Maternal Outcomes-PTB, Outcome 65 PTB (<37w)-Depth≥10-12mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 65 PTB (<37w)-Depth≥10-12mm vs Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Raio 1997 5/23 3/64 1.5 % 4.64 [ 1.20, 17.88 ]
Subtotal (95% CI) 23 64 1.5 % 4.64 [ 1.20, 17.88 ]
Total events: 5 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.23 (P = 0.026)
2 LLETZ
Noehr 2009a 168/2569 17106/510841 40.4 % 1.95 [ 1.69, 2.26 ]
Samson 2005 8/83 14/558 3.7 % 3.84 [ 1.66, 8.88 ]
Subtotal (95% CI) 2652 511399 44.2 % 2.40 [ 1.30, 4.43 ]
Total events: 176 (Treated), 17120 (Untreated)
Heterogeneity: Tau2 = 0.13; Chi2 = 2.43, df = 1 (P = 0.12); I2 =59%
Test for overall effect: Z = 2.81 (P = 0.0049)
3 Excisional Treatment NOS
Castanon 2012 316/2719 34153/510660 47.8 % 1.74 [ 1.57, 1.93 ]
Lima 2011 2/14 3/58 1.0 % 2.76 [ 0.51, 14.99 ]
Simoens 2012 12/47 16/176 5.6 % 2.81 [ 1.43, 5.52 ]
Subtotal (95% CI) 2780 510894 54.3 % 1.82 [ 1.49, 2.22 ]
Total events: 330 (Treated), 34172 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 2.17, df = 2 (P = 0.34); I2 =8%
Test for overall effect: Z = 5.84 (P < 0.00001)
Total (95% CI) 5455 1022357 100.0 % 1.96 [ 1.66, 2.32 ]
Total events: 511 (Treated), 51295 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 8.28, df = 5 (P = 0.14); I2 =40%
Test for overall effect: Z = 7.90 (P < 0.00001)
Test for subgroup differences: Chi2 = 2.43, df = 2 (P = 0.30), I2 =18%
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Analysis 1.66. Comparison 1 Maternal Outcomes-PTB, Outcome 66 PTB (<37w)-Depth≥10-12mm vs
Untreated Internal Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 66 PTB (<37w)-Depth≥10-12mm vs Untreated Internal Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Raio 1997 5/23 1/29 25.7 % 6.30 [ 0.79, 50.27 ]
Subtotal (95% CI) 23 29 25.7 % 6.30 [ 0.79, 50.27 ]
Total events: 5 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.74 (P = 0.082)
2 Excisional Treatment NOS
Castanon 2012 316/2719 98/1173 74.3 % 1.39 [ 1.12, 1.73 ]
Subtotal (95% CI) 2719 1173 74.3 % 1.39 [ 1.12, 1.73 ]
Total events: 316 (Treated), 98 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.99 (P = 0.0027)
Total (95% CI) 2742 1202 100.0 % 2.05 [ 0.56, 7.48 ]
Total events: 321 (Treated), 99 (Untreated)
Heterogeneity: Tau2 = 0.57; Chi2 = 2.01, df = 1 (P = 0.16); I2 =50%
Test for overall effect: Z = 1.09 (P = 0.28)
Test for subgroup differences: Chi2 = 2.01, df = 1 (P = 0.16), I2 =50%
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Analysis 1.67. Comparison 1 Maternal Outcomes-PTB, Outcome 67 PTB (<37w)-Depth≥10-12mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 67 PTB (<37w)-Depth≥10-12mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 17/175 10/278 1.8 % 2.70 [ 1.27, 5.76 ]
Noehr 2009a 168/2569 1318/31630 38.2 % 1.57 [ 1.34, 1.83 ]
Subtotal (95% CI) 2744 31908 40.0 % 1.80 [ 1.13, 2.87 ]
Total events: 185 (Treated), 1328 (Untreated)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.89, df = 1 (P = 0.17); I2 =47%
Test for overall effect: Z = 2.49 (P = 0.013)
2 Excisional Treatment NOS
Castanon 2012 316/2719 586/7263 52.5 % 1.44 [ 1.27, 1.64 ]
Sadler 2004 43/215 52/426 7.5 % 1.64 [ 1.13, 2.37 ]
Subtotal (95% CI) 2934 7689 60.0 % 1.46 [ 1.29, 1.65 ]
Total events: 359 (Treated), 638 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.42, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 6.08 (P < 0.00001)
Total (95% CI) 5678 39597 100.0 % 1.52 [ 1.37, 1.68 ]
Total events: 544 (Treated), 1966 (Untreated)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.19, df = 3 (P = 0.36); I2 =6%
Test for overall effect: Z = 8.04 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.74, df = 1 (P = 0.39), I2 =0.0%
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Analysis 1.68. Comparison 1 Maternal Outcomes-PTB, Outcome 68 PTB (<37w)-Depth≥15-17mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 68 PTB (<37w)-Depth≥15-17mm vs Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 14/61 7/150 31.1 % 4.92 [ 2.09, 11.59 ]
Subtotal (95% CI) 61 150 31.1 % 4.92 [ 2.09, 11.59 ]
Total events: 14 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.64 (P = 0.00027)
2 LLETZ
Noehr 2009a 119/1451 17106/510841 68.9 % 2.45 [ 2.06, 2.91 ]
Subtotal (95% CI) 1451 510841 68.9 % 2.45 [ 2.06, 2.91 ]
Total events: 119 (Treated), 17106 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 10.16 (P < 0.00001)
Total (95% CI) 1512 510991 100.0 % 3.04 [ 1.62, 5.73 ]
Total events: 133 (Treated), 17113 (Untreated)
Heterogeneity: Tau2 = 0.14; Chi2 = 2.44, df = 1 (P = 0.12); I2 =59%
Test for overall effect: Z = 3.45 (P = 0.00057)
Test for subgroup differences: Chi2 = 2.44, df = 1 (P = 0.12), I2 =59%
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Analysis 1.69. Comparison 1 Maternal Outcomes-PTB, Outcome 69 PTB (<37w)-Depth≥15-17mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 69 PTB (<37w)-Depth≥15-17mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 9/48 10/278 14.8 % 5.21 [ 2.23, 12.16 ]
Noehr 2009a 119/1451 1318/31630 51.6 % 1.97 [ 1.64, 2.36 ]
Subtotal (95% CI) 1499 31908 66.4 % 2.92 [ 1.14, 7.46 ]
Total events: 128 (Treated), 1328 (Untreated)
Heterogeneity: Tau2 = 0.38; Chi2 = 4.86, df = 1 (P = 0.03); I2 =79%
Test for overall effect: Z = 2.24 (P = 0.025)
2 Excisional Treatment NOS
Sadler 2004 25/101 52/426 33.6 % 2.03 [ 1.33, 3.10 ]
Subtotal (95% CI) 101 426 33.6 % 2.03 [ 1.33, 3.10 ]
Total events: 25 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.26 (P = 0.0011)
Total (95% CI) 1600 32334 100.0 % 2.30 [ 1.57, 3.35 ]
Total events: 153 (Treated), 1380 (Untreated)
Heterogeneity: Tau2 = 0.06; Chi2 = 4.86, df = 2 (P = 0.09); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000016)
Test for subgroup differences: Chi2 = 0.48, df = 1 (P = 0.49), I2 =0.0%
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Analysis 1.70. Comparison 1 Maternal Outcomes-PTB, Outcome 70 PTB (<37w)-Depth≥20mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 70 PTB (<37w)-Depth≥20mm vs Untreated External Comparison Group
Study or subgroup Treatment Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 12/42 7/150 36.5 % 6.12 [ 2.57, 14.57 ]
Subtotal (95% CI) 42 150 36.5 % 6.12 [ 2.57, 14.57 ]
Total events: 12 (Treatment), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.10 (P = 0.000042)
2 LLETZ
Noehr 2009a 72/801 17106/510841 63.5 % 2.68 [ 2.15, 3.35 ]
Subtotal (95% CI) 801 510841 63.5 % 2.68 [ 2.15, 3.35 ]
Total events: 72 (Treatment), 17106 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.76 (P < 0.00001)
Total (95% CI) 843 510991 100.0 % 3.63 [ 1.67, 7.90 ]
Total events: 84 (Treatment), 17113 (Untreated)
Heterogeneity: Tau2 = 0.24; Chi2 = 3.26, df = 1 (P = 0.07); I2 =69%
Test for overall effect: Z = 3.25 (P = 0.0012)
Test for subgroup differences: Chi2 = 3.26, df = 1 (P = 0.07), I2 =69%
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Analysis 1.71. Comparison 1 Maternal Outcomes-PTB, Outcome 71 PTB (<37w)-Depth≥20mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 71 PTB (<37w)-Depth≥20mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treatment Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 3/8 10/278 44.1 % 10.43 [ 3.53, 30.76 ]
Noehr 2009a 72/801 1318/31630 55.9 % 2.16 [ 1.72, 2.71 ]
Total (95% CI) 809 31908 100.0 % 4.32 [ 0.93, 20.03 ]
Total events: 75 (Treatment), 1328 (Untreated)
Heterogeneity: Tau2 = 1.08; Chi2 = 7.80, df = 1 (P = 0.01); I2 =87%
Test for overall effect: Z = 1.87 (P = 0.061)
Test for subgroup differences: Not applicable
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Analysis 1.72. Comparison 1 Maternal Outcomes-PTB, Outcome 72 PTB (<37w)-Depth 10/13-15/16mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 72 PTB (<37w)-Depth 10/13-15/16mm vs Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Noehr 2009a 49/1118 17106/510841 100.0 % 1.31 [ 0.99, 1.72 ]
Total (95% CI) 1118 510841 100.0 % 1.31 [ 0.99, 1.72 ]
Total events: 49 (Treated), 17106 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.92 (P = 0.054)
Test for subgroup differences: Not applicable
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Analysis 1.73. Comparison 1 Maternal Outcomes-PTB, Outcome 73 PTB (<37w)-Depth 10/13-15/16mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 73 PTB (<37w)-Depth 10/13-15/16mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 8/127 10/278 6.7 % 1.75 [ 0.71, 4.33 ]
Noehr 2009a 49/1118 1318/31630 70.8 % 1.05 [ 0.80, 1.39 ]
Subtotal (95% CI) 1245 31908 77.5 % 1.12 [ 0.80, 1.57 ]
Total events: 57 (Treated), 1328 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.11, df = 1 (P = 0.29); I2 =10%
Test for overall effect: Z = 0.68 (P = 0.50)
2 Excisional Treatment NOS
Sadler 2004 18/114 52/426 22.5 % 1.29 [ 0.79, 2.12 ]
Subtotal (95% CI) 114 426 22.5 % 1.29 [ 0.79, 2.12 ]
Total events: 18 (Treated), 52 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
Total (95% CI) 1359 32334 100.0 % 1.14 [ 0.90, 1.44 ]
Total events: 75 (Treated), 1380 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.43, df = 2 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Chi2 = 0.22, df = 1 (P = 0.64), I2 =0.0%
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Analysis 1.74. Comparison 1 Maternal Outcomes-PTB, Outcome 74 PTB (<37w)-Depth 15/16-19/20mm vs
Untreated External Comparison Group.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 74 PTB (<37w)-Depth 15/16-19/20mm vs Untreated External Comparison Group
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC
Andersen 1999 2/19 7/150 3.3 % 2.26 [ 0.50, 10.08 ]
Subtotal (95% CI) 19 150 3.3 % 2.26 [ 0.50, 10.08 ]
Total events: 2 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.06 (P = 0.29)
2 LLETZ
Noehr 2009a 47/650 17106/510841 96.7 % 2.16 [ 1.64, 2.84 ]
Subtotal (95% CI) 650 510841 96.7 % 2.16 [ 1.64, 2.84 ]
Total events: 47 (Treated), 17106 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.47 (P < 0.00001)
Total (95% CI) 669 510991 100.0 % 2.16 [ 1.65, 2.84 ]
Total events: 49 (Treated), 17113 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 5.57 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.96), I2 =0.0%
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Analysis 1.75. Comparison 1 Maternal Outcomes-PTB, Outcome 75 PTB (<37w)-Depth 15/16-19/20mm vs
Untreated Colposcopy+/-CIN+/-Biopsy.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 1 Maternal Outcomes-PTB
Outcome: 75 PTB (<37w)-Depth 15/16-19/20mm vs Untreated Colposcopy+/-CIN+/-Biopsy
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ
Kitson 2014 6/40 10/278 35.8 % 4.17 [ 1.60, 10.85 ]
Noehr 2009a 47/650 1318/31630 64.2 % 1.74 [ 1.31, 2.30 ]
Total (95% CI) 690 31908 100.0 % 2.38 [ 1.04, 5.42 ]
Total events: 53 (Treated), 1328 (Untreated)
Heterogeneity: Tau2 = 0.26; Chi2 = 2.97, df = 1 (P = 0.08); I2 =66%
Test for overall effect: Z = 2.06 (P = 0.040)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Other maternal Outcomes, Outcome 1 sPTB (<37w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 1 sPTB (<37w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 4/21 0/13 0.4 % 5.73 [ 0.33, 98.41 ]
Jones 1979 11/66 8/264 3.0 % 5.50 [ 2.30, 13.13 ]
Ortoft 2010 7/67 283/6889 3.9 % 2.54 [ 1.25, 5.17 ]
Subtotal (95% CI) 154 7166 7.2 % 3.53 [ 2.05, 6.05 ]
Total events: 22 (Treated), 291 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.93, df = 2 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 4.57 (P < 0.00001)
2 LC vs No Treatment
Sadler 2004 3/88 2/62 1.0 % 1.06 [ 0.18, 6.14 ]
Simoens 2012 4/24 5/48 1.8 % 1.60 [ 0.47, 5.42 ]
Subtotal (95% CI) 112 110 2.8 % 1.40 [ 0.51, 3.81 ]
Total events: 7 (Treated), 7 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.14, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
3 NETZ vs No Treatment
Ortoft 2010 17/71 301/7328 6.2 % 5.83 [ 3.80, 8.95 ]
Subtotal (95% CI) 71 7328 6.2 % 5.83 [ 3.80, 8.95 ]
Total events: 17 (Treated), 301 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.05 (P < 0.00001)
4 LLETZ vs No Treatment
Blomfield 1993 6/40 9/80 2.6 % 1.33 [ 0.51, 3.48 ]
Crane 2006 10/75 1/46 0.7 % 6.13 [ 0.81, 46.36 ]
Himes 2007 5/114 56/962 2.9 % 0.75 [ 0.31, 1.84 ]
Noehr 2009a 530/8180 14758/434520 9.2 % 1.91 [ 1.75, 2.07 ]
Ortoft 2010 55/572 2426/59065 8.0 % 2.34 [ 1.82, 3.02 ]
Paraskevaidis 2002 9/28 1/28 0.8 % 9.00 [ 1.22, 66.40 ]
Poon 2012 41/473 1156/25772 7.5 % 1.93 [ 1.43, 2.60 ]
Sadler 2004 13/247 7/179 2.8 % 1.35 [ 0.55, 3.31 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Simoens 2012 7/52 3/104 1.6 % 4.67 [ 1.26, 17.31 ]
Stout 2015 115/598 178/1129 8.3 % 1.22 [ 0.99, 1.51 ]
Werner 2010 7/511 7403/240348 3.7 % 0.44 [ 0.21, 0.93 ]
Subtotal (95% CI) 10890 762233 48.2 % 1.60 [ 1.22, 2.08 ]
Total events: 798 (Treated), 25998 (Untreated)
Heterogeneity: Tau2 = 0.10; Chi2 = 43.22, df = 10 (P<0.00001); I2 =77%
Test for overall effect: Z = 3.45 (P = 0.00055)
5 LA vs No Treatment
Sadler 2004 8/208 6/148 2.3 % 0.95 [ 0.34, 2.68 ]
Subtotal (95% CI) 208 148 2.3 % 0.95 [ 0.34, 2.68 ]
Total events: 8 (Treated), 6 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.10 (P = 0.92)
6 CT vs No Treatment
Crane 2006 1/36 0/22 0.3 % 1.86 [ 0.08, 43.87 ]
Subtotal (95% CI) 36 22 0.3 % 1.86 [ 0.08, 43.87 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
7 Excisional Treatment NOS vs No Treatment
Shanbhag 2009 113/1103 5448/94846 8.7 % 1.78 [ 1.49, 2.13 ]
Simoens 2012 2/12 5/24 1.3 % 0.80 [ 0.18, 3.54 ]
Subtotal (95% CI) 1115 94870 9.9 % 1.70 [ 1.17, 2.46 ]
Total events: 115 (Treated), 5453 (Untreated)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.10, df = 1 (P = 0.29); I2 =9%
Test for overall effect: Z = 2.81 (P = 0.0049)
8 Ablative Treatment NOS vs No Treatment
Noehr 2009a 95/2027 3666/107951 8.5 % 1.38 [ 1.13, 1.68 ]
Shanbhag 2009 26/285 1405/24457 6.8 % 1.59 [ 1.10, 2.30 ]
Subtotal (95% CI) 2312 132408 15.2 % 1.42 [ 1.20, 1.70 ]
Total events: 121 (Treated), 5071 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.43, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 3.96 (P = 0.000076)
9 Treatment NOS vs No Treatment
Bruinsma 2007 92/1951 130/3597 7.9 % 1.30 [ 1.00, 1.69 ]
Subtotal (95% CI) 1951 3597 7.9 % 1.30 [ 1.00, 1.69 ]
Total events: 92 (Treated), 130 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.046)
Total (95% CI) 16849 1007882 100.0 % 1.76 [ 1.47, 2.11 ]
Total events: 1181 (Treated), 37257 (Untreated)
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.09; Chi2 = 95.89, df = 23 (P<0.00001); I2 =76%
Test for overall effect: Z = 6.10 (P < 0.00001)
Test for subgroup differences: Chi2 = 47.92, df = 8 (P = 0.00), I2 =83%
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Analysis 2.2. Comparison 2 Other maternal Outcomes, Outcome 2 sPTB (<32-34w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 2 sPTB (<32-34w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 0/21 0/13 Not estimable
Ortoft 2010 2/67 47/6889 4.2 % 4.38 [ 1.08, 17.65 ]
Subtotal (95% CI) 88 6902 4.2 % 4.38 [ 1.08, 17.65 ]
Total events: 2 (Treated), 47 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.07 (P = 0.038)
2 NETZ vs No Treatment
Ortoft 2010 5/71 49/7328 8.2 % 10.53 [ 4.33, 25.65 ]
Subtotal (95% CI) 71 7328 8.2 % 10.53 [ 4.33, 25.65 ]
Total events: 5 (Treated), 49 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.18 (P < 0.00001)
3 LLETZ vs No Treatment
Crane 2006 3/75 1/46 1.9 % 1.84 [ 0.20, 17.17 ]
Kitson 2014 8/278 2/278 3.6 % 4.00 [ 0.86, 18.67 ]
Noehr 2009a 119/8180 2324/434519 21.1 % 2.72 [ 2.27, 3.27 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Ortoft 2010 11/572 399/59065 12.7 % 2.85 [ 1.57, 5.15 ]
Poon 2012 16/473 336/25772 14.7 % 2.59 [ 1.58, 4.25 ]
Stout 2015 40/598 51/1129 16.7 % 1.48 [ 0.99, 2.21 ]
Subtotal (95% CI) 10176 520809 70.6 % 2.37 [ 1.82, 3.08 ]
Total events: 197 (Treated), 3113 (Untreated)
Heterogeneity: Tau2 = 0.04; Chi2 = 7.98, df = 5 (P = 0.16); I2 =37%
Test for overall effect: Z = 6.44 (P < 0.00001)
4 CT vs No Treatment
Crane 2006 1/36 0/22 1.0 % 1.86 [ 0.08, 43.87 ]
Subtotal (95% CI) 36 22 1.0 % 1.86 [ 0.08, 43.87 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
5 Excisional Treatment NOS vs No Treatment
Simoens 2012 3/88 0/176 1.1 % 13.92 [ 0.73, 266.57 ]
Subtotal (95% CI) 88 176 1.1 % 13.92 [ 0.73, 266.57 ]
Total events: 3 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.75 (P = 0.080)
6 Ablative Treatment NOS vs No Treatment
Noehr 2009a 17/2027 578/107952 15.0 % 1.57 [ 0.97, 2.53 ]
Subtotal (95% CI) 2027 107952 15.0 % 1.57 [ 0.97, 2.53 ]
Total events: 17 (Treated), 578 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.067)
Total (95% CI) 12486 643189 100.0 % 2.63 [ 1.91, 3.62 ]
Total events: 225 (Treated), 3787 (Untreated)
Heterogeneity: Tau2 = 0.12; Chi2 = 23.60, df = 10 (P = 0.01); I2 =58%
Test for overall effect: Z = 5.96 (P < 0.00001)
Test for subgroup differences: Chi2 = 15.73, df = 5 (P = 0.01), I2 =68%
0.01 0.1 1 10 100
More Harm Untreated More Harm Treated
244Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.3. Comparison 2 Other maternal Outcomes, Outcome 3 sPTB (<28w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 3 sPTB (<28w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 1/67 19/6889 8.3 % 5.41 [ 0.74, 39.84 ]
Subtotal (95% CI) 67 6889 8.3 % 5.41 [ 0.74, 39.84 ]
Total events: 1 (Treated), 19 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.66 (P = 0.097)
2 NETZ vs No Treatment
Ortoft 2010 3/71 21/7328 16.2 % 14.74 [ 4.50, 48.32 ]
Subtotal (95% CI) 71 7328 16.2 % 14.74 [ 4.50, 48.32 ]
Total events: 3 (Treated), 21 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.44 (P < 0.00001)
3 LLETZ vs No Treatment
Noehr 2009a 50/8180 1055/434519 31.8 % 2.52 [ 1.90, 3.34 ]
Ortoft 2010 5/572 166/59065 21.1 % 3.11 [ 1.28, 7.54 ]
Subtotal (95% CI) 8752 493584 52.9 % 2.57 [ 1.96, 3.36 ]
Total events: 55 (Treated), 1221 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.20, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 6.86 (P < 0.00001)
4 Ablative Treatment NOS vs No Treatment
Noehr 2009a 6/2027 262/107952 22.5 % 1.22 [ 0.54, 2.74 ]
Subtotal (95% CI) 2027 107952 22.5 % 1.22 [ 0.54, 2.74 ]
Total events: 6 (Treated), 262 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Total (95% CI) 10917 615753 100.0 % 3.18 [ 1.64, 6.16 ]
Total events: 65 (Treated), 1523 (Untreated)
Heterogeneity: Tau2 = 0.34; Chi2 = 12.31, df = 4 (P = 0.02); I2 =67%
Test for overall effect: Z = 3.41 (P = 0.00064)
Test for subgroup differences: Chi2 = 12.11, df = 3 (P = 0.01), I2 =75%
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Analysis 2.4. Comparison 2 Other maternal Outcomes, Outcome 4 pPROM (<37w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 4 pPROM (<37w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Sozen 2014 5/15 1/24 1.5 % 8.00 [ 1.03, 62.01 ]
Guo 2013 5/36 3/29 2.7 % 1.34 [ 0.35, 5.15 ]
Ortoft 2010 5/67 151/6775 4.0 % 3.35 [ 1.42, 7.90 ]
Klaritsch 2006 13/76 775/29711 5.2 % 6.56 [ 3.98, 10.81 ]
Subtotal (95% CI) 194 36539 13.4 % 4.11 [ 2.05, 8.25 ]
Total events: 28 (Treated), 930 (Untreated)
Heterogeneity: Tau2 = 0.23; Chi2 = 5.84, df = 3 (P = 0.12); I2 =49%
Test for overall effect: Z = 3.98 (P = 0.000070)
2 LC vs No Treatment
Sagot 1995 6/53 1/59 1.5 % 6.68 [ 0.83, 53.69 ]
Sadler 2004 15/100 3/70 3.0 % 3.50 [ 1.05, 11.64 ]
Andersen 1999 6/75 7/150 3.4 % 1.71 [ 0.60, 4.92 ]
Raio 1997 16/64 14/64 4.8 % 1.14 [ 0.61, 2.14 ]
Subtotal (95% CI) 292 343 12.7 % 1.89 [ 0.97, 3.66 ]
Total events: 43 (Treated), 25 (Untreated)
Heterogeneity: Tau2 = 0.16; Chi2 = 4.55, df = 3 (P = 0.21); I2 =34%
Test for overall effect: Z = 1.88 (P = 0.061)
3 NETZ vs No Treatment
Ortoft 2010 14/71 161/7208 5.2 % 8.83 [ 5.39, 14.46 ]
Subtotal (95% CI) 71 7208 5.2 % 8.83 [ 5.39, 14.46 ]
Total events: 14 (Treated), 161 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 8.65 (P < 0.00001)
4 LLETZ vs No Treatment
Braet 1994 6/78 2/78 2.2 % 3.00 [ 0.62, 14.41 ]
Himes 2007 2/114 20/962 2.5 % 0.84 [ 0.20, 3.56 ]
Guo 2013 4/48 3/39 2.5 % 1.08 [ 0.26, 4.55 ]
Kitson 2014 14/278 5/278 3.6 % 2.80 [ 1.02, 7.67 ]
Samson 2005 20/571 5/571 3.7 % 4.00 [ 1.51, 10.58 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Sadler 2004 22/256 7/175 4.1 % 2.15 [ 0.94, 4.92 ]
Werner 2010 18/511 6281/240348 5.4 % 1.35 [ 0.86, 2.12 ]
Ortoft 2010 38/572 1296/58095 5.7 % 2.98 [ 2.18, 4.07 ]
Subtotal (95% CI) 2428 300546 29.6 % 2.15 [ 1.48, 3.12 ]
Total events: 124 (Treated), 7619 (Untreated)
Heterogeneity: Tau2 = 0.11; Chi2 = 12.39, df = 7 (P = 0.09); I2 =43%
Test for overall effect: Z = 4.00 (P = 0.000063)
5 LA vs No Treatment
Saunders 1986 8/97 4/97 3.1 % 2.00 [ 0.62, 6.42 ]
Sadler 2004 10/210 5/144 3.4 % 1.37 [ 0.48, 3.93 ]
Subtotal (95% CI) 307 241 6.5 % 1.62 [ 0.74, 3.55 ]
Total events: 18 (Treated), 9 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.22, df = 1 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 1.22 (P = 0.22)
6 CT vs No Treatment
Hemmingsson 1982 4/115 2/65 2.0 % 1.13 [ 0.21, 6.00 ]
Subtotal (95% CI) 115 65 2.0 % 1.13 [ 0.21, 6.00 ]
Total events: 4 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.14 (P = 0.89)
7 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 5/55 1/55 1.5 % 5.00 [ 0.60, 41.42 ]
Van Hentenryck 2012 10/106 4/212 3.2 % 5.00 [ 1.61, 15.57 ]
Sjoborg 2007 47/735 5/742 3.8 % 9.49 [ 3.80, 23.72 ]
Wuntakal 2013 16/261 17/257 4.7 % 0.93 [ 0.48, 1.79 ]
Shanbhag 2009 84/1103 5653/94846 6.0 % 1.28 [ 1.04, 1.57 ]
Subtotal (95% CI) 2260 96112 19.1 % 2.66 [ 1.13, 6.24 ]
Total events: 162 (Treated), 5680 (Untreated)
Heterogeneity: Tau2 = 0.69; Chi2 = 25.19, df = 4 (P = 0.00005); I2 =84%
Test for overall effect: Z = 2.25 (P = 0.025)
8 Ablative Treatment NOS vs No Treatment
Shanbhag 2009 25/285 1458/24457 5.6 % 1.47 [ 1.01, 2.15 ]
Subtotal (95% CI) 285 24457 5.6 % 1.47 [ 1.01, 2.15 ]
Total events: 25 (Treated), 1458 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.045)
9 Treatment NOS vs No Treatment
Bruinsma 2007 67/1951 86/3597 5.7 % 1.44 [ 1.05, 1.97 ]
Subtotal (95% CI) 1951 3597 5.7 % 1.44 [ 1.05, 1.97 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 67 (Treated), 86 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.26 (P = 0.024)
Total (95% CI) 7903 469108 100.0 % 2.36 [ 1.76, 3.17 ]
Total events: 485 (Treated), 15970 (Untreated)
Heterogeneity: Tau2 = 0.36; Chi2 = 124.14, df = 26 (P<0.00001); I2 =79%
Test for overall effect: Z = 5.77 (P < 0.00001)
Test for subgroup differences: Chi2 = 46.41, df = 8 (P = 0.00), I2 =83%
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Analysis 2.5. Comparison 2 Other maternal Outcomes, Outcome 5 pPROM (<32w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 5 pPROM (<32w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 1/67 19/6775 23.6 % 5.32 [ 0.72, 39.19 ]
Subtotal (95% CI) 67 6775 23.6 % 5.32 [ 0.72, 39.19 ]
Total events: 1 (Treated), 19 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
2 NETZ vs No Treatment
Ortoft 2010 5/71 20/7208 37.3 % 25.38 [ 9.80, 65.74 ]
Subtotal (95% CI) 71 7208 37.3 % 25.38 [ 9.80, 65.74 ]
Total events: 5 (Treated), 20 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 6.66 (P < 0.00001)
3 LLETZ vs No Treatment
Ortoft 2010 6/572 163/58095 39.1 % 3.74 [ 1.66, 8.41 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 572 58095 39.1 % 3.74 [ 1.66, 8.41 ]
Total events: 6 (Treated), 163 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.19 (P = 0.0014)
Total (95% CI) 710 72078 100.0 % 8.30 [ 2.03, 33.98 ]
Total events: 12 (Treated), 202 (Untreated)
Heterogeneity: Tau2 = 1.15; Chi2 = 9.20, df = 2 (P = 0.01); I2 =78%
Test for overall effect: Z = 2.94 (P = 0.0033)
Test for subgroup differences: Chi2 = 9.20, df = 2 (P = 0.01), I2 =78%
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Analysis 2.6. Comparison 2 Other maternal Outcomes, Outcome 6 pPROM (<28w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 6 pPROM (<28w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 0/67 7/6775 26.0 % 6.64 [ 0.38, 115.16 ]
Subtotal (95% CI) 67 6775 26.0 % 6.64 [ 0.38, 115.16 ]
Total events: 0 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.30 (P = 0.19)
2 NETZ vs No Treatment
Ortoft 2010 3/71 7/7208 40.1 % 43.51 [ 11.48, 164.86 ]
Subtotal (95% CI) 71 7208 40.1 % 43.51 [ 11.48, 164.86 ]
Total events: 3 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.55 (P < 0.00001)
3 LLETZ vs No Treatment
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Ortoft 2010 1/572 56/58095 33.9 % 1.81 [ 0.25, 13.08 ]
Subtotal (95% CI) 572 58095 33.9 % 1.81 [ 0.25, 13.08 ]
Total events: 1 (Treated), 56 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.55)
Total (95% CI) 710 72078 100.0 % 9.09 [ 1.04, 79.18 ]
Total events: 4 (Treated), 70 (Untreated)
Heterogeneity: Tau2 = 2.58; Chi2 = 7.15, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 2.00 (P = 0.046)
Test for subgroup differences: Chi2 = 7.15, df = 2 (P = 0.03), I2 =72%
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Analysis 2.7. Comparison 2 Other maternal Outcomes, Outcome 7 Threatened PTB.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 7 Threatened PTB
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Buller 1982 5/47 6/79 25.9 % 1.40 [ 0.45, 4.34 ]
Subtotal (95% CI) 47 79 25.9 % 1.40 [ 0.45, 4.34 ]
Total events: 5 (Treated), 6 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
2 LC vs No Treatment
Sagot 1995 7/53 5/59 28.1 % 1.56 [ 0.53, 4.62 ]
Subtotal (95% CI) 53 59 28.1 % 1.56 [ 0.53, 4.62 ]
Total events: 7 (Treated), 5 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.42)
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
3 LLETZ vs No Treatment
Acharya 2005 4/79 2/158 11.8 % 4.00 [ 0.75, 21.37 ]
Subtotal (95% CI) 79 158 11.8 % 4.00 [ 0.75, 21.37 ]
Total events: 4 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.62 (P = 0.10)
4 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 5/55 0/55 4.0 % 11.00 [ 0.62, 194.25 ]
Van Hentenryck 2012 10/106 5/212 30.2 % 4.00 [ 1.40, 11.41 ]
Subtotal (95% CI) 161 267 34.2 % 4.51 [ 1.68, 12.06 ]
Total events: 15 (Treated), 5 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.42, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 3.00 (P = 0.0027)
Total (95% CI) 340 563 100.0 % 2.44 [ 1.37, 4.33 ]
Total events: 31 (Treated), 18 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.83, df = 4 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 3.03 (P = 0.0024)
Test for subgroup differences: Chi2 = 3.41, df = 3 (P = 0.33), I2 =12%
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Analysis 2.8. Comparison 2 Other maternal Outcomes, Outcome 8 Chorioamnionitis.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 8 Chorioamnionitis
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Klaritsch 2006 2/76 313/28455 45.5 % 2.39 [ 0.61, 9.43 ]
Subtotal (95% CI) 76 28455 45.5 % 2.39 [ 0.61, 9.43 ]
Total events: 2 (Treated), 313 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
2 LC vs No Treatment
Sagot 1995 1/53 0/59 8.5 % 3.33 [ 0.14, 80.11 ]
Subtotal (95% CI) 53 59 8.5 % 3.33 [ 0.14, 80.11 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
3 LLETZ vs No Treatment
Acharya 2005 5/79 1/158 18.9 % 10.00 [ 1.19, 84.15 ]
Subtotal (95% CI) 79 158 18.9 % 10.00 [ 1.19, 84.15 ]
Total events: 5 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.12 (P = 0.034)
4 Excisional Treatment NOS vs No Treatment
Van Hentenryck 2012 3/106 2/212 27.2 % 3.00 [ 0.51, 17.68 ]
Subtotal (95% CI) 106 212 27.2 % 3.00 [ 0.51, 17.68 ]
Total events: 3 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.21 (P = 0.22)
Total (95% CI) 314 28884 100.0 % 3.43 [ 1.36, 8.64 ]
Total events: 11 (Treated), 316 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.26, df = 3 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 2.61 (P = 0.0091)
Test for subgroup differences: Chi2 = 1.26, df = 3 (P = 0.74), I2 =0.0%
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Analysis 2.9. Comparison 2 Other maternal Outcomes, Outcome 9 Caeserean Section.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 9 Caeserean Section
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Jones 1979 7/66 16/264 0.7 % 1.75 [ 0.75, 4.08 ]
Buller 1982 3/47 0/79 0.1 % 11.67 [ 0.62, 221.02 ]
Kuoppala 1986 4/62 5/62 0.3 % 0.80 [ 0.23, 2.84 ]
Klaritsch 2006 14/76 3657/29707 2.1 % 1.50 [ 0.93, 2.40 ]
Crane 2006 6/21 3/13 0.4 % 1.24 [ 0.37, 4.11 ]
Guo 2013 20/36 17/29 2.5 % 0.95 [ 0.62, 1.45 ]
Subtotal (95% CI) 308 30154 6.0 % 1.24 [ 0.91, 1.68 ]
Total events: 54 (Treated), 3698 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 5.47, df = 5 (P = 0.36); I2 =9%
Test for overall effect: Z = 1.35 (P = 0.18)
2 LC vs No Treatment
Hagen 1993 13/56 15/112 1.1 % 1.73 [ 0.89, 3.39 ]
Sagot 1995 6/53 1/59 0.1 % 6.68 [ 0.83, 53.69 ]
Bekassy 1996 19/250 21/250 1.4 % 0.90 [ 0.50, 1.64 ]
Andersen 1999 16/75 19/150 1.3 % 1.68 [ 0.92, 3.08 ]
Lima 2011 3/11 7/22 0.4 % 0.86 [ 0.27, 2.69 ]
Subtotal (95% CI) 445 593 4.3 % 1.38 [ 0.90, 2.11 ]
Total events: 57 (Treated), 63 (Untreated)
Heterogeneity: Tau2 = 0.07; Chi2 = 5.65, df = 4 (P = 0.23); I2 =29%
Test for overall effect: Z = 1.47 (P = 0.14)
3 LLETZ vs No Treatment
Gunasekera 1992 2/22 1/22 0.1 % 2.00 [ 0.20, 20.49 ]
Blomfield 1993 3/40 12/80 0.4 % 0.50 [ 0.15, 1.67 ]
Haffenden 1993 9/152 13/152 0.7 % 0.69 [ 0.31, 1.57 ]
Braet 1994 6/78 6/78 0.4 % 1.00 [ 0.34, 2.97 ]
Cruickshank 1995 16/147 38/295 1.6 % 0.84 [ 0.49, 1.46 ]
Paraskevaidis 2002 5/28 9/28 0.6 % 0.56 [ 0.21, 1.45 ]
Tan 2004 17/119 28/119 1.6 % 0.61 [ 0.35, 1.05 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Samson 2005 125/571 117/571 6.5 % 1.07 [ 0.85, 1.34 ]
Crane 2006 18/75 10/46 1.1 % 1.10 [ 0.56, 2.18 ]
Lima 2011 7/18 11/36 0.9 % 1.27 [ 0.60, 2.72 ]
Andia 2011 22/189 20/189 1.5 % 1.10 [ 0.62, 1.95 ]
Frey 2013 189/598 332/1140 9.9 % 1.09 [ 0.94, 1.26 ]
Guo 2013 28/48 22/39 3.2 % 1.03 [ 0.72, 1.49 ]
Kitson 2014 62/278 53/278 3.8 % 1.17 [ 0.84, 1.62 ]
Subtotal (95% CI) 2363 3073 32.2 % 1.04 [ 0.94, 1.15 ]
Total events: 509 (Treated), 672 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 9.79, df = 13 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.76 (P = 0.44)
4 LA vs No Treatment
Anderson 1984 11/68 12/70 0.9 % 0.94 [ 0.45, 1.99 ]
Saunders 1986 7/97 11/97 0.6 % 0.64 [ 0.26, 1.57 ]
Gunasekera 1992 10/109 7/109 0.6 % 1.43 [ 0.56, 3.62 ]
van Rooijen 1999 22/236 56/472 2.1 % 0.79 [ 0.49, 1.25 ]
Subtotal (95% CI) 510 748 4.2 % 0.86 [ 0.61, 1.20 ]
Total events: 50 (Treated), 86 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.77, df = 3 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.89 (P = 0.37)
5 CT vs No Treatment
Hemmingsson 1982 11/115 1/65 0.1 % 6.22 [ 0.82, 47.08 ]
Crane 2006 13/36 4/22 0.5 % 1.99 [ 0.74, 5.33 ]
Subtotal (95% CI) 151 87 0.7 % 2.47 [ 1.02, 6.01 ]
Total events: 24 (Treated), 5 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.99, df = 1 (P = 0.32); I2 =0.0%
Test for overall effect: Z = 2.00 (P = 0.046)
6 Excisional Treatment NOS vs No Treatment
El-Bastawissi 1999 234/950 56/282 5.4 % 1.24 [ 0.96, 1.61 ]
Shanbhag 2009 210/1103 19785/94846 11.4 % 0.91 [ 0.81, 1.03 ]
Fischer 2010 30/85 29/85 2.6 % 1.03 [ 0.68, 1.56 ]
van de Vijner 2010 13/58 16/56 1.2 % 0.78 [ 0.42, 1.48 ]
Armarnik 2011 13/53 16634/104617 2.1 % 1.54 [ 0.96, 2.47 ]
Van Hentenryck 2012 14/106 40/212 1.5 % 0.70 [ 0.40, 1.23 ]
Simoens 2012 22/97 45/194 2.3 % 0.98 [ 0.62, 1.53 ]
Wuntakal 2013 86/261 65/257 5.0 % 1.30 [ 0.99, 1.71 ]
0.01 0.1 1 10 100
More Harm Untreated More Harm Treated
(Continued . . . )
254Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Kirn 2015 36/135 43/135 3.1 % 0.84 [ 0.58, 1.22 ]
Subtotal (95% CI) 2848 200684 34.6 % 1.03 [ 0.89, 1.20 ]
Total events: 658 (Treated), 36713 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 14.67, df = 8 (P = 0.07); I2 =45%
Test for overall effect: Z = 0.44 (P = 0.66)
7 Ablative Treatment NOS vs No Treatment
El-Bastawissi 1999 13/81 1/25 0.1 % 4.01 [ 0.55, 29.17 ]
Shanbhag 2009 58/285 5102/24457 6.2 % 0.98 [ 0.77, 1.23 ]
Subtotal (95% CI) 366 24482 6.4 % 1.38 [ 0.42, 4.58 ]
Total events: 71 (Treated), 5103 (Untreated)
Heterogeneity: Tau2 = 0.48; Chi2 = 1.93, df = 1 (P = 0.17); I2 =48%
Test for overall effect: Z = 0.53 (P = 0.59)
8 Treatment NOS vs No Treatment
Bruinsma 2007 361/1951 589/3597 11.6 % 1.13 [ 1.00, 1.27 ]
Subtotal (95% CI) 1951 3597 11.6 % 1.13 [ 1.00, 1.27 ]
Total events: 361 (Treated), 589 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.044)
Total (95% CI) 8942 263418 100.0 % 1.06 [ 0.98, 1.14 ]
Total events: 1784 (Treated), 46929 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 51.55, df = 42 (P = 0.15); I2 =19%
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Chi2 = 8.70, df = 7 (P = 0.27), I2 =20%
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Analysis 2.10. Comparison 2 Other maternal Outcomes, Outcome 10 Instrumental Deliveries
(ventouse/forceps).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 10 Instrumental Deliveries (ventouse/forceps)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Jones 1979 8/66 21/264 1.9 % 1.52 [ 0.71, 3.29 ]
Kuoppala 1986 2/62 3/62 0.4 % 0.67 [ 0.12, 3.85 ]
Subtotal (95% CI) 128 326 2.3 % 1.33 [ 0.66, 2.70 ]
Total events: 10 (Treated), 24 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.72, df = 1 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 0.80 (P = 0.42)
2 LC vs No Treatment
Bekassy 1996 16/250 15/250 2.4 % 1.07 [ 0.54, 2.11 ]
Hagen 1993 5/56 7/112 0.9 % 1.43 [ 0.47, 4.30 ]
Subtotal (95% CI) 306 362 3.3 % 1.16 [ 0.65, 2.07 ]
Total events: 21 (Treated), 22 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.20, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.49 (P = 0.62)
3 LLETZ vs No Treatment
Blomfield 1993 1/40 4/80 0.2 % 0.50 [ 0.06, 4.33 ]
Braet 1994 3/78 8/78 0.7 % 0.38 [ 0.10, 1.36 ]
Gunasekera 1992 2/22 1/22 0.2 % 2.00 [ 0.20, 20.49 ]
Haffenden 1993 16/152 18/152 2.8 % 0.89 [ 0.47, 1.68 ]
Kitson 2014 46/278 52/278 8.6 % 0.88 [ 0.62, 1.27 ]
Tan 2004 17/119 15/119 2.7 % 1.13 [ 0.59, 2.16 ]
Subtotal (95% CI) 689 729 15.1 % 0.89 [ 0.68, 1.17 ]
Total events: 85 (Treated), 98 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.00, df = 5 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
4 LA vs No Treatment
Anderson 1984 8/68 14/70 1.7 % 0.59 [ 0.26, 1.31 ]
Gunasekera 1992 15/109 12/109 2.2 % 1.25 [ 0.61, 2.55 ]
Saunders 1986 16/97 16/97 2.8 % 1.00 [ 0.53, 1.88 ]
Subtotal (95% CI) 274 276 6.7 % 0.94 [ 0.62, 1.41 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 39 (Treated), 42 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.97, df = 2 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 0.31 (P = 0.76)
5 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 1/58 5/56 0.2 % 0.19 [ 0.02, 1.60 ]
Van Hentenryck 2012 17/106 39/212 4.1 % 0.87 [ 0.52, 1.47 ]
Wuntakal 2013 15/261 24/257 2.9 % 0.62 [ 0.33, 1.15 ]
Subtotal (95% CI) 425 525 7.3 % 0.71 [ 0.46, 1.10 ]
Total events: 33 (Treated), 68 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 2.25, df = 2 (P = 0.32); I2 =11%
Test for overall effect: Z = 1.54 (P = 0.12)
6 Treatment NOS vs No Treatment
Bruinsma 2007 296/1951 539/3597 65.3 % 1.01 [ 0.89, 1.15 ]
Subtotal (95% CI) 1951 3597 65.3 % 1.01 [ 0.89, 1.15 ]
Total events: 296 (Treated), 539 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
Total (95% CI) 3773 5815 100.0 % 0.97 [ 0.88, 1.08 ]
Total events: 484 (Treated), 793 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 12.27, df = 16 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Chi2 = 3.90, df = 5 (P = 0.56), I2 =0.0%
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Analysis 2.11. Comparison 2 Other maternal Outcomes, Outcome 11 Precipitous Labour (<2hours).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 11 Precipitous Labour (<2hours)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Guo 2013 0/16 0/13 Not estimable
Jones 1979 5/55 15/205 21.2 % 1.24 [ 0.47, 3.27 ]
Subtotal (95% CI) 71 218 21.2 % 1.24 [ 0.47, 3.27 ]
Total events: 5 (Treated), 15 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
2 LLETZ vs No Treatment
Cruickshank 1995 7/131 11/257 23.2 % 1.25 [ 0.50, 3.15 ]
Guo 2013 0/20 0/16 Not estimable
Haffenden 1993 19/152 15/152 48.6 % 1.27 [ 0.67, 2.40 ]
Paraskevaidis 2002 3/23 2/19 7.0 % 1.24 [ 0.23, 6.67 ]
Subtotal (95% CI) 326 444 78.8 % 1.26 [ 0.76, 2.08 ]
Total events: 29 (Treated), 28 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 2 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.90 (P = 0.37)
Total (95% CI) 397 662 100.0 % 1.26 [ 0.80, 1.96 ]
Total events: 34 (Treated), 43 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 3 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.98), I2 =0.0%
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Analysis 2.12. Comparison 2 Other maternal Outcomes, Outcome 12 Prolonged labour (>12hours).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 12 Prolonged labour (>12hours)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Guo 2013 0/36 0/29 Not estimable
Jones 1979 8/55 15/205 14.4 % 1.99 [ 0.89, 4.45 ]
Subtotal (95% CI) 91 234 14.4 % 1.99 [ 0.89, 4.45 ]
Total events: 8 (Treated), 15 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.67 (P = 0.094)
2 LC vs No Treatment
Bekassy 1996 11/250 12/250 14.6 % 0.92 [ 0.41, 2.04 ]
Subtotal (95% CI) 250 250 14.6 % 0.92 [ 0.41, 2.04 ]
Total events: 11 (Treated), 12 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
3 LLETZ vs No Treatment
Gunasekera 1992 2/22 5/22 4.0 % 0.40 [ 0.09, 1.85 ]
Guo 2013 0/48 0/39 Not estimable
Haffenden 1993 9/152 8/152 10.9 % 1.13 [ 0.45, 2.84 ]
Tan 2004 11/119 10/119 14.0 % 1.10 [ 0.49, 2.49 ]
Subtotal (95% CI) 341 332 28.8 % 0.96 [ 0.55, 1.70 ]
Total events: 22 (Treated), 23 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.48, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
4 LA vs No Treatment
Anderson 1984 13/68 11/70 17.5 % 1.22 [ 0.59, 2.53 ]
Gunasekera 1992 22/109 14/109 24.7 % 1.57 [ 0.85, 2.91 ]
Subtotal (95% CI) 177 179 42.1 % 1.41 [ 0.88, 2.26 ]
Total events: 35 (Treated), 25 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.28, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.44 (P = 0.15)
Total (95% CI) 859 995 100.0 % 1.25 [ 0.92, 1.69 ]
Total events: 76 (Treated), 75 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 4.67, df = 6 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.42 (P = 0.16)
Test for subgroup differences: Chi2 = 2.91, df = 3 (P = 0.41), I2 =0.0%
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Analysis 2.13. Comparison 2 Other maternal Outcomes, Outcome 13 Induction of Labour.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 13 Induction of Labour
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 8/21 4/13 1.6 % 1.24 [ 0.46, 3.30 ]
Kuoppala 1986 6/52 6/51 1.4 % 0.98 [ 0.34, 2.84 ]
Subtotal (95% CI) 73 64 3.0 % 1.11 [ 0.54, 2.29 ]
Total events: 14 (Treated), 10 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.10, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
2 LLETZ vs No treatment
Acharya 2005 9/79 10/158 2.1 % 1.80 [ 0.76, 4.25 ]
Blomfield 1993 1/40 4/80 0.3 % 0.50 [ 0.06, 4.33 ]
Braet 1994 14/78 14/78 3.4 % 1.00 [ 0.51, 1.96 ]
Crane 2006 13/75 14/46 3.5 % 0.57 [ 0.29, 1.10 ]
Frey 2013 185/598 313/1140 36.1 % 1.13 [ 0.97, 1.31 ]
Haffenden 1993 25/152 30/152 6.3 % 0.83 [ 0.52, 1.35 ]
Samson 2005 155/571 136/571 26.3 % 1.14 [ 0.93, 1.39 ]
Tan 2004 19/119 30/119 5.6 % 0.63 [ 0.38, 1.06 ]
Subtotal (95% CI) 1712 2344 83.6 % 0.99 [ 0.82, 1.20 ]
Total events: 421 (Treated), 551 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 11.27, df = 7 (P = 0.13); I2 =38%
Test for overall effect: Z = 0.08 (P = 0.94)
3 CT vs No Treatment
Crane 2006 6/36 6/22 1.6 % 0.61 [ 0.22, 1.66 ]
Subtotal (95% CI) 36 22 1.6 % 0.61 [ 0.22, 1.66 ]
Total events: 6 (Treated), 6 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
4 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 10/44 15/55 3.2 % 0.83 [ 0.42, 1.67 ]
Van Hentenryck 2012 26/106 56/212 8.7 % 0.93 [ 0.62, 1.39 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 150 267 11.9 % 0.90 [ 0.64, 1.28 ]
Total events: 36 (Treated), 71 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.07, df = 1 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
Total (95% CI) 1971 2697 100.0 % 1.01 [ 0.89, 1.15 ]
Total events: 477 (Treated), 638 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 13.38, df = 12 (P = 0.34); I2 =10%
Test for overall effect: Z = 0.22 (P = 0.82)
Test for subgroup differences: Chi2 = 1.18, df = 3 (P = 0.76), I2 =0.0%
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Analysis 2.14. Comparison 2 Other maternal Outcomes, Outcome 14 Oxytocin Use.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 14 Oxytocin Use
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Kuoppala 1986 19/52 19/51 18.4 % 0.98 [ 0.59, 1.63 ]
Subtotal (95% CI) 52 51 18.4 % 0.98 [ 0.59, 1.63 ]
Total events: 19 (Treated), 19 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
2 LLETZ vs No Treatment
Blomfield 1993 9/40 18/80 13.2 % 1.00 [ 0.49, 2.02 ]
Haffenden 1993 15/152 22/152 15.3 % 0.68 [ 0.37, 1.26 ]
Samson 2005 101/571 83/571 26.1 % 1.22 [ 0.93, 1.59 ]
Tan 2004 6/119 21/119 10.2 % 0.29 [ 0.12, 0.68 ]
Subtotal (95% CI) 882 922 64.7 % 0.76 [ 0.43, 1.34 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total events: 131 (Treated), 144 (Untreated)
Heterogeneity: Tau2 = 0.23; Chi2 = 11.52, df = 3 (P = 0.01); I2 =74%
Test for overall effect: Z = 0.95 (P = 0.34)
3 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 16/44 17/55 16.9 % 1.18 [ 0.67, 2.05 ]
Subtotal (95% CI) 44 55 16.9 % 1.18 [ 0.67, 2.05 ]
Total events: 16 (Treated), 17 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
Total (95% CI) 978 1028 100.0 % 0.90 [ 0.64, 1.26 ]
Total events: 166 (Treated), 180 (Untreated)
Heterogeneity: Tau2 = 0.10; Chi2 = 11.81, df = 5 (P = 0.04); I2 =58%
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Chi2 = 1.17, df = 2 (P = 0.56), I2 =0.0%
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Analysis 2.15. Comparison 2 Other maternal Outcomes, Outcome 15 Epidural Use.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 15 Epidural Use
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Blomfield 1993 6/40 17/80 13.4 % 0.71 [ 0.30, 1.65 ]
Braet 1994 9/78 13/78 14.6 % 0.69 [ 0.31, 1.53 ]
Haffenden 1993 28/152 29/152 22.9 % 0.97 [ 0.60, 1.54 ]
Tan 2004 23/119 26/119 22.0 % 0.88 [ 0.54, 1.46 ]
Subtotal (95% CI) 389 429 73.0 % 0.86 [ 0.64, 1.16 ]
Total events: 66 (Treated), 85 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.74, df = 3 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.99 (P = 0.32)
2 Excisional Treatment NOS vs No Treatment
Armarnik 2011 21/53 23120/104617 27.0 % 1.79 [ 1.29, 2.50 ]
Subtotal (95% CI) 53 104617 27.0 % 1.79 [ 1.29, 2.50 ]
Total events: 21 (Treated), 23120 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.44 (P = 0.00058)
Total (95% CI) 442 105046 100.0 % 1.02 [ 0.68, 1.53 ]
Total events: 87 (Treated), 23205 (Untreated)
Heterogeneity: Tau2 = 0.13; Chi2 = 11.21, df = 4 (P = 0.02); I2 =64%
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Chi2 = 10.47, df = 1 (P = 0.00), I2 =90%
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Analysis 2.16. Comparison 2 Other maternal Outcomes, Outcome 16 Pethidine Use.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 16 Pethidine Use
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No treatment
Braet 1994 35/78 39/78 68.3 % 0.90 [ 0.64, 1.25 ]
Tan 2004 26/119 25/119 31.7 % 1.04 [ 0.64, 1.69 ]
Total (95% CI) 197 197 100.0 % 0.94 [ 0.72, 1.24 ]
Total events: 61 (Treated), 64 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.24, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.44 (P = 0.66)
Test for subgroup differences: Not applicable
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Analysis 2.17. Comparison 2 Other maternal Outcomes, Outcome 17 Analgesia Use NOS.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 17 Analgesia Use NOS
Study or subgroup
More
Harm
Untreated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Kuoppala 1986 17/52 15/51 100.0 % 1.11 [ 0.62, 1.98 ]
Total (95% CI) 52 51 100.0 % 1.11 [ 0.62, 1.98 ]
Total events: 17 (More Harm Untreated), 15 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
Test for subgroup differences: Not applicable
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Analysis 2.18. Comparison 2 Other maternal Outcomes, Outcome 18 Cervical stenosis.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 18 Cervical stenosis
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Bekassy 1996 1/250 0/250 49.9 % 3.00 [ 0.12, 73.29 ]
Subtotal (95% CI) 250 250 49.9 % 3.00 [ 0.12, 73.29 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
2 CT vs No Treatment
Hemmingsson 1982 1/115 0/65 50.1 % 1.71 [ 0.07, 41.31 ]
Subtotal (95% CI) 115 65 50.1 % 1.71 [ 0.07, 41.31 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.33 (P = 0.74)
Total (95% CI) 365 315 100.0 % 2.26 [ 0.24, 21.59 ]
Total events: 2 (Treated), 0 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.06, df = 1 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Chi2 = 0.06, df = 1 (P = 0.81), I2 =0.0%
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Analysis 2.19. Comparison 2 Other maternal Outcomes, Outcome 19 Antepartum Haemorrhage.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 19 Antepartum Haemorrhage
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 4/21 2/13 17.9 % 1.24 [ 0.26, 5.83 ]
Subtotal (95% CI) 21 13 17.9 % 1.24 [ 0.26, 5.83 ]
Total events: 4 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.79)
2 LC vs No Treatment
Hagen 1993 4/56 0/112 8.9 % 17.84 [ 0.98, 325.68 ]
Subtotal (95% CI) 56 112 8.9 % 17.84 [ 0.98, 325.68 ]
Total events: 4 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.94 (P = 0.052)
3 LLETZ vs No Treatment
Braet 1994 7/78 8/78 23.8 % 0.88 [ 0.33, 2.30 ]
Crane 2006 3/75 7/46 20.3 % 0.26 [ 0.07, 0.97 ]
Subtotal (95% CI) 153 124 44.1 % 0.52 [ 0.16, 1.67 ]
Total events: 10 (Treated), 15 (Untreated)
Heterogeneity: Tau2 = 0.38; Chi2 = 2.12, df = 1 (P = 0.15); I2 =53%
Test for overall effect: Z = 1.09 (P = 0.27)
4 LA vs No Treatment
van Rooijen 1999 4/236 1/472 12.8 % 8.00 [ 0.90, 71.18 ]
Subtotal (95% CI) 236 472 12.8 % 8.00 [ 0.90, 71.18 ]
Total events: 4 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.86 (P = 0.062)
5 CT vs No Treatment
Crane 2006 2/36 3/22 16.4 % 0.41 [ 0.07, 2.25 ]
Subtotal (95% CI) 36 22 16.4 % 0.41 [ 0.07, 2.25 ]
Total events: 2 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
Total (95% CI) 502 743 100.0 % 1.11 [ 0.40, 3.12 ]
Total events: 24 (Treated), 21 (Untreated)
Heterogeneity: Tau2 = 0.92; Chi2 = 12.32, df = 5 (P = 0.03); I2 =59%
Test for overall effect: Z = 0.21 (P = 0.84)
Test for subgroup differences: Chi2 = 9.58, df = 4 (P = 0.05), I2 =58%
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Analysis 2.20. Comparison 2 Other maternal Outcomes, Outcome 20 Postpartum Haemorrhage (>600ml).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 20 Postpartum Haemorrhage (>600ml)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ludviksson 1982 14/75 3/74 100.0 % 4.60 [ 1.38, 15.36 ]
Total (95% CI) 75 74 100.0 % 4.60 [ 1.38, 15.36 ]
Total events: 14 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.48 (P = 0.013)
Test for subgroup differences: Not applicable
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Analysis 2.21. Comparison 2 Other maternal Outcomes, Outcome 21 Massive Obstetric Haemorrhage
(>1000ml).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 21 Massive Obstetric Haemorrhage (>1000ml)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ludviksson 1982 4/75 1/74 100.0 % 3.95 [ 0.45, 34.48 ]
Total (95% CI) 75 74 100.0 % 3.95 [ 0.45, 34.48 ]
Total events: 4 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.24 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 2.22. Comparison 2 Other maternal Outcomes, Outcome 22 Cervical cerclage.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 2 Other maternal Outcomes
Outcome: 22 Cervical cerclage
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Klaritsch 2006 0/76 71/29711 12.2 % 2.70 [ 0.17, 43.17 ]
Kuoppala 1986 22/62 0/62 12.1 % 45.00 [ 2.79, 725.79 ]
Moinian 1982 19/108 0/725 12.1 % 259.76 [ 15.80, 4271.21 ]
Subtotal (95% CI) 246 30498 36.4 % 31.42 [ 2.32, 426.22 ]
Total events: 41 (Treated), 71 (Untreated)
Heterogeneity: Tau2 = 3.29; Chi2 = 5.26, df = 2 (P = 0.07); I2 =62%
Test for overall effect: Z = 2.59 (P = 0.0096)
2 LC vs No Treatment
Sagot 1995 6/53 1/59 14.4 % 6.68 [ 0.83, 53.69 ]
Subtotal (95% CI) 53 59 14.4 % 6.68 [ 0.83, 53.69 ]
Total events: 6 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.79 (P = 0.074)
3 LLETZ vs No Treatment
Paraskevaidis 2002 5/28 0/28 11.9 % 11.00 [ 0.64, 189.96 ]
Subtotal (95% CI) 28 28 11.9 % 11.00 [ 0.64, 189.96 ]
Total events: 5 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.65 (P = 0.099)
4 Excisional Treatment NOS vs No Treatment
Armarnik 2011 18/53 837/104617 18.8 % 42.45 [ 28.99, 62.16 ]
Fischer 2010 0/85 0/85 Not estimable
Subtotal (95% CI) 138 104702 18.8 % 42.45 [ 28.99, 62.16 ]
Total events: 18 (Treated), 837 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 19.26 (P < 0.00001)
5 Treatment NOS vs No Treatment
Bruinsma 2007 27/1951 23/3597 18.6 % 2.16 [ 1.24, 3.76 ]
Subtotal (95% CI) 1951 3597 18.6 % 2.16 [ 1.24, 3.76 ]
Total events: 27 (Treated), 23 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.73 (P = 0.0062)
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 2416 138884 100.0 % 14.29 [ 2.85, 71.65 ]
Total events: 97 (Treated), 932 (Untreated)
Heterogeneity: Tau2 = 3.57; Chi2 = 81.99, df = 6 (P<0.00001); I2 =93%
Test for overall effect: Z = 3.23 (P = 0.0012)
Test for subgroup differences: Chi2 = 76.33, df = 4 (P = 0.00), I2 =95%
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Analysis 3.1. Comparison 3 Neonatal Outcomes, Outcome 1 LBW (<2500g).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 1 LBW (<2500g)
Study or subgroup
More
Harm
Untreated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 1/20 1/12 0.2 % 0.60 [ 0.04, 8.73 ]
Guo 2013 15/36 4/29 1.5 % 3.02 [ 1.12, 8.12 ]
Jones 1979 14/66 22/264 2.9 % 2.55 [ 1.38, 4.70 ]
Klaritsch 2006 14/76 2280/29705 3.7 % 2.40 [ 1.49, 3.86 ]
Weber 1979 5/48 1/48 0.4 % 5.00 [ 0.61, 41.22 ]
Subtotal (95% CI) 246 30058 8.7 % 2.51 [ 1.78, 3.53 ]
Total events: 49 (More Harm Untreated), 2308 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.68, df = 4 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 5.24 (P < 0.00001)
2 LC vs No Treatment
Bekassy 1996 8/250 12/250 1.8 % 0.67 [ 0.28, 1.60 ]
Forsmo 1996 13/51 12/130 2.4 % 2.76 [ 1.35, 5.64 ]
Lima 2011 3/11 0/22 0.2 % 13.42 [ 0.75, 238.96 ]
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(. . . Continued)
Study or subgroup
More
Harm
Untreated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Simoens 2012 5/24 6/48 1.3 % 1.67 [ 0.57, 4.91 ]
Subtotal (95% CI) 336 450 5.6 % 1.76 [ 0.72, 4.35 ]
Total events: 29 (More Harm Untreated), 30 (Untreated)
Heterogeneity: Tau2 = 0.48; Chi2 = 8.12, df = 3 (P = 0.04); I2 =63%
Test for overall effect: Z = 1.23 (P = 0.22)
3 LLETZ vs No Treatment
Acharya 2005 8/79 8/158 1.6 % 2.00 [ 0.78, 5.13 ]
Andia 2011 20/189 7/189 1.9 % 2.86 [ 1.24, 6.60 ]
Blomfield 1993 9/38 5/73 1.4 % 3.46 [ 1.25, 9.59 ]
Braet 1994 12/78 4/78 1.3 % 3.00 [ 1.01, 8.90 ]
Crane 2006 6/74 3/46 0.9 % 1.24 [ 0.33, 4.73 ]
Guo 2013 9/48 6/39 1.6 % 1.22 [ 0.47, 3.13 ]
Haffenden 1993 19/152 17/152 2.8 % 1.12 [ 0.60, 2.07 ]
Kitson 2014 24/278 14/278 2.7 % 1.71 [ 0.91, 3.24 ]
Lima 2011 7/18 1/36 0.4 % 14.00 [ 1.86, 105.27 ]
Paraskevaidis 2002 2/28 3/28 0.6 % 0.67 [ 0.12, 3.69 ]
Samson 2005 31/571 11/571 2.5 % 2.82 [ 1.43, 5.55 ]
Simoens 2012 10/52 4/104 1.2 % 5.00 [ 1.65, 15.18 ]
Subtotal (95% CI) 1605 1752 18.9 % 2.11 [ 1.51, 2.94 ]
Total events: 157 (More Harm Untreated), 83 (Untreated)
Heterogeneity: Tau2 = 0.11; Chi2 = 16.30, df = 11 (P = 0.13); I2 =32%
Test for overall effect: Z = 4.40 (P = 0.000011)
4 LA vs No Treatment
Anderson 1984 5/68 7/70 1.2 % 0.74 [ 0.25, 2.20 ]
Forsmo 1996 1/20 3/44 0.4 % 0.73 [ 0.08, 6.62 ]
Saunders 1986 11/97 4/97 1.2 % 2.75 [ 0.91, 8.34 ]
van Rooijen 1999 12/236 28/472 2.6 % 0.86 [ 0.44, 1.66 ]
Subtotal (95% CI) 421 683 5.4 % 1.07 [ 0.59, 1.92 ]
Total events: 29 (More Harm Untreated), 42 (Untreated)
Heterogeneity: Tau2 = 0.08; Chi2 = 3.76, df = 3 (P = 0.29); I2 =20%
Test for overall effect: Z = 0.22 (P = 0.83)
5 CT vs No Treatment
Crane 2006 6/36 1/22 0.4 % 3.67 [ 0.47, 28.47 ]
Subtotal (95% CI) 36 22 0.4 % 3.67 [ 0.47, 28.47 ]
Total events: 6 (More Harm Untreated), 1 (Untreated)
Heterogeneity: not applicable
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(. . . Continued)
Study or subgroup
More
Harm
Untreated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 1.24 (P = 0.21)
6 Excisional Treatment NOS vs No Treatment
El-Bastawissi 1999 90/1009 17/304 3.5 % 1.60 [ 0.97, 2.64 ]
Jakobsson 2007 304/4846 19126/612976 6.7 % 2.01 [ 1.80, 2.24 ]
Ortoft 2010 64/746 2223/73282 5.7 % 2.83 [ 2.23, 3.59 ]
Reilly 2012 133/1546 1631/30535 6.3 % 1.61 [ 1.36, 1.91 ]
Shanbhag 2009 111/1103 6688/94846 6.2 % 1.43 [ 1.19, 1.71 ]
Simoens 2012 2/12 5/24 0.7 % 0.80 [ 0.18, 3.54 ]
Sjoborg 2007 93/735 25/742 4.1 % 3.76 [ 2.44, 5.77 ]
van de Vijner 2010 4/52 0/54 0.2 % 9.34 [ 0.52, 169.28 ]
Van Hentenryck 2012 13/106 7/212 1.7 % 3.71 [ 1.53, 9.03 ]
Wuntakal 2013 26/261 17/257 3.0 % 1.51 [ 0.84, 2.71 ]
Subtotal (95% CI) 10416 813232 38.2 % 2.01 [ 1.62, 2.49 ]
Total events: 840 (More Harm Untreated), 29739 (Untreated)
Heterogeneity: Tau2 = 0.06; Chi2 = 40.75, df = 9 (P<0.00001); I2 =78%
Test for overall effect: Z = 6.40 (P < 0.00001)
7 Ablative Treatment NOS vs No Treatment
El-Bastawissi 1999 2/85 1/26 0.3 % 0.61 [ 0.06, 6.48 ]
Jakobsson 2007 151/3576 13850/443879 6.4 % 1.35 [ 1.16, 1.58 ]
Reilly 2012 41/532 564/10562 5.1 % 1.44 [ 1.06, 1.96 ]
Shanbhag 2009 26/285 1725/24457 4.6 % 1.29 [ 0.89, 1.87 ]
Subtotal (95% CI) 4478 478924 16.4 % 1.36 [ 1.19, 1.55 ]
Total events: 220 (More Harm Untreated), 16140 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.66, df = 3 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 4.61 (P < 0.00001)
8 Treatment NOS vs No Treatment
Bruinsma 2007 212/1951 289/3596 6.3 % 1.35 [ 1.14, 1.60 ]
Subtotal (95% CI) 1951 3596 6.3 % 1.35 [ 1.14, 1.60 ]
Total events: 212 (More Harm Untreated), 289 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.51 (P = 0.00045)
Total (95% CI) 19489 1328717 100.0 % 1.81 [ 1.58, 2.07 ]
Total events: 1542 (More Harm Untreated), 48632 (Untreated)
Heterogeneity: Tau2 = 0.07; Chi2 = 109.33, df = 40 (P<0.00001); I2 =63%
Test for overall effect: Z = 8.61 (P < 0.00001)
Test for subgroup differences: Chi2 = 25.22, df = 7 (P = 0.00), I2 =72%
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Analysis 3.2. Comparison 3 Neonatal Outcomes, Outcome 2 LBW (<2000g).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 2 LBW (<2000g)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Forsmo 1996 7/51 4/130 23.9 % 4.46 [ 1.36, 14.59 ]
Subtotal (95% CI) 51 130 23.9 % 4.46 [ 1.36, 14.59 ]
Total events: 7 (Treated), 4 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.47 (P = 0.013)
2 LA vs No Treatment
Forsmo 1996 1/20 2/44 11.3 % 1.10 [ 0.11, 11.44 ]
van Rooijen 1999 6/236 13/472 27.7 % 0.92 [ 0.36, 2.40 ]
Subtotal (95% CI) 256 516 39.0 % 0.95 [ 0.39, 2.29 ]
Total events: 7 (Treated), 15 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
3 Excisional Treatment NOS vs No Treatment
Ortoft 2010 36/746 769/73282 37.0 % 4.60 [ 3.32, 6.37 ]
Subtotal (95% CI) 746 73282 37.0 % 4.60 [ 3.32, 6.37 ]
Total events: 36 (Treated), 769 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 9.16 (P < 0.00001)
Total (95% CI) 1053 73928 100.0 % 2.49 [ 0.97, 6.36 ]
Total events: 50 (Treated), 788 (Untreated)
Heterogeneity: Tau2 = 0.59; Chi2 = 10.89, df = 3 (P = 0.01); I2 =72%
Test for overall effect: Z = 1.91 (P = 0.057)
Test for subgroup differences: Chi2 = 10.88, df = 2 (P = 0.00), I2 =82%
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Analysis 3.3. Comparison 3 Neonatal Outcomes, Outcome 3 LBW (<1500g).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 3 LBW (<1500g)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Forsmo 1996 5/51 1/130 8.6 % 12.75 [ 1.53, 106.44 ]
Subtotal (95% CI) 51 130 8.6 % 12.75 [ 1.53, 106.44 ]
Total events: 5 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.35 (P = 0.019)
2 LLETZ vs No Treatment
Andia 2011 3/189 0/189 4.7 % 7.00 [ 0.36, 134.59 ]
Subtotal (95% CI) 189 189 4.7 % 7.00 [ 0.36, 134.59 ]
Total events: 3 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.29 (P = 0.20)
3 LA vs No Treatment
Forsmo 1996 0/20 1/44 4.2 % 0.71 [ 0.03, 16.81 ]
van Rooijen 1999 2/236 6/472 13.9 % 0.67 [ 0.14, 3.28 ]
Subtotal (95% CI) 256 516 18.1 % 0.68 [ 0.16, 2.80 ]
Total events: 2 (Treated), 7 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
4 Excisional Treatment NOS vs No Treatment
Ortoft 2010 12/746 378/73282 44.5 % 3.12 [ 1.76, 5.52 ]
Sjoborg 2007 17/735 4/742 24.1 % 4.29 [ 1.45, 12.69 ]
Subtotal (95% CI) 1481 74024 68.5 % 3.34 [ 2.02, 5.54 ]
Total events: 29 (Treated), 382 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 1 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 4.69 (P < 0.00001)
Total (95% CI) 1977 74859 100.0 % 3.00 [ 1.54, 5.85 ]
Total events: 39 (Treated), 390 (Untreated)
Heterogeneity: Tau2 = 0.18; Chi2 = 6.75, df = 5 (P = 0.24); I2 =26%
Test for overall effect: Z = 3.22 (P = 0.0013)
Test for subgroup differences: Chi2 = 6.48, df = 3 (P = 0.09), I2 =54%
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Analysis 3.4. Comparison 3 Neonatal Outcomes, Outcome 4 LBW (<1000g).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 4 LBW (<1000g)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LA vs No Treatment
van Rooijen 1999 0/236 3/472 45.6 % 0.29 [ 0.01, 5.50 ]
Subtotal (95% CI) 236 472 45.6 % 0.29 [ 0.01, 5.50 ]
Total events: 0 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
2 Excisional Treatment NOS vs No Treatment
Sjoborg 2007 11/735 1/742 54.4 % 11.10 [ 1.44, 85.79 ]
Subtotal (95% CI) 735 742 54.4 % 11.10 [ 1.44, 85.79 ]
Total events: 11 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.31 (P = 0.021)
Total (95% CI) 971 1214 100.0 % 2.09 [ 0.06, 74.71 ]
Total events: 11 (Treated), 4 (Untreated)
Heterogeneity: Tau2 = 5.02; Chi2 = 3.98, df = 1 (P = 0.05); I2 =75%
Test for overall effect: Z = 0.41 (P = 0.69)
Test for subgroup differences: Chi2 = 3.98, df = 1 (P = 0.05), I2 =75%
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Analysis 3.5. Comparison 3 Neonatal Outcomes, Outcome 5 NICU Admission.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 5 NICU Admission
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 1/20 1/12 0.7 % 0.60 [ 0.04, 8.73 ]
Sozen 2014 5/15 5/24 4.5 % 1.60 [ 0.56, 4.61 ]
Subtotal (95% CI) 35 36 5.2 % 1.40 [ 0.52, 3.75 ]
Total events: 6 (Treated), 6 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.45, df = 1 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.50)
2 LLETZ vs No Treatment
Blomfield 1993 4/40 4/80 2.9 % 2.00 [ 0.53, 7.58 ]
Crane 2006 6/74 3/46 2.8 % 1.24 [ 0.33, 4.73 ]
Kitson 2014 16/278 5/278 5.2 % 3.20 [ 1.19, 8.61 ]
Paraskevaidis 2002 6/28 3/28 3.1 % 2.00 [ 0.55, 7.22 ]
Samson 2005 78/571 66/571 54.1 % 1.18 [ 0.87, 1.61 ]
Subtotal (95% CI) 991 1003 68.1 % 1.42 [ 1.01, 1.99 ]
Total events: 110 (Treated), 81 (Untreated)
Heterogeneity: Tau2 = 0.02; Chi2 = 4.35, df = 4 (P = 0.36); I2 =8%
Test for overall effect: Z = 2.01 (P = 0.045)
3 CT vs No Treatment
Crane 2006 4/36 1/22 1.1 % 2.44 [ 0.29, 20.49 ]
Subtotal (95% CI) 36 22 1.1 % 2.44 [ 0.29, 20.49 ]
Total events: 4 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
4 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 15/58 9/58 9.2 % 1.67 [ 0.79, 3.50 ]
Van Hentenryck 2012 20/106 22/212 16.3 % 1.82 [ 1.04, 3.18 ]
Subtotal (95% CI) 164 270 25.5 % 1.76 [ 1.13, 2.75 ]
Total events: 35 (Treated), 31 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 2.49 (P = 0.013)
Total (95% CI) 1226 1331 100.0 % 1.45 [ 1.16, 1.81 ]
Total events: 155 (Treated), 119 (Untreated)
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.0; Chi2 = 6.13, df = 9 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 3.22 (P = 0.0013)
Test for subgroup differences: Chi2 = 0.80, df = 3 (P = 0.85), I2 =0.0%
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Analysis 3.6. Comparison 3 Neonatal Outcomes, Outcome 6 Perinatal Mortality.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 6 Perinatal Mortality
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Jones 1979 2/66 3/264 2.3 % 2.67 [ 0.45, 15.64 ]
Larsson 1982 6/197 6/284 4.8 % 1.44 [ 0.47, 4.40 ]
Kristensen 1985 6/85 742/12792 7.5 % 1.22 [ 0.56, 2.64 ]
Kuoppala 1986 2/62 0/62 0.9 % 5.00 [ 0.24, 102.07 ]
Klaritsch 2006 0/76 165/29711 1.0 % 1.17 [ 0.07, 18.55 ]
Crane 2006 0/20 0/13 Not estimable
Ortoft 2010 0/67 29/6889 1.0 % 1.72 [ 0.11, 27.82 ]
Subtotal (95% CI) 573 50015 17.6 % 1.46 [ 0.83, 2.57 ]
Total events: 16 (Treated), 945 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.34, df = 5 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.32 (P = 0.19)
2 LC vs No Treatment
Bekassy 1996 2/250 3/250 2.3 % 0.67 [ 0.11, 3.96 ]
Forsmo 1996 4/51 2/130 2.6 % 5.10 [ 0.96, 26.98 ]
Andersen 1999 0/75 0/150 Not estimable
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 376 530 4.9 % 1.89 [ 0.26, 13.87 ]
Total events: 6 (Treated), 5 (Untreated)
Heterogeneity: Tau2 = 1.30; Chi2 = 2.67, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 0.63 (P = 0.53)
3 NETZ vs No Treatment
Ortoft 2010 3/71 31/7328 4.5 % 9.99 [ 3.13, 31.92 ]
Subtotal (95% CI) 71 7328 4.5 % 9.99 [ 3.13, 31.92 ]
Total events: 3 (Treated), 31 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 3.88 (P = 0.00010)
4 LLETZ vs No Treatment
Blomfield 1993 1/40 1/80 1.0 % 2.00 [ 0.13, 31.15 ]
Braet 1994 1/78 0/78 0.8 % 3.00 [ 0.12, 72.53 ]
Samson 2005 3/571 0/571 0.9 % 7.00 [ 0.36, 135.21 ]
Acharya 2005 1/79 1/158 1.0 % 2.00 [ 0.13, 31.56 ]
Crane 2006 1/74 1/46 1.0 % 0.62 [ 0.04, 9.70 ]
Ortoft 2010 4/572 252/59065 5.7 % 1.64 [ 0.61, 4.39 ]
Werner 2010 6/511 2175/240348 7.3 % 1.30 [ 0.59, 2.88 ]
Subtotal (95% CI) 1925 300346 17.8 % 1.53 [ 0.88, 2.67 ]
Total events: 17 (Treated), 2430 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.85, df = 6 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.50 (P = 0.13)
5 LA vs No Treatment
Saunders 1986 1/97 0/97 0.8 % 3.00 [ 0.12, 72.74 ]
Forsmo 1996 0/20 0/44 Not estimable
Subtotal (95% CI) 117 141 0.8 % 3.00 [ 0.12, 72.74 ]
Total events: 1 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
6 CT vs No Treatment
Hemmingsson 1982 0/115 1/65 0.8 % 0.19 [ 0.01, 4.59 ]
Crane 2006 0/36 0/22 Not estimable
Subtotal (95% CI) 151 87 0.8 % 0.19 [ 0.01, 4.59 ]
Total events: 0 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
7 Excisional Treatment NOS vs No Treatment
Jakobsson 2007 47/4846 3638/612976 14.0 % 1.63 [ 1.23, 2.18 ]
Sjoborg 2007 6/735 2/742 2.7 % 3.03 [ 0.61, 14.96 ]
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Shanbhag 2009 7/1103 636/94846 7.9 % 0.95 [ 0.45, 1.99 ]
van de Vijner 2010 0/55 0/55 Not estimable
Armarnik 2011 3/53 1151/104617 4.9 % 5.14 [ 1.71, 15.47 ]
Subtotal (95% CI) 6792 813236 29.5 % 1.85 [ 1.02, 3.36 ]
Total events: 63 (Treated), 5427 (Untreated)
Heterogeneity: Tau2 = 0.19; Chi2 = 6.81, df = 3 (P = 0.08); I2 =56%
Test for overall effect: Z = 2.03 (P = 0.043)
8 Ablative Treatment NOS vs No Treatment
Jakobsson 2007 15/3576 2634/443879 10.8 % 0.71 [ 0.43, 1.17 ]
Shanbhag 2009 1/285 164/24457 1.9 % 0.52 [ 0.07, 3.72 ]
Subtotal (95% CI) 3861 468336 12.8 % 0.69 [ 0.42, 1.13 ]
Total events: 16 (Treated), 2798 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.08, df = 1 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 1.46 (P = 0.14)
9 Treatment NOS vs No Treatment
Bruinsma 2007 27/1951 50/3597 11.4 % 1.00 [ 0.63, 1.58 ]
Subtotal (95% CI) 1951 3597 11.4 % 1.00 [ 0.63, 1.58 ]
Total events: 27 (Treated), 50 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.99)
Total (95% CI) 15817 1643616 100.0 % 1.51 [ 1.13, 2.03 ]
Total events: 149 (Treated), 11687 (Untreated)
Heterogeneity: Tau2 = 0.14; Chi2 = 37.50, df = 24 (P = 0.04); I2 =36%
Test for overall effect: Z = 2.80 (P = 0.0051)
Test for subgroup differences: Chi2 = 23.02, df = 8 (P = 0.00), I2 =65%
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Analysis 3.7. Comparison 3 Neonatal Outcomes, Outcome 7 Perinatal Mortality (<37w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 7 Perinatal Mortality (<37w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 0/67 9/6889 19.1 % 5.33 [ 0.31, 90.71 ]
Subtotal (95% CI) 67 6889 19.1 % 5.33 [ 0.31, 90.71 ]
Total events: 0 (Treated), 9 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.16 (P = 0.25)
2 NETZ vs No Treatment
Ortoft 2010 3/71 10/7328 39.5 % 30.96 [ 8.71, 110.13 ]
Subtotal (95% CI) 71 7328 39.5 % 30.96 [ 8.71, 110.13 ]
Total events: 3 (Treated), 10 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.30 (P < 0.00001)
3 LLETZ vs No Treatment
Ortoft 2010 3/572 79/59065 41.4 % 3.92 [ 1.24, 12.38 ]
Subtotal (95% CI) 572 59065 41.4 % 3.92 [ 1.24, 12.38 ]
Total events: 3 (Treated), 79 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.33 (P = 0.020)
Total (95% CI) 710 73282 100.0 % 9.40 [ 2.01, 43.89 ]
Total events: 6 (Treated), 98 (Untreated)
Heterogeneity: Tau2 = 1.15; Chi2 = 5.76, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 2.85 (P = 0.0044)
Test for subgroup differences: Chi2 = 5.76, df = 2 (P = 0.06), I2 =65%
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Analysis 3.8. Comparison 3 Neonatal Outcomes, Outcome 8 Perinatal Mortality (<32w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 8 Perinatal Mortality (<32w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 0/67 7/6889 19.3 % 6.75 [ 0.39, 117.10 ]
Subtotal (95% CI) 67 6889 19.3 % 6.75 [ 0.39, 117.10 ]
Total events: 0 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
2 NETZ vs No Treatment
Ortoft 2010 3/71 7/7328 38.9 % 44.23 [ 11.67, 167.61 ]
Subtotal (95% CI) 71 7328 38.9 % 44.23 [ 11.67, 167.61 ]
Total events: 3 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.58 (P < 0.00001)
3 LLETZ vs No Treatment
Ortoft 2010 3/572 57/59065 41.8 % 5.43 [ 1.71, 17.30 ]
Subtotal (95% CI) 572 59065 41.8 % 5.43 [ 1.71, 17.30 ]
Total events: 3 (Treated), 57 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.87 (P = 0.0042)
Total (95% CI) 710 73282 100.0 % 12.81 [ 2.70, 60.87 ]
Total events: 6 (Treated), 71 (Untreated)
Heterogeneity: Tau2 = 1.16; Chi2 = 5.62, df = 2 (P = 0.06); I2 =64%
Test for overall effect: Z = 3.21 (P = 0.0013)
Test for subgroup differences: Chi2 = 5.62, df = 2 (P = 0.06), I2 =64%
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Analysis 3.9. Comparison 3 Neonatal Outcomes, Outcome 9 Perinatal Mortality (<28w).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 9 Perinatal Mortality (<28w)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Ortoft 2010 0/67 5/6889 21.6 % 9.21 [ 0.51, 164.95 ]
Subtotal (95% CI) 67 6889 21.6 % 9.21 [ 0.51, 164.95 ]
Total events: 0 (Treated), 5 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.51 (P = 0.13)
2 NETZ vs No Treatment
Ortoft 2010 3/71 6/7328 39.5 % 51.61 [ 13.17, 202.29 ]
Subtotal (95% CI) 71 7328 39.5 % 51.61 [ 13.17, 202.29 ]
Total events: 3 (Treated), 6 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.66 (P < 0.00001)
3 LLETZ vs No Treatment
Ortoft 2010 2/572 46/59065 38.9 % 4.49 [ 1.09, 18.45 ]
Subtotal (95% CI) 572 59065 38.9 % 4.49 [ 1.09, 18.45 ]
Total events: 2 (Treated), 46 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 2.08 (P = 0.037)
Total (95% CI) 710 73282 100.0 % 13.76 [ 2.37, 79.89 ]
Total events: 5 (Treated), 57 (Untreated)
Heterogeneity: Tau2 = 1.55; Chi2 = 6.05, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 2.92 (P = 0.0035)
Test for subgroup differences: Chi2 = 6.05, df = 2 (P = 0.05), I2 =67%
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Analysis 3.10. Comparison 3 Neonatal Outcomes, Outcome 10 Stillbirth.
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 10 Stillbirth
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Jones 1979 1/66 1/264 2.6 % 4.00 [ 0.25, 63.11 ]
Kuoppala 1986 1/62 0/62 1.9 % 3.00 [ 0.12, 72.25 ]
Larsson 1982 3/197 4/284 8.9 % 1.08 [ 0.24, 4.78 ]
Subtotal (95% CI) 325 610 13.4 % 1.61 [ 0.48, 5.40 ]
Total events: 5 (Treated), 5 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.84, df = 2 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
2 LC vs No Treatment
Andersen 1999 0/75 0/150 Not estimable
Bekassy 1996 1/250 3/250 3.8 % 0.33 [ 0.03, 3.18 ]
Subtotal (95% CI) 325 400 3.8 % 0.33 [ 0.03, 3.18 ]
Total events: 1 (Treated), 3 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
3 LLETZ vs No Treatment
Cruickshank 1995 1/147 3/295 3.9 % 0.67 [ 0.07, 6.38 ]
Samson 2005 1/571 0/571 1.9 % 3.00 [ 0.12, 73.49 ]
Turlington 1996 1/15 0/15 2.0 % 3.00 [ 0.13, 68.26 ]
Werner 2010 4/511 1329/240348 20.5 % 1.42 [ 0.53, 3.76 ]
Subtotal (95% CI) 1244 241229 28.3 % 1.42 [ 0.62, 3.26 ]
Total events: 7 (Treated), 1332 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.86, df = 3 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
4 LA vs No Treatment
Forsmo 1996 0/20 0/44 Not estimable
Subtotal (95% CI) 20 44 Not estimable
Total events: 0 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 Excisional Treatment NOS vs No Treatment
van de Vijner 2010 0/55 0/55 Not estimable
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 55 55 Not estimable
Total events: 0 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: not applicable
6 Treatment NOS vs No Treatment
Bruinsma 2007 15/1951 36/3597 54.5 % 0.77 [ 0.42, 1.40 ]
Subtotal (95% CI) 1951 3597 54.5 % 0.77 [ 0.42, 1.40 ]
Total events: 15 (Treated), 36 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
Total (95% CI) 3920 245935 100.0 % 0.98 [ 0.63, 1.52 ]
Total events: 28 (Treated), 1376 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 4.62, df = 8 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Chi2 = 2.92, df = 3 (P = 0.40), I2 =0.0%
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Analysis 3.11. Comparison 3 Neonatal Outcomes, Outcome 11 Apgar score (≤5)(1min).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 11 Apgar score (≤5)(1min)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LC vs No Treatment
Andersen 1999 2/75 7/150 100.0 % 0.57 [ 0.12, 2.68 ]
Total (95% CI) 75 150 100.0 % 0.57 [ 0.12, 2.68 ]
Total events: 2 (Treated), 7 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Not applicable
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Analysis 3.12. Comparison 3 Neonatal Outcomes, Outcome 12 Apgar score (<7)(1min).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 12 Apgar score (<7)(1min)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LLETZ vs No Treatment
Guo 2013 0/48 2/39 41.3 % 0.16 [ 0.01, 3.30 ]
Subtotal (95% CI) 48 39 41.3 % 0.16 [ 0.01, 3.30 ]
Total events: 0 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.18 (P = 0.24)
2 CKC vs No Treatment
Guo 2013 2/36 1/29 58.7 % 1.61 [ 0.15, 16.90 ]
Subtotal (95% CI) 36 29 58.7 % 1.61 [ 0.15, 16.90 ]
Total events: 2 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
Total (95% CI) 84 68 100.0 % 0.63 [ 0.07, 5.71 ]
Total events: 2 (Treated), 3 (Untreated)
Heterogeneity: Tau2 = 0.72; Chi2 = 1.38, df = 1 (P = 0.24); I2 =28%
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Chi2 = 1.38, df = 1 (P = 0.24), I2 =28%
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Analysis 3.13. Comparison 3 Neonatal Outcomes, Outcome 13 Apgar score (<7)(5min).
Review: Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease
Comparison: 3 Neonatal Outcomes
Outcome: 13 Apgar score (<7)(5min)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC vs No Treatment
Crane 2006 0/20 0/12 Not estimable
Subtotal (95% CI) 20 12 Not estimable
Total events: 0 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 LLETZ vs No Treatment
Crane 2006 3/74 2/46 70.7 % 0.93 [ 0.16, 5.37 ]
Subtotal (95% CI) 74 46 70.7 % 0.93 [ 0.16, 5.37 ]
Total events: 3 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
3 CT vs No Treatment
Crane 2006 1/36 1/22 29.3 % 0.61 [ 0.04, 9.28 ]
Subtotal (95% CI) 36 22 29.3 % 0.61 [ 0.04, 9.28 ]
Total events: 1 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.72)
4 Excisional Treatment NOS vs No Treatment
Lima 2011 0/29 0/58 Not estimable
Subtotal (95% CI) 29 58 Not estimable
Total events: 0 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 159 138 100.0 % 0.82 [ 0.19, 3.59 ]
Total events: 4 (Treated), 3 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.07, df = 1 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.26 (P = 0.80)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.80), I2 =0.0%
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
CENTRAL search strategy
#1 MeSH descriptor Uterine Cervical Neoplasms explode all trees
#2 cervi* and (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinom*)
#3 MeSH descriptor Cervical Intraepithelial Neoplasia explode all trees
#4 CIN
#5 cervi* and (intraepithel* or epithel* or dysplasia or pre-cancer* or precancer*)
#6 (#1 OR #2 OR #3 OR #4 OR #5)
#7 MeSH descriptor Conization explode all trees
#8 conisation or conization
#9 MeSH descriptor Laser Therapy explode all trees
#10 laser
#11 MeSH descriptor Cryotherapy explode all trees
#12 cryotherapy
#13 cold coagulation
#14 MeSH descriptor Diathermy explode all trees
#15 diatherm*
#16 cone biopsy
#17 loop
#18 LLETZ
#19 LEEP
#20 ablat*
#21 excision*
#22 transformation zone
#23 CKC or LA or LC or CC or RD or TZ
#24 conservative and (method* or treatment* or intervention* or management)
#25 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR
#22 OR #23 OR #24)
#26 (#6 AND #25)
#27 MeSH descriptor Premature Birth explode all trees
#28 preterm or premature
#29 MeSH descriptor Infant, Low Birth Weight explode all trees
#30 birth weight
#31 MeSH descriptor Perinatal Mortality explode all trees
#32 perinatal mortality
#33 MeSH descriptor Intensive Care, Neonatal explode all trees
#34 neonat* and (intensive care)
#35 MeSH descriptor Fertility explode all trees
#36 fertil*
#37 conception
#38 MeSH descriptor Pregnancy explode all trees
#39 pregnancy
#40 gestation*
#41 MeSH descriptor Abortion, Spontaneous explode all trees
#42 miscarriage*
#43 MeSH descriptor Cesarean Section explode all trees
#44 cesarean or caesarean
#45 MeSH descriptor Obstetric Labor, Premature explode all trees
287Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
#46 MeSH descriptor Labor, Obstetric explode all trees
#47 labor or labour
#48 MeSH descriptor Fetal Membranes, Premature Rupture explode all trees
#49 pPROM
#50 (#27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41
OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49)
#51 (#26 AND #50)
Appendix 2. MEDLINE search strategy
1 exp Uterine Cervical Neoplasms/
2 (cervi* and (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinom*)).mp.
3 exp Cervical Intraepithelial Neoplasia/
4 CIN.mp.
5 (cervi* and (intraepithel* or epithel* or dysplasia or pre-cancer* or precancer*)).mp.
6 or/1-5
7 exp Conization/
8 (conisation or conization).mp.
9 exp Laser Therapy/
10 laser.mp.
11 exp Cryotherapy/
12 cryotherapy.mp.
13 cold coagulation.mp.
14 exp Diathermy/
15 diatherm*.mp.
16 cone biopsy.mp.
17 loop.mp.
18 LLETZ.mp.
19 LEEP.mp.
20 ablat*.mp.
21 excision*.mp.
22 transformation zone.mp.
23 (CKC or LA or LC or CC or RD or TZ).mp.
24 (conservative and (method* or treatment* or intervention* or management)).mp.
25 or/7-24
26 6 and 25
27 exp Premature Birth/
28 (preterm or premature).mp.
29 exp Infant, Low Birth Weight/
30 birth weight.mp.
31 Perinatal Mortality/
32 perinatal mortality.mp.
33 exp Intensive Care, Neonatal/
34 (neonatal and intensive care).mp.
35 exp Fertility/
36 fertil*.mp.
37 conception.mp.
38 exp Pregnancy/
39 pregnancy.mp.
40 gestation*.mp.
41 exp Abortion, Spontaneous/
42 miscarriage*.mp.
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43 exp Cesarean Section/
44 (cesarean or caesarean).mp.
45 exp Obstetric Labor, Premature/
46 exp Labor, Obstetric/
47 (labor or labour).mp.
48 Fetal Membranes, Premature Rupture/
49 pPROM.mp.
50 or/27-49
51 26 and 50
key:
mp=title, original title, abstract, name of substance word, subject heading word
Appendix 3. Embase search strategy
1 exp uterine cervix tumor/
2 (cervi* and (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinom*)).mp.
3 uterine cervix carcinoma in situ/
4 CIN.mp.
5 (cervi* and (intraepithel* or epithel* or dysplasia or pre-cancer* or precancer*)).mp.
6 or/1-5
7 uterine cervix conization/
8 (conisation or conization).mp.
9 low level laser therapy/
10 laser.mp.
11 exp cryotherapy/
12 cryotherapy.mp.
13 cold coagulation.mp.
14 diathermy/
15 diatherm*.mp.
16 cone biopsy.mp.
17 loop.mp.
18 LLETZ.mp.
19 LEEP.mp.
20 ablat*.mp.
21 excision*.mp.
22 transformation zone.mp.
23 (CKC or LA or LC or CC or RD or TZ).mp.
24 (conservative and (method* or treatment* or intervention* or management)).mp.
25 or/7-24
26 6 and 25
27 prematurity/
28 (preterm or premature).mp.
29 exp low birth weight/~
30 birth weight.mp.
31 perinatal mortality/
32 perinatal mortality.mp.
33 newborn intensive care/
34 (neonat* and intensive care).mp.
35 female fertility/
36 fertil*.mp.
37 conception/
38 conception.mp.
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39 exp pregnancy/
40 pregnancy.mp.
41 gestation*.mp.
42 spontaneous abortion/
43 miscarriage*.mp.
44 cesarean section/
45 (cesarean or caesarean).mp.
46 premature labor/
47 (labor or labour).mp.
48 premature fetus membrane rupture/
49 pPROM.mp.
50 or/27-49
51 26 and 50
key:
mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name
Appendix 4. List of abbreviations
CENTRAL: Cochrane Central Register of Controlled Trials
CC: Cold Coagulation
CI: (95%) Confidence Interval
CIN: Cervical Intra-epithelial Neoplasia
CKC: Cold Knife Conisation
CS: Ceasarean Section
CT: Cryotherapy
FCBE: Fischer Cone Biopsy Excisor
LA: Laser Ablation
LBW: Low Birth Weight
LEEP: Loop Electrosurgical Excision Procedure
LLETZ: Large Loop Excision of the Transformation Zone
NETZ: Needle Excision of the Transformation Zone
NICU: Neonatal Intensive Care Unit
NOS: Not Otherwise Specified
pPROM: preterm premature rupture of membranes
PTB: Preterm Birth
RCT: Randomised Controlled Trial
RD: Radical Diathermy
RR: Relative Risk
SWETZ: Straight Wire Excision of the Transformation Zone
TZ: Transformation Zone
Appendix 5. List of definitions
Extreme prematurity: delivery (spontaneous or iatrogenic) at less than 28 to 30 weeks of gestation
First trimester miscarriage: miscarriage at less than 12 weeks of gestation
Low birth weight: birth weight less than 2500 g
Perinatal mortality rate: number of stillbirths and neonatal deaths occurring within seven days after birth (early perinatal mortality) or
within seven to 28 days after birth (late perinatal mortality) per 1000 total births
Overall prematurity: delivery (spontaneous or iatrogenic) at less than 37 weeks of gestation
Preterm prelabour rupture of membranes: rupture of membranes at less than 37 weeks of gestation and prior to initiation of labour
Second trimester miscarriage: miscarriage between 12 and 24 weeks of gestation
Severe prematurity: delivery (spontaneous or iatrogenic) at less than 32 to 34 weeks of gestation
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The original protocol was drafted to analyse fertility, early pregnancy and obstetric outcomes in women with a history of treatment
for CIN versus untreated controls. Due to the clinical difference of the outcomes and the large number of studies, interventions and
outcomes, it was decided to split the review into two. Fertility and early pregnancy outcomes were removed and published in a prior
review (Kyrgiou 2015b).
The current review addresses the impact of conservative treatment on obstetric outcomes. We also included two treatment techniques,
called needle excision of the transformation zone (NETZ) or straight wire excision of the transformation zone (SWETZ) and Fischer
cone biopsy excisor (FCBE), respectively as they are a variation of large loop excision of the transformation zone (LLETZ)/loop
electrosurgical excisional procedure (LEEP). We also extended the inclusion criteria to include women treated for early cervical cancer
(stage IA1).
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Only studies published in English were included as given the large number of included studies and the low quality of these small studies
we considered that their inclusion would not alter the conclusions of the review. In future updates we will consider the inclusion of
these reports (Characteristics of studies awaiting classification).
We considered both studies with adjusted or unadjusted data and extracted unadjusted data for the analysis as previously described in
our protocol. More recent guidance recommends the use of adjusted data and this will be incorporated in future updates of this review.
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